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 L-selectin has been well characterised as a cell adhesion molecule, which plays 
a role in the recruitment of leukocytes to sites of inflammation and is responsible for 
the recirculation of lymphocytes to secondary lymphoid organs. Recent evidence has 
shown that L-selectin also acts as a signalling molecule to activate pathways and 
regulate the inflammatory response. The cytosolic tail of L-selectin plays a crucial role 
in regulating its activity through its interaction with binding partners, such as 
calmodulin (CaM) and the ERM protein family. However, little is known about how the 
interaction between L-selectin and its binding partners is regulated. The aim of this 
multidisciplinary PhD project is to use biophysical and cell biological methods to 
address the role of the interaction between L-selectin and its binding partners during 
leukocyte recruitment. To this end, the interaction between CaM and the L-selectin 
cytosolic tail was assessed using isothermal titration calorimetry (ITC) and nuclear 
magnetic resonance (NMR) spectroscopy. Analysis revealed that phosphorylation of 
serine residues within the cytosolic tail of L-selectin did not affect CaM binding. To 
enable the observation of the interaction between L-selectin and CaM whilst 
leukocytes are undergoing transendothelial migration (TEM), the THP-1 monocytic cell 
line was engineered to stably express L-selectin-GFP and CaM-RFP so their interaction 
could be monitored at different stages of TEM. The data showed that phosphorylation 
of serine 364 in the L-selectin tail is important for regulating CaM interaction. 
Discrepancies were identified between the biophysical and cell biological results, 
implying the leukocyte plasma membrane may play a vital role in regulating the 
interaction between L-selectin and CaM. This highlights the importance of studying 
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Chapter 1: Introduction 
1.1 The Inflammatory Response 
Inflammation is a natural response to injury, brought about by infection, 
physical or chemical trauma, allergy or autoimmunity. The inflammatory response is 
designed to contain and resolve the injurious stimulus and initiate the healing process. 
Inflammation is characterised by pain, swelling, redness, heat and loss of function (of 
the organ or tissue) at the sight of insult. These signs of inflammation require the co-
ordinated actions of the innate immune and adaptive immune systems.  
The inflammatory response can be divided into two components: a vascular 
arm and a cellular arm. The vascular arm is controlled by endothelial cells, which are 
activated by leukocyte- and fibroblast-derived cytokines, promoting adhesion molecule 
expression on the luminal surface of the endothelial cells to actively recruit leukocytes 
from the microcirculation and the subsequent migration of the leukocytes to the site 
of insult (8,9). Endothelial cells that are local to a site of inflammation transport 
stromal-derived chemokines from the abluminal side and deliver them to the luminal 
side (10). Note that endothelial cells can also produce chemokines (11). This ultimately 
activates leukocytes that possess the appropriate chemokine receptor. Inflammatory 
signals also cause vasodilation (through the relaxation of local vascular smooth muscle 
cells in arterioles) which additionally leads to an increased permeability of the 
microvasculature (9). This causes a decrease in the velocity of blood flow (as blood is 
now flowing through dilated vessels), which increases the chance for passing 
leukocytes to bind to the endothelium that is local to the site of inflammation (12). 
 The cellular arm of the inflammatory response involves the passage of 
leukocytes from the circulation into the surrounding tissue. Leukocytes, such as 
monocytes and neutrophils, originate in the bone marrow. Once mature, they reside in 
tissues or organs, the blood stream and the lymphatics - ready to respond to 
inflammatory signals. There are two lineages that define the leukocytes; myeloid cells 
and lymphoid cells. Myeloid cells are precursors to a majority of cells that partake in 
the innate immune response, which is the initial stage of the response following an 
inflammatory insult. Myeloid cells are precursors for granulocytes, mast cells, dendritic 
cells and monocytes (which differentiate into macrophages after they have migrated in 
to tissue). These cells remove the injurious stimuli via phagocytosis and release of 
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granule contents, which activate the adaptive immune system. Lymphoid cells give rise 
to the cells of the adaptive immune system, which involves the production of 
pathogen-specific receptors to focus the immune response on a particular pathogen, 
i.e. B-cells and T-cells. The different cell types have different roles during an 
inflammatory response, which is summarised in Table 1.1. All subsets of leukocytes are 
thought to communicate to one another by releasing cytokines and chemokines to 
activate and attract other immune cells, to amplify the immune response (13,14). 
 
Type Diagram Main Functions 
Monocytes 
 
Differentiate into macrophages, 
which phagocytose infectious 
species and cell debris and act as 
APCs 
Dendritic cells  Act as APCs to present antigens 
for recognition by T-cells 
Neutrophils (also 
referred to as 
polymorphonuclear 
leukocytes (PMNs) 
due to the presence of 
the multi-lobe nucleus  
 Phagocytosis and release 
cytoxins from granules to destroy 
bacteria and fungi 
Eosinophil  Phagocytosis and release of 
granule contents to remove 
larger parasites. Also responsible 
for allergic reactions 
Basophils  Involved in allergic reactions by 
releasing histamine  
Lymphocytes  B-cells: secrete antibodies to 
label infectious species and 
target them for destruction. 
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Release IgE following exposure to 
allergen, leading to the activation 
of basophils and mast cells. 
Cytoxic T-cells: release cytotoxins 
to kill virus-infected cells. 
Helper T-cells: produce and 
release cytokines to activate 
other lymphocytes. The subset 
TH2 cells recognise allergens and 
activate B cells to produce IgE. 
Regulator T-cells: produce anti-
inflammatory cytokines to 
supress the immune response. 
Natural killer cells: release 
cytotoxins to kill cells recognised 





Acute inflammation is a fast response to an inflammatory stimulus and is 
initiated by leukocytes migrating directly to the site of the insult.  The inflammatory 
response normally lasts a few days, after which the stimulus has been removed. 
However, in certain circumstances inflammation remains unresolved (“non-resolving” 
inflammation), which is the driver of multiple chronic inflammatory diseases, including 
atherosclerosis (15), rheumatoid arthritis and lupus (12). Non-resolving inflammation 
leads to the continued destruction and necrosis of cells. Recent evidence has shown 
that patients suffering from chronic inflammatory disease have increased susceptibility 
to cardiovascular disease, such as atherosclerosis, although little is known about how 
this is initiated and manifested (15). As leukocyte recruitment is a key driver of chronic 
inflammation, a key goal in the area of inflammation biology is to expose novel 
therapeutic targets for blocking the chronic recruitment of leukocytes to non-resolving 
sites of inflammation. Note that “sterile inflammation” refers to an inflammatory 
Table 1.1: Summary of the leukocyte subsets and their function in inflammatory responses. 
The different types of leukocytes are listed, with a representative diagram of each cell type 
shown. The major role of each cell type in the inflammatory response is described.  
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stimulus driven by non-infectious cell necrosis. In Section 1.8.1 the development of 
atherosclerosis is described, with reference to the role of sterile inflammation. 
1.2 The Multi-Step Leukocyte Adhesion Cascade. 
 As stated above, during an inflammatory response leukocytes must exit the 
bloodstream and enter the surrounding microenvironment. This process is controlled 
by cell adhesion molecules on both the leukocyte and endothelial cell. The multi-step 
leukocyte adhesion cascade is a paradigm that has been established through the work 
of many labs and describes the way in which leukocytes migrate out of the 
bloodstream through a series of discrete and inter-dependent steps. As shown in 
Figure 1.1, the multi-step adhesion cascade is broken down in to increasingly adhesive 
interactions called: capture (or tethering), rolling, slow rolling, firm adhesion and 
transmigration (10).  Note that in order for the adhesion cascade to progress, the 
previous step in the cascade must be executed correctly. Therefore, firm adhesion 
cannot proceed without rolling, and rolling without tethering, etc. Each step of the 


















Figure 1.1: The Multi-Step Leukocyte Adhesion Cascade. A diagram showing the individual 
stages of the multi-step leukocyte adhesion cascade.  The selectins and the integrins are 
absolutely essential for successful progression through the adhesion cascade. It should be 
noted that other cell adhesion molecules are also involved in this process, and some detail of 
these will be discussed later. Diagram modified from bme.virginia.edu/ley/. 
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1.2.1 Leukocyte tethering and the selectins 
 Tethers are transient interactions between leukocytes and endothelial cells 
lining the blood vessels, and are predominantly mediated by members of the selectin 
family of cell adhesion molecules. There are three selectin family members: E-, P-, and 
L-selectin. E- and P-selectin are expressed in endothelial cells, P-selectin is expressed 
specifically in platelets, and L-selectin is expressed on leukocytes (details of the 
selectins are described in Section 1.3) (10). Following injury, tissue-resident 
macrophages release the cytokines interleukin-1 (IL-1) and tumour necrosis factor-α 
(TNF-α), both of which activate endothelial cells causing them to express selectins (see 
Section 1.2.2 for details of selectin expression on endothelial cells). L- and P-selectin 
interact with P-selectin glycoprotein ligand-1 (PSGL-1) (16) and other glycoproteins on 
the plasma membrane of corresponding cells to form the tethers between the 
leukocyte and endothelium, enabling the leukocyte to adhere to the endothelium from 
blood flow. The importance of L-selectin in tether formation has been investigated in 
vitro, with L-selectin function blocking antibody reducing the adhesion of lymphocytes, 
neutrophils and monocytes to the endothelial monolayer under flow conditions (17-
19).  
Leukocytes can also tether to one another, with L-selectin on a free-flowing 
leukocyte able to interact with PSGL-1 on the surface of a leukocyte tethered to the 
endothelium (or vice versa), a process known as secondary tethering, to further 
amplify the inflammatory response (16).  
 
1.2.2 Rolling and regulation of selectin expression 
Once tethers have formed between leukocytes and endothelial cells, and if 
there is sufficient ligand available (i.e. the ligand density is high enough), cells will 
begin to roll along the endothelium. Rolling is important as it brings the leukocyte into 
close proximity to the endothelium allowing the leukocyte-derived receptors to 
recognise apically presented chemokine more readily. This triggers activation of the 
leukocyte integrins, which can mediate arrest from blood flow (see later in Section 
1.2.3). During rolling, bonds between selectins and their counter ligands are formed 
and broken. Selectins are suited to this process as the interaction between them and 
their ligands have fast on and off rates (20).  
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L-selectin has been shown to cause leukocyte rolling both in the recirculation of 
lymphocytes to secondary lymphoid organs and during inflammation, with the role of 
L-selectin in these processes discussed in detail in Sections 1.7.1 and 1.7.2. Pre-B-cells 
transfected with L-selectin were shown to roll in inflamed rat mesenteric venules (21) 
and inflamed rabbit venules (22). The role of L-selectin in leukocyte rolling has been 
studied using intravital microscopy and L-selectin function blocking antibodies, with 
rolling inhibited in rat and rabbit mesenteric venules in the presence of the antibody 
(21,23). Studies in L-selectin knockout mice have shown a decrease in the rolling of 
leukocytes in mesenteric venules by 70 % (24). In vitro studies of L-selectin-dependent 
rolling using a flow chamber assay has also revealed that neutrophil (25) and monocyte 
(26) rolling on Human Umbilical Vein Endothelial Cells (HUVECs) were both inhibited by 
L-selectin function blocking antibody. 
Many potential ligands for L-selectin-dependent rolling have been explored (as 
discussed in detail in Section 1.3.2). PSGL-1 has been implicated as a possible ligand, as 
when a function blocking antibody for PSGL-1 was used, L-selectin dependent rolling 
was blocked in the flow chamber assay and neutrophils treated with L-selectin function 
blocking antibody no longer rolled on PSGL-1 (27,28). L-selectin-dependent rolling was 
also lacking in vivo with PSGL-1 knockout mice and in wildtype mice treated with PSGL-
1 function blocking antibody (29), further highlighting the role of PSGL-1 in L-selectin 
dependent rolling. However, there has been some dispute over the capability of PSGL-
1 to support L-selectin-dependent rolling due to a lack of expression on the 
endothelium, with Sperandino et al (2003)(16) showing no expression of PSGL-1 on 
resting or inflamed endothelial cells in mice. A study did reveal, however, that HUVECs 
and foreskin microvascular endothelial cells (FMVECs) both expressed PSGL-1 and 
could support monocyte adhesion and rolling (30). This clearly shows further research 
is required to determine if PSGL-1 can act as a ligand for L-selectin-dependent rolling. 
P-selectin has been shown to be involved in the early stages of rolling, with no 
rolling initially observed in the surgically exteriorised cremaster venules of P-selectin 
deficient mice (31,32). Neutrophil recruitment to the peritoneum after an 
inflammatory stimulus is delayed by 2-4 hours in P-selectin knockout mice (31), 
suggesting a role for P-selectin in the early steps of the adhesion cascade. P-selectin is 
produced and stored in α-granules and Weibel-Palade bodies, which are secretory 
storage granules that contain different substances for rapid release upon cell 
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activation. Once the cell is activated, these granules fuse with the plasma membrane 
to deliver P-selectin to the surface (33,34), with the protein detectable within minutes 
of cell activation (31), allowing P-selectin to play a role in early rolling. PSGL-1 is the 
main leukocyte-restricted ligand for P-selectin. Using antibodies against PSGL-1 blocks 
the rolling of neutrophils, monocytes and eosinophils on P-selectin in vitro (27).  
  Unlike P-selectin, E-selectin expression is controlled by transcriptional 
activation only. It was shown using COS7 cells transfected with E-selectin that 
expression was induced by the cytokines IL-1 and TNF-α, with the protein present at 
the cell surface two to four hours after activation (35). Expression was also assessed in 
HUVEC cells activated with TNF-α, with peak expression observed three to six hours 
after stimulation (36). As there is a delay in surface expression of E-selectin, rolling 
becomes dependent on E-selectin binding its ligands after this time (37). The capability 
of E-selectin to support leukocyte rolling has been assessed both in vitro and in vivo 
(31), with neutrophils able to roll on E-selectin in the flow chamber (38,39) and E-
selectin-dependent rolling evident in murine mesenteric venules activated with 
Interleukin-1β (IL-1 (40). However, blocking E-selectin with antibodies or knocking 
out E-selectin in mice does not affect rolling (31). This is due to the co-expression of P-
selectin compensating for the loss of E-selectin. 
All types of selectin-dependent rolling have been shown to depend on a 
threshold of shear stress, which is the force applied to the cells due to the flow of the 
blood through the vessel (41,42). Shear stress is required for the rolling of the HL-60 
human promyelocytic leukaemia cells on P- and E-selectin and without flow, gravity 
causes the detachment of the cells when the flow chamber is placed upside down (41). 
Different cell types have been transfected with either PSGL-1 or L-selectin and in all 
cases rolling was only seen under shear stress conditions (41), showing that this 
requirement is neither molecule nor cell type specific. It is likely this mechanism exists 
to prevent the aggregation of leukocytes at sites of low blood flow (42). How the 
increase in shear stress increases the adhesion between selectins and their ligands 
remains unclear. It has been proposed that selectins form catch-bond interactions with 
their ligands (reviewed in (43)), where the increase in force causes the straightening of 
the L-selectin molecule, enhancing its ability to interact with the ligand pocket of its 
binding partner. However, due to experimental limitations it is not possible to monitor 
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the conformational rearrangement of L-selectin under flow, so this has yet to be 
confirmed.     
1.2.3 Slow rolling and the three integrin activation states  
The slow rolling step of the adhesion cascade is important for initialising arrest 
of the leukocyte through the activation of integrins. The process has recently been 
revealed to occur through E-selectin, which can bind to PSGL-1, CD44 and CD43 on the 
leukocyte (37). The rolling velocity of leukocytes from E-selectin knockout mice were 
much higher than that of wildtype mice (44), showing its importance in initialising slow 
rolling.  
β1- and β2-integrins are expressed on the surface of leukocytes and upon 
activation they switch from the low-affinity bent state to a high-affinity extended 
state, which leads to the opening of the ligand pocket, via the intermediate state 
(Figure 1.2) [1]. Three integrins are expressed on leukocytes, namely Lymphocyte 
function-associated antigen-1 (LFA-1), Macrophage-1 (MAC-1) and Very Late Antigen-4 
(VLA-4). They bind cell adhesion molecules (CAMs) expressed on endothelial cells. LFA-
1 interacts with endothelial Intercellular Adhesion Molecule-1(ICAM-1) and the 
endothelial Intercellular Adhesion Molecule-2 (ICAM-2), MAC-1 interacts with ICAM-1 
and the VLA-4 interacts with Vascular Cell Adhesion Molecule-1 (VCAM-1) [1]. 
Both the integrins LFA-1 and MAC-1 become activated to an intermediate state 
following E-selectin-dependent rolling. In fact clustering of PSGL-1 and CD44 is 
sufficient to activate integrins to the intermediate state, which results in weak binding 
to their cognate ligands (32). When E-selectin and the integrin ligand ICAM-1 were co-
immobilised the number of cells engaged in slow rolling increased (45). Antibody 
blocking of β2-integrins increases the rolling velocity of lymphocytes on endothelial 
cells in flow chamber assays (46), showing integrin ligand binding promotes slow 
rolling. Studies of the role of integrins in slow rolling have been assessed in vivo using 
knockout mice and assessing leukocyte rolling in the cremasteric muscle venules by 
intravital microscopy. The velocity of rolling in LFA-1-/- and MAC-1-/- mice was higher 
compared to wildtype mice, with the double knockout having an even higher rolling 
velocity (47). VLA-4 has also been shown to support rolling, with lymphocytes shown 
to roll on VCAM-1 via VLA-4 in vitro (10,48). 
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During slow rolling chemokine signalling activates integrins, which leads to the 
arrest of the cell on the surface of the endothelium (10). One example of this is the 
interaction between VLA-4 and VCAM-1. Chemokines up-regulate this interaction by 
increasing the affinity of VLA-4 for VCAM-1, leading to an increase in adhesion and 















1.2.4 Leukocyte arrest and chemokine-induced integrin activation 
 Binding of the integrins to their ligands causes leukocytes to arrest under flow 
conditions. Chemokines presented by endothelial cells increase the avidity and affinity 
of integrins to promote leukocyte arrest (10). It has been shown in vitro that 
chemokines trigger the extension of the bent form of LFA-1. ICAM-1 then binds to LFA-
1 fully activating it and causing high affinity binding, leading to arrest (50).   
Chemokines also induce the mobility of integrins to sites that enhance the frequency 
of binding, which increases the likelihood of arrest. Phosphatidylinositide 3-kinase 
(PI3K) inhibition has been shown to block the mobility of LFA-1 and as a result prevents 
the firm adhesion to ICAM-1 immobilised at low densities (51).  
 The signalling pathways behind chemokine-induced leukocyte arrest have been 
investigated. Chemokines bind to G Protein Coupled Receptors (GPCRs) on the surface 
of the leukocyte, which leads to phospholipase C (PLC) activation (10). VLA-4-
Figure 1.2 Conformations of integrins. A schematic showing the different conformational 
states of α4β1-integrin during cell activation. The α domain is shown in blue and the β domain 
is shown in pink. In resting cells integrins exist in a bent inactive state (1). After the first stage 
of activation the integrins are in an extended closed intermediate state (3). The high activity 
state is achieved when the integrins become extended and open, exposing the ligand binding 
site (shown in green). Figure modified from Johansson, M. W., and Mosher, D. F. (2013) 




dependent arrest is blocked when an inhibitor to PLC is added to neutrophils (52). PLC 
cleaves the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) into diacyl-
glycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), both of which act as secondary 
messengers. DAG activates PKCs and IP3 binds to receptors on the endoplasmic 
reticulum (ER) to cause the release of calcium into the cytosol. With the use of 
inhibitors against these two molecules it was found that the release of calcium was 
required for VLA-4-dependent arrest (52). Calcium release from the ER induces the 
influx of extracellular calcium via activation of calcium ion channels. Using and 
inhibitor of these channels also blocked VLA-4 binding (52), showing that it is this influx 
that leads to the conformation change of VLA-4 and firm adhesion. The calcium 
binding protein calmodulin (CaM) was also implicated in this pathway, as blocking this 
protein with the CaM specific inhibitor W7 inhibited firm adhesion (52). It is possible 
that release of calcium from the ER binds to CaM enabling it to interact with the 
calcium channels, leading to their opening, though how calcium influx causes a change 
in affinity of VLA-4 remains unclear. 
 It is possible that activation of signalling pathways lead to the binding of 
partners to the cytosolic tail of integrins, affecting their binding affinity. Talin has been 
shown to bind to β3-integrins and this interaction either induces or stabilises the high 
affinity conformation of the adhesion molecule (10,53,54). 
 Activation of integrins by chemokines also initiates signalling in the leukocytes. 
Studies have revealed that a lack of integrin signalling accelerates the detachment of 
neutrophils (10,55). The Src family kinase members Fgr and Hck have been shown to 
be involved in integrin signalling. When these kinases were knocked out in neutrophils 
the cells were able to adhere to co-immobilised ICAM-1 and P-selectin under flow at 
the same rate as wildtype cells, but detached much quicker (55), showing that integrin 
signalling is required for the sustained arrest of leukocytes. 
 
1.2.5 Leukocyte crawling 
 After leukocyte arrest, cells must transmigrate across the endothelial 
monolayer. The first step of this process is the crawling of the leukocytes on the 
luminal surface of the endothelium in order to seek a preferred site of transmigration 
(10,56,57). This process has been shown to be dependent on the integrin MAC-1, as 
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blocking this integrin on monocytes in vitro (56) or analysis of neutrophils in MAC-1 
knockout mice (57) showed that crawling did not occur. Blocking of ICAM-1 also 
inhibited crawling in vitro (56), showing it is the ligand for MAC-1. Inhibition of 
crawling in monocytes led to the cells spinning in circles where they became arrested 
(56), thus the cells were unable to undergo directive movement. Neutrophils from 
MAC-1 knockout mice would transmigrate more slowly at the site of arrest, with more 
cells using the transcellular pathway (see later in Section 1.2.6.2) (57). This shows the 
importance of crawling in facilitating rapid transmigration. 
1.2.6 Transmigration 
 The movement of leukocytes across the endothelial monolayer is known as 
transendothelial migration (TEM) or diapedesis. Leukocytes can either transmigrate 
between the junctions formed by opposing endothelial cells (paracellular route) or 
through an individual endothelial cell (transcellular route).  
 
1.2.6.1 Paracellular Route 
For leukocytes to pass between endothelial cells, the tight junctions between 
the cells must be disrupted. It is thought that ligation of adhesive molecules on the 
endothelial cells leads to activation of signalling pathways that disrupt the inter-
endothelial contacts to facilitate migration. Clustering of VCAM-1 on endothelial cells 
has been shown to cause the disruption of adherens junctions (58,59). VE-cadherin is 
found in tight junctions and binds to β-catenin to form contacts between endothelial 
cells. The presence of VE-cadherin in junctions blocks the migration of leukocytes. 
Using function-blocking antibodies against VE-cadherin accelerates the migration of 
neutrophils in to the inflamed peritoneum – a commonly used mouse model of acute 
inflammation (60). It has been shown that VE-cadherin is cleaved  during TEM (58) and 
as a result is removed from the junctions. Neutrophil binding causes the production of 
fragments of VE-cadherin and the proteases elastase and cathespin G on the surface of 
neutrophils were found to be responsible for this production (58). 
Members of the RhoGTPase family have been implicated in regulating signalling 
pathways that promote paracellular migration. Rac1 is activated by VCAM-1 and is 
thought to be responsible for the disruption of adherens junctions (58). ICAM-1 
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clustering has been shown to activate RhoA leading to the contraction of adjacent 
endothelial cells, and the opening of the junctions (58).  
 A number of junctional proteins are involved in the paracellular route of 
migration, such as Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) and 
Junctional Adhesion Molecules (JAMs). PECAM-1 is involved with homophilic 
interactions whereas JAMs can form homotypic interactions and interact with 
integrins. Studies have shown the importance of these molecules in transmigration 
(61,62). PECAM-1 is expressed on the surface of all types of leukocytes and endothelial 
cells (63) and has been shown to mobilise to the surface of the endothelial cell after 
neutrophil interaction (58), presumably to enable the interaction between PECAM-1 
on the leukocyte and endothelial cell. Blocking PECAM-1 with antibodies blocks 
paracellular migration in vitro (60). There are three different JAMs: JAM-A, JAM-B and 
JAM-C. JAM-A and JAM-C are expressed on leukocytes and endothelial cells and JAM-B 
is expressed on endothelial cells (64). LFA-1 interacts with JAM-A on endothelial cells. 
Blocking JAM-A with antibodies inhibited transmigration of monocytes in vitro and also 
reduced the recruitment of monocytes and neutrophils to sites of inflammation (64). 
This shows the importance of the interaction between adhesion molecules on 
leukocytes and endothelial junctions in paracellular transmigration.  
  
1.2.6.2 Transcellular Route 
  Transcellular migration accounts for only 5-20% of transmigration in activated 
HUVECs (65). Vesiculo-vacuolar organelles are continuous membrane-associated 
channels present at the sites of leukocyte adhesion, suggesting they act as the site for 
leukocytes to pass through the body of the endothelial cell (10,66). Structures 
containing junctional cell adhesion molecules have been observed just below the 
plasma membrane and it is possible that these facilitate transcellular migration (10). 
Cross-linking of ICAM-1 with monoclonal antibody translocates it to caveolin-rich 
membrane domains and is subsequently transcytosed to the basal plasma membrane 
(67). Similarly, as leukocytes bind ICAM-1, their protrusions meet with sites within the 
endothelium that are enriched in caveolin and F-actin, which form a passage for the 
leukocyte to pass through (67). This suggests that ICAM-1 internalisation within 
caveolin-rich sites initiates the formation of a channel for transcellular migration. Using 
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RNA interference (RNAi) to reduce the expression of caveolin decreased the number of 
cells undergoing transcellular migration (67), showing the importance of this protein in 
the process.    
 
1.2.6.3 Migration through the Basement Membrane and Pericyte Sheath  
 Once the leukocyte has transmigrated across the endothelium it must 
penetrate the basement membrane and the pericyte sheath. The basement membrane 
is made up of laminins and collagen type IV (68). Studies have determined that certain 
areas of the basement membrane contain less of these molecules, with 60% less 
laminin 10, collagen IV and nidogen-2 at these sites compared with the average 
content of these proteins in the basement membrane (69), and these sites are where 
most neutrophils migrate through. Interestingly, these sites are also co-localised with 
gaps between pericytes, which loosely surround post-capillary venules. So, it seems 
that neutrophils migrate through areas of least resistance (10,69). Interestingly, these 
areas have been shown to be enlarged after stimulation with the cytokine IL-1β and 
this increase in size was dependent on neutrophil elastase (69). Inhibition of neutrophil 
elastase caused a reduction in transmigration (69).  
 Integrins also play a role in migration through the basement membrane to the 
site of inflammation. α6-integrin is activated by the engagement of PECAM-1 and is 
able to bind to the laminin molecules in the basement membrane, therefore 
facilitating the migration through the basement membrane (10). Antibodies blocking 
α6-integrins binding inhibited the migration of neutrophils across inflamed cremasteric 
venules (70). 
Now that all of the individual steps of the adhesion cascade have been 
discussed, the next section will focus on more detailed aspects of cell adhesion 
molecules that relate to this PhD project, namely L-selectin, it’s binding partners and 
their involvement in signal transduction. 
1.3 L-selectin form and function 
 The selectin family of proteins are a group of three adhesion molecules which 
have been shown to be critical in leukocyte trafficking. The members of the family are 
named after the location of their first discovery. P-selectin was first classified by 
expression on platelets, but has since been shown to be expressed on endothelial cells, 
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E-selectin is expressed on endothelial cells and L-selectin is expressed on most 
circulating leukocytes. There are many similarities between the three family members, 
including their structural similarity and ligand specificity, which is discussed below. 
 
1.3.1 Structure of the Selectins 
All members of the selectin family have a C-type lectin domain, followed by an 
epidermal growth factor (EGF) like domain, two to nine short consensus repeat (SCR) 
domains, a single transmembrane domain and a cytoplasmic tail (Figure 1.3). The 
number of SCR domains varies between the selectins and different species, with L-
selectin containing two SCR domains in all species studied and E- and P-selectin having 
between four and nine SCR domains (31). The homology between the extracellular 
domains between the different selectins is high, with around 52% homology amongst 
the lectin domains, 35-40% amongst the SCR domains and 47% amongst the EGF 
domains (31). Interestingly, there is no conservation in the transmembrane domain 
and the cytoplasmic tail across the three selectins, but these two domains for each 
individual selectin is well conserved between species, for example the L-selectin 
cytosolic tail in human and mouse share 78 % identity. This suggests they may play an 
important role in regulating selectin-specific properties. 
 
1.3.1.1 C-type Lectin Domain 
 The C-type lectin domain is a carbohydrate binding domain ‘C’ indicates that 
carbohydrate binding is dependent on calcium. It has been shown that the interaction 
between the C-type lectin domain and carbohydrate moieties is required for the 
binding of lymphocytes to lymph node high endothelial venules (HEVs). The addition of 
carbohydrate mimetics inhibited this interaction in vitro (71), as did the addition of the 
enzyme neuraminidase (72), which cleaves the carbohydrate moiety sialic acid from 
the surface of the HEVs. The importance of calcium in regulating the interaction 
between selectins and their ligands was assessed by chelating calcium with ethylene 
glycol tetra-acetic acid (EGTA) (73). This blocked selectin adhesion under flow, clearly 
showing adhesion occurs in a calcium-dependent lectin-like fashion. Mutagenesis 
studies have mapped the carbohydrate-binding site to near the calcium-binding site, 
with positive amino acids surrounding the calcium binding site responsible for 
39 
 
recognising carbohydrate moieties (74). The carbohydrate ligands of selectins are 
discussed elsewhere in more detail (see Section 1.3.2). 
 
1.3.1.2 EGF-like Domain 
 Deletion of the EGF-like domain has been shown to abolish adhesion (31). It is 
thought that this is due to an alteration in the structure of the selectin protein, 
affecting its ability to interact with carbohydrate moieties (75). Further evidence that 
the EGF-like domain plays a structural role and does not specifically interact with 
selectin ligands is provided by domain swapping studies. When the EGF-like domains of 
the L-selectin and P-selectin were swapped with one another, there was no effect on L-
selectin-dependent adhesion of lymphocytes to HEVs of the lymph nodes and 
mesenteric venules in vivo (76). Similarly, when the EGF-like domain of E-selectin was 
swapped with that of protein factor IX, cell adhesion was not affected (74). 
Interestingly, when the EGF-like domain of P-selectin was swapped with one of the 
other EGF-like domains, interaction with P-selectin specific ligands was suboptimal 
(76), showing both the lectin and EGF-like domains of P-selectin are required for 
optimal interaction with its ligands and suggests the P-selectin EGF-like domain does 
play a role in ligand specificity.  
 
1.3.1.3 SCR Domain 
 Deletion mutagenesis of the SCR domains reveal an impairment in ligand 
binding under flow (75). Further evidence of the importance of the SCR domains in 
ligand recognition has been shown by antibody studies. The addition of an antibody 
against the SCR domain inhibited the adhesion of both L- and E-selectin, with 
lymphocyte adhesion to HEVs and neutrophil adhesion to E-selectin respectively 
blocked (77). However, the swapping of the L- and P-selectin SCR domains had no 
effect on adhesion (76), showing the SCR domains do not play a role in ligand 
specificity. This has led to the hypothesis that the SCR domain could be important in 
controlling the distance of the C-type lectin domain from the membrane, which could 
be important for ligand interaction. For example, L-selectin is anchored to microvilli 
(78) and, as such, is less likely to require many SCR domains during tethering and 
rolling events (as it stands head and shoulders above other molecules that reside on 
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the planar part of the plasma membrane). In contrast, P-selectin contains 9 SCR 
domains and is thought not to localise to microvilli.  
 L-selectin contains a unique membrane proximal cleavage domain (shown as a 
pentagon in Figure 1.3) located below the SCR domains. This allows the regulation of L-
selectin surface levels via the cleavage of the extracellular domain, as will be explained 

















1.3.2 Selectin Ligands 
 As stated, the C-type lectin domain of selectins is responsible for interacting 
with carbohydrate moieties on the surface of corresponding cells. The carbohydrate 
moieties required for binding are sialyl Lewis X (sLex)-based tetrasaccharides. This is a 
sialofucosylated glycan with a terminal sialic acid linked to a galactose and a fucose, 
both linked to N-acetyl-glucosamine (Figure 1.4) (79,80). Selectin ligands are also often 
sulphated (81). Studies have been carried out in order to decipher which components 
are required for selectin binding. The loss of sialic acid from sLex by the addition of 
sialidase abolishes the interaction between lymphocytes and HEVs, therefore inhibiting 
lymphocyte homing to the lymph node (82). The role of fucose was assessed in 
Figure 1.3: Structure of selectins. A diagram showing the different domains of the selectins, 
including the C-type lectin ectodomain, epidermal growth factor (EGF)-like domain, short 
consensus repeat (SCR) domains, a single transmembrane region and a C-terminal 17 amino 
acid cytoplasmic tail. The structural domains are similar for all family members, except the 
number of SCR domains varies and the sequence of the transmembrane and cytosolic domains 
is not conserved between family members. L-selectin also contains a membrane proximal 




fucosyltransferase knockout mice. This resulted in HEV cells with no ligand activity, 
resulting in the loss interaction between lymphocytes and the cells of HEV (82). The 
addition of the sulphation inhibitor sodium chlorate also led to a reduction in the 
binding between the selectins and their ligands (82).  
 Although the carbohydrate moiety sLex is capable of acting as the ligand for 
selectins, highlighted by the fact it can support leukocyte rolling, the number of ligands 
required is two-three orders of magnitude higher than physiologic selectin ligands (83). 
This shows that other components are required to enhance the selectin/ligand 
interaction. The protein backbone upon which sLex is attached is important for 
displaying the carbohydrate moiety in the correct orientation for presentation to 
selectins (31,80). The glycoprotein also plays important roles in ensuring correct 
posttranslational modifications, initiating outside-in signalling and sorting of the ligand 










  1.3.3 Regulation of L-selectin expression  
 L-selectin is constitutively expressed on the surface of a majority of circulating 
leukocytes, including monocytes, neutrophils, naïve T- and B-cells (31). The expression 
of L-selectin is controlled both at the mRNA and the protein level. Analysis of the DNA 
sequence upstream of the L-selectin start codon has revealed several transcription 
factors are capable of binding to the promoter region. Site-directed mutagenesis and 
chromatin immunoprecipitation experiments have shown that Mzf1, Klf2, Sp1, Fts1, 
Irf1 bind to and activate the murine L-selectin promoter (84). The role of these 
transcription factors was further assessed by over expressing them in EL4 cells, which 
led to an increase in L-selectin mRNA levels (84). It was also shown that when Sp1 
Figure 1.4: Sialyl Lewis X. A diagram showing the composition of sLex and the attachments 
between them. R represents any glycoprotein to which sLex is attached. 
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expression was silenced using siRNA, the expression of L-selectin mRNA was decreased 
(84), further highlighting the ability of this transcription factor to promote L-selectin 
expression. The analysis of the promoter region also found a potential Forkhead box 1 
(FOXO1) binding sequence upstream of the L-selectin start codon (85). Studies have 
shown FOXO1 is capable of activating expression of L-selectin in several different cell 
lines. A constitutively active form of FOXO1 expressed in Jurkat T-cells led to an up-
regulation of L-selectin expression, as did overexpression of FOXO1 (85). FOXO1 has 
been reported to control L-selectin expression in naïve T-cells (86,87) and in B-cells, 
where a lack of FOXO1 has been shown to lead to lower L-selectin expression and as a 
result fewer B-cell populating peripheral lymph nodes (88). 
 Although the transcription factors responsible for promoting L-selectin 
expression have been deciphered, the signalling pathways leading to their activation 
remain unclear. Several pathways have been shown to regulate L-selectin mRNA levels 
in T-cells. Activation of T-cells through the T-cell receptor (TCR) has been shown to 
down-regulate L-selectin within a few hours through an acceleration of L-selectin 
cleavage (see Section 1.3.4) (89). Over the next few days L-selectin levels increase then 
decrease once again via regulation of mRNA levels (89), though how mRNA levels are 
regulated is unclear. It has also been shown that the PKC pathway is capable of up-
regulating L-selectin mRNA levels in Jurkat T-cells (90). In this study PMA was used to 
activate PKCs, which initially causes shedding of L-selectin (see Section 1.3.4), followed 
by a progressive increase in the surface expression of L-selectin and an increase in 
mRNA levels (90). It is possible that the increase in L-selectin expression is in response 
to the induction of shedding and further research is required to assess the role of PKC 
signalling in inducing L-selectin expression in T-cells. 
 In B-cells, L-selectin mRNA levels are increased by the cytokine interferon 
(IFN)-α (91), although again the signalling pathway remains unclear. The role of nitric 
oxide (NO) synthase (NOS) in regulating L-selectin expression has also been 
investigated. It has been reported that when rats were treated with the NOS inhibitor 
L-NAME, the expression of L-selectin was reduced and this was due to an overall 
reduction in L-selectin mRNA (92). The cytokine IL-7 has been shown to negatively 
regulate L-selectin expression. IL-7 is a regulator of T-cell development and as T-cells 
enter the lymph node they encounter IL-7 (93). IL-7 regulates Cdc25A, a phosphatase 
that activates cyclin-dependent kinases and actively promotes T-cell proliferation (93). 
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High doses of IL-7 promote low-level L-selectin expression and a higher level of 
nuclear-localised Cdc25A causing T-cell proliferation (93). This causes the 
sequestration of FOXO1 in the cytosol, therefore blocking the promotion of L-selectin 
expression (93).  
 L-selectin is down-regulated from the surface by cleavage at an extracellular 
site, leading to soluble L-selectin present in the plasma. Details of how L-selectin 
shedding is regulated can be found in Section 1.3.4. 
 
1.3.4 Shedding of L-selectin 
 The biological significance of shedding of L-selectin remains unclear, although it 
is likely to rapidly halt L-selectin-dependent adhesion and signalling events, as 
discussed below. Shedding of L-selectin from the plasma membrane occurs rapidly, 
following several different stimuli including: phorbol 12-myristate 13-acetate (PMA) 
(94), antibody cross-linking (6), thrombin, IL-8 (95), TNF-α (6) and mechanical force due 
to rolling (96). Shedding has been shown to occur rapidly after activation of both 
neutrophils and lymphocytes (97,98), suggesting that it plays a role in rapidly shutting 
down signalling from this molecule.  
The process of shedding is regulated by metalloproteases, such as a disintegrin 
and metalloprotease domain 17 (ADAM17) (also known as TNF-α converting enzyme 
(TACE)) (99). This is a transmembrane protein with an extracellular metalloproteinase 
domain (100) that cleaves L-selectin at an extracellular membrane-proximal site 
(Figure 1.5A). Over 70 different substrates for ADAM17 have been identified, with 
ligands involved in development and inflammation characterised (101,102). These 
ligands can broadly be grouped in 3 categories: 1) membrane-anchored ligands, such 
as growth factors and cytokines that are synthesised and attached to the membrane 
and ADAM17 cleavage forms an active soluble protein, for example TGF-α and TNF-α 
(99), 2) receptors, whose cleavage may either block signalling or induce an alteration in 
signalling, with the membrane retained fragment capable of inducing different signals, 
for example Notch (103) and ErbB4 and 3) cell adhesion molecules, with ADAM17 
cleavage blocking adhesion, for example ICAM-1 (104) and VCAM-1 (105). It must be 
noted that many adhesion molecules also act as signalling receptors, and therefore 
cleavage by ADAM17 will also impact signalling events. ADAM17 is expressed in all cell 
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types, including endothelial cells and leukocytes, with inflammatory stimuli shown to 
increase its expression (101). Surface expression of ADAM17 is also induced by 
translocation of stored protein to the plasma membrane (100). This is controlled by 
threonine phosphorylation of ADAM17 by the p38 MAPK or ERK (106,107). The activity 
of ADAM17 is controlled at the protein conformation level. It exists in a closed inactive 
conformation, maintained by intramolecular disulphide bonds, which in turn is 
regulated by the activity of extracellular protein disulphide isomerases (PDIs) 
(108,109). Upon stimulation with PMA, reaction oxygen species (ROS) are produced, 
which inactivate PDI and thereby activate ADAM17 (108).  
 Initial analysis of the role of ADAM17 in inflammation was attempted with 
knockout mice, however, the loss of ADAM17 was embryonic lethal (99). For that 
reason lymphocytes lacking ADAM17 were adoptively transferred in to wildtype mice. 
Results showed that survival against bacterial infection was improved, with a greater 
number of neutrophils infiltrating to the site of infection to aid bacterial clearance 
(110), suggesting ADAM17 has a protective role in curbing infection. However, 
evidence also points to ADAM17 being pro-inflammatory, with the risk of septic shock 
reduced  when ADAM17 was lacking in lymphocytes (101). It was also observed that 
the number of ADAM17-/-neutrophils recruited to the lung was reduced compared to 
wildtype cells following inflammation (111). ADAM17 is also up-regulated in chronic 
inflammatory diseases (112), including atherosclerosis (101). These differences are 
most likely down to the different targets of ADAM17 cleavage being involved in 
different processes during inflammation.  
The role of ADAM17 in negatively regulating L-selectin expression is highlighted 
in ADAM17-null neutrophils, where it is 10-fold higher than in wildtype cells (113). The 
location of the cleavage site in L-selectin is located between residues K321 and S322 
(114,115). Studies focusing on site specificity found that the sequence of amino acids 
surrounding the cleavage site was not important, but the actual distance of the 
cleavage site from the plasma membrane is vital (114,116-118). This suggests that the 
ADAM17 active site is poised on a fixed stalk, and lacks flexibility when cleaving its 
substrates. Mutants of L-selectin, where the extracellular domain adjacent to the 
membrane has been truncated by eight amino acids (a mutation referred to as ΔM-N 
in humans and ΔK-N in mice), showed a blockage of shedding (98,119) (Figure 1.5B).  
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The cytoplasmic tail has also been shown to play an important role in 
regulation of shedding of L-selectin. Truncating the entire tail of L-selectin leads to just 
44% shedding (114,118), suggesting that there are critical elements within the tail that 
are sufficient to drive the shedding response. As explained in a later section in this 
thesis, the binding of CaM to L-selectin has been shown to be involved in regulating L-
selectin shedding (Section 1.3.7.3). It is also possible that PKC phosphorylation of the 
cytosolic tail of L-selectin is important in regulating shedding, as inhibitors of PKCs also 
block shedding (120). 
Experiments where L-selectin cleavage is inhibited have been undertaken in 
order to decipher the role of shedding. Results showed that rolling velocities are 
reduced, with a velocity of 59 µm/s before inhibition and 39 µm/s velocity when 
shedding was inhibited, and this leads to an increase in the accumulation of leukocytes 
attached to endothelial cells (121,122). Similarly, ADAM17-null neutrophils roll slower 
and adhere more readily to endothelial cells, with a greater number of neutrophils 
being recruited to the site of inflammation (113). Mouse models expressing “sheddase 
resistant” L-selectin have been produced to study the effect of shedding in the whole 
organism. The expression of sheddase resistant L-selectin in neutrophils leads to the 
prevention of neutrophil migration into tissue following activation (114,123). Sheddase 
resistant L-selectin also leads to activated T-cells re-entering the lymph nodes 
(114,124).  
Cleavage of L-selectin results in the creation of a soluble extracellular fragment 
of L-selectin, which is able to bind to its ligand and therefore competes for binding 
sites on both the leukocyte (e.g. PSGL-1) and the endothelium, antagonising further 
recruitment of leukocytes (125). As L-selectin is a signalling molecule (see Section 
1.3.6), shedding will presumably halt the activation of L-selectin-dependent signalling 
pathways. This is highlighted by the fact that shedding limits the activation of integrin 
molecules (114,126). Therefore L-selectin cleavage may be required to limit L-selectin-
dependent signalling. All these factors suggest shedding is important for limiting the 
inflammatory response by ensuring that the number of leukocytes recruited to the 
sight of infection is controlled and limit the activation of the cells by halting L-selectin 
signalling. 
Shedding of L-selectin also creates a membrane-retained fragment, often 
referred as the “stump”. It is possible that this fragment of L-selectin is able to induce 
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different signalling pathways to the full length L-selectin, however, this has not been 
studied in any detail. The stump remains intact for 30 minutes after cleavage before 
being degraded (127), giving it ample time to activate signalling pathways. One 
possible pathway is the activation of PKC isozymes. PKCs have been shown to bind 
phosphorylated L-selectin cytosolic tail (see Section 1.3.7.2 for details), possibly after L-
selectin has been cleaved. However, further research is required to determine if this is 
the case. There are several other examples of the stump of transmembrane proteins 
produced by ADAM17 cleavage acting as signalling molecules (102,128). The stump of 
CD44 is susceptible to γ-secretase cleavage, which is an intramembrane protease that 
cleaves transmembrane proteins at residues within the transmembrane domain. This 
produces a fragment of the protein, which enters the nucleus and induces protein 
expression (129). It is possible that the same mechanism also occurs with L-selectin. 
The importance of the stump formation may be highlighted by an in vivo chemotaxis 
assay using L-selectin knockout and ΔK-N-L-selectin mice. In both cases, leukocytes 
failed to chemotax towards the keratinocyte-derived chemokine (KC) (123,130). The 
similarity in both cases is the lack of the formation of the stump, implying it may be 

























It has been observed that non-steroidal anti-inflammatory drugs (NSAIDs) 
induce shedding of L-selectin (131). NSAIDs inhibit the interaction between neutrophils 
and endothelial cells, leading to a reduction in the number of neutrophils migrating to 
the site of inflammation (132,133). Experiments have been carried out to try to 
decipher the mechanism by which NSAIDs induce L-selectin shedding. Inhibiting the 
protease ADAM17 blocks the induction of L-selectin shedding (134), showing this 
protease is responsible for shedding L-selectin in response to NSAIDs. How NSAIDs 
activate ADAM17 remains unclear, although studies have revealed that ROS are 
involved. NSAIDs have previously been shown to induce the production of ROS. When 
neutrophils were incubated with both antioxidants and NSAIDs, the capability of 
NSAIDs to reduce the basal expression of L-selectin was diminished (135), showing 
NSAID-induced shedding requires a high oxidative status. Analysis of the ROS required 
has shown that superoxide is responsible, as the presence of superoxide dismutase 
(SOD), which catalyses the conversion of superoxide to oxygen and hydrogen peroxide, 
abrogates NSAID induced shedding almost entirely (135). Further investigation is 
required to fully decipher the mechanism behind NSAID induced shedding of L-
selectin.  
 
1.3.5 L-selectin Ligands 
 As stated above, L-selectin ligands normally consist of glycoproteins decorated 
with sLex moieties, although glycolipids can also act as ligands. It has also been shown 
that sulphation of sLex is required for L-selectin interaction with ligands expressed by 
HEVs, as mice deficient in the enzyme capable of sulphating sLex, namely N-
acetlyglucosamine 6-O-sulfotransferase-1, results in a reduction of lymphocyte homing 
to peripheral lymph nodes, mesenteric lymph nodes and Peyer’s Patch (136). Many 
potential L-selectin ligands have been identified, though the specific role of each 
Figure 1.5: The shedding of L-selectin by ADAM17. (A) In cells expressing wildtype L-selectin, 
upon stimulation with PMA etc., ADAM17 (shown in blue) comes into close proximity to L-
selectin and can access the cleavage site (shown by the hexagon), leading to shedding of L-
selectin from the cell surface. (B) In cells expressing sheddase resistant L-selectin (known as 
ΔM-N-L-selectin in humans), 8 amino acids proximal to the cleavage site have been deleted 
resulting in a cleavage site being closer to the plasma membrane. When the cell is activated 




individual ligand remains unclear. Several of the ligands whose role, to a certain 
extent, has been deciphered are described below, with further examples shown in 
Table 1.2, though this is not an exhaustive list.  
The ligands can be broadly classed in two categories, those found on the 
luminal side of the endothelial (Figure 1.6A) and those primarily found in the ECM 
beneath the endothelium (Figure 1.6B). A majority of those on the luminal side are 
glycoproteins decorated with sLex, whereas those within the ECM lack sLex and instead 
L-selectin adhesion depends on highly sulphated proteoglycans. Another interesting 
difference is the fact the L-selectin binds to luminal ligands under shear flow, which is 
required for the interaction (see Section 1.2.2), whereas shear flow is obviously lacking 
subluminally. It is therefore possible that the binding mechanisms are different in both 
cases, though further research is required to understand this difference. The fact that 
the L-selectin encounters the different subsets of ligands in distinctive 
microenvironments may be fundamental in fine-tuning L-selectin signalling in these 
very different locations.  
 
1.3.5.1 L-selectin ligands expressed on the luminal surface 
PSGL-1 is the best-characterised luminal ligand of L-selectin and is expressed on 
leukocytes and endothelial cells as a homodimer, with two subunits linked together by 
a disulphide bond (137). It has been demonstrated that L-selectin binding depends on 
sialylation, fucosylation (138) and sulphation of at least one of three tyrosine residues 
of PSGL-1 (139). Mutating one or two of the tyrosine residues to phenylalanine, and 
therefore blocking sulphation, led to a lowering in the binding affinity between L-
selectin and PSGL-1 (137). This is likely to be due to a loss of charge on PSGL-1 
preventing the formation of electrostatic interactions between L-selectin and PSGL-1 
(137). As stated above (Section 1.2.2) PSGL-1 is able to support L-selectin dependent 
rolling. Mutating either the tyrosine residues or the threonine residue to which sLex is 
attached abrogated rolling (140). The interaction between L-selectin and PSGL-1 has 
been implicated in secondary tethering, as described in Section 1.2.1. 
 Glycosylation-dependent cell adhesion molecule-1 (GlyCAM1) has also been 
shown to bind to L-selectin, with the interaction requiring the sialylation and 
sulphation of GlyCAM-1 (141). It is expressed by HEVs and lacks a transmembrane 
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domain, so is secreted as a soluble protein (142).  As GlyCAM-1 is secreted it may not 
play a role in cell-cell interactions and instead be involved in initiating L-selectin 
dependent signalling. In fact, studies have demonstrated that treatment of naïve T 
cells with GlyCAM-1 stimulates adhesion via β2-integrins (142,143). It is also possible 
that GlyCAM-1 is immobilised on to the luminal surface of the endothelial cells, likely 
through electrostatic interactions. If this is the case then it is possible that GlyCAM-1 is 
capable of supporting leukocyte attachment to the endothelium through its 
interaction with L-selectin. The levels of GlyCAM-1 found in the plasma after an 
inflammatory stimulus has been shown to increase (144), suggesting a role in 
inflammatory induced signalling. 
 Another luminal ligand of L-selectin is mucosal vascular addressin cell adhesion 
molecule 1 (MAdCAM-1). MAdCAM-1 is a member of the immunoglobulin superfamily 
expressed on the surface of the endothelium of venules, including HEVs in Payer’s 
Patch and mesenteric lymph nodes (145). It has been shown that MAdCAM-1 can be 
post-translationally modified with sLex to enable L-selectin binding (145). Studies have 
divulged that lymphoid cells transfected with L-selectin are capable of adhering to 
MAdCAM-1 isolated from mesenteric lymph nodes under shear flow (146) and rolling 
of the lymphoid cells was observed (146). This shows that MAdCAM-1 may play a role 
in recruitment of lymphocytes to the secondary lymph nodes. 
 Members of the CD34 family of glycoproteins have also been implicated as L-
selectin ligands. CD34 is a single pass transmembrane sialomucin protein, which is 
expressed on endothelial cells. CD34 can be decorated with sulphated sLex and is then 
able to bind L-selectin (147) and mediate lymphocyte extravasation (148). In fact, 
antibodies against CD34 are capable of blocking T cell binding to lymph node and 
Peyer’s Patch HEVs and therefore block T cell extravastion from the blood into 
secondary lymphoid tissue (149). Blocking CD34 with antibody has also been shown to 
inhibit the recruitment of neutrophils and monocytes to the peritoneum following an 
inflammatory stimulus (150). Interestingly, studies carried out with CD34-deficient 
mice have shown that lymphocytes homed to the secondary lymphoid organs more 
frequently than wildtype mice (151). Analysis showed that lymphocytes were twice as 
likely to tether, roll and adhere in peripheral lymph nodes when CD34 was lacking 
(151). This suggests that CD34 may interfere with L-selectin dependent recruitment of 
lymphocytes and it is possible plays a dual role in regulating lymphocyte recruitment to 
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secondary lymph nodes. Other members of the CD34 family have also been shown to 
be capable of acting as L-selectin ligands, with podocalyxin presenting sulphated sLex 
to enable L-selectin binding (152) and endoglycan interacting with L-selectin through 
sulphated tyrosine residues and sLex (152). 
Proteoglycans (PGs) expressed on the cell surface form a part of the glycocalyx 
in addition to the extracellular matrix (ECM) and collectively act as L-selectin ligands. 
Heparan sulphate proteoglycans (HSPGs) are one class of proteoglycans that make up 
the glycocalyx and can bind L-selectin. Interestingly, it is thought that the glycocalyx 
acts as an anti-inflammatory sheath by repelling leukocytes and masking underlying 
binding molecules (153). The thickness of the glycocalyx differs in different vessel 
types, with large arteries, such as the aorta, having a significantly thicker glycocalyx 
than post capillary venules (154). In fact, it was shown that segments of the post 
capillary venules in both rat and mouse almost completely lacked the glycocalyx (154). 
As a majority of leukocytes exit the blood vessels in post capillary venules, these areas 
lacking glycocalyx may act as areas where leukocyte-endothelium interactions can 
occur, with the presence of the thicker glycocalyx blocking leukocyte adhesion in the 
arteries. Upon an inflammatory stimulus the glycocalyx is shed allowing leukocyte 
adhesion to occur. Degradation of heparan sulphate, by treatment with heparitinase I, 
causes an increase in the number of adherent leukocytes (155). 
Several different studies have shown that L-selectin is able to bind to HSPGs in 
several different vessels including the kidney and spleen (156-158). A role for HSPGs in 
monocyte binding to bovine aortic endothelial cells has also been demonstrated, as 
heparanase treatment inhibited approximately 80% of monocyte attachment to the 
aortic endothelium under flow (159). The importance of heparan sulphate in the 
interaction between L-selectin and HSPGs is highlighted by the inactivation of N-
deacetylase-N-sulfotransferase-I, an enzyme responsible for the addition of the 
sulphate group to the heparan sulphate chains. When this enzyme is inactive, the 
binding between L-selectin and its ligands is much weaker, leading to reduced 
neutrophil infiltration following an inflammatory stimulus (160). 
1.3.5.2 Potential L-selectin ligands beyond the vessel lumen 
 As stated above, HSPGs expressed in the ECM may potentially act as L-selectin 
ligands. Potential HSPG L-selectin ligands were identified by staining frozen tissue 
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samples with L-selectin-Ig and then using carbohydrate-degrading enzymes in order to 
classify the ligand type. Using this method it was revealed that L-selectin interacted 
with the HSPG collagen XVII, with cells transfected with L-selectin able to bind to wells 
coated with collagen XVII (156). A similar method was used to identify chondroitin 
sulphate proteoglycans (CSPGs) and dermatan sulphate proteoglycans (DSPGs) that 
were also capable of binding to L-selectin (157), with versican (157,161) and biglycan 
(162) both shown to be potential L-selectin ligands. Although the above method was 
able to show that L-selectin is capable of binding glycoproteins expressed in the 
basement membrane, it remains to be investigated if L-selectin is capable of 
interacting with these ligands in this microenvironment. 
 The importance of the L-selectin interaction with ECM components is 
highlighted in a model of kidney interstitial inflammation. It was revealed that the 
sulphated glycolipid sulphatide was able to act as a ligand for L-selectin (163) in the 
peritubular capillaries and interstitium following infection (164). It was revealed that 
the infiltration and migration of monocytes to the interstitium following an 
inflammatory stimulus was reduced in mice lacking sulphatide (164). It is possible that 
other components of the ECM may be important for migration of leukocytes into other 
tissue types. 
It is thought that PGs in the ECM have to be cleaved to enable leukocyte 
migration (153). It is possible that fragments of PGs bind to L-selectin and promote cell 
signalling in leukocytes to enhance directional migration. T-cells produce heparanase 
to degrade HS to sulphated disaccharides (DSs) (165,166). Treatment of T-cells with DS 
induces the adhesion of the cells to ECM components via integrins (166) and inhibits 
the production of TNF-α following an inflammatory stimulus (165). Both biglycan and 
versican have been shown to interact with toll-like receptors (TLRs) on T-cells to induce 
inflammatory responses, including production of TNF-α and IL-6. To date it is unclear if 
the L-selectin interaction with components of the ECM is capable of inducing signalling 
pathways. Further investigation is required to decipher the importance of the L-



















Ligand Expression Role of Interaction Reference 
PSGL-1 Leukocytes Secondary tethering (137-139) 




MAdCAM1 HEVs Recruitment of lymphocytes to 
secondary lymph organs? 
(145,146) 
CD34 Endothelial cells Regulation of lymphocyte recruitment 
to secondary lymph nodes. 
Recruitment of neutrophils and 
monocytes to sites of inflammation.  
(147,149-
151) 
Podocalyxin Pancreatic cancer Metastasis of cancer cells  (152,167) 
Figure 1.6: Ligands of L-selectin. A depiction of the location of different L-selectin ligands found 
on the luminal side of the endothelium (A) and in the ECM (B). It is worth noting that GlyCAM-1 is 








Metastasis of colon carcinoma cells 
and lymphocyte binding to HEVs 
(168,169) 
Endoglycan Vascular endothelial 




leukocyte interactions in vitro 
(152,170) 




Shown to support L-selectin-
dependent tethering and rolling in 
vitro 
(171,172) 
Sgp200 HEVs Support lymphocyte-HEV 
interactions? 
(173,174) 
Nucleolin Leukocytes Leukocyte-leukocyte interactions in 
vitro 
(175) 
E-selectin Endothelial cells Supports L-selectin-dependent 




ECM Link between L-selectin dependent 




ECM Leukocyte trafficking into the kidney 




ECM Tethering and rolling of CD16- NK cells 
on endometrial microvascular 
endothelial cells 
(162) 
Lubrican Synovial fluid (SF) Recruitment of polynuclear 







Table 1.2: L-selectin Ligands. A summary of glycoproteins identified as ligands for L-selectin. Note: 
this is not an exhaustive list. 
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1.3.5.3 The role of multivalent ligands in L-selectin function 
 Studies reveal an important role for multivalent ligands in regulating L-selectin 
function; for example, multivalent ligands are capable of inducing L-selectin shedding 
(114,180). Experiments using glycopolymers with sulphated sLex moieties showed 
these multivalent ligands bind to L-selectin molecules and not only cause L-selectin 
shedding, but, as a result, inhibit L-selectin-dependent rolling (180,181). Further 
analysis of the requirements of the multivalent ligands to induce shedding revealed 
that the spacings of the ligands on the polypeptide was important, as shedding 
occurred when the ligands are 17-35 Å apart, but not when they were 35-50 Å apart 
(182). This suggests that clustering of L-selectin, induced by multivalent ligands, is a 
prerequisite for L-selectin shedding (Figure 1.7). The mechanism underlying this 
shedding response remains unclear, although it is likely that signalling through 

















Figure 1.7: Multivalent ligand induced clustering of L-selectin causes L-selectin shedding. In 
resting cells L-selectin is distributed at the plasma membrane as a monomer. When a densely 
packed multivalent ligand is bound by L-selectin molecules clustering occurs, leading to L-
selectin shedding. Engagement of a loosely spaced multivalent ligand by L-selectin does not 
induce clustering and therefore shedding does not occur. Figure taken from Liu, S., and Kiick, K. 
(2011) Architecture effects on L-selectin shedding induced by polypeptide-based multivalent 
ligands. Polymer chemistry 2, 1513-1522 (2). 
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1.3.6 L-selectin-dependent Signalling 
 L-selectin has been described as a signalling receptor, with many studies 
undertaken in an attempt to decipher the pathways triggered upon ligand binding of L-
selectin. Although many effectors of L-selectin stimulation have been identified, the 
signalling pathways underlying them remain elusive. Those that have been deciphered 
are shown in Figure 1.8.  
Many examples of L-selectin signalling have been observed in neutrophils. In 
these cells, signalling downstream of L-selectin using sulphatide or antibody to cluster 
L-selectin increases the free cytosolic concentration of calcium (Figure 1.8, 2) (183-
185). An increase in superoxide production for use in the oxidative burst in neutrophils 
was also observed using these methods (Figure 1.8, 2) (183,184). L-selectin has also 
been shown to promote the activation of integrins and therefore facilitating the 
transition from rolling to firm adhesion and arrest of leukocytes. Clustering of L-
selectin activates both β1 and β2-integrins in both neutrophils and lymphocytes (Figure 
1.8, 2) (186-188). Interestingly, it is thought that L-selectin signalling induces a change 
in the integrin conformation leading to their activation, as opposed to mobilisation of 
internal stores of integrins, due to the rapid increase in adhesiveness observed not 
allowing a time for the mobilisation to occur (188). The pathway behind L-selectin-
dependent integrin activation in neutrophils has been investigated, in conjunction with 
PSGL-1. It has previously been shown that PSGL-1 was responsible for the activation of 
integrins through its interaction with and activation of Spleen tyrosine kinase (Syk) and 
Sarcoma (Src) family kinases (189,190). L-selectin and PSGL-1 are in close proximity in 
neutrophils and upon ligation of E-selectin this becomes more apparent with co-
localisation on microvilli and tethers evident on cells rolling on P-selectin, as shown by 
proximity ligation assay and FRET analysis (191). PSGL-1 knockout mice lack LFA-1-
dependent slow rolling (Section 1.2.3), as do L-selectin knockout mice (191), suggesting 
both molecules are required for the extension of LFA-1. Both Syk and the Src Kinase 
family members Fgr, Hck and Lyn were shown to interact with the L-selectin/PSGL-1 
complex in neutrophils, as shown by co-immunoprecipitation experiments with 
peptides representing the cytosolic tails of PSGL-1 and L-selectin (191). The activation 
of these kinases was assessed in neutrophils under shear stress by lysing adherent 
cells, immunoprecipitating the kinases and assessing their phosphorylation state (191). 
The kinases Fgr, Lyn, Hck and Syk were all phosphorylated following the interaction of 
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the cell with P- and E-selectin, but not in cells lacking L-selectin (191). Taken together 
these results suggest that both L-selectin and PSGL-1 are required for the activation of 
LFA-1 in neutrophils through their activation of Syk and Src family kinases. 
Antibody ligation of L-selectin in neutrophils has been shown to phosphorylate 
and therefore activate several tyrosine kinases, such as MAPK (192). In fact, activation 
of the p38 MAPK by L-selectin stimulation has been shown to be required for L-
selectin-dependent priming of degranulation in neutrophils (Figure 1.8, 3) (193). 
Another signalling pathway activated in neutrophils upon L-selectin stimulation leads 
to the activation of the transcription factor NF-κB. Using the L-selectin ligand 
sulphatide and by crosslinking L-selectin with antibodies this transcription factor 
becomes activated (194). It has previously been shown that NF-κB induces the 
transcription of TNF-α in the monocyte cell line Mono Mac 6 and Human Embryonic 
Kidney (HEK) cells (195,196) and sulphatide ligation of L-selectin in neutrophils also 
leads to expression of TNF-α (185). It is therefore possible that L-selectin induction of 
TNF-α expression in leukocytes involves the activation of NF-κB (Figure 1.8, 4). 
 Studies using T-cells have also been undertaken to gain insight into signalling 
pathways activated upon L-selectin stimulation. The most clearly defined pathway 
involves the tyrosine kinase p56lck, which is activated upon L-selectin cross-linking 
(197,198). It has been shown, following the activation of p56lck, that the Growth 
factor receptor-bound protein (Grb)/Son of sevenless (Sos) complex becomes 
associated with L-selectin (197) and this in turn leads to the activation of the Ras-
MAPK signalling pathway (197). Through the activation of this pathway superoxide 
generation (197) and cytoskeletal reorganisation (shown by a tenfold increase in actin 
polymerisation) both occur (Figure 1.8, 7) (199). Activation of p56lck is also involved in 
the activation of JNK via the Rac proteins (Figure 1.8, 8) (200), though the function of 
this kinase in L-selectin signalling remains unclear. L-selectin stimulation causes the 
translocation of the transcription factor family nuclear factor of activated T-cells 
(NFAT) (201). The Ras-MAPK pathway has been implicated in this process (201). The 
role of NFAT in L-selectin signalling is still being investigated, though it has been shown 
that L-selectin regulation of the cytokine colony-stimulating-factor-1 (CSF-1) 
expression is controlled through the translocation of NFAT (Figure 1.8, 6) (202). L-
selectin stimulation also leads to the increase in sphingomyelinase activity, which in 
turn leads to a release in ceramide (Figure 1.8, 5) (203). Ceramide is a secondary 
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messenger shown to modulate inflammatory responses by mediating TNF-α and IL-1 
activity (204) (205). Ceramide is also capable of stimulating the transcription factors c-
Myc and NF-κB (206,207), and thus may play a role in activating the adherent cell. The 
signalling pathway behind the sphingomyelinase activity remains unclear, though it is 
known that tyrosine kinase signalling is not involved (203).  
L-selectin signalling plays a role in chemokine signalling in lymphocytes. 
Ligation of L-selectin through antibody cross-linking and engagement of the ligands 
fucoidin and sulphatide has been shown to increase the surface expression of the 
chemokine receptor CXCR4 in T-cells (208) and natural killer (NK) cells (209). Analysis 
revealed that the increase in surface expression of this receptor was due to the 
mobilisation of internal stores of CXCR4 to the plasma membrane (Figure 1.8, 1) 
(208,209). It was also revealed that L-selectin ligation inhibited stromal cell-derived 
factor-1 (SDF-1) induction of the internalisation of CXCR4 (208), further increasing the 
surface levels of the receptor and its potential responsiveness to the chemokine. The 
higher levels of CXCR4 results in an increase in the adhesion and TEM of lymphocytes 
(208). Further evidence of the role of L-selectin in chemokine signalling was 
demonstrated by the fact that L-selectin ligation enhances the chemotaxis of murine T- 
and B-cells in response to the chemokine CCL21 (210). However, the mechanism 
behind this enhancement remains elusive, with results showing it is not a result of an 
increase in the expression levels of the receptor for the chemokine (CCR7), though the 
PKCs, MAPKs and the Syk family of kinases have been implicated in the chemotaxis 
mechanism (210). 
The examples above show the many different signalling roles of L-selectin, 
however, the molecular mechanisms of these processes remain elusive and more 
research is required to unearth the details of these pathways. Previous work by the 
Ivetic group has shown that, despite its short size, the cytoplasmic tail of L-selectin can 
accommodate both CaM and ERM in resting cells (3). This trimeric assembly is thought 
to play an important role in mediating signal transduction. Section 1.6 will discuss what 
is known about the formation of this complex, with the role of each individual protein 






















1.3.7 L-selectin binding partners 
 The cytosolic tails of E-, P- and L-selectin are the most divergent sub-domains, 
suggesting they may play unique roles in downstream signalling events. The tail of L-
selectin is composed of seventeen amino acids, with many basic residues (Figure 1.9). 
It has been reported that the tail is able to interact with several proteins, including α-
actinin, Calmodulin (CaM), the ezrin-radixin-moesin (ERM) family of cytoskeletal 
proteins (211,212) and PKC isozymes. In the following sections, each binding partner 
will be discussed individually in the context of how it might be involved in regulating L-
selectin function. As this thesis will focus on the interaction between L-selectin, CaM 
and moesin, these binding partners will be discussed in more detail in Sections 1.4 and 
1.5, with an emphasis on structure and binding mechanisms.  
 
Figure 1.8: Signalling pathways induced by L-selectin stimulation. A depiction of signalling 
pathways shown to be initiated upon L-selectin ligation. Pathways found in lymphocytes are 
indicated by a dotted boarder, those studied in neutrophils is highlighted by a dashed boarder 
and those in both are shown with a solid line. Numbers indicate the different pathways and are 
referred to in the text where the specific pathway is described. Where the components of the 
























 Studies have shown that α-actinin interacts with the last 11 amino acids of the 
cytosolic tail of L-selectin (213). Using the pre-B cell line 300.19, transfected with 
either full length or a truncated form of L-selectin lacking the last 11 residues of the 
cytosolic tail (213), it was shown through immunoprecipitation that α-actinin was co-
precipitated with full length but not the truncated form of L-selectin (213). When α-
actinin is not able to bind to L-selectin, reduced tethering and rolling were observed. α-
actinin is an actin-binding protein, so may be involved in connecting L-selectin to the 
cytoskeleton, which could be important for tethering and rolling (211,212). It is worth 
noting, however, that truncation of the last 11 amino acids of the L-selectin cytosolic 
tail may affect the interaction of the other binding partners. It is therefore possible 
Figure 1.9: Cytosolic tail of L-selectin. The seventeen amino acids that constitute the cytosolic 
tail of L-selectin are shown. Residues involved in the interaction with the different L-selectin 
binding proteins are highlighted, with residues important for CaM binding shown in blue, for 
ERMs shown in purple and α-actinin in red. The major functions of the interaction between L-
selectin and the proteins is shown, with CaM inhibiting L-selectin shedding, ERMs controlling 
localisation of L-selectin as well as having a role in shedding and tethering  and α-actinin 
shown to control leukocyte tethering in vitro. PKC isozymes are capable of phosphorylating 
and interacting with the two serine residues within the cytosolic tail of L-selectin. PKC 
interaction/phosphorylation of L-selectin has been implicated in shedding of L-selectin and 
activation of signalling pathways. 
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that the tethering defect observed with the truncated form of L-selectin is due to other 
L-selectin binding partners not interacting. By narrowing down the residues required 
for α-actinin binding specifically, the role of the interaction between this protein and L-
selectin can be fully investigated.   
 1.3.7.2 PKC Isozymes 
 Following the observation that the cytosolic tail of L-selectin was 
phosphorylated upon activation of the cell, Kilian et al (2004)(214) investigated which 
protein kinases were capable of interacting with and phosphorylating L-selectin. Using 
Glutathione S-transferase (GST)-tagged L-selectin cytosolic tail peptides to pull-down 
proteins from T cell lysates it was revealed that PKCs co-precipitated with the L-
selectin peptide and exhibited kinase activity. Analysis of which PKC isozymes were 
capable of interacting with L-selectin was undertaken by Western blot with isozymes 
specific antibodies. It was determined that PKCθ and PKCι interacted with L-selectin 
and were responsible for its phosphorylation (Figure 1.10) (214). Using serine to 
alanine mutated peptides, it was shown that these PKC isozymes were capable of 
phosphorylating both S364 and S367, however, there was a preference for 
phosphorylating S364 (214). Kilian et al (2004) further investigated whether 
phosphorylation of the L-selectin tail affected its ability to bind to PKCs, with the 
results showing that PKCθ binding was enhanced after phosphorylation and PKCα 
binding was induced (Figure 1.10) (214). It is therefore possible that phosphorylation 
of L-selectin by PKCs activates other PKC signalling pathways. 
 
1.3.7.3 Calmodulin (CaM) 
Several studies have shown that CaM is able to interact with the L-selectin 
cytosolic tail (215,216). Kahn et al (1998)(215) investigated the role of CaM binding to 
L-selectin using several CaM inhibitors, such as calmidazolium and trifluoperazine. 
They showed that L-selectin-dependent adhesion of lymphocytes to HEVs was 
disrupted in the presence of the inhibitors (215). It was determined that the disruption 
of adhesion was due to the down-regulation of L-selectin from the surface of 
lymphocytes and that this cleavage of L-selectin was caused by metalloproteases, as 
shown by the co-treatment of cells with metalloprotease inhibitors blocking the down-
regulation (215). This has led to the hypothesis that CaM binding prevents the cleavage 
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of L-selectin (211). However, how this is achieved remains unclear. A possible 
mechanism of regulation is phosphorylation of serine residues located in the cytosolic 
tail of L-selectin (Figure 1.10), a theory that is investigated in this thesis. Interestingly, 
CaM has been shown to bind to several different transmembrane domains and protect 
them from extracellular cleavage. Examples include PECAM-1 (217), ACE2 (218), GPIb-
IX-V (219,220), GPVI (221) and TIM-2 (222), clearly highlighting a role for CaM in 



















An interesting study undertaken by Deng et al (2011)(216) investigated the 
interaction between L-selectin and CaM in the presence of a lipid bilayer to identify the 
role of the plasma membrane in regulating the interaction. To carry out these 
experiments a peptide consisting of L-selectin transmembrane and cytosolic domains 
was synthesised and inserted into liposomes containing different phospholipid species. 
It was revealed that the cytosolic tail of L-selectin was in closer proximity to the 
surface of the membrane when the negatively charged phospholipid 
Figure 1.10: Hypothesis of CaM regulation of L-selectin shedding. In resting cells CaM interacts 
with L-selectin and protects it from shedding. Upon cell activation CaM dissociation occurs and L-
selectin is cleaved by ADAM17 at the extracellular cleavage site. A possible mechanism of CaM 
dissociation is phosphorylation of serine residues within the cytosolic tail of L-selectin by PKC 
isozymes, which have been shown to be activated upon leukocyte activation. The PKC isozymes θ 
and ι are able to phosphorylate the serine residues in the tail, with a preference for S364 (shown 
by the thicker arrow). Phosphorylation of the tail also leads to the binding of PKCα and PKCθ. 
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phosphatidylserine (PS) was present (216), presumably due to electrostatic 
interactions between positive amino acids in the tail and the negative charge of PS. 
This interaction was shown to block CaM association with the L-selectin cytosolic tail 
(Figure 1.11A) (216). Further investigation showed that ERM binding desorbs the L-
selectin cytosolic tail from the lipid bilayer and allows CaM to bind (Figure 1.11B, 
described in detail in Section 1.6) (223). It would be interesting to determine if this also 

















1.3.7.4 ERM Proteins 
Previous work in the Ivetic lab showed that moesin is able to interact with the 
tail of L-selectin, although the nature of this interaction was not defined. Affinity 
chromatography, using an L-selectin cytosolic tail peptide conjugated to sepharose, 
revealed moesin and ezrin were purified from lymphocyte extracts (224). The N-
terminal domain of the protein was found to be required for this interaction (224). The 
interaction between moesin and L-selectin was also studied in phospholipid-containing 
liposomes to assess the effect of the presence of the lipid bilayer on the interaction 
(223). Analysis revealed that moesin and L-selectin were capable of interacting when L-
Figure 1.11: The cytosolic tail of L-selectin interacts with phosphatidyl serine (PS) in the 
plasma membrane. A study has shown that when PS is present in the plasma membrane the 
cytosolic tail of L-selectin interacts with the plasma membrane (A) through electrostatic 
interactions between negatively charged PS and positively charged amino acids in the tail. This 
interaction inhibits CaM binding to the tail. The FERM domain of ERMs is able to interact with 
the cytosolic tail of L-selectin and desorb it from the plasma membrane (B). This in turn allows 
CaM to bind (C).   
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selectin was embedded into the liposomes (223). Studies have shown that residues 
R357 and K362 within the L-selectin tail are involved in the interaction with the FERM 
domain of moesin (211,225). Mutation of these amino acids in pre-B cells causes a 
reduction in microvillar localisation and tethering efficiency (225).  
 
1.4 CaM form and function 
CaM is a calcium binding protein, which acts as a cytosolic calcium receptor. It 
binds four calcium ions in response to extracellular signals, causing a conformational 
change and enables calcium bound CaM (CaM-Ca) to bind and activate its target 
proteins by causing further conformational changes in the target (226). 
1.4.1 Structure of CaM 
 The structure of CaM with and without Ca2+ has been solved by NMR and X-ray 
crystallography (227-229). The crystal structure of CaM-Ca reveals a dumbbell shaped 
molecule, approximately 65Å in length (Figure 1.12A) (226). The N- and C-terminal 
domains are globular lobes made up of two EF hands, each of which is able to bind one 
calcium ion. The two globular domains are separated by an eight turn α-helix (226). 
NMR structures showed that the central helix is highly flexible and that the tumbling of 
the two lobes is effectively independent of one another (230). Structural studies of the 
calcium free CaM (ApoCaM) showed a more compact structure compared with the Ca-
bound form, with a loss of the central helix (Figure 1.12B). In agreement with this CD 
spectroscopy showed that calcium binding causes CaM to become more helical (231). 
Structural rearrangements upon calcium binding causes hydrophobic surfaces on the 
globular domains to form on the surface and allow it to bind to target proteins (226). 
The exposure of these hydrophobic groups results in a release of energy, which can be 
transduced as a change in affinity for the CaM effector and/or an alteration in effector 
function (232). 
NMR and several spectroscopy methods have been used to elucidate the 
changes to CaM upon calcium binding. These studies determined that there is a two-
step conformational change observed and this shows that the binding domains have 
different affinities for calcium, with the C-lobe EF hands having a three-fivefold higher 
affinity for calcium compared to the N-lobe (232,233). Analysis has also revealed that 
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target protein binding also affects the affinity of calcium, with the KD for Ca2+ 
increasing in the presence of target peptides (226). 
 
1.4.2 CaM-Binding Proteins 
 CaM is able to bind to and regulate the activity of many different proteins. 
Studies of several CaM-binding proteins have shown that the CaM-binding domain is 
made up of fourteen to twenty six residues that are able to form a basic amphiphilic α-
helix. Interestingly, there is no consensus sequence to which CaM binds. Instead, 
varying motifs exist with several hydrophobic anchor residues which are embedded 
into the hydrophobic pockets of CaM-Ca (234). The nature of the binding motif is 
based on the spacing of the hydrophobic anchor residues (Table 1.3), with the spacing 
dictating the compaction of the structure of the complex. Many different spacings of 
the hydrophobic anchors can be accommodated due to the flexibility of the linker 
between the two lobes of CaM-Ca (234). 
 The canonical mechanism of CaM binding is highly conserved: both globular 
domains interact with the target peptide and end up in close proximity to each other, 
with the central helix being disrupted, forming a hydrophobic channel which is 
occupied by the helical target peptide.  An example of this recognition mechanism is 
shown in Figure 1.12C. Analysis of the interactions in the complex showed that the 
binding is mainly driven by hydrophobic interactions with some salt bridges also 
contributing to complex formation (226). Several protein kinases, phosphatases and 
secondary messenger generators have been shown to interact with CaM in this 
manner, including CaMKII, MLCKs (235), calcineurin (236), Ca2+-ATPase (237) and NO 
synthase (238) (though different spacings of the hydrophobic anchors are observed). 
CaM acts as a calcium sensor to activate these proteins. In the absence of Ca2+ the 
target proteins are unable to bind to their substrates as the binding site is blocked by 
an inhibitory domain. An influx of Ca2+ will lead to CaM-Ca interacting with the target 
protein and a conformational change is induced, which relieves the auto-inhibition and 
promotes activation (226). Phosphorylation has been shown to be important in 
switching off the target protein again. Many kinases are able to phosphorylate 
residues in the CaM-binding site and reduce the affinity of CaM for the site and inhibit 

























Variations of this canonical binding mechanism have been observed, involving 
an extended conformation of CaM. The crystal structure of CaM-Ca bound to 
calcineurin showed that CaM was in an extended conformation of 63 Å. Interestingly, it 
also showed that the complex was formed in a 2:2 manner, with two CaM molecules 
associating head to tail with each peptide bound between the N-terminal domain of 
one molecule and the C-terminal of the other (236). Munc13-1 was also shown to 
interact with extended CaM, but in this case with a 1:1 stoichiometry: here an 
amphiphilic helix of munc13-1 interacts with the C-terminal domain of CaM and a 
tryptophan residue is embedded in the hydrophobic cleft of the N-terminal domain, 
rather than the peptide sitting in a channel (239). Other examples of CaM binding in an 
Figure 1.12: Structure of CaM. (A) The X-ray structure of calcium bound CaM, calcium ions shown in 
orange. (B) The structure of Apo-CaM. (C) An example of the canonical binding method of CaM, 
with both lobes wrapped around the binding peptide (shown in cyan) (in this case MLCK). 






extended conformation include Bacillus anthracis edema factor (240), small-
















It has been observed that CaM is also able to bind proteins in the absence of 
calcium, but this interaction is sensitive to Ca2+ concentration. One example of this is 
neuromodulin, which binds CaM with a higher affinity in the absence of Ca2+ and 
dissociates in the presence of Ca2+ (232). It is suggested that neuromodulin acts as a 
CaM-trap which releases CaM into the cytosol when the Ca2+ concentration increases 
(243), though further investigation is required to confirm this. There are many 
examples of different CaM binding mechanisms that highlight the plasticity of CaM 
function, allowing it to regulate a vast array of proteins. 
 CaM is capable of interacting with the FERM domain of several proteins. The 
FERM domain of erythrocyte protein band 4.1R was shown to interact with CaM (244), 
having two CaM binding domains, one calcium-independent and one calcium-sensitive 
and that binding to both sites is required for regulation of 4.1R binding to its 
membrane protein targets (245). The kinase CAKβ contains a FERM domain which 
inhibits the kinase activity. CaM has been shown to bind the FERM domain and 
requires calcium for the interaction. The site of interaction was shown to be an α-helix 
present in the F2 lobe of the FERM domain. Binding of CaM-Ca causes activation of the 
Figure 1.13: Non-canonical binding mode of CaM. An example of CaM binding to a target 
protein in a non-canonical mode. The example shown is CaM-Ca binding to a NaV1.5 peptide 
(shown in cyan), with the C-lobe of CaM-Ca on the left. In this example, only the C-lobe of CaM-
Ca interacts with the target peptide. PDB id 4DJC. 
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kinase domain by promoting the formation of a CAKβ homodimer, which leads to 
trans-phosphorylation of CAKβ (245). Sequence alignment of the FERM domain of 4.1R 
with ERM proteins showed that the CaM binding sequence was not highly conserved, 
so it was thought that CaM would not be able to bind to ERMs (245). However, 
comparing the structures of the proteins show this site is structurally conserved, so 
CaM could interact with the ERM proteins, which was shown to be true and will be 





















CaM Binding Motif 
Spacing 
Example of Binding Partner Reference 
1-14 Myosin light chain kinase (246,247) 
1-5-10 CaM-dependent protein kinase II (248) 
1-10-16 CaM-dependent protein kinase (249) 
1-(10)-14 Death-associated protein kinase-1 (234) 
1-(8)-14 Olfactory CNG channel 2 (250) 
 Alpha-II spectrin (251) 
1-7-10 Calcineurin A1 (252) 
 NMDA receptor (253) 
1-5-11 TNF receptor 16 (234) 
1-18 Plasma membrane Ca2+-ATPase (254) 
1-10 CaV1.1 (255) 
 TNF receptor 6 (234) 
 TRPV1 (256) 
1-17 Ryanodine receptor 1 (257) 
1-(5)-10 CaV1.2 (258) 
 CaV2.1 (234) 
 CaV2.3 (234) 
A B 
Table 1.3 CaM binding motifs for the canonical binding method. A list different CaM binding 
motifs for the canonical binding method of CaM, where both lobes of CaM-Ca interact with 
the binding target. The motifs are defined by the spacings of the hydrophobic residues within 
the motif. Examples of proteins with the specified binding motif spacing are listed. 
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1.5 ERM proteins – form and function 
 The ERM family of proteins has three members: ezrin, radixin and moesin. All 
ERMs are structurally similar and have redundant and non-redundant functions. They 
are composed of three domains, an N-terminal FERM domain, an extended alpha-
helical domain and a charged C-terminal domain. The FERM domain is responsible for 
interactions with proteins the plasma membrane. The C-terminal domain binds F-actin, 
enabling ERMs to link the cytoskeleton with the plasma membrane (259,260). This 
means that ERMs play a crucial role in regulating alterations in shape, which often 
involve changes in the plasma membrane protrusions and the underlying actin-based 
cytoskeleton, as discussed later (Section 1.5.3). 
 
1.5.1 Structure and Regulation of ERMs 
ERMs transition between active and inactive states. The FERM domain interacts 
with the C-terminal domain, which adopts an auto-inhibited conformation and renders 
the molecule inactive (Figure 1.14A). Phosphorylation of a conserved threonine 
residue in the C-terminal domain, T558 in the case of moesin, disrupts this interaction 
and activates the protein (Figure 1.14B and C) (1,259,261). Many different kinases 
have been suggested to be responsible for the phosphorylation, including Rho kinase 
(262), PKCα and PKCθ (1,263). It is thought that these kinases may act in a cell-type 
and stimulus-specific manner. The FERM domain is capable of binding 
phosphatidylinositol bisphosphate (PIP2) in the plasma membrane and this binding has 
also been implicated in playing a role in activating ERMs (264). PIP2 binding between 
the F1 and F3 lobes is thought to induce a conformational change that renders the 
threonine residue more accessible for phosphorylation, which will inhibit the C-
terminal domain from re-binding to the FERM domain, allowing both terminal domains 
to bind to their target partners (1).   
 The FERM domains of the three ERM proteins share around 75% identity and 
are thought to be isoforms with both redundant and non-redundant functions (259). 
This was thought to be the case as moesin knockout mice had no discernable 
phenotype (265), possibly due to the other ERMs compensating for the loss (259). 
However, it is worth noting that the expression profile of ERM differs in different cell 
types, for example ezrin is abundantly expressed in epithelial cells.  This means that, 
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although the ERMs do have redundant functions, they may possess tissue specific 
expression, in which case they play non-redundant roles in specific cell types. This is 
evident in ezrin knockout mice, where intestinal villi formation is impaired due to the 
lack of ezrin in intestinal epithelial cells, with these mice not able to survive past 
weaning (266), with a similar defect in microvilli formation on retina cells also 
observed when ezrin was lacking (267). Moesin has also been shown to be essential for 
lung alveolar structure preservation following lung injury (268) and for efficient B- and 
T-cell egression from the primary lymph organs (269).  
The crystal structure of the FERM domain has been solved for all three 
members and has shown they are all very similar (259,270). The F1 domain is made up 
of a five-stranded mixed β-sheet packed against an α-helix with a short linker helix 
between β-strand 3; a structure resembling ubiquitin. F2 contains five α-helices with a 
long loop and short α-helix between B and C and this lobe resembles acyl CoA-binding 
protein. The F3 lobe is a sandwich of two orthogonal antiparallel β-sheets connected 
by a loop containing small helix, followed by a long helix. This is a phosphotyrosine-
binding (PTB)-like domain (259,270). 
The crystal structure of inactive moesin has been solved, confirming the site of 
the interaction between the FERM and the C-terminal domains (Figure 1.14A) 
(259,270). The data showed that the C-terminal domain is made up of a β-strand and 
four α-helices that adopt an extended structure which binds to the FERM domain 
covering a large surface of the F2 and F3 lobes (as shown in Figure 1.14A), which is the 
area responsible for binding to the cytoplasmic tails of cell adhesion molecules (see 
later) (259,270). Multiple contact sites form between the FERM and C-terminal 
domains, which collectively strengthen the auto-inhibited interaction (259,261). The 
threonine, which regulates the auto-inhibition, is located on the helix C of the C-
terminal domain and is in contact with the FERM domain. This means that 
phosphorylation of this residue will likely disrupt the interaction due to steric clashes 
as well as electrostatic effects (259,270). Crystal structures also show that the α-helical 
linker (shown in yellow in Figure 1.14) between the FERM and C-terminal domains sits 
between the F1 and F3 lobes. This has been shown to be the site occupied by PIP2. This 
means that PIP2 may be able to displace the linker, which may cause the 























Figure 1.14: Structure of ERMs. (A) Shows the crystal structure the inactive structure of ERMs, 
with the C-terminal domain (also referred to as COOH-ERM associated domain (CERMAD)) 
(red) bound to the FERM domain (blue). (B) The structural change that occurs upon activation 
of ERMs, with the bottom diagram showing the extended active protein structure. Images are 
taken from Fehon, R. G., McClatchey, A. I., and Bretscher, A. (2010) Organizing the cell cortex: 
the role of ERM proteins. Nat Rev Mol Cell Biol 11, 276-287 (1).(C) Depicts the activation 
mechanism of ERM proteins. Upon activation, the C-terminal domain is phosphorylated 
(shown by the red P), causing dissociation of the two domains. This allows the FERM domain to 
interact with plasma membrane associated proteins (shown in blue) and the C-terminal 





1.5.2 ERM-binding proteins 
Many proteins have been shown to bind to the FERM domain of ERM proteins. 
Many of these have been observed to be transmembrane proteins, with the FERM 
domain interacting with their cytosolic tails. L-selectin (see later), CD44 (271), CD43 
(272), ICAM-1, ICAM-2 (273) ICAM-3, and PSGL-1 (274) are all examples of this. The 
crystal structures of the FERM domain of radixin in complex with the cytosolic tails of 
ICAM-2, CD44 and PSGL-1 have all been solved. They showed that all three peptides 
bind at the same site, namely the groove between the β-sheet and the α-helix of F3 
(271,273,274). This provides us with a possible site for the interaction between FERM 
domain and the tail of L-selectin. Interestingly, analysis of the function of ERM 
interaction with CD43 (272) and PSGL-1 (275,276) showed the interaction was required 
for normal tethering, rolling and trafficking of leukocytes, similarly to observations 
made with L-selectin and ERMs (Section 1.3.7.4). 
 Other non-transmembrane proteins have also been shown to interact with 
ERMs FERM domain. The protein ERM binding protein 50 (EBP50) (which acts as a 
linker between ERMs and membrane proteins) (277), and protein kinases such as 
sodium-hydrogen exchanger 3 (NHE3) kinase A have been shown to interact with 
ERMs. Studies have revealed that ERMs are able to interact with proteins that control 
the Rho GTPase pathway, such as several guanidine nucleotide exchange factors (GEFs) 
(278) and GDP dissociation inhibitors (GDIs) (279), though analysis has found both an 
activating and inhibiting role of ERMs in this signalling pathway, suggesting the 
relationship is very complex and is reviewed elsewhere (280). Briefly, ERM proteins 
interact with RhoGDI and sequester it away from interacting with RhoGTPases, leading 
to their activation (280). Dbl is a RhoGEF which has been shown to interact with ezrin, 
facilitating the activation of the Rho family member Cdc42 (281). ERMs also interact 
with Sos, a GEF that activates members of the Ras family of small GTPases, implicating 
ERMs in activating Ras signalling pathways (282). 
1.5.3 Role of ERMs in Leukocyte Function 
 Studies have been undertaken to understand the role of ERM proteins in 
leukocyte function. ERM-deficient lymphocytes show defects in homing to lymphoid 
organs (283), with a decrease in resident B- and T-cells in the lymph nodes (269). 
Analysis suggests this is due to impairment in the egression of T-cells from the thymus 
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and B-cells from bone marrow (269). The role of L-selectin in lymphocyte recirculation 
is well established (see Section 1.7.1) and it is therefore possible that this requires the 
interaction with ERMs. Studies have also been carried out with constitutively active 
ezrin, which has been mutated to mimic phosphorylation of the threonine residue 
required for activation of the protein. These results also showed a reduction in the 
number of T-cells in the lymph nodes (284). This was accompanied with a reduction in 
T cell shape change in response to cytokines and reduced migration (284). This shows 
that dephosphorylation of ezrin is required for migration of leukocytes. This is likely 
due to the fact that dephosphorylation of ERMs has been shown to precede the 
retraction of trailing uropods (285), so by blocking ezrin dephosphorylation the uropod 
cannot retract and migration is impaired. 
  
1.6 The L-selectin/ERM/CaM Complex  
 Following the discovery that L-selectin was capable of binding to CaM and ERM 
proteins, it was of interest to decipher whether both proteins were capable of 
interacting with L-selectin simultaneously. Deng et al (2013)(223) showed in two 
separate reports that CaM and moesin were capable of interacting with a peptide 
representing the cytosolic tail of L-selectin ((216) and (223) respectively). As explained 
in Section 1.3.7.3 they also found that CaM could not interact with L-selectin when it 
was embedded in liposomes containing PS. Deng et al (2013) revealed that the moesin 
FERM domain (moesin-FERM) was able to interact with L-selectin embedded in 
liposomes even in the presence of PS and that this interaction increases the distance 
between the lipid bilayer and the L-selectin cytosolic tail (223). It was then shown that 
this desorption allowed CaM to bind and therefore moesin-FERM binding to L-selectin 
primed it for CaM binding (223).  
The trimeric complex was also studied using L-selectin cytosolic peptide 
attached to sepharose, preloaded with one of the proteins and results revealed the 
other was still able to bind (3). Further study in COS7 cells revealed that FRET was 
observed between CaM-RFP and ezrin FERM-GFP upon clustering of L-selectin (3). This 
led to molecular modelling of the complex, depicted in Figure 1.14 (taken from (3)), 
showing all three were capable of interacting with one another, with CaM and moesin-
FERM contacting specific residues within the cytosolic tail of L-selectin. The model also 
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predicted that significant contacts between CaM and moesin-FERM were present, 
independently of L-selectin, which was confirmed biochemically (3). Interestingly, the 
site of interaction predicted between CaM and moesin shows similarities with the site 
of interaction between CaM and band 4.1R, namely CaM forming contacts with α-helix 
one of F3 in the FERM domain of both moesin (3) and band 4.1R (245). The predicted 
binding site for L-selectin within the moesin-FERM structure was very similar to the 
binding site for the other transmembrane proteins shown to bind to ERM family 
members, as described in Section 1.5.2. This shows that the model of the predicted 
structure of the tertiary complex provides a good representation of the possible 
interaction; however, further experiments are required to prove that the predicted 
interactions occur.  
Killock et al (2009) postulated that the formation of the complex is likely to be 
important for controlling L-selectin-dependent signalling. The importance of the 
individual binding partners in regulating L-selectin function is highlighted above. It is 
possible that CaM and moesin interact with other proteins as well as L-selectin and 
therefore lead to the activation of signalling pathways. Intriguingly, as stated above, 
ERMs are able to bind to the Ras activator Sos. As explained in Section 1.3.6, L-selectin 
activation has been shown to activate the Ras-MAPK signalling pathway. It is therefore 
possible that ligand binding of L-selectin promotes the formation of a complex with 
ERM and Sos to activate Ras. This hypothesis becomes more appealing as CaM is able 
to bind to K-Ras (286) and it is therefore plausible that activation of L-selectin leads to 
the formation of the L-selectin/CaM/ERM complex and enables the activation of Ras by 

















1.7 L-selectin-dependent trafficking    
1.7.1 The role of L-selectin in Lymphocyte Recirculation 
 L-selectin is exclusively responsible for the recirculation of T- and B-cells 
through secondary lymphoid organs. Naïve lymphocytes are produced in the primary 
lymphatic organs (i.e. the thymus and bone marrow) (287). The cells then circulate 
through the blood and home to secondary lymphoid organs to patrol specific zones for 
antigen (287). For the cells to exit the bloodstream and enter the lymphoid organs 
requires the interaction between lymphocytes and specialised post-capillary HEVs 
(287). Studies using L-selectin function blocking antibodies have shown that when L-
selectin adhesion is inhibited, the interaction between lymphocytes and HEVs is 
blocked and lymphocyte migration does not occur (31). In vitro analysis revealed that 
lymphocytes lacking L-selectin were not able to bind HEVs (24). The role of L-selectin in 
the accumulation of lymphocytes in lymph nodes was assessed in vivo by comparing L-
selectin deficient and wildtype mice. Results showed that the number of lymphocytes 
in the peripheral lymph nodes was decreased by 99 % in mice lacking L-selectin (24). L-
selectin knockout mice also present decreased lymphocyte trafficking to mesenteric 
lymph nodes (88 %) and Payer’s Patches (50 %) (24). Taken together, these results 
clearly show the importance of L-selectin in lymphocyte homing. 
 
1.7.2 The role of L-selectin in the Recruitment of Leukocytes during the 
Inflammatory Response 
 In vivo experiments using L-selectin function-blocking antibodies showed a 
reduction in neutrophil recruitment to peritoneum (288), skin (289) and lung (290) 
after the induction of inflammation. The role of L-selectin in migration of leukocytes 
during inflammation was further confirmed in L-selectin knockout mice, with a marked 
Figure 1.15: Model of the tertiary complex between L-selectin, CaM and the FERM 
domain of moesin. A computer generated model predicting the possible complex of L-
selectin (yellow), CaM (purple) and moesin-FERM (cyan). The image is taken from Killock, D. 
J., Parsons, M., Zarrouk, M., Ameer-Beg, S. M., Ridley, A. J., Haskard, D. O., Zvelebil, M., and 
Ivetic, A. (2009) In Vitro and in Vivo Characterization of Molecular Interactions between 




reduction in the accumulation of neutrophils (56-62%), macrophages (72-78%) and 
lymphocytes (70-75%) in inflamed peritoneum relative to wildtype mice (24,291). The 
role of L-selectin in TEM following inflammatory stimuli has been assessed in post 
capillary venules in the cremaster muscle of mice superfused with the inflammatory 
mediators platelet-activating factor and keratinocyte-derived chemokine and 
monitoring TEM with intravital microscopy. The results revealed that the recruitment, 
rolling flux and adhesion of leukocytes was similar for both wildtype and L-selectin -/- 
mice (130). However, the emigration was lower for L-selectin-/- and the directional 
migration was reduced (130), showing L-selectin plays a role in migration towards 
inflammatory stimuli. It is also worth noting that L-selectin has also been implicated in 
sterile inflammation. An example of this is atherosclerosis and the contribution of L-
selectin in the development of this condition is described in Section 1.8.3. 
 
1.8 L-selectin in Disease States 
 L-selectin has been implicated in the development of several disease states, 
including atherosclerosis (292), rheumatoid arthritis (179) and ischemia reperfusion 
injury (293). In a majority of cases L-selectin-dependent recruitment of leukocytes is 
involved in exacerbation of the disease. This has been shown to be the case for IR 
injury, where induction of shedding of L-selectin by activating ADAM17 with hydrogen 
sulphide led to a reduction in the recruitment of neutrophils to ischemic tissue (293). 
Other examples of L-selectin involved in disease development include ileitis, where T-
cells expressing L-selectin have been shown to enhance disease development 
compared to L-selectin- /- T-cells (294) and in allogeneic skin graft rejection, with 
rejection shown to be delayed in L-selectin deficient mice due to a reduction in the 
recruitment of lymphocytes to the graft site (295). The role of L-selectin in 
development of type 1 diabetes was assessed using the non-obese diabetic (NOD) 
mouse model. Treatment of these mice with an antibody against L-selectin prevented 
the development of the disease (296,297). This is due to a reduction in the infiltration 
of lymphocytes to β islets (296). L-selectin has also been implicated in the metastasis 
of tumour cells (298). With L-selectin deficient mice, metastasis of tumour cells was 
attenuated (299,300). Leukocytes can interact with cancer cells in the bloodstream and 
anchor them on the endothelium, thereby enabling their metastatic spread (301). It is 
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therefore likely that the interaction between leukocytes and cancer cells is in some 
part regulated by L-selectin on leukocytes interacting with ligands on cancer cells. 
  
1.8.1 Atherosclerosis 
 Cardiovascular diseases (CVDs), such as atherosclerosis, have become highly 
prevalent in the developed world, causing an economic burden on society. Research 
has revealed that inflammation is a major driver of disease progression in 
atherosclerosis, with L-selectin-dependent recruitment of leukocytes shown to play a 
role (see below). The development of atherosclerosis (depicted in Figure 1.15) and the 
evidence of the involvement L-selectin in disease development are described below. 
 
1.8.1.1 Development of Atherosclerosis 
Atherosclerosis is the thickening of the arterial walls caused by the 
accumulation of lipoproteins in the vessels. The first stage of atherosclerosis is the 
formation of fatty streaks, which are caused by the accumulation of lipid-rich 
macrophages and T cells in the intima; the inner most layer of the arterial wall (302). 
The fatty streaks develop into intermediate plaques or lesions, which are defined by 
layers of macrophages and vascular smooth muscle cells (VSMCs) (302). Complex 
lesions then develop, which are larger in size and project into the lumen. They are 
composed of a lipid and necrotic debris core overlaid with VSMCs and have a dense 
fibrous cap formed by components of the connective tissues, such as collagen (302). 
These plaques are unstable and often rupture, causing occlusion of blood vessels to 
feed oxygen-rich blood to the brain or heart, leading to stroke or myocardial infarction.  
Lesions form in large and medium sized elastic arteries, which contain large 
amounts of elastin and collagen, and muscular arteries, which contain layers of VSMCs 
(303). They are also most often found at branch points in vessels, where the shear flow 
is disturbed (304). This disturbance leads to a reduction in the generation of NO (304). 
NO production can protect against the development of atherosclerosis by inhibiting 
leukocyte adhesion to the endothelium (305,306) and inhibiting VSMC proliferation 
and migration, both of which contribute to atherogenesis.  
Many different processes and cell types are involved in the development of 
atherosclerosis. Endothelial injury leading to dysfunction is thought to be an early step 
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in atherogenesis. Oxidized low density lipoproteins (oxLDL) deposited on the surface of 
the endothelium cause injury to the cells. This leads to the up-regulation of adhesive 
glycoproteins on the luminal surface (302),  leading to the recruitment of leukocytes to 
the area. VCAM-1 expression has been observed in early atheroma and mice deficient 
for VCAM-1 show reduced plaque development (304), showing the role of this 
molecule in atherogenesis. The role of leukocytes in the development of 
atherosclerosis is described below. In brief, monocytes recruited to the area 
differentiate into macrophages, which then engulf oxLDL and differentiate into foam 
cells, causing them to secrete cytokines and chemokines that recruit other monocytes 
and leukocytes, such as T-cells, to the site and exacerbate the inflammatory response. 
Endothelial cells also release growth factors that promote VSMC proliferation and 
migration (303), which leads to the formation of more complex plaques. VSMC change 
from a contractile phenotype to a synthetic phenotype, which enables them to 
respond to growth factors, proliferate and deposit ECM components such as collagen 
that contributes to the formation of a fibrous cap (302). 
Other processes apart from lipoprotein deposition are thought to enhance 
atherogenesis, either by causing endothelial dysfunction or promoting inflammation. 
Homocysteine is toxic to the endothelium and degrades structural components of the 
artery, such as collagen (303). High plasma levels of homocysteine have been linked to 
an increase the development of atherosclerosis (303). Hypertension can increase the 
risk of atherogenesis. Angiotensin II (AngII) levels are elevated in hypertension 
(303,304). AngII stimulates VSMC growth (303) and also increases the expression of 
VCAM-1 (304), both of which promote atherogenesis. Hyperglycaemia in diabetes 
leads to the release of pro-inflammatory cytokines, which potentially can induce 
atherogenesis (304). Diabetes also increases oxidative stress, which can lead to an 
increase in the formation of oxLDL and therefore enhance atherogenesis (304). 
Infection has also been implicated in atherogenesis. Herpes viruses and Chlamydophila 
pneumonia have both been found in lesions (303), though their role in atherogenesis 
remains unclear as the presence of these molecules alone does not induce the 
formation of atherosclerotic plaques (303). It is possible that infections accelerate 
atherogenesis by causing release of cytokines and activating leukocytes at the site of 
plaques (304). Further investigation is required to decipher the role of infectious 











1.8.1.2 Role of Leukocytes in Atherosclerosis 
 Atherosclerosis is characterised by chronic inflammation and abundant 
immune cells are found in atherosclerotic plaques, especially macrophages and T-cells, 
implicating these cells in the development of atherosclerosis. Due to lipid 
accumulation and other stimuli, monocytes are allowed to cross the endothelium and 
differentiate to macrophages (307-310). Pattern recognition receptors (PRRs) 
expressed by macrophages recognise oxLDL, which leads to its uptake (307,311). As 
lipid accumulates in macrophages they transform in to foam cells (called according to 
their appearance), many of which will die (307). Lipid accumulation also induces 
macrophages to release netrin-1, which blocks the migration of macrophages out of 
the lesion (307,312). When netrin-1 is deleted smaller plaques develop (312). 
Macrophages also enhance atherosclerosis development by secreting cytokines that 
Figure 1.16: Development of atherosclerosis. A schematic showing the stages of atherogenesis. 
OxLDL deposition leads to endothelial dysfunction and the recruitment of monocytes to the 
vessel wall. The monocytes differentiate into macrophages that ingest the LDL, become foam 
cells and, overwhelmed with lipid, die through the process of necrosis. Vascular smooth muscle 
cells proliferate and migrate to form a fibrous cap, along with components of the connective 
tissues, such as collagen, over the necrotic cells. During plaque development angiogenesis occurs 
to form microvessels within the plaque. As atherosclerosis progresses the lesion grows in size, 
becomes unstable and ruptures. This leads to a rapid block in the vasculature, blocking the vital 
supply of oxygen to the heart and/or the brain, which will lead to myocardial infarction and/or 
stroke. Figure taken from Orbay, H., Hong, H., Zhang, Y., and Cai, W. (2013) Positron emission 
tomography imaging of atherosclerosis. Theranostics 3, 894-902 (5). 
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attract other leukocytes, disturbing VSMC function and producing proteinases that 
digest the ECM, which can cause thinning of the fibrous cap covering the lesion and 
leads to plaque rupture (304) (307). 
 T-cells have also been found in atherosclerotic plaques and have been shown to 
account for 10-20% of the total leukocyte population (310). Different subsets of T-cells 
are believed to have different roles in atherosclerosis. Both TH1 and TH17 have been 
shown to be atherogenic and TH2 and Treg cells are protective (307,313,314). Recent 
research showed that T-cells produce heparan-binding epidermal growth factor-like 
growth factor (HB-EGF) in vitro and these proteins act as mitogens to stimulate VSMC 
proliferation (315). This may have a role in VSMC proliferation in atherosclerosis. 
 B-cells have also been implicated in atherosclerosis. They produce natural 
antibodies that recognise oxLDL (310) and this is thought to be atheroprotective as it is 
suggested that these antibodies mark lipids for removal (307). Neutrophils have been 
shown to be atherogenic by releasing proteins that contribute to oxidative stress, 
which leads to endothelial dysfunction and the growth of the plaque (307). Mast cells 
have been shown to accumulate at sites of plaque rupture (310,316). They are capable 
of producing proteases that degrade the ECM and it is possible that this contributes to 
plaque rupture and progression of atherosclerosis (316). 
 The information above shows the role of different leukocytes in the 
development and protection against atherosclerosis. This shows how important 
understanding their function in this process is and studying their roles further will 
provide targets for the prevention of atherosclerosis development. 
  
1.8.1.3 Implication of L-selectin in atherosclerosis  
 The role of L-selectin in the development of atherosclerosis has been disputed. 
A report has shown that advanced plaques contain “lesional microvessels”, produced 
in response to hypoxic necrosis.  These microvessels promote lesion growth by 
providing a nutrient supply and also contribute to plaque rupture by causing 
haemorrhage within in the plaque, increasing the lipid core and increases plaque 
development (317). Microvessels act as important entry sites for leukocytes to gain 
access to the plaque. Rolling within these microvessels was observed and studies 
showed that L-selectin was required for recruitment. Interestingly, PSGL-1 was found 
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to be the primary ligand on the endothelium (292), and shows a direct link between L-
selectin-dependent trafficking of leukocytes to a developing atheromatous plaque. It 
has also been observed that L-selectin-dependent secondary tethering (see Section 
1.2.1 on secondary tethering) occurs in atherosclerotic plaques in the aorta of mice 
(318). It is possible that this secondary tethering increases the leukocyte recruitment 
to atherosclerotic plaques and therefore enhances plaque development. A study using 
L-selectin-/- mice revealed that recruitment of both B-cells and T-cells to 
atherosclerotic plaques in the aorta was reduced by around 50% (319). This shows that 
L-selectin is partially responsible for the recruitment of leukocytes to atherosclerotic 
plaques. 
 The above results showed that L-selectin played a role in the development of 
atherosclerosis, however, another study has shown that the deletion of L-selectin in 
ApoE-/- mice increased the development of atherosclerosis (320). It was observed that 
more plaques were present in ApoE-/- L-selectin-/- compared to ApoE-/- mice (320), 
suggesting L-selectin does not play a role in plaque formation and rather acts to limit 
plaque burden. When analysis was carried out to decipher the reason for the increase 
in plaque formation, it was found that there was no difference in leukocyte capture, 
rolling or accumulation in plaques between the two groups (320), suggesting the other 
selectins are capable of maintaining the leukocyte-endothelial interaction. There was, 
however, an increase in the number of lymphocytes found in the blood in the ApoE-/- L-
selectin-/- mice, likely due to impaired migration into tissues (320). It is argued that this 
increase in circulating pro-atherogenic lymphocytes promotes the enhanced 
atherogenesis (320), though the exact mechanism by which this occurs remains 
elusive. It is worth noting that location of the plaque size measurement and the 
cellular composition of the plaques are measured in different locations, with them 
being measured in the descending aorta and aortic sinuses respectively (320). Ideally 
these two characteristics would be measured in the same location before firm 
conclusions for the role of L-selectin in atherogenesis can be made.  
 
1.9 Selectins as therapeutic targets 
 The well-defined role of selectins in leukocyte recruitment and the evidence of 
their involvement in disease states made them attractive prospects for possible anti-
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inflammatory targets. To this end, several clinical trials have been undertaken using 
function blocking antibodies and synthetic ligands. Early analysis revealed that anti-L-
selectin antibodies reduced inflammation and myocardial necrosis in murine models 
(321). However, a clinical trial using an L-selectin function blocking antibody, named 
aselizumab, had limited success against recovery from trauma, with no significant 
benefit with the administration of the drug in Phase II trials (322). sLex mimics have 
also been utilised as a way of inhibiting all three selectins (323). Promising results have 
been observed with the treatment of asthma (324) and psoriasis (325), but had no 
effect on IR injury in infants in phase III trials (323), showing different roles of selectins 
in different diseases. A soluble form of recombinant PSGL-1 conjugated to IgG1 (PSGL-
1-Ig) has been developed as a potential inhibitor of selectins. PSGL-1-Ig is capable of 
inhibiting leukocyte rolling in a murine model on all three selectins (326). It has also 
been shown to inhibit inflammation in rat and mouse models of inflammation, 
including trauma, haemorrhagic shock and IR (327-329). However, clinical trials were 
discontinued due to the cost and the limited efficacy of PSGL-1-Ig (330). Several small 
molecules have also been tested as possible therapeutic inhibitors of selectins. Heparin 
is able to bind to P- and L-selectin and inhibit their interactions (331). A study has 
shown that heparin blocks selectin-dependent cancer metastasis (331). 
 The limited success of clinical trials using selectin antagonists may suggest the 
complex role of selectins in disease states. Further understanding the mechanisms that 
regulate selectin function during recruitment may provide more targets for the 
development of more potent therapies. This thesis will endeavour to explore the 
regulation of L-selectin in order to add insight to such approaches.   
 
1.10 Original Hypothesis 
 Interaction between the L-selectin tail and its binding partners plays a critical 
role in regulating L-selectin-dependent adhesion and signalling. Specifically, CaM 
binding protects L-selectin from being shed and interaction with ERM regulates L-
selectin-dependent tethering and shedding. Although these interactions have been 
addressed during tethering and rolling, very little is known about how these 
interactions are co-ordinated during TEM. It is therefore hypothesised that monocyte 
TEM is regulated at the level of L-selectin and its interaction with CaM and ERM. 
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Understanding how these interactions are co-ordinated may identify novel 
mechanisms for therapeutic targeting chronic inflammation. 
1.11 Aims of the Project 
 The aims of this thesis are as follows: 
1) Produce recombinant soluble CaM and FERM domain of moesin proteins in 
order to study the interaction between these proteins and L-selectin cytosolic 
tail peptide in vitro.  
2) Use biophysical techniques to characterise the interaction between the L-
selectin tail and its binding partners, and assessing the role of serine 
phosphorylation in modulating the interaction.  
3) Generate monocytic cell lines to co-express GFP/RFP-tagged forms of CaM and 
L-selectin, so that their interaction can be analysed in resting cells.  
4) Characterise the interaction between CaM-RFP and L-selectin-GFP during TEM 
and determine: (i) the sub-cellular distribution of L-selectin-GFP and CaM-RFP 
interaction specifically during TEM; (ii) the effect of blocking phosphorylation at 
one or both serine residues within the cytosolic tail of L-selectin on the L-
selectin-GFP/CaM-RFP interaction during TEM; (iii) if changes in cell 
morphology during TEM are directly affected when specific residues within the 




Chapter 2: Materials and Methods 
2.1 Chemicals and Reagents 
 A list of the chemicals and reagents used in this thesis is shown in Table 2.1 
 Chemical/Product Supplier 
Cell Culture RPMI media Life technologies 
 M199 media Life technologies 
 Penicillin/Streptomycin Life technologies 
 FBS Sigma Aldrich 
 Β-Mercaptoethanol Sigma Aldrich 
 Trypsin-EDTA Sigma Aldrich 
E.coli growth LB media Sigma Aldrich 
 LB agar Sigma Aldrich 
 Ampicillin Sigma Aldrich 
Buffers and Solutions Nuclease Free Water Ambion 
 PBS Severn Biotech Ltd 
 HEPES Life Technologies 
 BSA Sigma Aldrich 
 MES 20X Invitrogen 
 Transfer Buffer 10X Life Technologies  
 Tris-Glycine Native running 
buffer 10X 
Life Technologies 
 Protein Ladder Life Technologies 
 Native Protein Ladder Life Technologies 
 ECL Perkin Elmer 
Chemicals PFA BDH Laboratory Supplies 
 Glutaraldehyde VWR international 
 NP-40 Fluka, Sigma Aldrich 
 Tween 20 Sigma Aldrich 
 Protease inhibitor cocktail Roche  Diagnostics GmbH 
 DMSO Sigma Aldrich 




 Sodium Borohydride  Sigma Aldrich 
 Nitrogen15 NH4Cl Goss Scientific, 
Manufacturer Cambridge  
Isotope Laboratories Inc. 
 D2O Goss Scientific, 
Manufacturer Cambridge  
Isotope Laboratories Inc. 
 Calyculin A Sigma Aldrich 
 Bisindolylmaleimide Calbiochem  






 A list of the primary and secondary antibodies used in this thesis is provided in 
Table 2.2, along with the concentration at which each is used. 
Antibody Species Dilution Factor Company 
Anti-CaM mouse 1:1000 Millipore 
Anti-GFP  rabbit 1:500 SantaCruz 
CA21:anti- L-selectin tail mouse 1:1000  
Anti-Actin goat 1:1000 Santa Cruz 
Goat-anti-mouse-HRP goat 1:1000 DAKO 
Goat-anti-rabbit-HRP goat 1:1000 DAKO 




2.3 Peptides and plasmids 
 Peptides were synthesized at the department of Biochemistry, University of 
Bristol. For E. coli production of proteins the pET duet-1 vector was used (Figure 2.1). 
Table 2.2: Antibodies used during this project. Table shows the primary and secondary 
antibodies used in this thesis. The source, concentration used and the company that supplies 
each antibody is listed. 
 
Table 2.1: List of Reagents used during the project. Table shows the reagents and chemicals used 
in this thesis. The supplier of each reagent is listed. The concentrations used are stated in the 
specific sections in the Material and Methods.  
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Wildtype cDNA of full length CaM was cloned into multiple cloning site (MSC) 1 of the 
pETduet-1 vector. SalI and NotI restriction sites were engineered at the 5’ and 3’ ends 
using PCR for the Hexa Histidine (His6)-tagged CaM with a Tobacco Etch Virus (TEV) 
protease cleavage site engineered between the coding sequence of CaM and the His6-
tag. The His6-tagged moesin-FERM domain was cloned in the same way. Untagged 
moesin-FERM was also cloned into pET duet-1 vector at MSC 2 using the restriction 
enzymes NdeI and XhoI. A vector containing untagged CaM was a kind gift from 
Antonio Villalobo. CaM was also purchased from Enzo. The N and C lobes of CaM were 
cloned into pET duet-1 vector at MSC 2 using NdeI and XhoI restriction sites.  
The pET46 Ek/LIC vector (Figure 2.2) containing the Trp-Cage sequence (Figure 
2.2Aiii) was a gift from Dr Pete Simpson, Imperial College London. The L-selectin 
cytosolic tail was cloned into the vector using EcoRI and BaMHI restriction sites. 
 For lentiviral vector production, the pHR’SIN-SEW vector, which was a gift from 
Prof. Adrian Thrasher (Institute of Child Health, UCL), was used with either GFP or RFP 
C-terminal tag (Figure 2.3). For CaM cloning into the vector, BaMHI and XhoI restriction 
sites were engineered at the 5’ and 3’ ends using PCR. Moesin was cloned with XhoI 
and KpnI restriction sites at the 5’ and 3’ ends. Ezrin was cloned with either XhoI and 
SalI or XhoI and KpnI restriction sites at the 5’ and 3’ end depending on the method of 





















Figure 2.1: Vector Maps of the Plasmids used for Cloning of Recombinant Proteins. (Ai) 
Vector map of pETDuet-1 showing the two multiple cloning sites (MCS) and the restriction 
sites found in each, with the details of the cloning site shown in (Aii). There is also Ampicillin 










Figure 2.2: Vector Map of the Plasmid used to Clone Trp-Cage-L-selectin. (Ai) The vector 
map of pET-46 EK/LIC vector with the ampicillin resistant gene (Ap) and lacI gene shown. 
(Aii) shows the detail of the cloning site into which the Trp Cage was cloned, with (Aiii) 
showing the sequence cloned into the site, including the Trp Cage, a TEV cleavage site and 














2.4 E.coli Strains 
 KRX E.coli cells (genotype F´, [traD36, ΔompP, proA+B+, lacIq, Δ(lacZ)M15] 
ΔompT, endA1, recA1, gyrA96 (Nalr), thi-1, hsdR17 (rK–, mK+), e14– (McrA–), relA1, 
supE44, Δ(lac-proAB), Δ(rhaBAD)::T7 RNA polymerase) were used for cloning of the 
DNA vectors. The strains BL21(DE3)pLysS (genotype F– ompT hsdS(rB– mB–) gal dcm 
λ(DE3) pLysS (Camr )  ( λ(DE3): lacI, lacUV5-T7 gene 1, ind1, sam7, nin5 )) and 
Rosetta2(DE3) (genotype F-ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE2 (CamR))were 
used for protein expression. For proteins found to be insoluble with BL21(DE3)pLysS 
and Rosetta2(DE3) cells, expression was carried out using E.coli ArcticExpress cells 
(genotype F–ompT hsdS(rB– mB–) dcm+ Tetr gal (DE3) endA Hte [cpn10 cpn60 Gentr]). 
All the E.coli strains used for protein expression contain the DE3 bacteriophage γ 
lysogen, which encodes for T7 RNA polymerase under the control of a lacUV5 
promoter and the lacI gene. This allows provides a system for the control of 
expression of the recombinant protein, through the addition of IPTG (see Section 
3.2 for details). 
 
2.5 PCR 
PCR amplification of the desired DNA was carried out using the following 
method for Pyrococcus furiosus (Pfu) DNA polymerase: 1 μl of each primer (10 μM), 
100 ng of template, 1 μl dNTPs, 5 μl of Pfu polymerase buffer and 1 μl of Pfu 
Figure 2.3: Vector Maps of the Plasmids used for Cloning of Lentiviral Vectors.  (A) Vector 
Map of pHR’SIN-SEW showing the cloning site for either GFP containing vector or RFP 
containing vector. (Ai) shows the cloning site of the vector with the GFP sequence and (Aii) 
shows the cloning site for the vector containing RFP. The restriction sites are highlighted in 
different colours, with BamHI shown in red, XhoI shown in blue, KpnI shown in yellow and 








polymerase, made up to a final volume of 50 μl and placed in a thermo cycler 
(Perkin Elmer, GeneAmp 34 PCR System 2400) using the following conditions: hot-
start denaturation 95°C 5 min, followed by 25 cycles of denaturation 95°C 30 
seconds, annealing 55°C 40 seconds, elongation 72°C (30 seconds per 500 bp), with 
72°C 2 min end. For Thermococcus kodakaraensis (KOD) polymerase: 1.5 μl of each 
primer, 0.5 μl of template and 25 μl KOD polymerase mix made up to 50 μl and 
placed in a thermo cycler using the following conditions: hot-start denaturation 
95°C 5 min, followed by 25 cycles of denaturation 95°C 20 seconds, annealing 55°C 
14 seconds, elongation 75°C (15 seconds per 1kb). PCR products were run on a 0.8-
1% agarose gel, cut out and purified using QIAquick Gel Extraction kit (Qiagen) or 
Wizard® SV Gel and PCR Clean-Up System (promega) according to manufacturer’s 
protocol. All primers used are summarised in Table 2.3. 
 
 







































Table 2.3: Primers for cloning of Recombinant and Lentiviral Proteins. Table showing the primers 
used for the PCR of CaM and moesin-FERM for cloning into pET duet-1 vector and cloning CaM, 
moesin and ezrin into the lentiviral vector pHR’SIN-SEW. 
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2.6 Restriction Digest and Ligation 
 The clean PCR product and the vector were cut with the appropriate 
restriction enzymes for 2 hours at 37 °C. The vector was also treated with Calf 
Intestinal Alkaline Phosphatase (CIP) for one hour at 37 °C and the DNA was purified 
using QIAquick Gel Extraction kit (Qiagen) or Wizard® SV Gel and PCR Clean-Up 
System (promega) according to manufacturer’s protocol. The ligation was carried 
out with a molar vector to insert ratio of 1:3 with T4 DNA ligase (Promega) in a 10 
μl reaction at 15°C overnight and was then used to transform KRX E.coli cells. 
2.6.1 Partial Digestion of Ezrin Insert 
 After the ezrin PCR reaction, 10 μl of the product was digested with the 
restriction enzyme which does not cleave in the ezrin sequence as described above. 
Once the first digestion was completed the reaction was diluted up to 100 μl using 
dH2O and the appropriate restriction enzyme buffer. The solution was then 
aliquoted into five tubes. The second restriction enzyme was added to the first tube 
and a serial dilution using this solution was carried out into the other tubes. All the 
tubes were then incubated at 37 °C for 3 minutes. The tubes were then pooled and 
purified using the QIAquick column system. The purified DNA was run on an 
agarose gel and the band corresponding to the correct weight for the desired 
product was excised and purified using QIAquick Gel Extraction kit (Qiagen). The 
purified DNA was then used for ligation as described above. 
 
 2.7 Transformation and plasmid detection 
 50 μl of bacteria was incubated with 1 μl of plasmid DNA or 5 μl of ligation 
reaction for 45 mins on ice. The bacteria were then heat shocked at 42 °C for 45 
secs. 500 μl of LB was added and the cells were incubated for one hour at 37 °C 
shaking. The cells were then plated on LB plates with the appropriate antibiotic and 
incubated overnight at 37 °C. Colonies were picked for colony PCR, to test if the 
insert is present, and grown for plasmid isolation using PureYield™ Plasmid 
Miniprep Kit (Promega) according to the manufacturer’s protocol. The plasmid was 
then sent for sequencing by Geneservice to confirm the presence of the insert. 
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2.8 Glycerol Stock Generation of Transformed E.coli Cells 
 To produce frozen stocks of the E.coli cells expressing the recombinant 
proteins, 3 ml of E.coli cells were cultured overnight. The overnight culture was 
mixed 1:1 with 100 % sterile glycerol and kept on ice. The vials were then 
transferred to -80 °C for long time storage and could be used for inoculating future 
growth cultures. 
 
 2.9 Agarose Gel Electrophoresis 
 0.8-1% agarose Tris-acetate-EDTA (TAE) gels were made with 1:1000 
ethidium bromide. DNA samples were mixed with loading buffer (0.25% 
bromophenol blue, 0.25% xylene cyanol FF, 30% glycerol) and loaded on the gel. 
The gel was run at 120 V until bands were separated. DNA was visualized by UV 
transillumination.  
 
2.10 Oligonucleotide Kinase Treatment and Annealing 
 Oligonucleotides (oligos) for the L-selectin cytosolic tail were designed with 
EcoRI and BamHI sticky ends (Table 2.4). The oligos were treated with 
polynucleotide kinase in the following reaction: 1 μl kinase buffer, 1 μl 10 mM ATP, 
2.5 μl kinase, 2 μg oligo. The reaction was incubated at 37 °C for 1 hour and then 
heated to 75 °C for 10 minutes to deactivate the kinase.  The kinase treated oligos 
were mixed in a 1:1 molar ratio in annealing buffer (10 mM tris, 1 mM EDTA, 100 
mM NaCl, pH 7.5) the mixture was heated to 95 °C for 5 minutes then left to cool to 
room temperature overnight. The annealed oligos were then used for ligation into 
the restriction digested vector. 
 
 










Table 2.4: Oligonucleotides used to clone L-selectin Cytosolic Tail. Oligos were annealed together 
(see Section 2.10 for experimental details) and used for ligation as described in Section 2.6. 
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2.11 Mutagenesis of L-selectin cytosolic tail 
pHR’SIN-SEW vectors containing the cDNA of human wildtype L-selectin, or 
the sheddase-resistant mutation ΔM-N-L-selectin, fused with GFP were used as the 
templates for generating mutations in the cytosolic tail of L-selectin at residue L358 
to L358E. PCR was carried out using primers engineered to contain the mutation 
(see Table 2.5), followed by digestion with DpnI for one hour at 37 °C, to remove 
the methylated parental DNA which did not contain the mutation. The digested PCR 
product was then used to transform BL21 competent E. coli. Colonies were picked 
and cultured overnight. Minipreps were carried out and DNA was sent for 
sequencing to confirm the presence of the mutation. Once this was confirmed the 






2.12 Production of Recombinant Proteins  
2.12.1 Overexpression of Recombinant Proteins  
 CaM, moesin-FERM and the N and C lobes of CaM were expressed in either 
BL21  strain (Stragene) or Rosetta II strain (Novagen) E.coli cells and moesin and C-
CaM were also expressed in arctic cells (Agilent Technologies). For large scale 
production of the proteins, two litres of bacteria were cultured. For the starter 
culture a colony was picked from an agar plate or cells were taken from glycerol 
frozen stocks and diluted in 3 ml of lysogeny broth (LB) with the appropriate 
antibiotics. The starter culture was then grown overnight at 37 °C with agitation. 
The next morning 1 ml of the starter culture was used to inoculate 1 L of LB. The 
cells were then grown at 37 °C under agitation until an optical density measured at 







Table 2.5: Primers used for mutagenesis of L-selectin. The primers used to produce the 




600 nm (OD600) of 0.6 was reached. At this point 1 ml of 1 M isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to the 1 L of bacterial culture, so a final 
concentration of 1 mM IPTG was achieved,   in order to induce expression of the 
recombinant protein. The bacterial growth and protein expression conditions for 
















2.12.2 Production of Soluble Protein 
After growth and induction, the cells were pelleted by centrifugation 
(Beckman Avanti J-26XP centrifuge with a JLA-8.1000 rotor) at 2500xg for 20 
minutes. The pellet was re-suspended in the appropriate buffer (depending on the 
purification method to be used). The solution was then sonicated for three minutes, 
amplitude 30%, pulsing five seconds on five seconds off, repeated twice. The 
soluble and insoluble fractions were separated by centrifugation at 20000xg using a 
Beckman Avanti J-26S centrifuge with a JA-18 rotor for one hour. 
To improve the amount of soluble protein, the Sarkosyl method was used on 
the insoluble fraction produced after sonication and centrifugation. This method 







CaM 37 4 
Moesin-FERM 37 4 
 18 12-16 
 13 24 
N-CaM 37 4 
 18 12-16 
C-CaM 37 4 
 18 12-16 
 13 24 
Table 2.6: Growth and expression conditions of E.coli cells expressing recombinant 
proteins. A table summarising the temperature and length of time used for the induction of 
the recombinant proteins. 
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(see Section 3.3.2 for an explanation). The pellet was re-suspended in 2 ml of 10 % 
sarkosyl solution and was left on ice for one hour. The sarkosyl solution was then 
diluted to 1 % with the appropriate buffer required for protein purification up to 20 
ml. The solution was centrifuged at 20000xg for 45 minutes. The supernatant was 
then collected and used for purification. 
2.12.3 Hexahistidine-tag (His6-tag) Purification 
  For the recombinant proteins expressed with a His6-tag, purification was 
carried out using a nickel column attached to an AKTA system. The E.coli cells were 
suspended in nickel buffer A (20 mM Tris pH 8, 10 mM imidazole, 300 mM NaCl, 5% 
glycerol) prior to sonication and centrifugation. The soluble fraction was then 
loaded onto a 5 ml nickel column pre-equilibrated with nickel buffer A. The column 
was washed with thirty column volumes (CV) of nickel buffer A and proteins were 
eluted using a concentration gradient of nickel buffer B (20 mM Tris pH 8, 500 mM 
imidazole, 300 mM NaCl, 5% glycerol) from 0 to 100% in 25 CV. Fractions containing 
the protein of interest identified using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) gel (see Section 2.16.1 for details) were collated and 
underwent TEV protease cleavage, to remove the His6-tag, during dialysis in TEV 
cleavage buffer (50 mM Tris pH 8, 1 mM EDTA, 1 mM DTT, 50 mM NaCl) and the 
protein solution was passed through the nickel column once again to remove the 
His6-tagged TEV protease, the His6-tag and any uncleaved product. CaM was then 
dialysed in NMR buffer (20 mM Tris, 100 mM KCl, 1 mM DTT, and 1 mM EDTA pH 
7.25) or the same buffer plus 5 mM CaCl2 for Ca2+ bound CaM (CaM-Ca). The 
protein was then concentrated to the desired concentration. 
 
2.12.4 Hydrophobic Interaction Chromatography Purification of CaM 
and CaM lobes 
 Untagged CaM and the lobes of CaM were purified using a phenyl sepharose 
column. The soluble fraction was prepared as before except the E.coli pellet was re-
suspended in 50 mM Tris pH 7.5 and 2 mM EDTA prior to sonication, with 5 mM 
CaCl2 added after centrifugation. A 5 ml phenyl sepharose column attached to the 
AKTA system and pre-equilibrated with 50 mM Tris pH 7.5, 5 mM CaCl2, 0.1 M NaCl 
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(known as pre-equilibration buffer). The supernatant containing the recombinant 
protein was loaded onto the column, after which the column was washed with 1st 
wash buffer (50 mM Tris pH 7.5, 0.1 M CaCl2, 0.1 M NaCl) until UV absorption at 280 
nm was constant. It was then washed with 2nd wash buffer (50 mM Tris pH 7.5, 5 
mM CaCl2, 0.5 M NaCl) again, until a constant UV absorption at 280 nm was 
observed. CaM was eluted from the column with 50 mM Tris pH 7.5 and 1 mM 
EGTA (elution buffer). Fractions containing CaM were dialysed in either NMR buffer 
with 5 mM CaCl2 or NMR buffer with 5 mM EGTA, then NMR buffer.  
 
2.12.5 Purification of untagged Moesin-FERM 
 The soluble fraction of E.coli expressing moesin-FERM domain was produced 
as above, except the bacteria pellet was re-suspended in hydroxyapatite buffer A 
(200 mM potassium phosphate pH 7) prior to sonication. The soluble fraction was 
loaded onto a hydroxyapatite column pre-equilibrated with hydroxyapatite buffer 
A. The column was then washed with 10 CV of buffer A and the protein was eluted 
with 5 CV hydroxyapatite buffer B (600 mM potassium phosphate buffer pH 7). The 
protein was the dialysed in potassium phosphate buffer (17.4 mM KH2PO4, 27 mM 
Na2HPO4 at pH 7) or 100 mM sodium acetate buffer and then concentrated to the 
desired concentration. 
 
2.13 Purification of Peptides 
 The peptides purchased from Bristol University were purified using PD 
MidiTrap G-10 desalting columns. The column was equilibrated with 16 ml dH2O, 
then 1 ml of peptide dissolved in dH2O was loaded onto the column, followed by 
0.7 ml of dH2O and this was allowed to completely enter the packed bed. The 
peptide was eluted in 1.2 ml of distilled H2O. The solution was then freeze dried and 






2.14 Concentrating Proteins 
 Proteins were concentrated using Amicon Ultra-15 Centrifugal filter units 
(cellulose membrane) with a molecular weight cut off of either 3 kDa or 10 kDa, 
depending on the size of the protein. The concentrators were centrifuged at 4 °C 
with a speed of 1200xg using the JA-18 rotor until the desired concentration of 
protein was achieved.  
2.15 Determination of Protein Concentration 
 The protein concentration was determined using the Beer Lambert law:
clA   where A is the absorbance at 280 nm, ε is the molar extinction coefficient 
of the protein (determined using Protparam (332)), c is the concentration and l is 
the path length. The absorbance was measured using a Nanodrop 
spectrophotometer, with the protein buffer used to set the baseline. 
 
2.16 Protein Analysis 
2.16.1 SDS-PAGE 
  SDS-PAGE is a method used to separate proteins based on their size. SDS is 
an anionic detergent which when added to the protein sample removes the high 
order structure of the protein, forming an unstructured linear chain, and imparts a 
negative charge to the linearized protein. This means that separation of proteins in 
the sample depends on molecular weight only. 
 12.5% SDS-PAGE resolving gel was made by diluting polyacrylamide in 
protogel resolving buffer with APS and TEMED following the manufacturer’s 
protocol. Once the resolving gel had set, the stacking gel was made in the same 
way, except protogel stacking buffer was used. Precast NuPAGE 4-12% Bis-Tris gels 
were also purchased (Novex). The protein samples were mixed with loading buffer 
(63 mM Tris-HCl, pH 6.8, 10% (w/v) glycerol, 2% (w/v) SDS and 0.0025% (w/v) 
bromophenol blue) and loaded on the gel. The gel was run with Tris-glycine running 
buffer at 200V for around 45 minutes. Gels were stained with 0.25% (w/v) 
Coomassie Brilliant Blue R-250 in 45% (v/v) methanol, 10% (v/v) acetic acid and de-
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stained in 45% (v/v) methanol, 10% (v/v) acetic acid, or the proteins were 
transferred to nitrocellulose membrane for western blot analysis. 
 
2.16.2 Western Blot Analysis 
Polyvinylidene difluoride (PVDF) Immobilon-P (Millipore) transfer 
membrane was equilibrated in 100% methanol followed by transfer buffer 
(Invitrogen). Polyacrylamide gels were transferred to the membrane using the 
NuPAGE transfer module (Invitrogen) and run for 35V for 1 hour 45 minutes. After 
transfer the membrane was fixed in 0.3% glutaraldehyde for 15 minutes at room 
temperature. The membrane was then washed three times in tris-buffered saline 
(TBS) (150 mM NaCl, 15 mM Tris-HCl pH 7.4)  supplemented with 0.05% Tween20 
(TBST), each wash lasting 10 minutes. The membrane was then blocked in 5% milk 
in TBST for 1 hour with agitation. The primary antibody was added at the desired 
concentration in blocking solution and the membrane was incubated overnight at 4 
°C with agitation. The next day the membrane was washed three times with TBST as 
described above. Horseradish peroxidise (HRP)- conjugated secondary antibody was 
then added at a dilution of 1:1000 in blocking solution and incubated for 1 hour at 
room temperature with agitation. The membrane was washed with TBST as 
described above. Protein detection was performed using Western Lightning 
chemiluminescent reagent, with 500 μl of the two solutions being mixed together 
and incubated with the membrane for 1 minute. The membrane was then exposed 
with SuperRX X-ray film (Fuji) and films were developed using a compact X4 
automatic X-ray film developer (X-ograph imaging systems).  
 
2.16.3 Densitometric Analysis of Western Blot Images 
 Western blot X-ray films were scanned using a conventional scanner (EPSON 
Perfection 2400). The scanned images were analysed using ImageJ software. 
Differences in protein levels were assessed by measuring the intensities of the 
selected bands. The intensities were first normalised against a loading control 
(actin) and then compared to the control or baseline value for each experiment. 
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2.17 Biophysical Techniques 
2.17.1 Isothermal Titration Calorimetry (ITC)  
2.17.1.1 Theory 
Isothermal titration calorimetry (ITC) is a technique used to characterise the 
interaction between two molecules in solution, by measuring any heat either 
absorbed or generated during the association. From the resultant ITC thermogram 
the binding constant, thermodynamic profile and stoichiometry of the interaction 
can be deduced. 
 The calorimeter is made up of a syringe, which injects one molecule into the 
other and two cells surrounded by an adiabatic jacket, which controls the 
temperature of the cells (Figure 2.3A). Temperature sensitive circuits monitor 
temperature differences between the two cells and switches on heaters, located on 
the cells or jacket, to maintain a constant temperature between the cells (333,334). 
One cell is the reference cell and contains buffer or water and the other cell is the 
sample cell, in which one molecule of interest will be placed. 
 Prior to the start of the experiment a constant power is applied to the 
reference cell. This causes the feedback circuit to activate the heater of the 
reference cell (334). This represents the baseline. During the experiment the 
amount of power required to maintain the same temperature between the two 
cells is measured (2,335) and this information provides the amount of heat 
associated with the interaction between the two molecules (333,334). 
 As the molecule in the syringe is titrated into the sample cell heat is 
absorbed or evolved depending on the type of interaction (333). For an exothermic 
reaction the temperature of the reference cell will increase, so the feedback power 
will be deactivated to maintain the same temperature as the reference cell (334). 
For an endothermic reaction heat will be taken up, meaning the feedback power 
must increase to maintain the temperature. The heat absorbed or evolved during 
the titration of one molecule into the other is proportional to the fraction of bound 
molecules (334,335). For the initial injections all of the injected molecules are 
bound to the molecules in the cell, which will cause a large change in heat and 
therefore a large signal. Later as the system becomes saturated, less change in heat 
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is observed and the signal is smaller. This produces a typical profile of peaks that 
decrease in size as the experiment proceeds (Figure 2.3B) (335), with the area 
under each peak corresponding to the heat associated with the interaction at that 
injection point (2). 
 From this profile the binding constant, stoichiometry and thermodynamic 
profile can be found. The area under each peak is integrated and plotted against 
the molar ratio of the two molecules. This will produce a sigmoidal curve for 
experiments with one binding site. From this curve the heat of binding (ΔH) is 
observed as the height of the curve, the binding constant (Kb) is measured from the 
slope of the curve (following curve fitting) and the stoichiometry (n) is observed as 
the middle point of the slope (Figure 2.3C). From this the Gibbs free energy (ΔG) 
and entropy (ΔS) can be calculated using the following equation: 
 STHKRTG b  ln    
Where R is gas constant and T is temperature. 
This means that from one experiment all the information about the interaction can 
be deciphered by simple manipulations. 
 There are some important considerations to take into account when setting 
up ITC experiments. It is important to ensure the concentrations of both molecules 
of interest are accurately measured. As the binding curve is produced using the 
molar ratio, any inaccuracies in the concentration will affect the binding curve and 
therefore the stoichiometry. It is also important to ensure that the buffer for both 
molecules is the same. This is ensured by dialysing both molecules in the same 
buffer for an extended period of time. If there are differences in the buffers when 
the two molecules are mixed, the mixing of the buffer components will also induce 
a change in heat. This will mean the heat due to the interaction will not observed 
accurately. It is also important to ensure all air bubbles are removed from the 
system. Air bubbles will affect the baseline and interfere with the feedback circuit, 
leading to abnormal peak profiles (334).  
 A potential problem with using this method to study interactions between 
two molecules is that it depends on measuring the ΔH associated with the 
interaction. If the ΔH of an interaction is small it is possible that it will not be seen 
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through the heat of dilution noise of the experiment or potentially will be too small 
to be measured by the equipment. Therefore this may lead to the incorrect 
assumption that no interaction occurred, whilst it is possible that the two molecules 
interact without large changes in enthalpy (in the particular experimental 
conditions used), in cases where the reaction is largely driven by changes in 
entropy. In the event that ΔH of a given interaction is close to zero, it is essential to 
optimise the experimental conditions of the interaction by changing the 
concentration of the molecules, the temperature at which the interaction is 
measured or the buffer in which the interaction is measured, aiming at increasing 
the ΔH to values that may be above the sensitivity threshold of the instrument.  
The change in ΔH as the temperature changes is described by Kirchhoff’s 
Law. This temperature dependence is due to the heat capacity (Cp) of the 







By measuring ΔH across a temperature range and plotting a graph of ΔH versus 
temperature, the ΔCp of the interaction can be calculated by the slop of the straight 
line profile produced (333,335). This graph can then be used to predict the ΔH at 
different temperatures so a temperature where ΔH should be measurable can be 
found.  
The buffer conditions will also affect ΔH, with the composition, 
concentration, pH and ionic strength having an affect (333). Of particular 
importance is the enthalpy of ionization of the buffer (ΔHion). Protons are taken up 
or released during the complex formation and the equivalent number of protons 
will be taken up or released from the buffer components (334), leading to the ΔHion. 
The measured enthalpy will reflect the ΔHion as well as the complex formation 
(334). Different buffers have different ΔHion, with sodium phosphate having a low 
ΔHion and Tris-HCl having a high ΔHion (334). By carrying out experiments in buffers 
with different ΔHion the measured enthalpy will also be different and this will help 
to find conditions in which ΔH is measurable.  
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2.17.1.2 Experimental Procedure 
ITC experiments were carried out using a MicroCal ITC200 instrument at 20 
or 10 °C. CaM was used at a concentration of 0.38 mM in the syringe (40 µl) and L-
selectin tail peptides at 0.04 mM in the cell (220 µl). CaM was titrated into the cell 
in twenty injections of 2 μl each with 180 seconds spacing between them and 
constant stirring at 1000 rpm. The heat of dilution was obtained from the heat of 
the last injections and was subtracted from the other peaks to obtain the heat of 
the interaction. The data was fit to a single site binding model using Origin7. This 
gave the stoichiometry, Kb and ΔH. The dissociation constant (KD) was calculated 







The ΔG and the entropic contribution (-TΔS) were calculated using the equation: 
STHKRTG b  ln  





























2.17.2 Nuclear Magnetic Resonance (NMR) Spectroscopy 
2.17.2.1 Theory 
 NMR spectroscopy is a method used to gain structural information of 
molecules by exploiting the physical properties of active nuclei to absorb 
electromagnetic radiation when placed in a magnetic field and the dependence of 
their resonance frequency on the environment of the nuclei. 
NMR is based on spin angular momentum, also known simply as spin, which 
is a property of all particles including nuclei (336). This spin will generate a magnetic 
moment. When the nuclei are placed in a magnetic field the nuclei exist in two spin 
states: one that aligns with the external magnetic field and the other that opposes 
it. The Boltzmann distribution for thermal equilibrium dictates that in a sample of 
molecules a majority of spins will be in the lower energy level, meaning that a bulk 
of the magnetization will be in the direction of the external magnetic field (336). A 
radio frequency pulse is applied to the system to rotate the magnetization of the 
nuclei, usually by 90° or 180°. When a 90° pulse is applied to the system, the 
magnetization of the nuclei will be perpendicular to the external magnetic field and 
this is known as transverse magnetization (336). The transverse magnetization will 
rotate around the static field, in a process known as precession (336). The 
precession of the magnetic field induces a current in a receiver coil, which is the 
signal (free induction decay or FID) which is measured (336). The Fourier transform 
is applied to produce the spectrum of intensity as a function of frequency (13).  
 The shell of electrons surrounding the nuclei has an effect on its resonance 
frequency, as they produce a local magnetic field opposing the applied magnetic 
Figure 2.4: ITC equipment and example of data produced.(A) Schematic showing the ITC 
machine. The instrument is made up a reference cell, sample cell containing one molecule of 
interest and a syringe containing the other molecule of interest. The cells are surrounding by 
an adiabatic jacket to control the temperature. Image taken from Feig, A. L. (2007) 
Applications of isothermal titration calorimetry in RNA biochemistry and biophysics. 
Biopolymers 87, 293-301 (2). (B)  A typical profile of the peaks of heat generated by each 
injection of the experiment. (C) A representation of the binding curve produced by 
integrating the area under the peaks. The affinity is calculated by the slope of the curve, the 
enthalpy is represented by the height of the curve and the stoichiometry is found by finding 




field (336). This causes a reduction in the magnetic field sensed at the nucleus, 
known as shielding. The degree of shielding depends on the electron density 
surrounding the nucleus. The different environment surrounding the nucleus will 
change the resonance at slightly different radiation frequencies. This difference in 
frequency can be measured in the NMR spectrum, a property known as chemical 
shift. This can be used to decipher structural properties of the molecule, as 
different local environments will lead to different chemical shifts. Therefore, each 
nucleus within a molecule with different chemical shifts will produce peaks at 
different frequencies. Protons within the molecule that are in the same chemical 
environment will have the same chemical shift value. This will mean the peak on 
the spectra representing that particular chemical shift will increase in area to 
represent the multiple protons.   
  1H is the most common nuclei used in NMR.  As the size of the molecule 
increases the 1H 1D spectrum becomes overcrowded and assigning individual peaks 
becomes too difficult (336). To analyse the structures and the properties of more 
complex molecules, such as proteins, 2D NMR experiments are carried out, where 
two nuclei are analysed and the data is plotted in a space defined by two frequency 
axes rather than one (337). 2D experiments consist of four consecutive time 
periods: preparation, evolution (t1), transfer and acquisition (t2) (336). After the 
preparation time transverse magnetization has been generated and this is allowed 
to evolve during t1. During the transfer time the magnetization is transferred to the 
other nucleus and the signal from the second nucleus is measured during t2. The 2D 
data are obtained from a series of 1D measurements with t1 increased between 
each one (336). To produce the spectra two Fourier transformations are performed, 
one with respect to t2, and one with respect to t1 (336). 
  For protein structure analysis, the protein must be labelled with 13C and 15N 
as the naturally occurring 12C and 14N will not produce an NMR signal as they do not 
have spin. To produce proteins labelled with 13C and/or 15N, E.coli are grown in 
media with a source of these isotopes. [1N-15N] Heteronuclear single quantum 
coherence (HSQC) spectroscopy is a 2D experiment that correlates hydrogen and 
nitrogen nuclei that are separated by one covalent bond thereby producing a 
spectrum with one peak for each pair of coupled nuclei representing the chemical 
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shift of those nuclei. For proteins this means one peak is present for every amino 
acid corresponding to the backbone NH groups (336). Peaks will also be generated 
for side chains that contain amino or amide groups. The spectrum produced is 
known as the fingerprint of the protein. [1N-15N] HSQC spectra are extensively used 
for studying the interaction between proteins and ligands, by titrating a ligand into 
the 15N-labelled protein of interest and following any changes in chemical shifts of 
the NH groups, indicating a change in the chemical environment. If the protein 
backbone has been fully assigned, this allows quick identification of amino acids 
whose chemical shift have been altered during the titration, suggesting an 
involvement in the molecular interaction or a conformational change upon binding 
(336). The [1N-15N] HSQC spectra for CaM, with and without calcium, have 
previously been assigned (for ApoCaM BMRB ID 5353 (338)and for CaM-Ca BMRB 
ID 1634 (339)), so this information can be used to assign the spectra produced in 
this study.  
 
2.17.2.2 Experimental Procedure 
 E.coli transformed with the protein of interest was grown in minimal media 
(Na2HPO4 6 g/L, KH2PO4 3 g/L, NaCl 0.5 g/L, 15NH4Cl 1 g/L, CaCl2 0.1 μM, MgSO4 2 
μM, glucose 2.5 % (v:v), thiamine 1 μM, 10 ml E.coli trace elements (100 mM 
FeCl3·6H2O, 10 mM ZnCl2·4H2O, 15 mM CoCl2·6H2O, 10 mM Na2MoO4·2H2O, 7 mM 
CaCl2·2H2O, 5 mM CuCl2·6H2O and 8 mM H3BO3)) and purified as before. Prior to 
experimentation, D2O was added to the purified protein to a final concentration of 
10%. 1D and 2D [1H-15N] HSQC spectra were recorded on a Bruker 500 NMR 
spectrometer at 25°C equipped with a cryoprobe. For analysis of the interaction 
between L-selectin and CaM, L-selectin cytoplasmic tail peptide was titrated in from 
0.2:1 to 1.2:1 concentration with respect to CaM. This was carried out in the 
presence and absence of calcium. Spectra were processed using NMRPipe and 
analysed using NMRView. Peaks were assigned by comparing to other assigned 
spectra (from Biological Magnetic Resonance Data Bank, for ApoCaM BMRB ID 5353 
for ApoCaM (338)and BMRB ID 1634 for CaM-Ca (339)).  
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2.17.2.2.1 Chemical Shift Perturbation (CSP) Calculation and Mapping onto 
Structural Models  
 Once the [1H-15N] HSQC spectra were assigned the peaks that shifted with 
titration of L-selectin were found. For each amino acid the chemical shift 
perturbation (CSP) was calculated using the formula: 
    22 2.0 NHAV   (340) 
Where ΔδH is the difference in the proton chemical shift of the amide and ΔδN is 
the difference in the chemical shift of the nitrogen amide. The CSPs were then 
divided into categories depending on their size and colour coordinated, with red 
representing the largest CSPs (ΔδAV≥0.03), orange representing moderate CSPs 
(0.01≤ΔδAV≥0.03), yellow representing small CSPs (0.005≤ΔδAV≥0.01) and white 
representing little or no CSPs (ΔδAV ≤0.005). The colour of each amino acid was then 
plotted on the structure of the protein obtained from the RSCB protein data bank 
(id 3CLN for CaM-Ca and 1CFC for ApoCaM).  
  
2.17.3 Circular Dichroism (CD) Spectroscopy  
2.17.3.1 Theory 
Circular dichroism (CD) spectroscopy is a form of spectroscopy used to 
analyse the secondary structure of proteins and peptides. When circular polarised 
light hits a protein or peptide the electronic structure of the molecule of interest 
will cause characteristic bands on the CD spectrum (341). This means that different 
secondary structures within the protein or peptide will give distinct spectral bands. 
This information can then be used to calculate the proportion of the different 
secondary structures within the protein and therefore indirectly provide 
information of the overall structure of the protein (342). 
 Circular polarised light is produced by superimposing two linearly polarised 
beams of light of the same magnitude that are oscillating perpendicular to one 
another, one right polarised and one left polarised (341). This light is passed 
through a solution of molecules of interest. If the left and right polarised light are 
not absorbed or equally absorbed the radiation generated will be polarised in the 
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same plane, so no signal will be seen on the spectrum (343). If the solution contains 
chiral (asymmetric) molecules then the right and left polarised light will be 
refracted differently (343), the two beams will travel at different speeds and will be 
absorbed to different extents at each energy (341).  The difference in absorption 
between right and left polarised light is measured and plotted against the 
wavelength to produce the CD spectrum (341). There are several different methods 
used to measure the difference in absorbance: a) modulation where the incident 
radiation is continuously switched between left and right polarised light, b) direct 
subtraction where the absorbances of left and right polarised light are measured 
separately and subtracted from one another and c) ellipsometric where elliplicity of 
the transmitted radiation is measured. Modulation is the most common method 
used (343). 
There are several different causes of chirality: a) a molecule can be 
intrinsically chiral such as molecules contain carbon atoms that have different 
groups attached at each bonding site, b) if the moiety is covalently attached to a 
chiral centre within a molecule and c) the asymmetric environment the moiety is in 
due to the 3D structure of the molecule (343). In proteins there are several 
different species that contribute to chirality. These include the peptide bond, 
aromatic amino acid side chains and disulphide bonds. Information on the 
secondary structure of the molecule comes from the peptide bond, which produces 
bands on the spectrum from 240 nm and below (343). Figure 2.4 shows the typical 
spectra for alpha helix, beta sheet and random coil.  
 
 












The electronic structure of the molecule produces characteristic bands in 
specific regions in the spectrum. As the different secondary structures have 
different electronic structures they will produce the different spectra seen in Figure 
2.4 (341).  
In this report CD was used to assess the secondary structure of L-selectin 
cytosolic tail peptides in solution. 
2.17.3.2 Experimental Procedure 
 Purified lyophilised peptides were dissolved in NMR buffer or potassium 
phosphate buffer at a concentration of 0.2 mg/ml. CD spectra were measured by Dr 
Tam T.T. Bui (Biomolecular Spectroscopy Centre, King’s College London) using 
Chirascan Plus spectrometer (Applied Photophysics Ltd). The CD spectra were 
measured between 260-190 nm in a 0.5 mm rectangular cell.  The instrument was 
flushed continuously with pure evaporated nitrogen throughout the 
measurements.  Spectra were recorded with a 1 nm step size, a 3 s measurement 
time-per-point and a spectral bandwidth of 1 nm.  
 
2.17.4 Microscale Thermophoresis (MST) 
2.17.4.1 Theory 
Microscale thermophoresis (MST) is a biophysical technique used to analyse 
the interaction between two molecules. It has been observed that a temperature 
gradient in an aqueous solution of molecules induces a flow of molecules, an effect 
known as thermophoresis (344,345). The thermophoretic effect is controlled by the 
charge of the molecule, the size of the molecule and the interaction with the 
solvent environment (344). When two molecules interact with one another, one or 
more of these properties will be altered. This allows the binding event to be 
analysed and the binding constant measured.    
Figure 2.5: CD Spectra of Secondary Structure. A graphic representation of CD spectrum for 
different secondary structures, showing the difference in absorption at different 





One of the molecules of interest is labelled with a fluorescent probe. This is 
then added to a serial dilution of the other molecule of interest and placed in 
capillaries (344). An infrared (IR) laser is then focused on the sample to heat it with 
high precision at a specific spot, allowing a localised temperature increase over a 
few hundred micrometres (344,345). The fluorescence of the heated area is 
measured to assess the movement of the molecules in the heated area. This is 
repeated for all dilutions then fluorescence is plotted against the concentration of 
the titrated molecule to produce the binding curve, from which the binding 
constant can be found. 
Figure 2.5 depicts a typical MST signal for one capillary (344). It shows the 
five stages of the signal. The initial fluorescence is the fluorescence of the sample 
prior to laser heating. The temperature jump is the fluorescence change induced by 
heating the sample and is prior to the thermophoretic molecule transport. This 
temperature jump represents the change in fluorescence yield of the dye due to 
the temperature increase (344). This is not necessarily influenced by the binding 
event but can be affected in some cases as the local environment will affect the 
temperature dependence of the dye (344). This means that if the molecule binds in 
close proximity to the dye or induces a conformational change close to the dye the 
temperature dependence of the fluorescence will change and be detected in the 
temperature jump. The next stage of the signal is thermophoresis, which is the 
change in fluorescence due to the thermophoretic movement of the molecules. 
This is a diffusion limited transport process and reflects any changes that have an 
effect on the thermophoretic mobility of the labelled molecule (344). Both the 
temperature jump and thermophoresis can be affected by the binding event, 
temperature jump is affected if binding alters the internal state of the labelled 
molecule, whereas size, charge and hydration shell changes from the binding event 
affects the thermophoresis signal (344). Analysis can include temperature jump as 
well as thermophoresis if desired. After a steady state is reached the laser is turned 
off and an inverse temperature jump is observed, as the reduction of temperature 
affects the fluorescent dye as before, after which back-diffusion is seen (345), 




 To produce the binding curve the normalised fluorescence (Fnorm) is plotted 
against the concentration of the titrated molecule (344). In principle normalised 
fluorescence can be calculated by: F (hot)/F (initial), however, this does not take into 
consideration the change in the fluorescence due to the temperature jump. It is 
possible to separate the contribution of temperature jump and thermophoresis to 
the MST signal by choosing different times to calculate the Fnorm, with temperature 
jump occurring less than one second after the temperature increase and 
thermophoresis occurring after one second (344). For analysis of just 
thermophoresis the Fnorm is calculated by comparing the fluorescence after thirty 
seconds to fluorescence after one second. The change in fluorescence will depend 
on the binding of the labelled molecule and can is given by: 
Fnorm= (1-x) Fnorm (unbound) +xFnorm (bound) 
where x is the fraction of labelled molecules bound to their target, Fnorm (unbound) 
is the normalised fluorescence of unbound labelled molecules and Fnorm(bound) is 
the normalised fluorescence of complexes (344). From this equation differences in 
the normalised fluorescence of the bound and unbound state allows the 
determination of the fraction of molecules bound at different known 
concentrations of binding partners, and from this the dissociation constant can 
calculated. 
There are many advantages to using this method to analyse the binding 
event between two molecules; it is quick, with each measurement only taking 
around 20 minutes, and requires very little material, with concentrations of low 
micromolar used and very small volumes required to fill the capillaries. The main 
disadvantage is that as it depends on measuring changes in fluorescence one 
molecule must be labelled, contrary to ITC, which is a label-free technique, and this 
labelling may affect the binding. Fluorescent dyes are covalently attached to 
cysteine residues using a dye attached to a maleimide group, or covalently attached 
to lysine residues using a dye attached to an N-hydroxysuccinimide (NHS) ester 
group. If the residues labelled are located in the binding site for the ligand of 




Thermodynamics of the binding can be calculated by carrying out 
experiments at different temperatures and plotting lnKb against inverse 
temperature to obtain ΔH from the slope of the straight line graph and the 












2.17.4.2 Experimental Procedure 
 Samples for MST analysis were sent to NanoTemper Technologies GmbH for 
experimentation. Both CaM and the peptides were sent in NMR buffer with 5 mM 
CaCl2, with 0.05% TWEEN-20 added at NanoTemper Technologies GmbH. CaM was 
labelled with NT-647 dye (Lys-coupling technology) at NanoTemper Technologies 
using Nanotemper’s protein labelling kit RED (Nanotemper Technologies) and 
mixed with the unlabelled peptide. CaM was kept at a concentration of 20 nM, with 
peptide concentration starting at 262.2 µM for wildtype and 375 µM for S364phos, 
S367A and S364A, and diluted down to 1:1, with 16 dilutions carried out and 
incubated at room temperature for 30 minutes. Each different dilution was loaded 
into an enhanced gradient standard treated MST-grade glass capillary using 
capillary force and the ends of the capillary were sealed with wax. The capillaries 
were placed into the instrument tray in concentration order and the tray was 
Figure 2.6: A typical profile of the fluorescence during an MST experiment. At the start the 
solution is homogeneous and fluorescence is constant. When the IR laser is switched on 
fluorescence changes are observed, first due to the temperature jump and then due to 
thermophoretic movement of the molecule. The IR laser is then switched off and there is an 
inverse temperature jump followed by back diffusion. 
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transferred to the instrument. Analysis of each capillary was carried out using a 
Monolith NT.115 instrument with 15 % LED power and 20 % IR power.  
  
2.18 Cell lines and Culturing 
 All cell lines used were cultured at 37 °C in a 5 % CO2 incubator. 
2.18.1 Human Embryonic Kidney (HEK) 293T Cells 
 HEK cells were a gift from Dr Yolanda Calle (Cancer Division, King’s College 
London). The cells were cultured in RPMI-1640 media (Life Technologies) 
supplemented with 10 % FBS, 1 % antibiotics (penicillin/ streptomycin). The media 
was changed every 2 days and once confluent, cells were passaged with a sub-
cultivated ratio of 1:6. 
2.18.2 THP-1 cells (Acute Monocytic Leukaemia, Human) 
 THP-1 cells were purchased from American Type Culture Collection (ATCC) 
and those containing wildtype L-selectin or the mutants ΔM-N, S364A, S367A, and 
SSAA all tagged with GFP were produced by Karolina Rzeniewicz (Cardiology, King’s 
College London). Cells were cultured in RPMI-1640 media supplemented with 10 % 
FBS, 1 % antibiotics (penicillin/ streptomycin) and 0.05 mM β-mercaptoethanol. 
Cells were seeded at a density of 0.5 x 106 cells/ml and split every 2-3 days. 
2.18.3 Human Umbilical Vein Endothelial Cells (HUVECs) 
 HUVECs were purchased from Lonza and cultured in M199 media 
supplemented with 10 % FBS, 1 % antibiotics (penicillin/ streptomycin) and 
endothelial cell growth supplement in fibronectin (10 µg/ml) coated plates. Cells 
were grown to confluence then used in experiments. 
2.18.4 Cryopreservation of Cells 
 For cryopreservation, around 10x106 cells were collected by centrifugation 
and re-suspended in 1 ml 90% FBS 10% DMSO. The cells were immediately 
transferred to pre-chilled Corning freezing vials and placed on ice prior to being 
stored at -80 °C. After 48 hours the vials were transferred to liquid nitrogen for long 
term storage. For re-culturing, vials were rapidly thawed in a 37 °C water bath. 
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After thawing the cells were added to 9 ml of fresh media and the cells were 
harvested by centrifugation. The cell pellet was then re-suspended in fresh media 
and placed in a flask for culturing. 
 
2.19 Lentiviral Production and Generation of Stable Cell lines 
2.19.1 Lentivirus Production 
 Lentiviral particles were produced using HEK cells as the packaging cell line. 
Cells were plated one day before transduction at a density of 10-15 x 106 cells per 
14 cm dish. On the day of transduction 30 μg Pax2, 10 μg pMD.G helper vectors and 
40 μg of the vector of interest were added to 4 ml of OPTIMEM media. 1 μl of 10 
mM polyethylene imine (PEI) was added to 4 ml of OPTIMEM in a separate tube (all 
quantities are correct for one dish; if more than one dish is required the reagents 
were adjusted accordingly). The two tubes were mixed and left at room 
temperature for 15 minutes. The culture media was aspirated from the HEK cells 
and the transduction media was added to the cells in a drop wise manner. The cells 
were incubated at 37 °C for 4 hours, after which the transduction media was 
removed and fresh media was added to the cells.  Cell supernatant containing 
lentiviral particles was collected 48 and 72 hours after transduction. The lentiviral 
particles were concentrated by ultracentrifugation using a SORVALL® Discovery 
ultracentrifuge with a TH641 rotor, spinning at 19900 rpm, at 4 °C for 2 hours. After 
ultracentrifugation the supernatant was decanted and 50 μl of RPMI was added to 
each tube and incubated on ice for 20-40 minutes. The lentivirus pellets were re-
suspended, pooled together, aliquoted in 25 μl fractions and stored at -80 °C until 
used. 
 
2.19.2 Titration of Lentivirus 
 In order to establish lentiviral titres, HEK cells were transduced with 
different dilutions of the concentrated lentivirus. HEK cells were plated in 24-well 
plates at a density of 150-200x105 cells/well. A serial dilution was carried out with 
the lentivirus (10-1 to 10-6) in HEK cell media, and added to the cells. The next day 
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the media was changed and two days later the cells were collected by trypsinisation 
and re-suspended in PBS. The expression of GFP/RFP was analysed using FACs to 
identify the percentage of GFP/RFP positive cells. The virus titre was established 








where T=titer, P=GFP/RFP positive cells, N= number of cells, D=dilution and 
V=volume. The volume of lentivirus required for the transduction of the target cells 









2.19.3 Production of THP-1 transduced cells 
 The lentivirus produced was used to transduce either THP-1 ATCC cells or 
THP-1 cells that had previously been transduced with different L-selectin-GFP 
lentiviruses. 1x106 THP-1 cells were collected and re-suspended in THP-1 media 
containing the volume of lentivirus required for the desired MOI. The media was 
changed the next day and the cells were grown until 10x106 cells were produced. 
The cells were then sorted using a Beckman Coulter cell sorter at a core funded 
FACs sorting facility, to produce a population expressing the fluorescent protein 
required. The sorted cells were then cultured for use in experiments. 
 
2.20 Parallel Plate Flow Chamber Assay  
 Transmigration of THP-1 cells through TNF-α activated HUVECs was carried 
out using a parallel plate flow chamber assay. Coverslips were covered with 
fibronectin (10 µg/ml) in PBS and incubated for 2-4 hours at 37 °C. The fibronectin 
solution was removed and HUVECs were plated onto the coverslips. The HUVECs 
were left to reach confluence (3-5 days) and were then stimulated with TNF-α for 
between 4 hours and overnight. The coverslip of HUVECs was attached to the flow 
chamber using a vacuum pump and was placed on the microscope (Figure 2.6). 
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THP-1 cells were re-suspended in THP-1 media with 25 mM HEPES at a density of 
0.5 x 106 cells/ml. The cells were then perfused over the HUVECs at a flow rate of 
0.25 ml/min, applied using a Harvard syringe pump. Experiments were carried out 
at 37 °C. Experiments were visualized using an Olympus IX81 time-lapse inverted 
fluorescence microscope attached to a Hamamatsu C10600 ORCA-R2 video camera. 
For short transmigration experiments cell were perfused for 5-7 minutes, and 
images were recorded at three random fields of view with three time points per 
minute. For long transmigration experiments cells were perfused for 5 minutes 
then media only was perfused over the HUVECs for a further 20 minutes, with 
images recorded at three random fields of view with one time point per minute. All 
experiments were recorded using a 10x objective. Images were acquired into video 






Figure 2.7: Parallel plate Flow Chamber system. Diagram illustrating the system used for the parallel 
plate flow chamber assay. The chamber is attached to a coverslip with a monolayer of HUVECs grown 
over it using the vacuum force and placed over the objective of an inverted microscope. A syringe 
pump is used to draw THP-1 cells suspended in media through the chamber with a set flow rate (set 
by a syringe refill rate). The footage is recorded by the CCD camera connected to the computer. The 
data is visualised and analysed Volocity. Image modified from Wiese, G., Barthel, S. R., and Dimitroff, 
C. J. (2009) Analysis of physiologic E-selectin-mediated leukocyte rolling on microvascular 




2.21 Preparation of Coverslips for FRET/FLIM Analysis 
 
2.21.1 Poly-L lysine (PLL) coated coverslips 
 Coverslips were placed in the bottom of the wells in a 24-well plate and 100 
µl of PLL was added to each well. The plate was incubated at room temperature for 
twenty minutes, after which time the PLL was aspirated and the coverslips were 
allowed to dry overnight. The next day 0.1 x 106 THP-1 cells were suspended in 100 
µl of PBS, placed on top of the coverslips and left for ten minutes. After this time 
the coverslips were aspirated and fixed with 4 % paraformaldehyde (PFA) for ten 
minutes at room temperature. The coverslips were then washed with PBS several 
times and permeabilised with ice cold 0.1 % Nonidet P-40 (NP-40) substitute for a 
maximum of three minutes. The NP-40 was then aspirated and the coverslip was 
washed several times with PBS. Sodium borohydride (1 mg/ml) was added to the 
coverslips for ten minutes and they were left in the dark. This is a reducing agent 
used to decrease the background fluorescence. The sodium borohydride was 
aspirated and the coverslips were washed several times in PBS. The coverslips were 
then mounted on glass slides and stored in the dark at 4 °C until analysis was 
carried out by Dr Maddy Parsons, KCL. 
 
2.21.2 Coverslips from flow chamber assay experiments 
 Once flow chamber assay experiments were completed, the coverslips were 
removed and placed in 4 % PFA for ten minutes at room temperature to fix the 
cells. The coverslips were washed several times in PBS and then permeabilised with 
ice cold 0.1 % NP-40 substitute for no more than three minutes. The NP-40 solution 
was then aspirated and the coverslip was washed several times with PBS. Sodium 
borahydride (1 mg/ml) was then added for ten minutes and the coverslips were 
placed in the dark. After aspiration of the sodium borohydride, the coverslips were 
washed several times in PBS. The coverslips were then blocked with 5 % BSA in PBS 
for 20 minutes at 4 °C, after which time they were placed in a humidifying chamber 
on top of phalliodin-Alexa633 diluted 1:300 in 5 % BSA in PBS. The chamber was 
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placed at 4 °C in the dark overnight. The next day the coverslips were removed 
from the chamber and washed several times with PBS. They were then mounted on 
slides and stored in the dark at 4 °C until analysed. All FRET/FLIM analysis was 
carried out by Dr Maddy Parsons, KCL.  
 
2.22 Analysis of cell characteristics during TEM 
 The videos produced during the parallel plate flow chamber assay were used 
to analyse the protrusion number, cell area and circularity of the THP-1 bound to 
the HUVEC monolayer. The videos were paused at 7, 15 and 25 minutes and the 
THP-1 cells within the field of view were characterised as having no, one, two or 
multiple protrusions. ImageJ software was then used to draw around each cell, 
including any protrusions that were visible. The cell area and circularity were then 
calculated by the ImageJ software. For each experiment three fields of view were 
analysed at each time point, with between 20 and 100 cells being assessed. 
 
2.23 GFPTrap Immunoprecipitation Assay 
2.23.1 Cells in suspension 
 GFPTrap beads were purchased from chromotek. Cell lysate was produced 
by collecting 2 x 107 cells, which were washed with PBS. The cells were then re-
suspended in 200 μl lysis buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM 
EDTA, 0.5% NP40, 1 x protease inhibitor cocktail, 50 nM calyculin, 1 μM 
bisindolylmaleimide). The lysis solution was placed on ice for thirty minutes with 
vigorous mixing every ten minutes. The lysate was then spun at 20000 xg for ten 
minutes at 4 °C using an eppendorf 5417R microcentrifuge. The supernatant was 
collected and 550 μl of wash buffer (10 mM Tris-HCl pH 7.5, 50 mM NaCl, 0.5 mM 
EDTA, 1 x protease inhibitor cocktail, 50 nM calyculin, and 1 μM 
bisindolylmaleimide). 25 μl of GFPTrap beads were re-suspended in 500 μl of wash 
buffer and spun down at 2700 xg for two minutes at 4 °C. The supernatant was 
discarded and the wash steps were repeated twice more. The cell lysate was added 
to the beads and incubated at 4 °C overnight with constant mixing. The next day the 
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beads were spun down at 2700 xg for two minutes at 4 °C and the supernatant was 
discarded. The beads were washed three times with cold wash buffer (500 μl). After 
washing, the beads were re-suspended in 2x SDS protein loading buffer and boiled 
for ten minutes at 95 °C. The beads were collected by centrifugation at 2700 xg for 
two minutes at 4 °C. The supernatant was used for SDS-PAGE and Western blot 
analysis was carried out to detect CaM and GFP. 
 Experiments were also carried out as above, except 1% ovalbumin was 
added to the lysis and wash buffers. 
 
2.23.2 THP-1 cell co-culture with TNF-α activated HUVECs 
HUVECs were plated in six well plates and left to grow until confluent. Once 
confluent, the HUVEC were activated with TNF-α for 4 hours. 2 x 106 THP-1 cells 
were re-suspended in 1.5 ml of media and added on top of the activated HUVECs. 
The cells were incubated at 37 °C for five minutes, then the media was aspirated 
and 400 μl of lysis buffer or lysis buffer supplemented with 1% ovalbumin was 
added and the plate was placed on ice for thirty minutes, with mixing every ten 
minutes. The lysate was then spun down as before and the supernatant collected 
and diluted with 1 ml of wash buffer or wash buffer containing 1% ovalbumin. The 
immunoprecipitation was then carried out as described above (Section 2.23.1). 
 
2.24 Co-Culture of THP-1 cells with HUVECs for Shedding 
Analysis 
 HUVECs were grown in six well plates until confluent and were then 
activated with TNF-α overnight. 0.75 x 106 THP-1 cells were re-suspended in 1 ml of 
THP-1 media and added to each well of the plate. Each well was allocated a time 
point: 0, 5, 10, 20, 30 or 60 minutes. At the corresponding time point the media 
from that well was collected as the unbound fraction and the bound fraction was 
collected from the well using a cell scraper. CytoBuster (Novagen) supplemented 
with protease inhibitors was used to lyse the cells using the manufacturer’s 
protocol. Protein loading buffer was added to the cell lysate and the samples were 
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run on SDS-PAGE and Western blot analysis was carried out as described in Section 
2.16 to detect L-selectin-GFP. 
 
2.25 Statistical Analysis 
 Quantitative data was collated and analysed using Microsoft Excel 2010, 
which was also used to produce all bar and line graphs, except for those produced 
by the analysis of the ITC, which were produced by Origin7. To determine significant 
differences between data an independent two-tailed Student’s T test or a One-way 





Chapter 3: Production and Characterisation of 
Recombinant Proteins for Biophysical Assays 
3.1 Introduction 
 L-selectin has a 17 amino acid cytosolic tail, which has been reported to bind 
several proteins, including CaM and the ERM family of proteins (215,216,223,224). 
The binding of such proteins is thought to mediate numerous functions of L-selectin 
function, which includes downstream signalling (Section 1.3.6). Study of the 
interaction between L-selectin, CaM, and moesin was carried out in vitro using a 
peptide corresponding to the cytosolic tail of L-selectin coupled to sepharose 
beads. The results showed that both CaM and moesin were able to interact with 
the peptide and when the beads were preloaded with one of the proteins, the 
other was still capable of interacting, suggesting that a tertiary complex was formed 
(3). The interaction was then studied in vivo using COS-7 cells transfected with 
ezrin-FERM-GFP, CaM-RFP and wildtype full-length L-selectin. The FRET efficiency 
between ezrin-FERM-GFP and CaM-RFP increased when all three proteins were co-
expressed and L-selectin was clustered using antibody, providing further proof that 
the three proteins form a tertiary complex (3). Although it has been shown that this 
interaction occurs, little is known about the mechanism or the regulation of this 
process. 
To gain further insight into the interaction between the cytoplasmic tail of L-
selectin, CaM and moesin, a detailed characterisation was performed using 
complementary in vitro biophysical techniques, such as NMR, ITC and MST. The 
details of these methods are described in Section 2.17 of Materials and Methods. 
Peptides representing the 17 amino acid cytosolic tail of L-selectin, either wildtype, 
phosphorylated or alanine-mutated versions were commercially sourced. 
Recombinant CaM and the FERM domain of moesin (moesin-FERM) were produced 
in an E.coli system to produce large quantities of the protein. Recombinant proteins 
expressed in E.coli have been successfully purified, using a number of 
chromatography procedures. This chapter describes in detail the methods that 
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were used to clone and express CaM and moesin-FERM so that these could be used 
in the following chapter.  
3.2 Experimental Design 
When large quantities of recombinant protein are required for 
experimentation, genetically modified expression systems are used. There are 
several different expression systems available, including E.coli, yeast and 
mammalian systems, all with different advantages and disadvantages. The most 
commonly used system is the E.coli expression system. This involves cloning 
recombinant genes into vectors used to transform E.coli cells, which will then 
produce the protein under the control of an induction system. A common induction 
method employs the T7 RNA polymerase to over-produce the recombinant protein. 
This polymerase is often used for recombinant protein expression due to its ability 
to rapidly transcribe mRNA. The E.coli cells used to produce recombinant proteins 
all encode the T7 RNA polymerase under the control of a lacUV5 promoter (347). 
The cells also contain the lacI gene, which encodes the lac repressor that binds to 
the lacUV5 promoter, inhibiting transcription of the T7 RNA polymerase. Addition of 
the lactose analogue IPTG blocks this inhibition by binding to the lac repressor, 
causing allosteric alterations to the lac repressor and therefore promoting the 
release of the repressor from the promoter, allowing transcription of T7 RNA 
polymerase and therefore production of the recombinant protein of interest, which 
has been cloned downstream of a T7 promoter, allowing tight control of the 
expression of the recombinant protein of interest (347,348). There are several 
advantages to using the E.coli expression system, which include: easy growth 
conditions and the ease in which production can be scaled up. The major 
disadvantage of this system is that it is estimated that only 10 % of mammalian 
proteins expressed by E.coli are soluble and proteins larger than 60 kDa are more 
likely to be insoluble (349). Solubility can be improved by altering growth conditions 
(348), or by the co-expression of chaperone proteins. It is also possible to purify 
insoluble proteins by controlled denaturation, followed by refolding the proteins 
after purification; however, this is time consuming and the success is again very 
dependent on the protein.  
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In this thesis, an E.coli expression system was chosen for the production of 
recombinant proteins due to the simple transformation and growth of the cells and 
the quick production of large quantities of protein possible. This method has 
previously been utilised to successfully produce recombinant CaM (350), which was 
employed in the first instance. 
 Many different E.coli cells have been engineered to replicate the vector and 
enhance the production of recombinant proteins, with several of these different 
strains being used in this thesis. The KRX E.coli strain (which will be referred to as 
KRX cells) was used to replicate the vector containing the recombinant protein. It 
has been engineered to lack the nuclease endoA (351), which co-purifies with 
plasmid DNA and will therefore contaminate the vector containing the recombinant 
protein. KRX have a mutated version of the RecA gene (351), which encodes a 
recombination protein, and therefore undesirable recombination events are 
minimized. It also contains a partially defective restriction modification system 
(351), limiting the degradation of the vector containing the recombinant protein 
gene. KRX cells have also been modified to enhance protein production, including 
mutations of the protease genes OmpT and OmpR to minimize proteolysis of the 
recombinant protein (351). The cells contain a copy of the T7 RNA polymerase 
controlled by a rhamnose promoter. Using a rhamnose promoter enables tight 
control of the expression of the protein (351). In this study KRX cells were not 
utilised for protein production as the presence of glucose in the growth media 
inhibits the rhamnose promoter. This means that 13C-labelled glucose cannot be 
added to minimal media for the production of labelled protein required for NMR 
studies. It is possible to use 13C-labelled glycerol as an alternative; however this is 
much more costly. For this reason two other E.coli strains were utilised for protein 
production in this thesis. The first is the BL21-DE3-pLysS strain, which is deficient in 
the proteases Lon and OmpT (348,352). The pLysS gene encodes a plasmid for T7 
lysozyme. This lowers the background of recombinant protein expression prior to 
induction, but has no effect after protein expression has been induced, therefore 
reducing the leakiness of the expression (353). The second E.coli strain used was 
the Rosetta 2 strain (referred to as Rosetta cells). This strain contains a plasmid 
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containing tRNA for seven codons rarely used by E.coli strains. This allows for quick 
translation that would otherwise be delayed by the E.coli codon use (354,355). Due 
to the advantages of using both these strains of E.coli for recombinant protein 
production, both strains are used for different proteins in this report. A third E.coli 
strain was utilised for the production of proteins that had been produced in the 
insoluble fraction by the other E.coli strains. This strain is known as “Arctic cells”, as 
it has been engineered to produce proteins at very low temperatures. The 
alterations that have been made to these cells to promote protein expression are 
described below (Section 3.3.2). 
 Once the E.coli expression system has been used to produce large quantities 
of recombinant protein, the protein must be isolated from the cell lysate to very 
high purity. The most efficient way to purify recombinant proteins is via affinity 
chromatography, which requires the protein to be cloned as a fusion protein with 
an affinity tag. Affinity chromatography is very efficient in separating the desired 
protein from other contaminant proteins. Several different tags have been 
engineered to aid purification of recombinant proteins, including a glutathione S-
transferase (GST) and Hexa Histidine tag (His6-tag), all with advantages and 
disadvantages. An advantage to using the GST-tag is that it provides some 
protection from proteolysis, leading to increased protein yield (356). There are 
several disadvantages to using this tag however, including a time-consuming 
purification (357). The tag can also promote oxidative aggregation (358), leading 
the recombinant protein becoming insoluble. Due to its large size, NMR analysis of 
the recombinant protein is not possible with the GST-tag attached (359), meaning it 
has to be removed prior to experimentation.   
In this study recombinant proteins were tagged with a His6-tag, which 
allowed for purification using immobilised metal affinity chromatography (IMAC). 
This method involves histidine interacting with immobilised transition metal ions, in 
this case nickel ions. The electron donor groups within the imidazole ring of 
histidine coordinate bonds with the nickel ions. The recombinant protein can be 
eluted by altering the pH, salt concentration or adding imidazole to the buffer to act 
as a direct competitor for the nickel ions. The nickel resin is formed by using a 
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chelator, such as nitrilotriacetic acid (NTA), to attach the nickel ions to an agarose 
matrix, therefore the resin is known as Ni-NTA (356). The advantage of using this 
resin for purification is that it is capable of withstanding a wide range of buffer 
conditions, including detergents, it is also inexpensive and can be regenerated for 
repeated use. A possible disadvantage is that the resin will interact with any protein 
containing clusters of histidine residues, which means that endogenous proteins 
often interact with the resin, causing contaminants to the recombinant protein 
(360). An advantage to using the His6-tag is that NMR studies can be carried out 
with the tag present due to its small size. Indeed studies have been carried out on 
proteins with and without the tag and have shown the resulting 3D structures were 
roughly equivalent (348). 
As the addition of affinity tags can pose problems, purification procedures 
without the addition of tags has been developed for several proteins. In this thesis, 
methods for purifying untagged CaM and moesin are also described. These 
methods take advantage of intrinsic chemico-physical properties of the protein to 
facilitate purification.  
In addition to recombinant proteins, the production of 15N/13C-labelled L-
selectin cytoplasmic tail was attempted. Peptides and small proteins that are 
intrinsically unfolded are often degraded when produced by E.coli cells (361,362). 
To help protect against degradation, the peptide was expressed with a tag. The 
scaffold protein Trp-Cage was chosen as the tag as it has previously been utilised as 
a tag for NMR studies, so has been characterised already and the method used can 
be followed here. 
3.3 Results 
3.3.1 Production of recombinant CaM protein 
 In order to produce recombinant CaM, a vector containing the cDNA for 
CaM was produced. The pETDuet vector (Figure 2.1A in Materials and Methods) 
was chosen as the expression vector. It contains two multiple cloning sites (MCS): 
MCS1 and MCS2, both of which contain a T7 promoter to allow for the control of 
the expression of the recombinant protein (as described in section 3.2). MCS1 
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enables proteins to be cloned with a His6-tag attached to aid purification of the 
recombinant protein. To enable the removal of the His6-tag after purification, CaM 
was cloned with primers that contained an N-terminal tobacco etch virus (TEV) 
protease cleavage site, positioned between the tag and the start of CaM. TEV 
protease is a highly specific cysteine protease from the tobacco etch virus. It 
recognises the amino acid sequence ENLYQS, cleaving between Q and S. The high 
specificity for this sequence is endowed by the presence of a binding tunnel for the 
substrate. This means that there is a large contact area between the TEV protease 
and the target sequence, allowing for high specificity (363) and therefore the use of 
this protease in removing protein tags is desirable, as it is highly unlikely that it will 
cleave within the sequence of the recombinant protein. 
 PCR was carried out using full length human CaM cDNA, a gift from Donald 
C. Chang (Hong Kong, China), as the template and primers containing restriction 
sites for SalI and NotI to allow the insertion of the CaM cDNA into MCS1 of the 
pETDuet vector. A PCR reaction was carried out as previously described (Section 
2.5) to amplify the CaM cDNA with the restriction sites required for cloning. The 
purified PCR product was then digested with appropriate restriction enzymes and a 
ligation of the CaM insert and the pETDuet vector was carried out as described in 
Section 2.6. The ligation reaction mixture was then used to transform KRX cells and 
the bacteria were grown on LB agar containing ampicillin, for the selection of 
colonies that had successfully been transformed with the pETDuet vector. Single 
colonies were picked, cultured overnight, and the plasmid DNA was isolated using 
the “mini prep” protocol, following the manufacturer’s instructions. The isolated 
plasmids were sent for sequencing to ensure the DNA sequence for CaM had been 
successfully cloned in frame with His6-tag and that no mutations had occurred 
during the cloning procedure. A plasmid containing the correct sequence was then 
used to transform Rosetta cells for protein expression. 
After cloning had been successfully achieved, expression of His6-tagged 
CaM (His6-CaM) by Rosetta cells had to be tested as well as whether any His6-CaM 
produced was soluble, and therefore could be purified. To assess this, an expression 
test was carried out at 37 °C inducing cells with 1 mM IPTG for six hours, taking 
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samples every hour. Expression of His6-CaM was clearly observed from one hour 
induction onwards, with a peak of expression observed at four hours (Figure 3.1A). 
The solubility of His6-CaM was tested by sonication followed by separating the 
insoluble fraction from the soluble fraction by centrifugation, then analysing both 
samples by SDS-PAGE. The results showed that the protein was found in the soluble 
fraction (Figure 3.1B). As the protein was soluble and highly expressed, large 













Large scale production of recombinant His6-CaM was carried out by growing 
two litres of bacteria culture using the conditions shown to be favourable for 
protein production in the expression test, namely 37 °C and induction with 1 mM 
IPTG for four hours. The bacteria were harvested and sonicated to disrupt the cell 
membrane and release the soluble proteins produced by the cell. The soluble 
proteins were separated from the cell debris by centrifugation at high speed. An 
AKTA system was used for the purification of His6-CaM. A 5 ml nickel (Ni2+) affinity 
A B 
Figure 3.1: Expression test of His6-CaM in BL21-DE3-pLys cells. (A) Test expression of His6-CaM 
in BL21-DE3-pLys E.coli cells showing the protein present between 0 and 6 hours post induction. 
(B) The solubility of His6-CaM was assessed by sonicating the cells and fractionating the lysate 
in to insoluble and soluble entities and analysing the fractions by SDS-PAGE. Arrows indicates 





column was attached to the system and equilibrated with 10 column volumes of 
Ni2+ buffer A (see Section 2.12.3 for the buffer recipe). The soluble proteins were 
loaded onto the column, which was pre-equilibrated with 10 column volumes of 
Ni2+ buffer A to remove any unbound proteins. His6-CaM was eluted from the 
column using a gradient of Ni2+ buffer B (see Section 2.12.3 for a recipe), which 
contains a high concentration of imidazole to compete with the His6-tag for Ni2+ 
binding sites, causing His6-tag dissociation from the Ni2+ resin and therefore elution 
of His6-CaM from the column. The AKTA purification system measures the 
absorbance of ultraviolet (UV) light of wavelength 280 nm. As proteins contain 
amino acids with aromatic rings, ultraviolet light of this wavelength will be 
absorbed. This allows one to follow the purification experiment with an absorbance 
profile, so that the elution of proteins can be observed by a change in the 
absorbance (Figure 3.2A). After the purification experiment was completed any 
fractions that were shown to contain protein by the 280 nm absorbance profile 
were analysed by SDS-PAGE (Figure 3.2B). This allowed for the selection of fractions 
that contained only His6-CaM. 
TEV protease was produced in-house as a His6-tag fusion protein to enable 
the easy removal of the protease from the recombinant protein of interest after 
His6-tag cleavage was carried out. Fractions eluted from the Ni2+ column shown to 
contain His6-CaM, were dialysed with TEV protease in TEV cleavage buffer (see 
Section 2.12.3) overnight to remove the His6-tag. The untagged CaM was then 
purified from the TEV protease, the cleaved tag and any CaM that remained tagged, 
by passing it once again through the Ni2+ affinity column, with cleaved CaM being 
present in the flow through (Figure 3.2C).  The yield of pure recombinant CaM 
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Figure 3.2: Purification of His6-CaM. (A) The purification profile for CaM passed through the 
nickel affinity column attached to the AKTA system. The blue trace represents the UV280 
absorbance measured in milli-absorbance units (mAU), green represents the concentration of 
buffer B, injection of the lysate onto the column is shown by the pink marker and collection 
fractions are shown in red. The zoom insert shows the elution peak for His6-CaM, with the 
fractions collected for analysis by SDS-PAGE shown. (B) Fractions from the purification were run 
on SDS-PAGE gel and those fractions shown to contain CaM were taken for TEV protease 
cleavage. (C) After TEV cleavage solution was passed through a nickel column to attempt to 
separate cleaved CaM from the His6-tag, uncleaved His6-CaM and the His6-tagged TEV protease. 
M=marker, with the molecular weight shown in kDa, tot=total lysate, FT= flow through, BC= 
before cleavage, W= wash with Ni
2+
 buffer A, E= elution with Ni
2+
 buffer B. Cleaved protein is 





Problems were encountered when separating the tagged CaM from the 
untagged. After TEV cleavage was carried out, and the solution was passed through 
the nickel column once again, both untagged and tagged proteins were found in the 
flow through. The flow through was then passed through the nickel column once 
more in an attempt to re-capture some of the unbound protein, and though some 
of the tagged CaM was removed, a proportion was still visible in the flow through 
(Figure 3.3). This meant that the His6-tag of the tagged CaM was not interacting 
efficiently with the Ni2+ affinity column. A possible explanation for this behaviour 
could be that CaM may be interacting with, and therefore masking, the His6-tag of 
tagged CaM molecules. If this was the case, the interaction may well affect 
subsequent binding studies. To avoid this potential problem, an E.coli vector 
containing an untagged CaM sequence was obtained (364) so untagged-CaM 
protein could be produced in-house and in the short term pure recombinant 













Figure 3.3:  Separation of His6-CaM from TEV protease cleaved CaM. TEV cleavage was 
carried out on His6-CaM and the solution was passed through nickel column. The flow 
through was collected (1st FT) and found to contain both cleaved and uncleaved protein. The 
1st FT was then passed through the column once again in an attempt to further separate 
cleaved CaM from uncleaved CaM and fractions collected for analysis by SDS-PAGE. Both 
cleaved and uncleaved CaM was once more found in the flow through (2nd FT). The marker is 
shown on the left, with molecular weights shown in kDa, BC= before cleavage, Total = total 
after incubation with TEV, W=wash with Ni2+ buffer A and E=elution with Ni2+ buffer B. 
Cleaved protein is shown with the blue arrow, whereas uncleaved protein is indicated with 





The vector encoding for untagged CaM was used to transform Rosetta cells 
and, as before, an expression test was carried out to ensure that CaM was 
produced in a soluble form. As soluble protein was observed at 37°C inducing cells 
with 1 mM IPTG for four hours for His6-CaM, these conditions were also used to 
test the expression of soluble untagged CaM. Analysis of the solubility of untagged 
CaM by SDS-PAGE revealed that the protein was in fact soluble (Figure 3.4A) and so 
therefore large quantities of the protein could be produced and purified.  
Production of untagged CaM was scaled-up by culturing two litres of E.coli 
using the growth conditions found to be favourable for the production of soluble 
protein in the expression test and the soluble fraction was obtained as described 
previously (Section 2.12.2).  The method used to purify untagged CaM altered 
slightly on the basis that the protein must be in its calcium loaded form (CaM-Ca). 
For this reason 5 mM CaCl2 was added prior to purification. CaM was then isolated 
using a phenyl sepharose column for hydrophobic affinity purification (350).  When 
calcium is bound to CaM it causes structural rearrangements that leads to the 
exposure of hydrophobic surfaces on CaM (365). When this was passed through the 
column the two hydrophobic surfaces interact and CaM remained bound to the 
column. Other proteins are removed from the column by several washing steps (see 
Section 2.12.4 for experimental details). CaM was then eluted from the column by 
the addition of buffer containing a high concentration of the chelating agent EGTA. 
The removal of calcium from the binding sites on CaM causes structural 
rearrangements of the protein, which leads to the hydrophobic surfaces of CaM 
becoming hidden within the protein and reversing the interaction with the 
hydrophobic column. The purification was also carried out using the AKTA system, 
and therefore the presence of protein was monitored by measuring the absorbance 
of ultraviolet light of 280 nm wavelength (Figure 3.4B). Fractions thought to contain 
protein were analysed by SDS-PAGE to assess if CaM was present (Figure 3.4C). 
Fractions containing CaM were collected, dialysed and concentrated for use in 
future experiments.  The yield of pure CaM produced using this method of 
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3.3.2 Production of N and C-lobes of CaM 
 In Killock et al (2009)(3), molecular modelling was used to look at the 
possible interaction between the L-selectin cytosolic tail, CaM and FERM domain of 
moesin. The model predicted that, in the ternary complex, only the C-lobe of CaM 
was involved in the interaction with L-selectin (3). To prove this experimentally, 
individual lobes of CaM were cloned separately to assess the ability of each domain 
to bind to the cytosolic tail of L-selectin.  
 The boundary domains for the two individual lobes of CaM (N-CaM and C-
CaM) were taken from published data (366). N- and C-CaM were cloned into MCS2 
of pETDuet using NdeI and XhoI restriction sites. This meant that both lobes were 
cloned without a tag. After ligation, KRX cells were transformed with the vector 
using the method described in Section 2.7. Positive colonies were tested for the 
presence of the correct insert, using colony PCR. Several positive colonies were 
observed and these were sent for sequencing to confirm the incorporation of the 
correct insert. 
The vector encoding N-CaM was used to transform Rosetta cells and small 
scale growth was carried out at 37°C and 18°C to test for expression of soluble 
protein. It was not obvious if soluble N-CaM was produced following induction 
(data not shown). This may have been because of the small size of the protein 
making it difficult to visualise on the SDS-PAGE gel. For this reason 1 L of culture 
C 
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Figure 3.4: Expression and purification of untagged CaM.  (A) E.coli cells were transformed 
with the vector encoding untagged CaM. Expression was tested using same conditions as 
His6-CaM. The soluble and insoluble fractions were separated by centrifugation and 
analysed by SDS-PAGE. The black arrow indicates CaM. M= marker, with protein molecular 
weight shown in kDa, UI= Uninduced, I Ins= Induced insoluble fraction, I S= Induced soluble 
fraction. (B) Purification profile of untagged CaM passed through phenyl sepharose column. 
The blue trace represents the UV280 absorbance measured in milli-absorbance units 
(mAU), green represents the concentration of buffer, the injection of the protein onto the 
column is shown by the pink marker and collection fractions are shown in red. The zoom 
insert represents the elution peak of CaM with the fraction collected for SDS-PAGE analysis 
labelled. (C) Fractions from the purification were analysed by SDS-PAGE and those 
containing CaM were collected for dialysis. Arrow shows CaM. M= marker, with protein 
molecular weight shown in kDa, FT= flow through. W1= wash with first wash buffer, W2= 




was grown to produce a larger amount of N-CaM and purification was attempted 
using the same method as untagged CaM. The results showed that at 37°C no 
protein eluted from the column (Figure 3.5A), whereas at 18°C protein was eluted 
from the column with a molecular weight corresponding to that of N-CaM (Figure 
3.5B), meaning soluble N-CaM was successfully produced at 18 °C. These growth 








As with N-CaM, the C-CaM vector was used to transform Rosetta cells and 
small-scale expression tests were performed at different growth temperatures in an 
attempt to produce soluble protein. The expression tests revealed that no soluble 
protein was produced when expression was induced at 37°C (Figure 3.6A) or 18°C 
(Figure 3.6B). In an attempt to obtain soluble protein the Sarkosyl method was 
used. This is a method that uses the detergent Sodium lauroyl sarcosinate, known 
as sarkosyl, to solubilise proteins found in inclusion bodies (367,368). During 
Figure 3.5: Expression and purification of N-CaM. N-terminal domain of CaM was expressed in 
Rosetta E.coli cells either at 37 °C (A) or at 18°C (B). Soluble and insoluble proteins were 
separated by sonication and centrifugation. N-CaM was separated from other soluble proteins 
using a HIC column attached to the AKTA system. M= marker, with protein molecular weight 
shown in kDa, Insol=insoluble proteins, sol= soluble proteins, FT= flow through, W1= wash with 






bacterial expression of recombinant proteins many become packaged in inclusion 
bodies or co-aggregate with bacterial proteins. By using sarkosyl detergent these 
inclusion bodies are disrupted and recombinant proteins can be solubilised. The 
major advantage of using this method is that it does not entail denaturing the 
protein. Proteins solubilised by denaturing require renaturing, which can be time 
consuming, costly and may result in incorrectly folded proteins, therefore avoiding 
denaturation is desirable. The sarkosyl detergent was used to re-suspend the pellet 
produced after sonication and centrifugation. After incubation on ice the solution 
was diluted and centrifuged once again. The supernatant was collected and 
analysed to decipher if the protein of interest was now found in the soluble 
fraction. The soluble and insoluble fractions produced using this method with 
Rosetta cells expressing C-CaM were analysed by SDS-PAGE, showing C-CaM 
remained in the insoluble fraction even after the Sarkosyl method (Figure 3.6C).   
A further attempt to produce soluble C-CaM was undertaken using Arctic 
cells to express the protein. These cells are engineered to increase the yield of 
folded, active proteins at lower temperatures. Standard E.coli cells contain 
chaperonins, such as GroEL and GroES, that help process and fold the recombinant 
proteins, but these chaperonins have a reduced activity when the temperature is 
lowered (369). Arctic cells contain the chaperonins Cpn10 and Cpn60 which have 
high refolding activity at lower temperatures (370). These cells were transformed 
with C-CaM and induced at 13°C with 1 mM IPTG for twenty four hours. The results 
showed that although most of the protein remained insoluble, a small amount was 
observed in the soluble fraction (Figure 3.6D). Further experiments are required to 































Figure 3.6: Expression tests of C-CaM. Expression tests were carried out for the C-lobe of 
CaM using different conditions to produce soluble protein. After induction the cells were 
sonicated and the soluble and insoluble fractions were separated by centrifugation. The 
different fractions were analysed by SDS-PAGE. (A) Induction carried out at 37 °C for 4 hours, 
(B) at 18 °C overnight. (C) Sarkosyl method was used on the insoluble protein produced after 
induction at 18 °C overnight. (D) Expression of C-CaM was also assessed using Arctic cells 
induced at 13 °C for 24 hours. Insol=insoluble fraction, sol=soluble fraction. The marker is 




3.3.3 Production of Moesin FERM domain 
 It has previously been shown that ERM proteins can bind to the cytosolic tail 
of L-selectin and play a role in locating it to microvilli (3,225). It was found that the 
FERM domain of moesin is responsible for interacting with L-selectin and other 
transmembrane proteins (223,371-373). For that reason, this domain was cloned 
and produced to further study the interaction between L-selectin and moesin. 
Moesin-FERM was cloned into MCS1 of pETDuet using the same restriction 
sites as full length CaM, so would therefore be expressed with a His6-tag. A TEV 
protease cleavage site was engineered between the His6-tag and the protein 
sequence.  The cloning was carried out as described before for CaM. The plasmid 
DNA from several colonies was isolated and sent for sequencing to confirm the 
presence of the correct insert. The vector with the correct sequence was then used 
to transform BL21-DE3-pLyS cells. 
 An expression test for His6-tagged moesin-FERM (His6-moesin-FERM) was 
carried out to assess protein expression and solubility and this showed that cells 
cultured at 37°C and induced with 1 mM IPTG for six hours produced His6-moesin-
FERM in the insoluble fraction (Figure 3.7A and B). For the expression at 18°C 
overnight, some soluble protein was seen, albeit the majority remained insoluble 
(Figure 3.7C). The Sarkosyl method was attempted to increase the amount of 
soluble protein, as previously described (Section 3.3.2). After incubation with 
Sarkosyl detergent, the solution was passed through a Ni2+ affinity column and 
fractions containing His6-moesin-FERM was determined by SDS-PAGE. A small 
amount of His6-moesin-FERM was eluted from the column, however a majority of 
the protein was found in the flow through (Figure 3.8A), showing it did not interact 
with the Ni2+ affinity column. One possible explanation for this is that the His6-tag is 
unable to bind to the column through partial folding, or non-specific interactions 
between the protein and the tag. There have been previous reports where the His6-
tag did not interact with the resin, which similarly hypothesise concealment of the 
tag (356). The His6-moesin-FERM eluted from the column was collected and TEV 
digestion was carried out as described earlier. After overnight cleavage, 
precipitation was observed in the digestion reaction. The solution was centrifuged 
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at 4000 rpm for five minutes to remove the precipitate and the soluble fraction was 
passed through the Ni2+ affinity column to separate tagged from untagged moesin-
FERM, the His6-tag and TEV protease. Fractions analysed by SDS-PAGE (Figure 3.8B) 
indicated that no moesin-FERM was observed in the flow through or elution 
fractions. A sample of the precipitate formed overnight was also analysed by SDS-
PAGE, showing that moesin-FERM was indeed precipitated (Figure 3.8B), indicating 
overnight aggregation. Taken together these results showed that the Sarkosyl 









Figure 3.7: Expression of His6-moesin-FERM. (A) Expression of His6-moesin-FERM was tested at 
37°C with IPTG induction over six hours. Samples were collected once every hour and analysed by 
SDS-PAGE. (B) Solubility at 37°C was tested by sonicating the cells and separating the soluble and 
insoluble fraction by centrifugation and analysing the fractions by SDS-PAGE. Sol= soluble fraction 
and Ins= insoluble fraction. (C) An expression test was carried out at 18°C overnight in an attempt 
to produce soluble protein. The soluble and insoluble fractions were analysed by SDS-PAGE. UI= 
Uninduced, IS= Induced soluble, I Ins= Induced insoluble. The marker (M) is shown on the left of 














Large-scale production of His6-moesin-FERM was carried out using 18°C 
induction overnight. The soluble fraction was produced as explained previously (see 
Section 3.3.1) and His6-moesin-FERM was purified with a Ni2+ affinity column using 
the protocol previously described (see Section 3.3.1). Fractions were collected from 
the column and those shown to contain protein by changes in the 280UV trace 
(Figure 3.9A) were analysed by SDS-PAGE (Figure 3.9B). His6-moesin-FERM then 
underwent TEV cleavage. Although the removal of the tag was successful, this 
caused precipitation of the protein (Figure 3.9C). This meant that this method could 
not be used to produce soluble untagged moesin-FERM.  
B A 
Figure 3.8: Purification of Moesin FERM domain after Sarkosyl treatment. (A) The insoluble 
fraction produced after protein induction at 18 °C was treated with sarkosyl reagent and the 
soluble fraction produced was passed through a Ni2+ affinity column. The flow through, wash 
and elution fractions were collected and analysed by SDS-PAGE. (B) The elution collected in 
(A) was digested with TEV protease overnight (Total 1). A precipitation was observed in the 
digestion solution the next day and centrifugation was carried out to separate the soluble 
from insoluble fractions. Soluble fraction (Total 2) was passed through the nickel column 
once again, with fractions collected for analysis by SDS-PAGE. However, moesin-FERM was 
found to be insoluble. Insol= insoluble fraction, sol= soluble fraction, FT= flow through, W= 
wash, E= elution. The marker is shown on the left of the gels, with the molecular weights 
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Figure 3.9: Purification of His6-moesin-FERM. (A) Purification profile of His6-moesin-FERM using a 
Ni2+ affinity column attached to the AKTA system. The blue trace represents the UV280 absorbance 
measured in milli-absorbance units (mAU), green represents the concentration of buffer B, 
injection onto the column is shown by the pink marker and collection fractions are shown in red. 
The zoom insert shows the elution peak of His6-moesin-FERM, with the fractions collected for SDS-
PAGE shown. (B) Fractions thought to contain protein were analysed by SDS-PAGE and those found 
to contain His6-moesin-FERM were subjected to TEV protease cleavage. (C) After cleavage the 
solution was passed through a nickel column and fractions were analysed by SDS-PAGE. Moesin-
FERM was found to be insoluble after cleavage. Black arrow shows uncleaved His6-moesin-FERM 
and blue arrow shows cleaved moesin-FERM. tot=total lysate, FT= flow through, BC= before 
cleavage, Ins= Insoluble fraction after cleavage, S= soluble fraction after cleavage, W= wash with 
Ni2+ buffer A, E= elution with Ni2+ buffer B. The marker (M) is shown on the left of each gel, with 





The His6-tag was attached to the N-terminus of moesin-FERM, which was 
predicted to be the binding site for CaM. This meant that it was possible that the 
tag might interfere with the binding between CaM and moesin-FERM. For that 
reason moesin-FERM was re-cloned into MCS2 of the pETDuet vector, so it would 
be expressed without a His6-tag. NdeI and XhoI restriction sites were used to clone 
moesin-FERM domain into the vector. After transformation, colony PCR was carried 
out to confirm the presence of the insert, revealing that the insert was present in 
the colonies tested. The vector was sent for sequencing confirming that the 
moesin-FERM sequence was correct.                                                                                                                                                                                                                                                                                                                                                                            
The vector with the correct sequence was used to transform Rosetta cells. 
Expression of moesin-FERM was assessed at 37°C and the SDS-PAGE analysis 
showed that the protein was present in the insoluble fraction (Figure 3.10A). At 
18°C some of the protein was seen in the soluble fraction but a majority of it was 
still insoluble (Figure 3.10B). In an attempt to improve the solubility further, Arctic 
cells were transformed with the vector and induced for twenty four hours at 13°C. 
This resulted in an increase in the amount of soluble protein produced (Figure 
3.10C) and so Arctic cells were used for future expression of moesin-FERM. 
 Untagged moesin-FERM was purified using hydroxyapatite resin, using a 
previously described protocol (261,274). The resin has the chemical formula 
Ca10(PO4)6(OH)2 and forms crystals with pairs of calcium ions (C-sites), clusters of six 
oxygen atoms from phosphate groups (P-sites) and hydroxyl groups, which are all 
arranged in a fixed pattern on the surface of the crystal (374-376). Amino groups of 
the protein are attracted to P-sites but repelled by C-sites, with the opposite being 
true for carboxyl groups. Phosphoryl groups interact with C-sites more strongly 
than carboxyl groups, therefore the proteins are loaded onto the column with a 
buffer of low potassium phosphate concentration and proteins are eluted by 
increasing the potassium phosphate concentration (376-379). Cell lysate from Arctic 
cells expressing moesin-FERM was added to the resin, which was then washed with 
hydroxyapatite buffer A (see Section 2.12.5 for a recipe) and then hydroxyapatite 
buffer B (the recipe is shown in Section 2.12.5) to elute the protein. Fractions were 




FERM was located in the elution fraction with no impurities (Figure 3.10D). This 
method was therefore successful in producing pure recombinant moesin-FERM, 
with a yield of approximately 0.95 mg/l being produced.  
 The protein was then dialysed in tris buffer, phosphate buffer and sodium 
acetate buffer to determine which was best for stabilising the protein. It was found 
that sodium acetate buffer allowed the protein to be concentrated to the highest 
level, with a low micromolar concentration reached in this buffer, whereas the 
protein precipitated earlier in the other buffers. However this concentration was 






Figure 3.10: Expression and purification of untagged moesin-FERM. Expression of untagged 
moesin-FERM was tested at different conditions in an attempt to produce soluble protein, first at 
37°C (A) then at 18°C (B) and 13°C (C). UI= Uninduced, IS= induced soluble, Ins= Induced insoluble 
fraction. (D) As soluble protein was produced at 13°C, purification of the protein produced under 
these conditions was attempted using a hydroxyapatite column. Arrow shows the location of 
FERM. Tot= total lysate, Sol= soluble fraction, FT= flow through, WA= wash with hydroxyapatite 
buffer A, E= elution with hydroxyapatite buffer B. Arrows shows the location of FERM. The marker 




3.3.4 L-selectin Peptides 
 L-selectin peptides, wildtype, alanine mutations and serine phosphorylated 
peptides, were purchased from the University of Bristol. They were purified using 
desalting columns to remove any impurities and salt that would interfere with ITC 
experiments. The peptides were then lyophilised and weighed to accurately 
calculate the concentrations required for biophysical techniques. 
  
3.3.5 Production of Trp-Cage-L-Selectin 
One possible method to pinpoint the residues involved in specifically 
interacting with CaM would be to carry out NMR experiments with 15N/13C-labelled 
L-selectin cytosolic tail peptides. To purchase labelled peptides is expensive; 
therefore it was desirable to produce peptides in-house using E.coli expression. 
However, production of recombinant peptides and unstructured proteins in E.coli 
cells is often unsuccessful because of degradation of the desired product by 
contaminating bacterial proteases (361,362). To circumvent this, peptides can be 
tagged with fusion partners that help protect against degradation (380). One of the 
possible tags is Exendin-4, a 39 residue peptide isolated from the saliva of the Gila 
monster (381). The NMR structure was solved and it showed that residues 21-38 of 
the C-terminus formed a stable tertiary structure, designated a Trp-Cage motif 
(382). The motif is a hydrophobic cluster with tryptophan residue 25 buried in the 
centre of the structure. Several proline residues, 31 and 36-38, form a cage around 
Trp-25 to shield the hydrophobic core from solvent exposure (383).  Mutational 
studies have been carried out on the Trp Cage motif to produce the folded 
structure with the fewest possible amino acids. The studies showed that the 20 
amino acids of the C-terminus are adequate for the formation of the Trp-Cage 
motif. Further mutations were carried out to improve the formation of the motif in 
water and the stability of the structure. The optimized sequence was found to be 
NLYIQWLKDGGWSSGRPPPS and known as TC5b (381), which is the sequence used 
in this study (known as Trp-Cage hereafter).  
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  The vector containing the Trp-Cage construct with an N-terminal His6-tag 
and a TEV cleavage site between the Trp-Cage and the cloning site was a gift from 
Dr Pete Simpson, Imperial College London. The L-selectin cytosolic peptide was 
cloned using primer oligonucleotides designed to span the entire sequence for the 
cytosolic tail of L-selectin and containing overhangs for the restriction enzymes 
EcoRI and BamHI to allow ligation of the insert into the vector cleaved with these 
restriction enzymes. The L-selectin insert was made by annealing the 
oligonucleotides together by heating the mixture to 95°C then allowing the solution 
to cool slowly. The insert was then treated with a kinase to phosphorylate the ends 
and enable ligation to occur, as the vector was treated with calf-intestinal alkaline 
phosphatase (CIP) after restriction digestion. The ligated vector was then used to 
transform E.coli. Several colonies were sent for DNA sequencing to confirm the 
presence of L-selectin, with results showing the correct sequence was present. 
 After transformation of Rosetta cells with the vector containing the correct 
sequence, expression of Trp-Cage-L-selectin was carried out at 20°C overnight, 
using a protocol provided by Dr Pete Simpson (Imperial College London). Analysis 
revealed that the Trp-Cage-L-selectin appeared to be soluble (Figure 3.11A). The 
protein was purified using Ni2+-NTA resin as described before, with a protein band 
visible on the SDS-PAGE gel corresponding to the molecular weight of the Trp-Cage-
L-selectin apparent in the elution fraction (Figure 3.11B). The presence of intact L-
selectin was confirmed by western blot analysis using antibody CA21, which 
recognises the tail of L-selectin (Figure 3.11C). 
 TEV cleavage was carried out to separate the Trp-Cage from L-selectin. The 
flow through was collected from the Ni2+ column following cleavage and samples 
were analysed by SDS-PAGE, but L-selectin was not visible on the gel due to its 
small size. UV analysis did suggest the presence of the peptide in the flow through 
so this was desalted into water then lyophilised. Analysis of the lyophilised product 








Figure 3.11: Expression and purification of Trp-Cage-L-selectin. (A) Rosetta cells were transformed 
with Trp-Cage-L-Selectin vector and expression was induced at 20 °C overnight. The soluble and 
insoluble fractions were produced by sonication and centrifugation and were analysed by SDS-
PAGE. (B) Trp-Cage-L-Selectin was purified from the cell lysate using nickel resin, with fractions 
collected and analysed by SDS-PAGE. (C) Western blot was carried out using CA21 antibody specific 
for the L-selectin tail to confirm the presence of L-selectin. Sol= total soluble fraction, FT= Flow 
through, W= wash, E= elution. The arrow shows the Trp-Cage-L-Selectin. The marker (M) is shown of 



















3.3.6 Characterisation of Recombinant CaM 
To check that the purified recombinant CaM protein was folded and to 
confirm its calcium-loaded state, 1D 1H NMR experiments were carried out on CaM 
samples thought to be calcium bound (CaM-Ca) (Figure 3.12B) and calcium free 
(ApoCaM) (Figure 3.12A). The 1D 1H spectrum shows the resonance signals for 
every proton in the protein (see Section 2.17.2.1 in Material and Methods for an 
explanation). Due to the difference in the structures of ApoCaM and CaM-Ca, the 
proton chemical shifts will be different for each one, producing clear differences in 
the proton spectrum. As there are many protons in the protein, there is much 
overlap within the spectrum, so these differences can only be seen at the 
periphery. These peripheral areas represent the methyl groups at around 0 ppm 
(red circle) and the NH groups around 10 ppm (blue circle). The spectra of CaM with 
and without calcium show clear differences that are consistent with spectra 
published in the literature (365,384). These differences can be used as a diagnostic 
















Figure 3.12: 1D 1H NMR of CaM. (A) Spectra for Apo CaM and  (B) CaM-Ca. The differences in 
the chemical shifts of the methyl groups and NH groups are shown in red and blue respectively. 
Spectra were recorded using a Bruker 700 MHz at 25 °C in NMR buffer (see Section 2.12.3) with 





The folding of CaM was also assessed using 2D NMR with proteins labelled 
with 15N and carrying out [1H-15N] HSQC experiments, where each peak on the 
spectrum represents one NH group (therefore one amino acid) of CaM. The 
experiments were carried out in the presence and absence of calcium as before, to 
check the differences in the spectrum between the two (Figure 3.13). The spectrum 
showed that both CaM-Ca and Apo-CaM were folded and there were clear 
differences between the spectra. 2D [1H-15N] HSQC spectra have previously been 
published and were used to assign the spectra produced here (for ApoCaM BMRB 

















Figure 3.13:  2D [1H-15N] HSCQ of CaM. (A) Spectra of ApoCaM and (B) CaM-Ca. Spectra were 
recorded using a Bruker 700 MHz at 25 °C in NMR buffer (see Section 2.12.3) with and 





3.3.7 Characterisation of L-selectin Peptides 
To assess the secondary structure of wildtype L-selectin in solution, CD 
experiments were carried out. Several buffers were used to see if different 
conditions affected the structure. The results showed that the peptide formed a 
random coil structure in both tris (Figure 3.14A) and phosphate buffer (Figure 
3.14B) and the addition of 0.05% TWEEN had little effect on the structure of the 
peptide (Figure 3.14C). 
CD experiments carried out on peptides with the serine to alanine 
mutations S364A and S367A indicated that these peptides also form random coils in 
the different buffers tested; no different to wildtype L-selectin. This shows that the 
alanine mutations did not affect the secondary structure of the peptide in solution.   
149 
 
















































































Figure 3.14: CD of L-selectin peptides. (A) CD spectra of peptides in 150 mM Tris buffer, 
(B) phosphate buffer and (C) 150 mM Tris with 0.05% TWEEN. Experiments were carried 
out by Tam Bui, Kings College London using an Applied Photophysics Chirascan Plus 

































3.3.8 Characterisation of Trp-Cage-L-selectin 
 N15-labelled Trp-Cage-L-selectin was produced using the protocol described 
in Section 2.17.2.2. Once purity of the protein was confirmed by SDS-PAGE analysis, 
the protein was concentrated to 124 µM and NMR experiments were performed. A 
1D 1H experiment was carried out (Figure 3.15A) and the spectrum was compared 
to a previous Trp-Cage spectrum produced by Imperial College London 
(unpublished data). The spectra were very similar and the protein was mainly 
folded, shown by the presence of sharp narrow peaks.  A 2D [1H-15N] HSQC 
experiment (Figure 3.15B) was undertaken to further assess the folding of the 
protein. Once again there were signs that the protein was folded, as well-dispersed 
and distinct peaks were observed. There were however, also signs of degradation 
or unfolding of the protein, as highlighted by a cluster of overlapping peaks in the 
centre of the spectra. Comparison of the spectra produced here and previous 
spectra (unpublished data, Imperial College London), showed some similarities but, 
as there were signs of unfolding, further analysis is required to decipher whether 




























Figure 3.15: NMR studies of Trp-Cage L-selectin. (A) A 1D 1H spectrum of Trp-Cage L-selectin 
and (B) a 2D [1H-15N] HSQC spectrum of Trp-Cage L-selectin. Both spectra were recorded 







3.4.1 Production of CaM 
 CaM was originally produced with an N-terminal His6-tag to aid purification. 
However, as mentioned above, removal of the tag became problematic. ITC 
experiments were attempted with His6-CaM and wildtype L-selectin peptide. 
Binding was seen but the results were different from those seen with untagged 
CaM (see Chapter 4), in particular the stoichiometry was much lower than 1. This 
may have been caused by the presence of the tag, affecting the binding 
characteristics or the structure of CaM. This is in agreement with previous studies in 
which the His6-tag was found to interfere with protein-protein interactions 
(356,385). For this reason CaM without a tag was used. This untagged CaM was 
purified using a protocol previously described by Hayashi et al (1998)(350) and has 
been widely used in the literature. Using this method not only removed the 
problem with the tag but also reduced the time required for production of the 
protein, as only one purification step was required. 
 Once CaM was produced, NMR experiments were carried out to check that 
the protein was folded. Both The 1D 1H NMR and the 2D [1H-15N]-HSQC spectra 
showed that the protein was folded and looked similar to spectra previously 
reported. This meant that CaM could be used for further experiments, confirming 
that it was correctly folded.  
 
3.4.2 Protein expression of the Individual Lobes of CaM 
 To be able to understand if one or both terminal domains of CaM are 
required for the interaction with L-selectin, each lobe was cloned separately. The N-
terminal lobe of CaM was successfully produced and purified. The method 
described here can now be used to produce large quantities of the N-lobe for 
biophysical studies. Production of the C-lobe was more problematic, as several 
different growth conditions were tested and only a small amount of soluble protein 
was yielded using Arctic cells. Further experiments are required to determine the 
possibility of purifying this domain of CaM with high efficiency. To facilitate 
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increased production of this domain may require altering the boundary used for the 
C-lobe, either extending the N-terminus or removing residues from the C-terminus, 
as this may somehow promote the production of soluble protein, as shown in many 
examples (348,386). It is also possible that the addition of a fusion partner may 
promote solubility. Several fusion partners have been shown to increase solubility, 
including maltose-binding protein and GST (356). Persechini (1996) (387) used a 
slightly different method to study the role of the different lobes of CaM. They 
produced mutants with one of the lobes “swapped out”, so CaM was made up of 
either two N-lobes (CaMNN) or two C-lobes (CaMCC) (387). They were then able to 
use these recombinant proteins to assess their ability to activate skeletal muscle 
myosin light chain kinase, known to become activated through CaM binding. A 
similar study could be employed here if it is not possible to clone the lobes 
separately; CaMNN and CaMCC could be produced and used to assess if there is a 
difference in their capacity to bind to the L-selectin cytosolic tail. 
 
3.4.3 Production of moesin FERM domain 
 A majority of the His6-moesin-FERM produced was found in inclusion 
bodies, especially when produced at 37 °C. This was likely due to insufficient time 
for correct folding (356). To improve the solubility, the temperature was decreased 
in an attempt to slow down the production of protein expression and increase the 
time available for correct folding to occur. This did improve the amount of soluble 
protein produced and more protein could be purified. However when the His6-tag 
was removed the protein precipitated. This may be due to an increase in protein 
stability or solubility in the presence of the His6-tag and once it was removed the 
protein aggregated/precipitated. Due to the concern that the His6-tag may 
interfere with the interaction between moesin-FERM and L-selectin or CaM, it was 
decided that production of moesin without a tag was a better approach to purify 
the protein using hydroxyapatite resin (261,274). This enabled the production of 
purified soluble protein. However, when this protein was concentrated it began to 
precipitate. ITC experiments were attempted with this purified protein, but the 
results were inconsistent. This was most likely due to the instability of the protein, 
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and having to use very low concentrations of moesin (results not shown). Therefore 
it was not possible to use ITC to study the interaction between moesin, L-selectin 
and CaM. There are no examples of moesin FERM domain being used for studies 
using ITC. In a recent study using recombinant ezrin FERM, the protein was purified 
in the same way that moesin was produced and purified in this chapter (261). It is 
possible that the ezrin FERM domain is slightly more stable and as it is likely to bind 
in the same way as moesin, it could be used to study the interaction between L-
selectin and the FERM domain. MST requires much lower concentrations of protein, 
so it is possible this technique could be attempted to study the interaction between 
moesin, L-selectin and CaM in the future.  
 
3.4.4 Production of Trp-Cage L-selectin 
 By using the Trp-Cage motif as a scaffold protein, it was possible to produce 
15N labelled L-selectin cytosolic tail peptide. However, further study is required to 
assess the stability of this construct. This means that future NMR studies could be 
carried out by titrating in CaM to observe which amino acids in the L-selectin tail 
undergo chemical shift perturbations (CSPs), upon CaM binding. This will provide 
useful information on which residues in the cytosolic tail of L-selectin are 
responsible for the interaction with CaM. The same method can be used to produce 
mutated labelled peptides to assess if they have an effect on the binding between 
CaM and L-selectin. For example aspartic acid can be substituted for serine residues 




Chapter 4: In vitro Analysis of the Interaction 
between CaM and L-selectin 
4.1 Introduction  
 The binding of CaM to the cytosolic tail of L-selectin in resting cells is 
thought to negatively regulate L-selectin’s cleavage by the metalloprotease TACE 
(114). Leukocyte activation results in CaM dissociation and subsequent cleavage of 
L-selectin (215). It is not known what causes the dissociation of CaM from the tail; 
although it is hypothesised that phosphorylation within the L-selectin cytosolic 
domain may play a key role. The cytosolic tail of L-selectin contains two serine 
residues, whose phosphorylation may potentially regulate the binding of CaM and 
moesin, and several PKCs isozymes have been shown phosphorylate L-selectin upon 
leukocyte activation (95,214). There are many examples in which phosphorylation 
at sites within CaM binding domains regulate CaM binding, for example in β-
adducin, which is a subunit of the heteromeric adducin protein involved in the 
assembly of the spectrin-actin network (226). Myristoylated alanine-rich C-kinase 
substrate (MARCKS), a membrane associated protein that interacts with actin, is 
another example where the CaM-binding domain contains phosphorylation sites 
that, when phosphorylated, result in a markedly reduced binding affinity for CaM 
(226).  
 In the previous chapter the production of recombinant CaM was described. 
This protein can now be used to study its interaction with L-selectin. As previously 
described, peptides corresponding to the cytosolic tail of L-selectin were 
synthesised commercially. Along with the wildtype sequence, peptides with alanine 
mutations and phosphorylated serines were used to assess which residues within 
the cytosolic tail of L-selectin contributed to the interaction and whether serine 
phosphorylation affected CaM binding.  
4.2 Experimental Design 
A variety of biophysical methods can measure the strength of interaction 
between molecules. These include isothermal titration calorimetry (ITC) (388), 
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mircoscale thermophoresis (MST) (344), surface plasmon resonance (SPR) (389) and 
fluorescence correlation spectroscopy (FCS) (390) and they all have advantages and 
disadvantages which must be considered when designing the experimental strategy 
to use. The advantages of SPR include the fact that labelling is not required, which is 
advantageous as the presence of a label could affect the binding between the 
molecules. Experiments can be carried out on crude cell lysates, meaning that 
purification of the protein of interest may not be necessary in all cases. The major 
disadvantage of this method is it requires the immobilisation of one of the 
molecules of interest onto a support metal surface, which could seriously affect its 
ability to bind to its partner (391). FCS does not require immobilisation but does 
require fluorescently labelling one of the molecules of interest. 
 The primary method chosen in this study to investigate protein-peptide 
interaction was ITC, on the basis that the molecules do not need to be labelled or 
immobilised, therefore there was a lower chance of binding interference. 
Furthermore a major advantage of this technique is that the thermodynamic profile 
of the interaction, the constant of binding and the stoichiometry can be analysed 
from a single experiment, providing further information about the mechanism of 
interaction beyond affinity strength. MST was used in parallel with ITC, not only to 
verify the results from ITC experiments but also to provide a valid alternative when 
ITC proved inconclusive.  MST was chosen because it is relatively straightforward to 
implement and uses little material, although it does require the labelling of the 
protein. 
 To map the regions of CaM involved in L-selectin binding, NMR spectroscopy 
was utilised. [1H-15N] HSQC titration experiments were carried out to assess the 
residues within CaM which experienced chemical shift perturbations upon addition 
of L-selectin, giving a more detailed picture of the potential surface of molecular 
interaction. As described previously, a chemical shift perturbation will result from a 
change in the chemical environment of the nuclei (see Section 2.17.2.1), therefore, 
the analysis of any residues within CaM that are affected by the presence of L-
selectin may provide information on CaM’s interacting surface, as well as 
conformational changes induced by the interaction. In this report the changes in 
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the chemical shifts, chemical shift perturbations (CSPs), were identified and 
quantitatively measured. 
In this chapter, the analysis of the interaction between CaM and L-selectin 
by ITC, NMR and MST is described. As CaM is a calcium-binding protein, the first 
question was whether calcium was required for L-selectin interaction. This was 
assessed by comparing the results from ITC experiments carried out in the presence 
and absence of calcium. The next key question was whether phosphorylation of 
serine residues within the tail of L-selectin affected the ability of CaM to bind and 
therefore decipher whether phosphorylation regulates CaM binding to L-selectin 
during leukocyte recruitment. To address this point, ITC and MST experiments with 
CaM and phosphorylated peptides were undertaken. A similar approach was used 
to assess whether mutating residues within the cytosolic tail of L-selectin affected 
the ability of CaM to bind and provide information about residues within the 
cytosolic tail of L-selectin that contribute to CaM interaction.  
 
4.3 Results 
4.3.1 Assessing the interaction between CaM and Wildtype L-selectin 
Cytosolic Tail 
To determine the ability of CaM to bind to the L-selectin cytosolic tail, ITC 
was carried out using recombinant purified CaM and commercially purchased L-
selectin tail peptide. Prior to CaM/L-selectin experiments being carried out, a 
negative control was undertaken, injecting CaM into NMR buffer to observe the 
heat of dilution. The results in Figure 4.1 represent an example of this control 
experiment and shows the ITC profile for CaM-Ca/buffer experiment. Small peaks of 
very similar in size are observed throughout the experiment. The last peak of the 
CaM/L-selectin experiments was seen to be similar to the peaks observed in the 
buffer experiment. For this reason it was decided that the final peak to the L-














CaM is a calcium binding protein and a number of its interactions have been 
reported to depend on the presence of Ca2+ (234,392,393). To understand whether 
this was the case for CaM binding to L-selectin, ITC experiments were carried out 
with wildtype L-selectin cytosolic tail peptide in the sample cell of the ITC 
equipment with calcium-bound CaM (CaM-Ca) or calcium-free CaM (ApoCaM) 
titrated into the cell from the syringe (see Section 2.17.1.1 for a schematic of the 
ITC equipment). For both experiments the integrated heat data showed that the 
binding process was composed of one clear event centred on a molar ratio of one 
(Figure 4.1). The binding isotherm curves have been interpolated using an 
independent-site model, revealing that at 20 °C CaM protein interacted with L-
selectin with a dissociation constant (KD ) of 1.6±0.3 μM, with an enthalpy change 
(H) of -416±110 cal/mol and an entropic contribution (defined as -TS) of -
6967±393 cal/mol in absence of calcium and a KD of 4.0±2.1 μM, a ΔH of 1430±341 
cal/mol and a -TΔS of  -8528±108 cal/mol in presence of calcium (Table 4.1). 
Although binding occurred with similar affinities, interestingly, the thermodynamic 
profiles of the two interactions were different (Figure 4.1C and F): CaM-Ca/L-
selectin interaction was described by an exothermic reaction (i.e. had a negative 
Figure 4.1: ITC results for CaM injected into buffer.  Raw data for NMR buffer injected into CaM-
Ca injected into NMR buffer. The experiment was carried out using a microcalorimeter, with CaM 
present in the syringe at a concentration of 0.38 mM (see Section 2.17.1.2 for experimental 


































change in enthalpy) and was both enthalpically and entropically driven (with a 
dominant entropic contribution); the binding of ApoCaM to L-selectin is an 
entropically driven endothermic reaction.  
For an interaction to occur spontaneously, the change in Gibbs free energy 
(ΔG) of the interaction must be negative (394). ΔG has both enthalpic (ΔH) and 
entropic (ΔS) contributions, which reflect different aspects of the protein-protein 
interaction. Enthalpy represents the strength of the interactions between the two 
molecules, such as Van der Waals interactions and hydrogen bonds (335,394). 
When binding between two proteins occur, new bonds and interactions will form 
between the two molecules and there will be a change in energy, such as heat 
being released or absorbed. In addition to bond formation, bonds are also broken 
during the interaction. These can come in the form of intramolecular interactions or 
intermolecular interactions – either with the other protein or the surrounding 
solvent. These processes all contribute to the ΔH (335,394). ΔS reflects the change 
in solvation and conformation during the interaction. When binding occurs, water is 
released from the binding site causing a gain in solvent entropy (333). There is also 
a loss in conformational freedom when two molecules interact, resulting in a 
negative change in conformational entropy (394). ΔS is the sum of the ΔS of 
solvation and ΔS of conformation.  
In the case of CaM-Ca interaction with L-selectin peptide, the reaction was 
both enthalpically and entropically driven, as both ΔH and -TΔS were negative and 
therefore contributed to the favourable negative ΔG. The interaction between Apo-
CaM was entropically driven, as -TΔS was negative whereas ΔH was positive, so only 
the ΔS contributed to a favourable negative ΔG. Different enthalpic and entropic 
contributions for CaM-Ca and Apo-CaM binding to the L-selectin cytosolic tail could 
either reflect different mechanisms of binding or could be linked to a different 
































































Figure 4.2: ITC results for CaM binding to wildtype L-selectin tail peptide.  Raw data for 
ApoCaM (A) and CaM-Ca (D) binding to wildtype L-selectin tail. (B and E) the normalised heat 
of interaction (the ΔH caused by the interaction of CaM and the L-selectin peptide) was 
obtained by integrating the raw data and subtracting the heat of dilution from each point. 
The red line represents the best fit obtained by a non-linear least-squares procedure based 
on one independent binding site model using origin 7.0. The thermodynamic profile for the 
interaction between L-selectin and ApoCaM (C) and CaM-Ca (F) is shown, with the ΔH, -TΔS 




 CaM-Ca  ApoCaM  
Stoichiometry (N) 0.97±0.12 1.21±0.15 
KD (μM) 4.01±2.15 1.6±0.3 
ΔH (cal/mol) -416±110 1430±341 
-TΔS (cal/mol) -6967±393 -8528±108 




To investigate further the interaction between CaM and the L-selectin 
cytosolic tail and to gain insight into the binding mechanisms for both CaM-Ca and 
ApoCaM, a series of 2D [1H-15N] HSQC NMR experiments were carried out with 15N-
labelled ApoCaM or CaM-Ca kept at a constant concentration whilst titrating in 
wildtype L-selectin peptide. Changes in amide 15N and 1H chemical shifts (ΔδAV), 
namely chemical shift perturbations (CSP), were calculated for all peaks that 
showed perturbation using the formula: 
    22 2.0 NHAV    (340), 
where ΔδH is the change in the chemical shift of the amide proton and ΔδN is the 
change in the chemical shift of the amide nitrogen. As described above, CSPs 
provide information about which residues of CaM may be involved in the 
interaction (Section 4.2). The CSPs were then colour coded depending on the extent 
of the perturbation, with red representing the largest CSPs (AV≥0.03), orange 
representing moderate CSPs (0.01≤AV<0.03), yellow representing small CSPs 
(0.005≤AV<0.01) and white representing little or no CSPs (AV<0.005). Given that 
the 3D structures of both Apo-CaM and CaM-Ca are available and that the 2D [1H-
Table 4.1: Thermodynamic parameters of the association of L-selectin and ApoCaM or CaM-
Ca. Measurements were taken using a MicroCal ITC200 instrument at 20 °C in NMR buffer (see 




15N] HSQC NMR spectra for CaM-Ca and Apo-CaM have been previously assigned, 
the residues showing CSPs can easily be identified and mapped onto the structure 
of the respective protein. 
The results showed that with both CaM-Ca (Figure 4.2) and ApoCaM (Figure 
4.3) most of the CSPs were observed in the C-terminal lobe of CaM, suggesting that 
this lobe was largely responsible for binding to L-selectin cytosolic tail. Interestingly, 
this suggests that CaM did not bind to L-selectin with the classical binding 
mechanism where both lobes are involved and wrap around the target binding site 
(see Section 1.4.2, Figure 1.12C). The large conformational rearrangement required 
for both lobes to interact with L-selectin would result in large CSPs across the entire 
structure of CaM, as observed in previous studies (254,395,396) but it is not seen 
here. This was also consistent with the small enthalpy changes observed from the 
ITC experiments for both CaM-Ca and ApoCaM binding to the L-selectin cytosolic 
tail peptide. If large structural rearrangements were taking place, larger changes in 
enthalpy would be expected, as found previously with several examples of 
canonical binding of CaM to its targets (396,397).  
Although both CaM-Ca and ApoCaM show a majority of the CSP in the C-
lobe of the protein, there were differences in the amino acid residues affected in 
one or the other experiments. This may suggest a difference in binding between L-
































































Figure 4.3: Chemical shift perturbation analysis of CaM-Ca/L-selectin interaction. (A) [1H-15N] HSQC 
of CaM-Ca (black) and CaM-Ca in the presence of 1.2 equivalent of the peptide (red). 15N chemical 
shifts are shown on the Y axis and 1H chemical shifts shown on the X axis, both in part per million 
(ppm). Chemical shifts were assigned from the Biological Magnetic Resonance Bank (BMRB) ID 1634.  
Spectra were recorded using a Bruker 700 MHz at 25 °C in NMR buffer (see Section 2.12.3 for recipe) 
with 5 mM CaCl2. (B) Chemical shift perturbations were calculated using the method described in 
Section 2.17.2.2.1 and (C) plotted on the structure of CaM-Ca, Protein Data Bank (PDB) id 3CLN. 
Residues coloured red represent CSPs of ΔδAV≥0.03, orange represent CSPs of 0.01≤ΔδAV<0.03, 




































































Figure 4.4: Chemical shift perturbation analysis of ApoCaM/L-selectin interaction. (A) [1H-15N] 
HSQC of ApoCaM (shown in black) and ApoCaM in the presence of 1.2 equivalent of the 
peptide (shown in red). 15N chemical shifts are shown on the Y axis with 1H chemical shifts 
shown on the x axis both measured in ppm. Chemical shifts were assigned from BMRB ID 5353. 
The spectra were recorded using a Bruker 700 MHz at 25 °C in NMR buffer (see Section 2.12.3 
for recipe). (B) Chemical shift perturbations were calculated using the method described in 
Section 2.17.2.2.1 and (C) plotted on the structure of ApoCaM, PDB id 1CFC. Residues coloured 
red represent CSPs of ΔδAV≥0.03, orange represent CSPs of 0.01≤ΔδAV<0.03, yellow represents 











4.3.2 Monitoring the binding of CaM to phosphorylated L-selectin 
peptides 
 To assess the importance of phosphorylation of two serine residues (S364 
and S367) within the cytosolic tail of L-selectin to the binding of CaM, 
phosphorylated L-selectin cytosolic tail peptides were sourced commercially, with 
either one of the serines (i.e. S364phos or S367phos) or both (hereafter termed: 
‘doublephos’) phosphorylated. These peptides were tested for CaM binding using 
ITC experiments.  
As with the wildtype L-selectin cytosolic peptide, ITC experiments were 
carried out with and without calcium in the same conditions used previously (in 
NMR buffer at 20°C). Integration of the heat of binding for the interaction of 
ApoCaM with S367phos, S364phos and doublephos peptides revealed that one 
binding event occurred with each peptide, with a molar ratio of around one. The 
data was fit to a one independent binding site model, which revealed KDs of 5.0±1.1 
µM for S364phos, 5.6±1.7 µM for S367phos and 4.1±1.1 µM for doublephos (Figure 
4.4 and Table 4.2). When these KDs were compared to that found with wildtype L-
selectin (1.6±0.3 µM), there was a difference of between 2.5 and 3.5 fold (3.5 fold 
for S364A, 3.1 fold for S367A and 2.5 fold for doublephos), which was not 
considered significant (see Discussion, Section 4.4.1). The ΔH of the interaction 
between ApoCaM and wildtype L-selectin (1430±341 cal/mol) was less than the ΔH 
with the mutated peptides (2236±680 cal/mol for S364phos, 2437±807 cal/mol for 
S367phos and 2227±380 cal/mol for doublephos, Table 4.2). Although the ΔH and –
TΔS were slightly larger with the phosphorylated peptides, this was not considered 
significant as the errors were quite large (between 17% for doublephos and 33% for 
S367phos) and ΔH remained endothermic.  
The experiments in presence of calcium however, were less straightforward 
because the changes in enthalpy observed here were particularly small and close to 
the limit of what can be rigorously measured by ITC (see below). The interaction 
between CaM-Ca and S367phos or doublephos peptides could barely be measured, 
but one binding event was observed and the data could be fit to the one 
independent binding site model. The comparison of the KDs, ΔH and –TΔS between 
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these peptides and wildtype L-selectin showed no differences that were considered 
significant (Figure 4.5 and Table 4.2). However, the ΔH values in the ITC experiment 
with S364phos were even smaller (Figure 4.5A), too small to obtain a clear fitting of 










Figure 4.5: Interaction between ApoCaM and phosphorylated L-selectin peptide. ITC 
experiments studying the interaction between ApoCaM and either S364phos (A and B), 
S367phos (C and D) or doublephos (E and F). The normalised heat of interaction was 
obtained by integrating the raw data and subtracting the heat of dilution from each point. 
The red line represents the best fit obtained by a non-linear least-squares procedure based 
on one independent binding site model using origin 7.0. These results are representative of 




















Figure 4.6: Interaction between CaM-Ca and phosphorylated L-selectin peptide. ITC 
experiments of CaM-Ca interacting with either S364phos (A and B), S367phos (C and D) 
or doublephos (E and F). The normalised heat of interaction was found by integrating 
the raw data and subtracting the heat of dilution from each point. The red line 
represents the best fit obtained by a non-linear least-squares procedure based on one 
independent binding site model using origin 7.0. The results shown here are 
















The determination of binding affinity using ITC relies on a ΔH value 
measurable above the heat of dilution (the heat associated with the dilution of the 
buffer components in the syringe into the sample cell) and, most importantly, 
above the limits of detection of the instrument: the ITC200 is not capable of 
measuring power compensation changes below 0.05 µcal/sec (388). Considering 
that the enthalpy changes for the interaction between CaM-Ca and wildtype L-
selectin were at the limit of the instrument sensitivity, the inconclusive outcome of 
the measurement with S364phos did not exclude the possibility that an interaction 
was indeed occurring between CaM-Ca and S364phos peptide in the experimental 
conditions used. In this scenario, the reaction would generate a ΔH smaller than the 
Proteins Stoichiometry 
(n)  






ApoCaM Wildtype  1.21±0.15 1.63±0.33 1430±341 -8528±108 -7028±246 
 S364phos  0.99±0.22 5.03±1.02 2236±680 -9441±560 -7204±120 
 S367phos  0.89±0.07 5.63±1.72 2437±807 -9583±991 -7146±183 
 Doublephos  0.92±0.18 4.12±1.10 2227±380 -9553±540 -7326±159 
CaM-Ca Wildtype  0.97±0.12  4.01±2.15 -416±110  -6967±393  -7383±291  
 S364phos  Binding could not be measured* 
 S367phos  0.81±0.11  7.58±3.09 -443±141  -6544±113  -6987±234  
 Doublephos  0.89±0.09  5.31±2.09  -248±109  -6946±192  -7195±227  
Table 4.2: Thermodynamic parameters of the association of CaM and phosphorylated L-
selectin peptide. Measurements were taken using ITC200 instrument at 20 °C in NMR buffer 
(see Section 2.12.3 for recipe) with and without 5 mM CaCl2. Results shown represent the 
mean and standard deviation of three independent experiments. *binding could not be 
measured either because no binding occurred or because the ΔH of interaction was too 




one observed with wildtype L-selectin tail binding to CaM-Ca and therefore below 
what could be reliably measured by ITC. To find out conclusively whether CaM-Ca 
was indeed capable of binding to the S364phos peptide, a different biophysical 
technique was needed, which would not rely on the changes of enthalpy generated 
during the reaction but measured a different biophysical parameter. MST was 
therefore chosen on the basis that the parameter followed in a titration-dependent 
experiment (the thermophoresis, see Section 2.17.4.1) was independent of 
enthalpy changes.  
Initial MST experiments, carried out during a demonstration of the MST 
Monolith NT.115 instrument at King’s College London, established that this method 
was competent in measuring the interaction between CaM-Ca and L-selectin 
cytosolic tail; hence samples were sent to NanoTemper Technologies GmbH for 
further tests and repeats. CaM was labelled with NT-647 dye, which uses 
hydroxysuccinimide (NHS)-ester to covalently couple the dye to lysine residues. A 
serial dilution of CaM (at constant concentration) with the peptide was then 
performed and the solutions were loaded into glass capillaries. The experiments 
were carried out in the presence of 0.05% TWEEN: detergents such as TWEEN are 
often added to the buffer in MST experiments in order to avoid molecular 
aggregation and to favour sample stability (344,398), given that this technique fails 
in the presence of even small aggregates. TWEEN also minimises adsorption of the 
protein to the glass capillary (399). The MST experiments showed that CaM-Ca 
bound to both wildtype and S364phos peptides with similar affinity (binding 
constant of 68 µM and 46 µM respectively, Figure 4.6 and Table 4.6), though, due 
to time constraints, only two experiments were carried out for each interaction and 
as a result further repeats are required for a statistical analysis to be performed.  
The outcome of MST experiments would indicate that CaM-Ca is capable of 
binding to all the phosphorylated peptides with comparable affinities, adding 
support to the hypothesis that the initial ITC experiments were unable to detect the 
interaction between CaM-Ca and the S364phos peptide in the conditions used. 
However, the experimental conditions used in the MST experiments were slightly 
different from the ITC tests, in that the buffer used in the former measurements 
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contained TWEEN, albeit in very small concentration (0.05%). TWEEN is a detergent 
and it cannot be excluded that it may have an effect on altering the conformation 
of the protein or peptide, thereby influencing the outcome of the experiment. It has 
in fact been shown that peptides can easily form helices in the presence of 
detergents, such as SDS and Tetrafluoroethylene (TFE), though concentrations 









The analysis of the effect of TWEEN on the L-selectin secondary structure 
was described in the previous chapter (Section 3.3.7), showing that the peptides 




Figure 4.7: Microscale thermophoresis showing the interaction of CaM-Ca and L-selectin 
peptides. Experiments were carried out with (A) wildtype and (B) S364phos. Experiments 
were carried out by Nanotemper technologies. CaM-Ca was labelled with NT-647 dye (Lys-
coupling chemistry) using NanoTemper’s Protein Labelling Kit RED (#L001, Nanotemper 
Technologies). The concentration of the labelled protein was kept constant at 20 nM, 
whereas for the peptides a 1:1 series of dilution was carried out, starting at a highest 
concentration of 262 µM for S364phos and 375 μM for wildtype. The samples were loaded 
into enhanced gradient standard treated MST grade glass capillaries after a short incubation 
period and an MST analysis was performed using the Monolith NT.115. Concentrations of 
the unlabelled peptide are in nM (shown on the x axis). n=2 for all experiments. 
Experiments were carried out by a third party at Nanotemper Technologies GmbH, Munich. 
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3.14). Next, the effect of TWEEN on the conformation of CaM-Ca was assessed by 
carrying out a 2D [1H-15N] HSQC experiment of CaM-Ca in NMR buffer with 0.05% 
TWEEN and comparing the spectra with that in NMR buffer alone. Figure 4.7A 
shows that CaM-Ca was folded in the presence of TWEEN; however, the chemical 
shift of a majority of the residues was altered (Figure 4.7B). Changes in buffer 
conditions have been shown to affect the [1H-15N] HSQC spectrum of proteins 
(403,404); nonetheless a significant buffer-induced conformational rearrangement 
of the protein could not be totally excluded from this NMR analysis. 
 In parallel to the analysis of the effect of 0.05% TWEEN on the conformation 
of the individual molecular species, its effect on the interaction between CaM-Ca 
and L-selectin was also investigated by repeating ITC experiments using the MST 
buffer. Experiments were undertaken with both wildtype and S364phos peptides to 
allow a direct comparison. Interestingly, the enthalpy of the interaction between 
CaM-Ca and wildtype L-selectin cytosolic tail peptide increased in these 
experimental conditions, and, accordingly, a detectable ΔH value was now observed 
for the interaction between CaM-Ca and the S364phos peptide. A dissociation 
constant for this interaction could therefore be derived from the curve fitting to the 
one independent binding site model and was found to be similar to that observed 
with wildtype L-selectin peptide (Table 4.3). Time constraints prevented further 
repeats to be carried out for each interaction and therefore a statistical analysis 
could not be undertaken. For this reason, these experiments were used to compare 
qualitatively the binding profiles of wild-type selectin and mutant rather than 
provide a quantitative assessment of the parameters of the interactions.  
Considering that the ΔH values increased across the board, a plausible 
explanation was that 0.05% TWEEN in the buffer could account for the shift of the 
ΔH values to measurable pulses above the ITC detection limits (see Section 2.17.1.1 
for a description of the dependence of ΔH on buffers, temperature etc.). 
Nonetheless, the changes in chemical shifts observed for CaM-Ca in presence of 
TWEEN prompted additional experiments to be undertaken to confirm this 
supposition. In particular, in support of the hypothesis that addition of TWEEN 
caused ΔH to change to a measurable value without altering any other parameters, 
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ITC experiments were performed with CaM-Ca and the L-selectin peptides at a 
different temperature (but without TWEEN), as temperature can also affect ΔH 
(Kirchhoff’s law of thermochemistry, see Section 2.17.1.1 for an explanation). The 
experiments (Figure 4.8) showed that at 10 °C the ΔH of the interaction between 
CaM-Ca and the S364phos peptide once again became detectable by ITC200 
instrument (compare Figure 4.5A and B with Figure 4.8C and D). The thermogram 
could be fitted to the one independent binding site model and the resultant KD for 
this interaction was found to be similar to that of the CaM-Ca wildtype L-selectin 
peptide interaction (Table 4.4), though only two experiments were undertaken for 
each interaction, so further repeats will be required to enable a proper statistical 
analysis.  
It should be noted that MST required covalent modification of primary 
amine groups derived from lysine residues within CaM, specifically for the 
attachment of the NT647 dye. Due to time constraints, chemical modification of 
CaM by the addition of the dye was not controlled for, but is discussed below (in 
Section 4.4.1). 
Taken together all these data support the hypothesis that phosphorylation 
of the L-selectin cytosolic tail did not affect CaM-Ca binding in a binary in vitro 
system. However, further work will be required to definitively understand the role 
of phosphorylation of L-selectin in regulating CaM binding. 
Peptide Stoichiometry 
(N) 




WT 0.8±0.02 11.4 -1038±32 -5679 -6717 
S364phos 0.9±0.04 6.5 -405±20 -6638 -7043 
Table 4.3: Thermodynamic parameters of the association of CaM and L-selectin peptides in 
the presence of 0.05% TWEEN. Measurements were taken using ITC200 instrument at 20 °C 
in NMR buffer (see section 2.12.3 for recipe) with 5 mM CaCl2 and 0.05% TWEEN. Results are 
from one experiment; with the error associated with fitting the data to the model shown 









Figure 4.8: Effect of 0.05% TWEEN 20 on CSP of CaM-Ca. (A) [1H-15N] HSQC of CaM-Ca 
(black) and CaM-Ca with 0.05% TWEEN 20 (red). Chemical shifts taken from BMRB ID 1634.  
Spectra were recorded using a Bruker 700 MHz at 25 °C in NMR buffer with 5 mM CaCl2. (B) 














WT 1.04±0.09 3.90±0.29 306±111 -7285±67 -6978±43 
S364phos 0.86±0.13 6.04±3.04 141±10 -6912±304 -6771±294 
Table 4.4: Thermodynamic parameters of the association of CaM and L-selectin peptides 
carried out at 10°C. Measurements were taken using ITC200 instrument at 10 °C in NMR 
buffer with 5 mM CaCl2. Results represent the mean and standard deviation of two 
experiments. 
Figure 4.9: Interaction between CaM-Ca and L-selectin peptides. ITC experiments for CaM-Ca 
with wildtype (A and B), S364phos (C and D) at 10 °C. The normalised heat of interaction was 
obtained by integrating the raw data and subtracting the heat of dilution from each point. The 
red line represents the best fit obtained by a non-linear least-squares procedure based on one 









NMR was also used to confirm the association between CaM-Ca and 
S364phos, whilst at the same time gaining further insight into the binding 
mechanism via the chemical shift perturbation analysis. The S364phos peptide was 
added to a solution containing 15N labelled CaM-Ca and a series of 2D NMR [1H-15N] 
HSQC experiments were carried out to follow the titration. The spectra showed 
changes in the chemical shifts of CaM-Ca amino acids upon S364phos peptide 
addition, implying that binding occurred (Figure 4.9). These CSPs were compared to 
those observed with wildtype peptide and were seen to be very similar, albeit some 
differences were observed (Figure 4.10), for example detectable CSPs for residues 
E54, K55 and A57 and higher CSPs for residues S101, L105, V108 and L116.  
Although this remains to be confirmed, the current working hypothesis is that 
differences in Ca-CaM CSPs induced by the wild-type peptide and the S364phos 
mutant interaction are likely to have arisen from local chemical environment 
perturbations due to the close proximity of some of the CaM residues to the 
phosphate group of S364phos.  
Overall the NMR experiments positively confirm that phosphorylation of 
S364 does not affect the ability of CaM-Ca to bind to the tail of L-selectin in vitro 
and that the binding mechanisms between CaM-Ca and S364phos or non-
phosphorylated full-length L-selectin peptide appeared to be not significantly 
dissimilar. Further experiments will be required to elucidate the precise point of 












N] HSQC of CaM-Ca (black) and CaM-Ca in the presence of 1.2 equivalent of the peptide 
(red).
 15
N chemical shifts are shown on the Y axis and 
1
H chemical shifts shown on the X axis, 
both measured in ppm. Chemical shifts were assigned from BMRB ID 1634. Spectra were 
recorded using a Bruker 700 MHz at 25 °C in NMR buffer with 5 mM CaCl
2
. (B) Chemical shift 
perturbations were calculated using the method described in Section 2.17.2.2.1 and (C) plotted 
on the structure of CaM-Ca, PBD id 3CLN. Residues coloured red represent CSPs of Δδ
AV
≥0.03, 
orange represent CSPs of 0.01≤Δδ
AV
<0.03, yellow represents CSPs of 0.005≤Δδ
AV
<0.01 and white 






























































Figure 4.11: Comparison of the CSPs of CaM-Ca with wildtype and S364phos L-selectin 
peptides. CSPs for CaM-Ca upon the addition of wildtype (A) or S364phos (B) L-selectin 
peptide were calculated and plotted against residue number to allow comparison of the 





4.3.3 Monitoring the Interaction between CaM and Alanine 
Mutations of the L-selectin Cytosolic Tail  
Much of the work carried out in the Ivetic lab uses cell lines that possess 
alanine mutations within the L-selectin tail. They have been used to better 
understand if shedding of L-selectin can be altered, using for example non-
phosphorylatable serine-to-alanine residues. To elucidate which residues within the 
L-selectin cytosolic tail were important for the binding of CaM, several peptides 
with different alanine mutations were purchased, namely K362A, S364A, S367A and 
Y372A. The two serine to alanine mutants were chosen to complement the 
experiments carried out in cell lines (see Chapter 5 and 6). A previous study 
investigated the role of basic residues in the cytosolic tail of L-selectin in the 
interaction with moesin (225). K362A was one of the mutations used and it was 
shown that it strongly inhibited the interaction between L-selectin cytosolic tail 
peptide and moesin (225) and it was therefore of interest to see its effect on CaM 
binding. In the same study the Y372A mutant was used as a control peptide with an 
alanine mutation in a non-basic position (225). The results showed this mutation 
had little effect on the interaction between moesin and the peptide (225). To 
understand if the same was true for the interaction between CaM and this peptide 
was analysed in this section.  
ITC experiments were carried out with these peptides as described above, 
with measurements taken at 20 °C in NMR buffer with or without CaCl2. The 
experiments with ApoCaM showed a binding process for all the peptides, with one 
event observed and a molar ratio of around one for each peptide. This allowed the 
data to be interpolated into binding curves using a one independent binding site 
model, from which the KD, ΔH and –TΔS for the binding of each peptide could be 
elucidated (Figure 4.11 and Table 4.5). The KDs were found to be 3.6±1.6 µM for 
K362A, 4.1±2.0 µM for S364A, 6.3±0.5 µM for S367A and 2.7±0.3 µM for Y372A. As 
with the phosphorylated peptides, the differences between these KD values and 
that observed with wildtype L-selectin were not considered significant. The same 
was true for the comparison between the ΔH and –TΔS for each peptide.  
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Results with CaM-Ca showed that binding occurred between CaM-Ca and 
S367A and Y372A peptides and binding curves could be produced by integrating the 
heat of interaction of each peak and fitting the data to the one independent binding 
site model. The KDs extrapolated from the binding curves (2.7±0.5 µM for S367A 
and 5.0±4.5 µM for Y372A) were compared to that found with wildtype L-selectin 
peptide (4.0±2.1 µM) and no significant difference was observed, showing the 
strength of binding was similar with all three peptides. The ΔH for the interaction 
between CaM-Ca and each peptide were also compared (-416±110 cal/mol for 
wildtype, -391±73 cal/mol for S367A and -341±225 for Y372A) revealing no 
significant difference. Experiments with K362A and S364A were inconclusive as no 
measurable ΔH was produced (Figure 4.12 and Table 4.5). Similarly to previous 
experiments with the S364phos peptide, the enthalpies of interaction were very 

















Figure 4.12: Interaction between ApoCaM and alanine mutant L-selectin peptides. ITC 
experiments for ApoCaM with K362A (A and B), S364A (C and D), S367A (E and F) and 
Y372A (G and H). The normalised heat of interaction was obtained by integrating the raw 
data and subtracting the heat of dilution from each point. The red line represents the best 
fit obtained by a non-linear least-squares procedure based on one independent binding site 














Figure 4.13: Interaction between CaM-Ca and alanine mutant L-selectin peptides. ITC 
experiments for CaM-Ca with K362A (A and B), S364A (C and D), S367A (E and F) and Y372A 
(G and H). The normalised heat of interaction (change in ΔH associated with the interaction 
between CaM and the L-selectin peptide) was obtained by integrating the raw data and 
subtracting the heat of dilution from each point. The red line represents the best fit obtained 
by a non-linear least-squares procedure based on one independent binding site model using 




















The inconclusive ITC results between CaM-Ca and S364A were reminiscent 
of what was observed with S364phos at 20 °C in NMR buffer. For this reason, the 
same experimental steps were undertaken to ascertain whether CaM-Ca was 
binding to the S364A peptide. MST experiments were carried out to test the CaM-
Ca and S364A association, using S367A peptide as a positive control because CaM-
Ca interaction with this peptide was already characterised by ITC. The MST 
experiments, performed in the presence of 0.05% TWEEN, revealed a clear 
interaction between CaM-Ca and S364A peptide, with a similar KD to that found 
with wildtype (Figure 4.13A and Table 4.6), though once again, statistical analysis 
was not possible, as only two experiments were carried out for each interaction. 
Interestingly, the KD value of the interaction between CaM-Ca and the S367A 
peptide obtained from MST was smaller than that of the other peptides (Figure 
4.13B and Table 4.6), indicating a stronger interaction between CaM-Ca and S367A 
in the experimental conditions used. However, the results from MST were the mean 
Proteins Stoichiometry 
(N) 





ApoCaM Wildtype  1.21±0.15 1.63±0.33 1430±341 -8528±108 -7028±246 
 K362A  0.84±0.010 3.62±1.64 2428±823 -9853±546 -7425±277 
 S364A  0.99±0.14 4.2±2.0 2350±218 -9719±203 -7369±357 
 S367A 0.92±0.11 6.29±0.58 1976±556 -9049±601 -7074±55 
 Y372A 0.99±0.22 2.79±0.28 2052±721 -8767±960 -7549±58 
CaM-Ca Wildtype  0.97±0.12  4.01±2.15  -416±110  -6967±393 -7383±291  
 K362A  Binding could not be measured* 
 S364A  Binding could not be measured* 
 S367A 1.02±0.19 2.72±0.53 -391±73 -7176±126 -7567±120 




Table 4.5: Thermodynamic parameters of the association of CaM and alanine mutant 
peptides. Measurements were taken using ITC200 instrument at 20 °C in NMR Buffer with 5 
mM CaCl2 for CaM-Ca or NMR alone for Apo-CaM Results represent the mean and standard 
deviation of three independent experiments. *binding could not be measured either because 





of only two experiments and therefore further repeats are required in order to 
carry out a comprehensive quantitative analysis on the different KD values obtained 















Figure 4.14: Microscale thermophoresis with CaM-Ca and L-selectin peptides. Experiments were 
carried out with (A) S364A and (B) S637A. CaM-Ca was labelled with NT-647 dye (Lys-coupling 
chemistry) using NanoTemper’s Protein Labelling Kit RED (#L001, Nanotemper Technologies). The 
concentration of the labelled protein was kept constant at 20nM, while a serial dilution of the 
peptide was carried out, with a starting concentration of 375 μM and diluting down to 1:1. The 
samples were loaded into enhanced gradient standard treated MST grade glass capillaries after a 
short incubation period and an MST analysis was performed using the Monolith NT.115. 
Concentrations of the unlabelled peptide (shown on the x axis) are in nM. N=2 for all experiments. 
















Akin to the S364phos analysis, ITC experiments were repeated with 0.05% 
TWEEN supplemented to the binding buffer to confirm the results seen with MST. 
Binding of CaM-Ca was observed with the S364A peptide giving a KD (12.2 µM), a ΔH 
(-772 cal/mol) and –TΔS (-5905 cal/mol) (Table 4.7). This indicated that CaM-Ca was 
capable of interacting with S364A, although only one experiment for each 
interaction was undertaken because of time restraints. As for before, ITC 
experiments were also carried out at 10 °C (without TWEEN) to be able to measure 
ΔH values without the use of TWEEN in the buffer, and this confirmed that CaM-Ca 
was capable of binding to S364A peptide with similar KD to wildtype (Figure 4.14. 
and Table 4.8). These results together confirm that CaM-Ca is able to bind to S364A 
peptide. 
 The same experimental conditions were used to assess the binding of CaM-
Ca to the S367A peptide, following the differences in the KDs measured with ITC at 
20 °C and MST. Binding was observed both in buffer supplemented with 0.05% 
TWEEN and at 10 °C in NMR buffer and the KDs measured were similar to those for 
wildtype L-selectin peptide, but due to time limitations, the necessary repeats could 
not be carried out and therefore the extent of the similarity between wildtype and 
S367A could not be assessed by statistical analysis.  
 





Table 4.6: Summary of dissociation constants of Cam-Ca and L-selectin peptides 
calculated by MST analysis. Measurements were taken with a Monolith NT.115 instrument 
by a third party at NanoTemper Technologies GmbH, Munich.  Results shown are the mean 














KD (μM)  ΔH (cal/mol)  -TΔS (cal/mol)  ΔG (cal/mol)  
WT 0.8±0.03 11.4 -1038±31 -5679 -6717 
S364A 0.8±0.06 12.2 -772±28 -5905 -6677 
S367A 0.9±0.02 7.3 -560±18 -6418 -6978 
Table 4.7: Thermodynamic parameters of the association of CaM and L-selectin peptides in 
the presence of 0.05% TWEEN. Measurements were taken using ITC200 instrument at 20 °C 
in NMR buffer with 5 mM CaCl2 and 0.05% TWEEN. Results are from one experiment, with 
the error in fitting the data to the model (calculated by Origin 7.0) shown. 
 
 
Figure 4.15: Interaction between CaM-Ca and L-selectin peptides. ITC experiments for 
CaM-Ca with S364A (A and B), S367A (C and D) at 10 °C. The normalised heat of 
interaction was calculated by integrating the raw data and subtracting the heat of 
dilution from each point. The red line represents the best fit obtained by a non-linear 
least-squares procedure based on one independent binding site model using origin 7.0. 














4.3.4 ITC Experiments with Trp-Cage L-selectin 
 In the previous chapter the Trp-Cage L-selectin construct was made in order 
to produce in-house L-selectin peptides (and mutants), in particular 15N-labelled 
peptides to be used in NMR investigations aimed at elucidating details of L-selectin 
interaction with CaM. It was therefore critical to test whether the presence of the 
Trp-Cage had any effect on the binding of the L-selectin peptide to CaM. To this 
aim, ITC experiments were used to probe the interaction of Trp-Cage-L-selectin and 
CaM-Ca and compared with L-selectin peptide alone. 
 The ITC experiments showed association between CaM-Ca and Trp-Cage-L-
selectin, with the interaction being fit to the one independent site model to 
produce the binding curve, from which the parameters associated with the 
interaction could be obtained. Comparison of the results for CaM-Ca with Trp-Cage-
L-selectin and L-selectin peptide showed a similar binding affinity, however, the 
thermodynamic profile was very different, with Trp-Cage-L-selectin having a large 
positive enthalpy (Figure 4.15) compared to a small negative enthalpy for L-selectin 
peptide (Figure 4.1D and Table 4.1). This may suggest that the Trp-Cage had an 
effect on the interaction and therefore it is vital to test whether the Trp-Cage motif 
alone can bind to CaM-Ca. The Trp-Cage motif was obtained from E.coli cells 
following the same protocols used for Trp-Cage-L-selectin (section 3.3.5). Soluble 
Peptide Stoichiometry 
(n) 
KD (μM)  ΔH (cal/mol)  -TΔS (cal/mol)  ΔG (cal/mol)  
WT 1.04±0.09 3.90±0.29 306±111 7285±67 6978±43 
S364A 0.92±0.25 2.72±0.13 119±30 7302±2 7182±27 
S367A 0.89±0.12 3.84±0.02 358±54 7347±52 6988±2 
Table 4.8: Thermodynamic parameters of the association of CaM-Ca and L-selectin peptides 
carried out at 10°C. CaM-Ca binding to L-selectin peptides. Measurements were taken using 
ITC200 instrument at 10 °C in NMR buffer with 5 mM CaCl2. Results shown represent the mean 
and standard deviation of two experiments. 
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protein was observed on a SDS-PAGE gel (data not shown), however, when 
purification of the Trp-Cage motif was attempted using a Ni2+ affinity column, a 
band on the gel corresponding to its expected molecular weight was observed in 
the flow through fraction, suggesting that the protein did not interact with the 





KD= 2.02±0.04 µM 
Figure 4.16: ITC data of CaM-Ca binding to Trp-Cage L-selectin. (A) ITC raw data profile of 
Trp-Cage L-selectin titrated into CaM-Ca. (B) binding curve produced by integrating the heat 
of interaction of each point and fitting the data to the one independent binding site model, 
with the stoichiometry (N) and dissociation constant( KD) shown. (C) The thermodynamic 
profile of the interaction, with the ΔH, -TΔS and ΔG for the interaction shown. 
Measurements were taken using ITC200 instrument at 20 °C in NMR buffer with 5 mM 
CaCl2. Results are representative of two independent experiments, with standard 









Previous work showed that L-selectin was capable of interacting with both 
CaM and ERM proteins at the same time to form a 1:1:1 complex (3). It is thought 
that this interaction regulates several functions of L-selectin, including localisation 
of L-selectin to microvilli and extracellular cleavage of L-selectin. Little is known 
about the mechanism behind the binding and how it is regulated. To study this, 
recombinant proteins were produced (Chapter 3) and biophysical techniques were 
used to assess the interaction of CaM to different L-selectin peptides and 
investigate possible regulation mechanisms of binding, particularly focussing on the 
requirement for calcium and the effect of L-selectin phosphorylation. 
 
4.4.1 Determining what is considered a significant difference 
between binding constants 
In this chapter, ITC and MST have been used to measure the binding 
constants of CaM with L-selectin peptides. Differences in binding affinities between 
CaM with wildtype L-selectin peptide and CaM with the mutant L-selectin peptides 
in any of the conditions tested were found to be fivefold or less with both methods. 
A fivefold difference in KDs obtained by ITC is generally not considered significant 
because of the limitations of the technique, as it has been reviewed in previous 
studies (405-408). In our case this evaluation is justified because of the large error 
associated with several of the measured KDs, in particular for experiments involving 
CaM-Ca, which are likely to derive from the small ΔH of interaction. A poor signal-
to-noise ratio will inevitably be associated with sizeable experimental errors.  
Several of the KDs for the interaction between CaM-Ca and the different L-
selectin cytosolic tail peptides measured using MST were also slightly different, with 
the largest difference being between wildtype and S367A L-selectin peptides, 
where a fivefold difference was observed (68 µM for wildtype and 13 µM for 
S367A). It is possible that this difference is significant, but due to time constraints 
only two experiments were carried out for each interaction and therefore a proper 
statistical comparison of the KDs could not be undertaken. 
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In these studies, the KDs for the CaM-Ca/L-selectin interaction measured 
using ITC and MST showed around a tenfold difference, 4.0±2.1 µM and 68 μM 
respectively. The exact reason for this difference remains unclear, though it is 
possible that it is linked to the different techniques used to measure the KDs and 
different conditions, including the temperature and buffer in which the interaction 
was measured. It would be useful to compare the KDs measured by ITC and MST in 
the same buffer (with TWEEN) directly, but further experiments are required for 
this. It is worth noting that there are several other examples reported in literature 
where MST and ITC have produced different binding constants for the same 
interaction (409), for example synaptotagmin binding to calcium (410,411) and 
riproximin interacting with asialofetuin (ASF) (412). Another consideration is the 
fact that CaM-Ca is labelled in the MST experiments. It is possible that the presence 
of the dye affects the interaction between L-selectin and CaM. There are several 
lysine residues within the C-lobe of CaM (the predicted binding site of L-selectin), 
such as K94, K115 and K148, with the possibility of the addition of the dye to these 
residues affecting the interaction, leading to a decrease in strength of binding. To 
test if this is the case, ITC experiments could be carried out with CaM with the dye 
covalently attached and comparing the KD measured with that without the dye 
and/or conducting MST using an N-terminal or C-terminal labelled protein (413). 
 
4.4.2 Calcium is not required for CaM interaction with L-selectin 
cytosolic tail in vitro, but may affect the mechanism of interaction  
 ITC measurements conducted in this study show that CaM is capable of 
binding to L-selectin cytosolic tail peptide in the absence and presence of calcium 
with comparable affinity. It has been disputed whether calcium is required for the 
interaction between CaM and L-selectin. Work by Matala et al (2001)(414) showed 
that CaM could be immunoprecipitated with anti-L-selectin antibodies in resting 
neutrophils and that this was abrogated when EDTA was present, suggesting a 
requirement of calcium for the interaction in resting cells. Conversely, Killock et al 
(2009) (3) reported that the L-selectin cytosolic tail peptide conjugated to 
sepharose beads was capable of pulling down purified recombinant CaM even in 
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the presence of 5 mM EGTA, implying CaM interacted with L-selectin in the 
presence and absence of calcium. Deng et al (2011)(216) also investigated this 
interaction using an L-selectin cytosolic tail peptide and modified CaM covalently 
attached to a fluorescent probe. The change in fluorescence was monitored as the 
peptide was titrated in a solution containing CaM, with or without calcium, 
revealing that binding occurred in both cases with similar dissociation constants. 
Furthermore they performed ITC experiments to confirm the fluorescence data, but 
the experiment was only carried out with calcium. Importantly, the dissociation 
constant found by Deng et al (2011) for CaM-Ca/L-selectin interaction was 
consistent with what was found in this chapter. Notably, this report provides for the 
first time a quantitative measure of the dissociation constants with and without 
calcium, indicating that CaM can bind to the L-selectin cytosolic tail peptide with 
similar affinities when calcium bound or calcium free. It is worth noting that the 
possible discrepancy between the study of Matala et al (2001) and the other studies 
may be due to different requirements in vivo and in vitro. All examples where 
binding appears independent of calcium entailed the use of the L-selectin tail 
peptide in vitro, whereas Matala et al (2001) carried out the experiment using 
neutrophils with full length L-selectin. This implies that the requirement of calcium 
for the interaction may be dependent on L-selectin being in its full length form or 
could highlight differences in the interaction depending on the context in which it is 
studied, i.e. in vitro compared to in vivo. Immunoprecipitation requires cellular 
disruption by non-ionic detergents, which produces a cell lysate and ultimately 
destroys the cellular architecture and compartmentalisation. As will be seen in the 
subsequent results chapters of this thesis, assessing L-selectin/CaM interaction in 
vivo may be the best way forward in determining these presumably simple binary 
interactions occurring in complex cellular systems.  
It remains to be defined how similar the binding mechanisms of L-selectin 
for CaM-Ca and ApoCaM are. The thermodynamics data here suggests that the 
binding mechanisms may be somewhat different. It is possible in the complex 
cellular environment that this change may have larger repercussions in vivo, 
whereby calcium influx into the cell, i.e. upon leukocyte activation (185), may lead 
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to CaM dissociation from L-selectin. One hypothesis may envisage that in resting 
leukocytes ApoCaM is bound to the tail of L-selectin, but once the leukocyte is 
activated, the calcium influx will result in CaM dissociation from L-selectin due to 
the conformational rearrangement of CaM upon calcium binding. It is also possible 
that cell activation exposes CaM-Ca to more abundant and higher affinity binding 
sites, which may sequester CaM-Ca away from L-selectin. For example both 
calcineurin and the CaM kinase family are up-regulated upon leukocyte activation 
(396) and could be other potential binding sites for CaM-Ca. Further experiments 
are required to establish the calcium content of CaM at different stages of cell 
activation to pinpoint the importance of calcium in regulating CaM binding to L-
selectin in leukocytes. 
  The CSPs measured from the analysis of the 2D [1H-15N] HSQC NMR 
titrations suggests that CaM, either in the CaM-Ca or ApoCaM form, interacts with 
L-selectin predominantly via the C-lobe, with very few perturbations seen in the N-
lobe. This suggests that the “wrap-around” mechanism of binding commonly seen 
with CaM binding to its target sequences does not occur with L-selectin. It is worth 
noting that the molar ratio of peptide to CaM used in these experiments was 1.2:1. 
This ratio was used as there was very little difference in the CSPs between this ratio 
and a ratio of 1:1, suggesting all binding events had occurred by this ratio. It is 
however, possible that CaM is not saturated in the results shown here. It maybe 
worth carrying out further titrations, increasing the amount of peptide added to 
ensure CaM is saturated. The NMR results observed in this thesis are consistent 
with molecular modelling of the CaM/ERM/L-selectin complex (3). Intriguingly, 
some of the residues of CaM predicted by this model to be involved in hydrogen 
bonding with L-selectin have been found in this study to exhibit some experimental 
CSPs. The majority of these residues are located within the C-lobe of CaM: I100, 
E114, L112, G134 and D131 are all predicted to form hydrogen bonds with L-
selectin and all experience moderate CSPs in the titration of CaM with L-selectin 
(Figure 4.16). Other residues in CaM surrounding those predicted to form hydrogen 
bonds have been found to have large CSPs, in particular N111, G113, K115 and 
L116, consistent with a close proximity to L-selectin. However, residues E127 and 
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E140 which are predicted to form hydrogen bonds with L-selectin showed no CSPs 
in the NMR analysis. There are also several residues with large CSPs that are distant 
from the predicted L-selectin binding site, namely M76, D78 and E82. Though there 
is a correlation between the residues predicted to be in the vicinity of the L-selectin 
binding site and those that show large CSPs, there are also some significant 
differences. This implies that the molecular model produced by Killock et al 
(2009)(3) may serve as a good starting point in the analysis of a structure of the 
complex between CaM and L-selectin, but further NMR experiments are required to 













The model of the tertiary complex of CaM, ERM and L-selectin predicts that 
the binding sites of CaM and ERMs on L-selectin are very close to one another, with 
some overlap predicted (3). It therefore seems unlikely that this seventeen amino 
acid domain would be able to accommodate both lobes of CaM and the FERM 
Figure 4.17: Comparison of predicted residues of CaM involved in Hydrogen bonding with CSP 
of CaM with L-selectin peptide. (A) The sites of the predicted Hydrogen bonds were mapped on 
the CaM structure (shown in blue). When compared to the CSP caused by binding to L-selectin 
peptide (B) it can be seen that several of the residues that have large CSP match those thought 








domain of ERMs. Although not as common as both lobes interacting with the CaM 
binding peptide, there are some examples of one lobe interacting with the target 
protein. Chagot et al (2011)(242) studied the interaction between ApoCaM and the 
IQ motif of human cardiac sodium channel NaV1.5 and found that only the C-lobe 
of CaM interacted with the CaM binding motif of NaV1.5, with several amino acids 
implicated in the binding overlapping with those that show CSPs in the CaM/L-
selectin interaction, including G113, L116 and M145. This so called extended 
conformation of the CaM-peptide complex was also confirmed by x-ray 
crystallography of the complex (415).  
Structural studies with CaM and the HIV-1 matrix protein Gag showed that 
when a short peptide, residues 11-28, was used to study the interaction, only the C-
lobe of CaM was involved in the interaction (416). ITC experiments also revealed 
this interaction had a binding constant similar to CaM-Ca/L-selectin peptide 
interaction (4.4±0.2 µM and 4.0±2.1 µM respectively), though ΔH was larger (-
8760±100 cal/mol versus -416±110 cal/mol) (416). When a longer peptide was 
used, residues 11-46, however, both lobes were found to interact with the peptide. 
The dissociation constant measured with the longer peptide was also much lower, 
showing the interaction was stronger (416). This is particularly interesting because 
when the L-selectin amino acid sequence was analysed for CaM binding domains, 
the sequence that was predicted to be a CaM binding site included part of the 
peptide studied here, but also several residues to the N-terminal side of this 
peptide, which are predicted to be located in the transmembrane domain of L-
selectin (Figure 4.17A). Gifford et al (2012) (396) carried out ITC experiments 
looking at the interaction between CaM and a peptide of L-selectin that contained 
the cytosolic tail plus seven N-terminal residues located in the transmembrane 
domain. They found that the binding of CaM to the longer peptide was stronger 
than the shorter peptide and this increase in affinity was dependent on calcium 
(396). Furthermore, NMR analysis showed that larger CSPs in CaM were seen with 
the longer peptide. Gifford et al (2012)(396) also determined the structure of the 
complex showing that CaM wrapped around the longer peptide, with both domains 
interacting with the peptide in the canonical CaM binding fashion. However, the 
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question remains whether CaM is able to access residues located in the 
transmembrane domain in the cell. Gifford et al (2012)(396) argue that CaM must 
perturb the membrane bilayer structure to gain access to the site or pull L-selectin 
down to remove this section from the plasma membrane. This is an interesting 
point, as it is known that shedding of L-selectin can be inhibited by moving the 
extracellular cleavage site closer to the plasma membrane by amino acid deletion 
mutagenesis (117), thus CaM binding in the cell may be responsible for pulling the 
extracellular cleavage site towards the plasma membrane. When calcium binds to 
CaM it causes structural rearrangements, which expose hydrophobic regions in 
both lobes and these are the sites of binding for most target sequences. It is 
possible that the hydrophobic regions of CaM-Ca can then interact with 
hydrophobic residues found in the transmembrane domain of L-selectin, forming a 
favourable environment for these residues when L-selectin is pulled down. But if L-
selectin is pulled down then presumably extracellular residues must move into the 
transmembrane domain. The extracellular amino acids that are proximal to the 
transmembrane domain consist of several hydrophilic residues (Figure 4.17B), 
which would make the insertion of these into the lipid bilayer energetically 
unfavourable. Clearly, more work is required to unearth this interesting hypothesis.  
Interestingly, several other examples of CaM binding to transmembrane 
proteins, including PECAM-1 (217) and ACE-2 (218) have been reported. CaM has 
been shown to interact with cytoplasmic domain of both these proteins and this 
interaction protects the protein from extracellular cleavage (217,218). 
Bioinformatics analysis of the amino acid sequence of these proteins shows a CaM 
binding motif extending into the transmembrane domain, similar to L-selectin 
(396).  
An attempt to study the interaction in a more biologically significant setting 
was carried out by Deng et al (2013)(417). CaM was fluorescently labelled with a 
donor in one lobe and a non-fluorescent acceptor in the other lobe. If both lobes 
interact with L-selectin they will become closer to one another and quenching of 
the fluorescence probes could be measured as a function of their binding proximity. 
An L-selectin peptide containing the cytosolic and transmembrane domains was 
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inserted into liposomes and the binding of the doubly-labelled CaM was assessed. 
The results showed that no quenching was observed when the L-selectin embedded 
liposomes were mixed with doubly-labelled CaM, suggesting the two lobes 
remained apart (417). This implies that CaM interacts with L-selectin in an extended 
conformation, with only one lobe participating in the interaction when the 
transmembrane domain is present in a lipid bilayer. The discrepancy in the results 
shows the complexities encountered when studying protein interactions and that 
the environment (as well as the appropriate experimental conditions) can have a 
dramatic effect on the outcome. 
  
Figure 4.18: Analysing the predicted CaM binding site of L-selectin. (A) Bioinformatic analysis 
shows the predicted location of the CaM binding site to be located towards the C-terminal end 
of L-selectin. The binding site contains juxtamembrane region as well as residues located in the 
transmembrane domain. Results produced by 
http://calcium.uhnres.utoronto.ca/ctdb/ctdb/sequence.html. (B) The location of the CaM 
binding site (red residues) and the transmembrane domain (blue box) are shown on the amino 
acid sequence of L-selectin, showing the residues within the predicted CaM binding site that are 
located in the transmembrane domain. Hydrophilic amino acids located extracellularly to the 
transmembrane domain are shown (*). 





4.4.3 Phosphorylation of the L-selectin cytosolic tail does not inhibit 
CaM binding in vitro   
 As phosphorylation has been shown to occur upon leukocyte activation, it 
was hypothesised that this was the mechanism by which CaM dissociation from L-
selectin was initiated. Nonetheless, the results in this chapter suggest this is not the 
case, with CaM association observed with both S364phos and S367phos peptides. 
Dr Ivetic has previously shown that phosphorylation, specifically at S364, abrogates 
L-selectin binding to CaM (Figure 4.18, unpublished data). In his experiments, 
decreasing concentrations of L-selectin peptide were mixed with a fixed amount of 
recombinant CaM and a chemical cross-linker. The cross-linked reactions were then 
resolved on SDS-PAGE and subsequently stained with Coomassie blue staining. At 
high concentrations of peptide, a higher molecular weight band could be observed 
above the unbound CaM, representing an electrophoretic mobility shift that 
corresponded to a complex of CaM and L-selectin peptide. When S364phos peptide 
was used the band representing the complex decreased in intensity, showing that 
less complex was formed in the presence of the phosphate group located on S364 
(Figure 4.18). Interestingly, the same experiment using the S367phos peptide 
revealed that the formation of the cross-linked complex was less affected when 
S367 was phosphorylated, though there was still less complex formation than with 

































Figure 4.19: DSS cross-linking reveals that phosphorylation of serine-364 mediates CaM/L-
selectin tail complex formation. Recombinant CaM was incubated with increasing 
concentrations of phosphorylated or non-phosphorylated L-selectin tail peptides and a fixed 
concentration of the DSS. Proteins were resolved by SDS PAGE and visualised by Coomassie 
staining. A reduction in the electrophoretic mobility of CaM was observed upon crosslinking 
to the L-selectin tail peptide resulting in an obvious band shift to a higher molecular weight 
(arrow). The amount of protein in the higher molecule weight band was drastically reduced 
by placing a phosphate group on serine-364, but was not significantly changed by serine-367 
phosphorylation. Bands corresponding to monomeric CaM and L-selectin peptide are 
indicated by asterix and arrowheads respectively. Gels are representative of three 
independent experiments. Results taken from Dr Ivetic, and previously presented in Dr 








The results produced in this chapter by employing a range of diverse 
biophysical techniques, such as ITC, MST and NMR, are all in agreement that 
phosphorylation of L-selectin on either S364 or S367 had no effect on the binding 
affinity of either CaM-Ca or ApoCaM. The discrepancies observed in the results with 
the S364phos peptide could be due to differences in methodology used. 
 If the Gifford et al (2012)(396) model of binding is correct, then it would be 
unlikely that phosphorylation of the serine residues in the tail would affect CaM 
binding. The structure of the CaM-L-selectin complex Gifford et al (2012)(396) 
produced showed that both serine residues were not comprised within the CaM 
binding site and furthermore phosphorylation was shown to have no effect on the 
[1H-15N] HSQC spectrum of the complex. The [1H-15N] HSQC spectrum of CaM-Ca 
complexed with S364phos peptide studied in this thesis (Figures 4.9 and 4.10) 
showed that although overall the CSPs were similar, some differences were 
observed with the S364phos peptide compared with wildtype L-selectin cytosolic 
tail peptide. This could be compatible with the phosphate group being located 
within the binding site, having a local effect on the chemical shift environment for a 
number of CaM residues. Although unlikely, lacking a validated structural model, it 
is not possible to exclude that the conformation of the CaM/L-selectin complex 
would not be different from wild-type - due to the presence of the phosphate 
group on S364.  
 It has been shown that several CaM-binding sites can be phosphorylated, 
but that this does not necessarily affect the binding of CaM (226). For example, 
calcineurin A can be phosphorylated within its CaM-binding domain, but 
phosphorylation prior to incubation with CaM did not affect the binding of CaM to 
calcineurin A, as revealed by mobility shift assays (418).  On the other hand, CaM 
bound to calcineurin A inhibited the phosphorylation within the CaM binding site to 
occur. The site of phosphorylation of calcineurin A is a serine which is predicted to 
be located towards the C-terminal boundary of the CaM-binding site; therefore it 
may be possible to argue that modification to this peripheral position may not have 
an effect in blocking the interaction with CaM.  Nevertheless, the presence of CaM 
prevents its phosphorylation, counter arguing that this serine is likely to be 
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positioned within the binding region occupied by CaM or close enough to the 
binding region to suffer from steric hindrance. Interestingly, bioinformatics 
predictions of the CaM binding site of L-selectin suggest that S364 is also towards 
the C-terminal boundary of the site of interaction, and, consistent with what was 
found with calcineurin A, its phosphorylation does not block binding of CaM to L-
selectin as demonstrated by the biophysical experiments carried out in this chapter. 
The fact that serine phosphorylation does not affect CaM binding to L-selectin 
according to the biophysical results does not exclude the possibility that in a 
complex cellular environment, with more players involved in an interplay of 
interactions, phosphorylation may cause CaM dissociation.  
 
4.4.4 Alanine mutation of K362 within the cytosolic tail of L-selectin 
may affect the interaction with CaM-Ca 
 The ITC experiments in this chapter could not detect an interaction between 
CaM-Ca and the L-selectin cytosolic tail peptide containing the K362A mutation 
when experiments were carried out at 20 °C. It is possible that, as with the S364A 
mutation, this is due to the small ΔH of interaction, which could not be measured 
by ITC. However, it cannot be excluded that the K362A mutation is capable of 
blocking the interaction between L-selectin and CaM-Ca. The molecular model 
produced by Killock et al (2009)(3) predicted that K362 was involved in forming a 
salt bridge with residue E114 of CaM, therefore postulating that mutating this 
residue could disrupt the molecular interaction. On the other hand if the structural 
model produced by Gifford et al (2012)(396), using the longer L-selectin peptide, is 
correct, residue K362 would be exposed to the solvent upon CaM binding and 
would be therefore available to interact with moesin FERM domain upon the 
formation of the tertiary complex. Immunoprecipitation experiments have 
previously been undertaken using 300.19 pre-B-cells expressing K362A-L-selectin 
(225). The results showed that CaM was co-precipitated in these cells, therefore 
implying CaM was able to bind to L-selectin in the presence of this mutant. Further 
experiments are required to investigate whether K362 is involved in the interaction 
with CaM-Ca, i.e. ITC in different experimental conditions, as well as MST and NMR 
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experiments that were successful in clarifying the first inconclusive ITC results 
obtained with S364A and S364phos.  
   
4.4.5 ITC analysis of Trp-Cage L-selectin and CaM 
The feasibility of producing in-house recombinant L-selectin peptide as a 
Trp-Cage fusion protein was tested by NMR analysis (Section 3.3.8). The rationale 
for attempting this was to be able to produce 15N-labelled peptides in a cost 
effective manner so NMR experiments can be carried out with the aim of 
elucidating details of L-selectin interaction with CaM. Whether this could be used 
for investigating the interaction between CaM and L-selectin was probed by ITC 
experiments conducted using Trp-Cage-L-selectin, to test the influence of the Trp-
Cage on CaM association. An interaction between CaM and Trp-Cage-L-selectin 
could be measured by ITC, but the thermodynamic parameters turned out to be 
different to those seen with L-selectin peptide alone, raising suspicions that the 
presence of the Trp-Cage may somehow alter the binding. ITC experiments with 
CaM and the Trp-Cage alone will therefore be required as a control experiment to 
ensure that CaM does not interact with the Trp-Cage motif per se. Purification of 
the Trp-Cage motif was attempted once, but was unsuccessful and lack of time 
prevented this being taken further.  
If the Trp-Cage was found to be interfering with CaM interaction, then it 
could theoretically be cleaved away from the peptide prior to ITC and NMR 
experiments. A TEV protease cleavage site is indeed present between the Trp-Cage 
and the L-selectin peptide in the construct used. Such cleavage was attempted 
(Section 3.3.6) but no analysis was carried out on the peptide produced by this 
reaction due to time constraints. 2D [1H-15N] HSQC titration experiments with 15N 
labelled Trp-Cage-L-selectin and CaM would be extremely valuable as they would 
enable the analysis of the CSPs within the L-selectin cytosolic tail and the 
consequent identification of residues involved in establishing interactions with 




4.4.6 Devising a cell-based model of analysing CaM/L-selectin 
interaction 
In conclusion, the experiments outlined in this chapter attempted to model 
a binary interaction between L-selectin and CaM with some interesting results. The 
following two results chapters will focus on the generation of monocyte-like cell 
lines to model the interaction between CaM and L-selectin in a more complex 
cellular setting. As the focus of this thesis is centred on understanding the 
contribution of CaM/L-selectin interaction during inflammation, the analysis is 
addressed specifically on monocytes undergoing transendothelial migration under 




Chapter 5: Generation and characterisation of a 
cellular model to explore the in vivo interaction 




 After exploring in vitro techniques to study the interaction between L-
selectin and its binding partners, the next step was to study the interaction in vivo. 
The role of L-selectin in monocytes has previously been studied. It has been shown 
that L-selectin-dependent adhesion is required for monocyte recruitment, with 
function blocking antibodies against L-selectin inhibiting monocyte recruitment to 
endothelial cells (17,18,419). In vivo, L-selectin has been shown to be responsible 
for monocyte recruitment to the skin (420), the interstitum of the kidney (421), the 
arterial endothelium (159) and the peritoneum (422) following an inflammatory 
stimulus. L-selectin dependent recruitment of monocytes has also been implicated 
in several chronic inflammatory disease states, including rheumatoid arthritis (423) 
and atherosclerosis (292). 
 As the literature clearly highlights an importance for L-selectin in monocyte 
adhesion, the interaction between L-selectin and its binding partners, using the 
THP-1 monocytic cell line as a leukocyte model, could be assessed. These cells were 
transduced with lentivirus expressing L-selectin tagged with GFP and the binding 
partners of L-selectin tagged with RFP. This allowed the study of the interaction by 
using fluorescence-lifetime imaging microscopy (FLIM) to measure the extent of 
fluorescence resonance energy transfer (FRET) between the tags. Increases in FRET 
efficiency would translate directly in to protein-protein interaction (see Section 
5.2). The FRET efficiency in this thesis was measured by exciting the donor 
fluorophore, in this case GFP, and then measuring its fluorescence lifetime, which 




5.2 Experimental Procedure 
Lentivirus transduction uses the properties of human immunodeficiency-1 
(HIV-1) virus to deliver a transgene to cells and insert it into the genome, therefore 
ensuring the transgene will be passed on to the cell progeny. The HIV-1 genome is 
modified so that it contains only the genes necessary for delivery of the transgene 
but is not capable of replicating itself, so there is no risk of infection (see Section 
5.3.1 for details). There are several advantages to using lentiviruses to deliver 
transgenes to target cells over other methods. Lentiviral vectors are very efficient at 
transduction (424) and are also able to transduce non-dividing cells, compared with 
retroviral vectors where the cells must divide within two hours of transduction to 
successfully deliver the transgene (425). Lentiviruses have previously been used to 
successfully modify monocyte cell lines (426), showing there is a precedence for 
using this method. 
 THP-1 cells are a monocytic cell line originating from an acute monocytic 
leukaemia. It has previously been shown that minimal levels of L-selectin was 
observed in this cell line (427); this allows for the transduction of L-selectin-GFP to 
study the role of L-selectin in these cells without endogenous L-selectin 
interference. Previously in the lab THP-1 cells had been transduced with L-selectin 
tagged with GFP (L-selectin-GFP). Cells expressing wildtype L-selectin, the mutants 
S364A, S367A, SSAA and the sheddase resistant mutant ΔM-N were all produced 
with a C-terminal GFP tag. The ΔM-N mutant involves the deletion of eight amino 
acids in the membrane-proximal region, which has been shown to resist shedding 
(98,116,117,119) and is appropriately called a “sheddase-resistant” mutant of L-
selectin (see Section 1.3.4 in Introduction). Analysis of wildtype L-selectin-GFP 
expressing cells showed that L-selectin was correctly located to the microvilli of the 
THP-1 cells and increased the binding of these cells to TNF-activated HUVECs under 
flow (Karolina Rzeniewicz, unpublished data). This means that the L-selectin-GFP 
was functioning correctly and the GFP tag was not affecting its function. Several 
other cell biological characterisations were also performed, such as rolling velocity, 
shedding in response to TNF, PMA and Calyculin A, as well as the sub-cellular 
localisation of L-selectin-GFP to microvilli (as judged by scanning electron 
204 
 
microscopy). These analyses all demonstrated that the GFP tag did not interfere 
with L-selectin function. Although noteworthy to mention, the exact experiments 
will not be discussed in this thesis as they formed a major part of another PhD 
student’s thesis in the Ivetic lab (Karolina Rzeniewicz). In this study CaM and moesin 
were cloned as RFP-tagged chimerae and lentivirus particles were produced. These 
were used to transduce cell lines stably expressing L-selectin-GFP. The interaction 
between L-selectin and its binding partners could then be assessed by studying the 
FRET efficiency between the two fluorescent tags. 
FRET is a method used to assess the proximity of two molecules to one 
another. It measures the transfer of energy between two fluorophores, one known 
as the donor and one the acceptor (428). The donor molecule is excited using light 
at the excitation wavelength. The donor will then transfer the energy to the 
acceptor through long range dipole-dipole coupling and the donor will return to its 
ground state (429). For the transfer of energy to occur the emission wavelength of 
the donor must overlap with the excitation wavelength of the acceptor (Figure 
5.1A) (428). The FRET efficiency depends on the distance between the two 
molecules, with FRET occurring between two molecules less than 10 nm apart 
(428). The closer the two molecules are to one another the higher the FRET 
efficiency.  As a result, this method can provide information about the interaction 
of two molecules. In this thesis the FRET efficiency is measured using fluorescence 
lifetime imaging microscopy (FLIM). With FLIM the fluorophore is excited and the 
decay of the fluorophore from the excited state to the resting state is measured 
(430). The fluorescence lifetime is the time the molecules spends in the excited 
state (430) and is dependent on the local environment of the molecule, including 
the presence of an acceptor molecule (431,432).  The presence of the acceptor will 
lead to a decrease in the lifetime of the donor (Figure 5.1B) (432,433). The 
fluorescence lifetime of the donor is calculated at each pixel in the image and is 
displayed as a pseudo-colour image (Figure 5.1C) (431,432,434,435). This allows for 
visualisation of the sub-cellular distribution of the fluorescence lifetime of the 
donor within a single cell and therefore the location of the interaction between the 
donor and acceptor within the cell. 
205 
 
 Fluorescent proteins can be tagged to the proteins of interest to study their 
interaction. As previously stated, the fluorescent proteins GFP and RFP are used in 
this thesis as the donor and acceptor fluorophores, respectively. The emission 
wavelength of GFP overlaps the activation wavelength of RFP, meaning they act as 
a FRET pair (Figure 5.1A). 
This chapter details the generation of cell lines used in this study to monitor the 
interaction between L-selectin and its binding partners during TEM. The ability of L-
selectin to bind to CaM was then assessed in more detail, with specific reference to 






































5.3.1 Generation of Lentivirus particles to deliver CaM-RFP to THP-1 
cells expressing L-selectin-GFP    
 CaM was cloned into the vector pHR’SIN-SEW (see Figure 2.2 in Materials 
and Methods), which was a gift from Prof. Adrian Thrasher (Institute of Child 
Health, UCL). The vector contains a spleen focus-forming virus (SFFV) promoter to 
initiate transcription, followed by the sequence encoding for red fluorescent 
protein (RFP) and a Woodchuck Hepatitis Virus (WHP) post transcriptional 
regulatory element (WPRE), which helps to enhance the expression of the gene of 
interest and stabilize the transcript. Two long terminal repeat (LTR) sequences are 
also present at the 5’ and 3’ ends of the cloning site. The 5’ LTR is able to act as a 
promoter for RNA polymerase II and the 3’ LTR terminates transcription. LTRs are 
also responsible for the insertion of the transgene into the host genome. CaM was 
cloned into the vector at the 5’ end of the RFP sequence using the restriction sites 
BamHI and XhoI, so CaM would be produced with RFP at the C-terminus. PCR was 
carried out and the product of the correct size was observed, cleaved from the gel 





Figure 5.1: Diagram of FRET/FLIM between GFP and RFP. (A) Graph showing the excitation and 
emission spectra of GFP and RFP. The overlap between GFP emission and RFP excitation is shown 
in grey. (B) A diagram showing the FRET between GFP and RFP. GFP is excited and light is emitted. 
If the proteins are close to one another FRET will occur and the fluorescent lifetime of the donor 
emission will decrease (green arrow) and acceptor emission increases (red arrow). This decrease in 
donor emission is measured during FLIM. (C) Depiction of how FLIM is used to produce images. 
The decay time of the donor fluorophore is measured throughout the whole cell and found to be 
different in three areas (T1, T2 and T3). The fluorescence lifetime is calculated for all areas and a 
pseudo-colour range is used to depict the difference in fluorescence lifetime. In reality the 
fluorescence lifetime of every pixel is measured, so images are produced with a range of colours to 
represent the differences between the individual pixels. 







A restriction digestion with the appropriate restriction enzymes was carried 
out on the purified PCR product and the vector as previously described (see Section 
2.6 for experimental procedure). The ligation of the CaM insert into the lentiviral 
vector was undertaken and the vector was then used for transformation of E.coli 
cells. To examine the presence of the CaM insert, E.coli colonies were selected and 
used to inoculate small scale cultures. These were grown overnight and the plasmid 
DNA was isolated using “mini-prep” kits. The plasmid DNA was then digested with 
restriction enzymes for one hour. The products of the digestion were analysed by 
agarose gel electrophoresis. The results showed that plasmid DNA from all the 
colonies tested produced a DNA band of around 0.5 Kb after digestion, which 
corresponded to the molecular weight expected for the CaM insert (Figure 5.3). 
This suggested that all the colonies contained the CaM insert. In parallel, the vector 
was also sent for sequencing to confirm the presence of the insert and ensure no 
spontaneous mutations had occurred. To enable the production of lentiviral 
particles, large quantities of the CaM-RFP lentiviral vector were required. E.coli cells 
expressing the CaM-RFP vector were grown on a large scale and the plasmid DNA 







Figure 5.2: Visualisation of CaM PCR product following the PCR reaction. PCR was carried out 
to produce a CaM sequence with XhoI and BamHI restriction sites at the 5’ and 3’ termini 
respectively. After the PCR reaction was completed, the reaction solution was analysed by 
agarose gel electrophoresis and visualizing the DNA bands with ethidium bromide. The band 
corresponding to the CaM product was cut from the gel and purified. The product was then 
cleaved with restriction enzymes and used for ligation into the vector.  Lane 1 represents the 








Using lentivirus to insert transgenes into the genome of target cells is 
efficient and enables stable integration of the transgene; therefore the progeny of 
the transduced cell will also express the gene. This means that the generated cell 
lines can be used multiple times. There is however, a potential risk with using 
lentiviruses. It is possible that replication-competent viruses could be generated. To 
minimize the risk of this, first the viral genes not required for lentivirus production 
are removed (436,437), and second the genes that are required are split into 
multiple vectors, each encoding the different genes required (438). In this report 
three vectors were used, the transfer vector containing the transgene which will be 
inserted into the cell genome, and two helper vectors containing the genes 
required for the assembly of the lentiviral particles. Only the transfer vector has the 
ability to integrate into the genome of the cell, whereas the helper vectors are not 
integrated. This means that the lentivirus produced does not contain the genes 
encoded by the helper vectors and therefore the host cells cannot produce 
functional lentivirus. 
The first helper vector used here was the lentiviral packaging vector Pax2. 
This carries the HIV genes gag, pol, rev and tat which all encode different 
components required for lentiviral production. The gag gene encodes four 
structural proteins that make up the core viral structure (438). The pol gene 
encodes virus specific enzymes that are required for the formation of double-
stranded DNA and integration of the DNA into the host genome (438). rev encodes 
a post translational regulator required for the efficient expression and production 
of the other viral genes and tat encodes a protein which enhances the efficiency of 
transcription of viral mRNA (438). The second helper vector was pMD2.G lentiviral 
Figure 5.3: Restriction digest of CaM-RFP lentiviral vector. Four colonies (labelled 1-4) 
were picked after transformation of E.coli with the lentiviral vector ligated with the CaM 
PCR product and the plasmid DNA was isolated using “mini-prep” kit. The isolated vector 
was cleaved with the restriction enzymes XhoI and BamHI to assess the presence of CaM. The 
digestion products were analysed by agarose gel electrophoresis using a 0.8% agarose gel and 
ethidium bromide for DNA visualisation. The cleaved vector (labelled C) was run next to the 
uncleaved vector (labelled UC) for comparison of the DNA bands produced. The arrow shows 
CaM cleaved from the vector.  
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vector, which encodes the viral envelope protein vesicular stomatitis virus (VSV) G 
protein. The two helper vectors were mixed with the transfer vector containing 
CaM-RFP and were used to transduce HEK cells for the production of the lentivirus. 
After 48 and 72 hours transduction the assembled lentiviral particles were collected 
from the tissue culture supernatant and concentrated by ultracentrifugation. 
To optimize the transduction of the target cells, the titre, the number of 
infectious units per millilitre (i.u./ml), was calculated. To calculate the titre a serial 
dilution of the concentrated lentiviral particles was carried out and added to HEK 
cells. Fluorescence-activated cell sorting (FACS) was used to assess the percentage 
of HEK cells expressing CaM-RFP. The first step in calculating the titre was to plot 
the percentage of RFP positive cells against the dilution of lentiviral particles (Figure 
5.4). The dilutions corresponding to between 1-20% transduction efficiency were 
then used for the titration calculation. These dilutions were used as they fall within 
the linear range of transduction and using dilutions in this range means multiple 
lentiviral integrations into the genome are avoided in the calculation. The titre for 
each of the dilutions within the linear range was calculated using the equation: 
DV
PN
T   , where T is the titre, P is the percentage of transduced cells, N is the 
number of cells on the day of transduction, D is the dilution of the lentivirus stock 
added to the cells and V is the volume of lentivirus added to the cells. The final titre 
was found by calculating the average of the titres of the dilutions within the linear 































0         10-6 10-            10-4          10-3         10-           10-











































Dilution % RFP  Titre 
10-6 2.23 14.87x109 
10-5 2.84 1.89x109  
10-4 6.04 0.41x109 
10-3 13.44 0.089x109 
  average titre 4.31x109 i.u./ml 
Figure 5.4: Transduction of HEK cells with lentivirus carrying the lentiviral vector for CaM-RFP. HEK 
cells were transduced with CaM-RFP lentivirus using a serial dilution (0, 10-6, 10-5, 10-4, 10-3, 10-2, 10-1) 
of the concentrated lentiviral particles. (i) The percentage of RFP positive cells was assessed using 
FACS and plotted against the lentiviral dilution. (ii) Low dilutions, in the linear range were used to 
calculate the titre to avoid multiple integrations. 
Table 5.1: Calculation of viral titre of CaM-RFP from dilutions within the linear range of 
transduction. The titre for dilutions with a transduction efficiency of between 1-20 % was 
calculated using the equation: 
DV
PN
T  . The final titre was found by calculating the mean of 
the titres for the dilutions within the linear range.  
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To ensure that similar levels of protein expression were observed between 
the different cell lines infected with the CaM-RFP lentivirus, the multiplicity of 
infection (MOI) was used. The MOI is a measure of the infectious units (lentiviral 
particles) delivered to each target cell. This was calculated using the equation:
N
VT
MOI  , where V is the volume of lentivirus added, T is the titre of the lentivirus 
and N is the number of cells to be transduced. Once the MOI of choice has been 
decided upon, the equation can be rearranged to find the appropriate volume of 
lentivirus required for that particular MOI. As CaM-RFP was being transduced into 
THP-1 cells to act the FRET acceptor for GFP tagged to L-selectin, it was decided to 
use an MOI of 20 for the transduction with CaM-RFP, as it was desirable for the 
expression of the acceptor to be in excess of the donor to cause saturation of the 
donor. This meant that for the transduction of 1 x 106 THP-1 cells, the volume of 
CaM-RFP lentivirus required was 4.6 µl.  
The required amount of lentivirus particles was added to THP-1 cells stably 
expressing L-selectin-GFP. Several L-selectin mutants tagged with GFP were also 
transduced with CaM-RFP. The serine to alanine mutants S364A, S367A and SSAA, 
where both serines are mutated to alanines, were chosen to assess the effect these 
mutations have on CaM binding to L-selectin. By mutating the serine residues to 
alanine, phosphorylation can no longer occur at these sites in the cytosolic tail of L-
selectin. As a result these mutants enable the assessment of the role of 
phosphorylation in regulating CaM binding. The sheddase resistant mutant ΔM-N 
was also transduced with CaM-RFP to assess the effect of blocking shedding on 
CaM/L-selectin interaction. The MOI of L-selectin-GFP in these cells was 5; meaning 
CaM-RFP expression should be greater than L-selectin-GFP and saturation of GFP 
should be achieved. After transduction, the cells were maintained in cell culture 
until several million were present. At this point samples of each cell line were taken 
for the analysis of fluorescent protein expression by fluorescence microscopy 
(Figure 5.5). Images were taken to assess the number of cells expressing both GFP 
and RFP. The images showed that all the cells were expressing L-selectin-GFP. This 
was to be expected as the cells had previously been sorted to select GFP positive 
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cells only. The percentage of cells also expressing CaM-RFP was calculated from 
three different fields of view for each of the cell lines. The results showed that 
transduction varied between the cell lines, with SSAA having the highest level of 
transduction (45%) and S364A having the lowest level (14.3%, Table 5.2). 
For future experiments with these cells it was important that all the cell 
lines had similar levels of expression of the CaM-RFP transgene to enable fair 
comparison between them. For this reason the cells were sorted to produce 
populations with uniform expression of CaM-RFP. If unsorted cells were used for 
future experiments the difference in the number of cells and the expression levels 
of CaM-RFP could lead to misinterpretation of results.  
The cell lines were taken to a core-funded FACs sorting facility for sorting 
into uniform-expressing populations. The cells were first gated for GFP expression 
and then within that population cells which expressed similar or higher levels of RFP 
were selected. The wildtype L-selectin-GFP/CaM-RFP cells were sorted first and the 
same gating was then used for the other cell lines to ensure the expression levels 
were similar between them all. Images of the sorted cells are shown in Figure 5.6. 















Figure 5.5: Fluorescence images of THP-1 cell lines transduced with L-selectin-GFP and CaM-RFP 
prior to cell sorting. Cells expressing wildtype L-selectin-GFP (A) and the mutants ΔM-N- (B), S364A-
(C), S367A- (D) and SSAA-L-selectin-GFP (E) were transduced with lentivirus carrying the lentiviral 
vector for CaM-RFP and maintained in cell culture until several million cells were present. Images 
were taken of the THP-1 cell lines with the GFP and RFP channel and the images were subsequently 
merged. Images were taken using an Olympus IX81 time-lapse inverted fluorescence microscope 
attached to a Hamamatsu C10600 ORCA-R2 video camera and analysed using Volocity imaging 

























Table 5.2: Percentage of RFP positive THP-1 cells after transduction with lentiviral particles 
carrying the lentiviral vector for CaM-RFP. The percentage of RFP positive cells were 
calculated for the L-selectin-GFP THP-1 cell lines after CaM-RFP lentiviral transduction by 
analysis of three fields of view for each cell line and finding the mean of the three. 
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Figure 5.6: Fluorescence images of THP-1 cell lines transduced with L-selectin-GFP and CaM-RFP 
after cell sorting. Cells expressing wildtype L-selectin-GFP and the different L-selectin mutants were 
sorted using FACs to produce a population of cell expressing L-selectin-GFP and CaM-RFP. After 
sorting images were taken of the THP-1 cell lines with the GFP and RFP channel and the images were 
subsequently merged. Images were taken using an Olympus IX81 time-lapse inverted fluorescence 
microscope attached to a Hamamatsu C10600 ORCA-R2 video camera and analysed using Volocity 


















































5.3.2 Generation of Lentivirus carrying the lentiviral vector 
encoding Moesin-RFP for the Transduction of THP-1 cell lines 
expressing L-selectin-GFP    
 Moesin was cloned into the lentiviral vector pHR’SIN-SEW using the same 
method described above (see Section 5.3.1) except the restriction sites XhoI and 
KpnI were used for the insertion of the moesin sequence into the lentiviral vector. 
Once the correct sequence of the lentivirus was confirmed, lentiviral particles were 
formed using HEK cells (the same method as in Section 5.3.1 was used). A titration 
with the lentivirus was carried out and the percentage of RFP positive cells was 
calculated by FACs (Figure 5.7). From this information the titre was calculated and 
found to be 1.19x109 i.u./ml (Table 5.3). As with CaM-RFP, the expression levels of 
moesin-RFP required must be in excess of L-selectin-GFP to cause saturation of the 
GFP, so an MOI of 20 was used to transduce the L-selectin-GFP cell lines. This meant 
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The moesin-RFP lentivirus was used to transduce the THP-1 cell lines stably 
expressing L-selectin-GFP, either wildtype or the mutations ΔM-N, S364A, S367A 
and SSAA. The cell lines were maintained in cell culture after transduction until 
several million cells were present, at which point samples were taken from each cell 
line for analysis of the transduction efficiency using fluorescence microscopy 
(Figure 5.8A-E). The percentage of RFP positive cells was calculated for each cell line 
using three fields of view. The results for all the cell lines showed that the 
percentage of cells transduced with the moesin-RFP lentiviral vector was between 
10 and 5% (Table 5.4). The images also showed that the RFP signal was strongest at 
one region within the THP-1 cell, close to the plasma membrane (Figure 5.8F) and 
this was observed in all the different cell lines. As the cells were in suspension it 
was not possible to see if this region was located at the leading edge or the uropod. 
It was also possible that this high intensity region represents an accumulation of 
moesin-RFP within the Golgi apparatus or the endoplasmic reticulum. Due to the 
low magnification used to acquire the images it was not possible to discern the 
precise sub-cellular location of the moesin-RFP signal.     
dilution RFP positive (%) titre 
10-5 5.44 4.08x109 
10-4 7.71 0.58x109 
10-3 10.84 0.081x109 
10-2 13.64 0.011x109 
 Average titre 1.19x109 i.u./ml 
Figure 5.7: Transduction of HEK cells with lentivirus carrying the lentiviral vector for moesin-RFP. 
HEK cells were transduced with moesin-RFP lentivirus using a serial dilution (0, 10-5, 10-4, 10-3, 10-2, 
10-1) of the concentrated lentiviral particles. (i) The percentage of RFP positive cells was assessed 
using FACS and plotted against the lentiviral dilution. (ii) Dilutions in the linear range of 
transduction were used to calculate the lentiviral titre to avoid multiple integrations. 
Table 5.3: Calculation of viral titre of moesin-RFP from dilutions within the linear range of 
transduction. Dilutions with a transduction of between 1-20 % were taken and the titre for 
each was calculated using the equation:
DV
PN
T  . The final titre was found by calculating the 
mean of the titres for all the lentivirus dilutions within the linear range.  
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 As with the THP-1 cell lines transduced with CaM-RFP, the cell lines 
transduced with moesin-RFP were taken to the core funded FACs sorting facility for 
the selection of cells expressing both L-selectin-GFP and moesin-RFP. The cells were 
first gated for cells expressing GFP and then cells within that population that 
expressed similar or higher levels of RFP were selected. The cells remaining after 







Figure 5.8: Fluorescence images of THP-1 cell lines expressing L-selectin-GFP and transduced 
with moesin-RFP acquired prior to sorting. Images of the THP-1 cell lines expressing wildtype 
(A), ΔM-N- (B), S364A- (C), S367A- (D) or SSAA-L-selectin-GFP and transduced with lentiviral 
particles containing moesin-RFP. Images are merged from acquiring individual stills from the 
GFP and RFP channels. (F) Digital zoom of THP-1 cells expressing moesin-RFP. The arrow 
shows the sub-cellular location of a high-intensity signal corresponding to moesin-RFP. Images 
were taken using an Olympus IX81 time-lapse inverted fluorescence microscope attached to a 
Hamamatsu C10600 ORCA-R2 video camera and analysed using Volocity imaging software. All 

























5.3.3 Cloning of Lentiviral Vector Expressing Ezrin-RFP 
 The cloning of ezrin into the pHR’SIN-SEW vector was problematic due to 
the fact that all the restriction sites in the vector, except XhoI, were also found in 
the sequence of ezrin, meaning they could not be used for conventional cloning as 
they would also cleave the ezrin sequence. For this reason ezrin was cloned with an 
XhoI site at the 3’ end and a SalI site at the 5’ site. The nucleotide base overhang 
produced by digestion with SalI is complimentary to that produced by digestion 
with XhoI, meaning that the two overhangs will interact (Figure 5.8). This meant 
that the vector was only cut with XhoI prior to ligation of the vector and ezrin 
insert. One disadvantage of using this method is that the ezrin insert can ligate in 
both the forward and reverse directions (Figure 5.8). After ligation of the cleaved 
insert and vector, E.coli cells were transformed with the ligation mixture. Colonies 
were then picked and used to inoculate small scale cultures, and the plasmid DNA 
was purified using the ‘mini-prep’ kit. Sequencing was used to check the orientation 
of ezrin. Several different colonies were tested but were found to either not contain 
ezrin or contain ezrin in the wrong orientation. 
  
Table 5.4: Percentage of RFP positive THP-1 cells after transduction with lentivirus carrying 
the lentiviral vector for moesin-RFP. The percentage of RFP positive cells were calculated for 
the L-selectin-GFP THP-1 cell lines after moesin-RFP lentiviral transduction by analysing three 









Figure 5.9: Cloning of Ezrin into pHR’SIN-SEW vector using one cloning site.  Ezrin was 
cloned with XhoI restriction site at the 3’ end and SalI restriction site at the 5’ end. Ezrin 
was then digested with both XhoI and SalI, which produces the same overhang sequence, 
whilst the lentiviral was digested with XhoI only. When ligation was carried out the ezrin 
insert could either ligate in the forward or reverse direction. 
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As using one restriction site was not successful, cloning using a partial digest 
was attempted. The restriction enzyme KpnI cleaves ezrin in the middle of the DNA 
sequence. Ezrin was cloned with an XhoI site at the 3’ end of the sequence and a 
KpnI sequence at the 5’ end. The PCR product was then fully digested with XhoI 
followed by the partial digest with KpnI (see Section 2.6.1 for experimental details). 
The digest mixture was purified and run on an agarose gel. The band corresponding 
to KpnI cleaving at the 5’ end only was cut from the gel and purified to use for the 
ligation with the vector. Sequencing results of vectors created using this method 
found that although ezrin was present, the first few amino acids of the sequence 
were missing. This could be due to a mistake with the PCR reaction or the protein 
being cleaved at a location at the 3’ end. This requires repeating to produce the 
lentiviral vector for ezrin. 
 
5.3.4 Production of THP-1 cells expressing L-selectin CaM-binding 
Mutants 
 It has previously been shown that mutating residue L358 to glutamate in the 
cytosolic tail of L-selectin inhibits CaM binding (215). By mutating this residue the 
hydrophobic face of the cytosolic tail of L-selectin is disrupted. Kahn et al 
(1998)(215) showed that when this mutation was present CaM could no longer co-
precipitate with  immunoprecipitates of L-selectin (215). For this reason, it was 
decided to use this mutation in THP-1 cells transduced with CaM-RFP to see if the 
interaction was blocked in this system. 
 The QuickChange site-directed mutagenesis protocol was used to introduce 
the mutation into wildtype L-selectin-GFP and the sheddase resistant mutant ΔM-
N-L-selectin-GFP. With this method primers are designed to contain the desired 
mutation with complimentary sequences present either side. The primers must 
bind to the same site on opposite strands of the vector. During the thermal cycling 
the primers bound to their complimentary sequences on the parental DNA and are 
extended by DNA polymerase. Once the thermal cycling reaction is completed the 
parental DNA is digested using DpnI endonuclease. This enzyme only cleaves 
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methylated and hemimethylated DNA. As the parental DNA has been isolated from 
E. coli cells, it will be dam methylated and so is digested by DpnI. The newly formed 
DNA containing the mutation is not methylated so remains un-cleaved. The DNA 
containing the mutation is then used to transform E. coli and the DNA can be 
isolated. 
 The lentiviral vector pHR’SIN-SEW containing either wildtype L-selectin-GFP 
or ΔM-N L-selectin-GFP were used for the mutagenesis of residue 358. Plasmid DNA 
was isolated from bacterial colonies observed after transformation with the DpnI 
digested PCR reaction and sequencing was carried out to verify that the appropriate 
mutation was successfully introduced. These vectors were then used to produce 
lentivirus as described previously and a titration was carried out with the lentiviral 
particles produced (see Section 5.3.1).  
The titre for lentiviral particles containing L358E-L-selectin-GFP was found to 
be 5.04x109 i.u./ml (Figure 5.9, Table 5.5). ATTC THP-1 cells were transduced with 
MOI5 and MOI20 to represent a low and high MOI. The cells were allowed to 
propagate for two weeks, until several million cells were present. The expression of 
L358E-L-selectin-GFP was assessed using fluorescence microscopy and images were 
taken (Figure 5.10). The percentage of GFP positive cells was calculated and the 
results are summarized in Table 5.6. The results showed that the number of GFP 
positive cells was 5.3% for MOI5 and 13.7% for MOI20. Due to the low percentage 
of GFP positive cells produced with MOI5, it was decided to use the MOI20 cells for 
future experiments. CaM-RFP and moesin-RFP lentiviruses were added to a sample 
of these cells using the MOI stated above to produce L358E-L-selectin-GFP/CaM-
RFP and L358E-L-selectin-GFP/moesin-RFP cell lines. These cell lines were 
maintained in cell culture ready for cell sorting to select the cells expressing both 




































































dilution GFP positive (%) Titre 
10-6 1.75 17.50x109 
10-5 1.89 1.89x109 
10-4 6.54 0.65x109 
10-3 11.61 0.12x109 
 Average titre 5.04x109i.u/ml 
Figure 5.10: Transduction of HEK cells with lentivirus carrying the lentiviral vector for L358E-L-
selectin-GFP. HEK cells were transduced with L358E-L-selectin-GFP lentivirus using a serial 
dilution (0, 10-6, 10-5, 10-4, 10-3, 10-2, 10-1) of the concentrated lentiviral particles. (i) The 
percentage of GFP positive cells was assessed using FACS and plotted against the lentiviral 
dilution. (ii) Those dilutions found in the linear range of transduction were used to calculate the 
lentiviral titre to avoid multiple integrations. 
Table 5.5: Calculation of viral titre of L-selectin-L358E-GFP from dilutions within the 
linear range of transduction. Lentiviral dilutions with a transduction efficiency of 




T  . The final titre was found by calculating the mean of the titres for the 
dilutions within the linear range.  
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Figure 5.11: Images of THP-1 cells transduced with L358E-L-selectin-GFP. ATTC THP-1 cells 
were transduced with lentivirus encoding L358E-L-selectin-GFP with MOI5 (A and B) or 
MOI20 (C and D). Images were taken with both the phase and GFP channels using an 
Olympus IX81 time-lapse inverted fluorescence microscope attached to a Hamamatsu 
C10600 ORCA-R2 video camera, with analysis undertaken using Volocity imaging software. All 
images were taken at 10x objective. 
Table 5.6: Percentage of GFP positive THP-1 cells after transduction with lentivirus carrying 
the lentiviral vector for L358E-L-selectin-GFP. The percentage of GFP positive cells was 
calculated for the THP-1 cell lines after L358E-L-selectin-GFP lentiviral transduction by 




















































The titre for L358E-ΔM-N-L-selectin-GFP was found to be 0.155x109 i.u./ml 
(Figure 5.11, Table 5.7). ATTC THP-1 cells were transduced with MOI5 and MOI20. 
The cells were left to propagate for two weeks, at which point the transduction 
efficiency was assessed using fluorescence microscopy. Images were taken (Figure 
5.12) and the percentage of GFP positive cells was calculated for cells transduced 
with each MOI. The results showed that for MOI5 59.7% of the cells were GFP 
positive and for MOI20 the percentage of GFP positive cells was 88.5% (Table 5.8). 
Due to the high levels of expression it was decided that cells transduced with MOI5 
would be used for future experiments. CaM-RFP and moesin-RFP lentiviruses were 
added to a sample of these cells using an MOI of 20 to produce L358E-ΔM-N-L-
selectin-GFP/CaM-RFP and L358E-ΔM-N-L-selectin-GFP/moesin-RFP cell lines. These 
cell lines were maintained in cell culture in preparation of cell sorting, so the cells 
expressing both GFP and RFP could be selected.    
 
   
Figure 5.12: transduction of HEK cells with lentivirus carrying the lentiviral vector for L358E-
ΔM-N-L-selectin-GFP. HEK cells were transduced with L358E-ΔM-N-L-selectin-GFP lentivirus 
using a serial dilution (0, 10-6, 10-5, 10-4, 10-3, 10-2, 10-1) of the concentrated lentiviral particles. (i) 
The percentage of GFP positive cells was assessed using FACS and plotted against the lentiviral 
dilution. (ii) In order to avoid multiple integrations, lentiviral dilutions in the linear range were 
used to calculate the lentiviral titre. 
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dilution GFP positive (%) Titre 
10-5 1.21 1.21x109 
10-4 2.15 0.22x109 
10-3 9.53 0.095x109 
 average titre 0.51x109 u/ml  
Phase GFP 
Figure 5.13: Images of THP-1 cells transduced with L358E-ΔM-N-L-selectin-GFP. ATTC THP-1 
cells were transduced with lentivirus expressing L358E-ΔM-N-L-selectin-GFP with MOI5 (A and 
B) or MOI20 (C and D). Images were taken using an Olympus IX81 time-lapse inverted 
fluorescence microscope attached to a Hamamatsu C10600 ORCA-R2 video camera and 
analysed using Volocity imaging software. All images were taken at 10x objective with both the 
phase and GFP channels. 
Table 5.7: Calculation of viral titre of L358E-ΔM-N-L-selectin-GFP from dilutions within the 
linear range of transduction. Dilutions of the lentivirus with a transduction efficiency of 




T  . The final titre was found by calculating the mean of the titres for the 



















5.3.5 Analysis of the Protein Expression Levels of CaM-RFP in THP-1 
cell lines 
 To assess the levels of CaM-RFP expressed in the different THP-1 cell lines, 
cell lysates were produced and analysed by Western blot, using an anti-CaM 
antibody. As a negative control THP-1 cells transduced with GFP protein were used, 
as this cell line would not express CaM-RFP. The results showed that a band with 
molecular weight of around 50 kDa was observed in all the cell lines except THP-1 
cells expressing GFP alone (Figure 5.13A, blue arrow). This molecular weight was 
consistent with that expected for CaM tagged with RFP (18 KDa for CaM and 27 KDa 
for RFP). The protein expression levels of CaM-RFP between the different cell lines 
was analysed using endogenous CaM as a loading control and comparing the CaM-
RFP expression levels of all the L-selectin mutant cell lines to wildtype L-selectin-
GFP. It was found that the expression levels were very similar, with SSAA having 
slightly higher levels compared to the others (Figure 5.13B). As all the cell lines 
expressed CaM-RFP at similar levels, comparison of the interaction between L-
selectin-GFP and CaM-RFP across the cell lines could be carried out without the 
concern of misinterpretation of results due to different protein expression levels.  
The anti-CaM antibody also recognised the endogenous CaM expressed in 
the THP-1 cell lines. A band with a molecular weight between 20 and 15 kDa was 
present in all the cell lines, corresponding to endogenous CaM, and the protein 
expression levels of endogenous CaM was similar between the cell lines (Figure 
ΔM-N-L358E-L-selectin-GFP GFP positive (%) 
MOI5 59.7 
MOI20 88.5 
Table 5.8: Percentage of GFP positive THP-1 cells after transduction with lentivirus carrying 
the lentiviral vector for L358E-ΔM-N-L-selectin-GFP. The percentage of GFP positive cells 
were calculated for the THP-1 cell lines after L358E-ΔM-N-L-selectin-GFP lentiviral 













































Relative  protein expression of CaM-RFP
5.13A, back arrow). When the levels of endogenous CaM were compared to CaM-
RFP it was clear that endogenous CaM was expressed at a higher level than CaM-
RFP. Densitometric analysis was performed to analyse the extent of the difference 
in the protein expression levels between endogenous CaM and CaM-RFP. Analysis 
revealed that the expression levels of CaM-RFP were around a quarter of that of 




























5.3.6 Monitoring the biochemical interaction of L-selectin-GFP with 
endogenous CaM and CaM-RFP  
 To study the interaction between L-selectin and CaM, a GFP-Trap assay was 
performed. This entails using a GFP-binding protein coupled to agarose beads to 
immunoprecipitate GFP (see Section 2.23 in Materials and Methods). When THP-1 
cell lysate was added to the GFP-Trap beads, L-selectin would be 
immunoprecipitated, as L-selectin was tagged with GFP. Any proteins that were 
interacting with L-selectin will co-precipitate, allowing for the identification of 
binding partners of L-selectin. 
 GFP-Trap assays were carried out on cell lysates derived from THP-1 cells 
expressing wildtype and mutant L-selectin-GFP to determine if any of the mutations 
had an effect on CaM binding. THP-1 cells expressing GFP were used as a negative 
control, to ensure that any protein co-precipitated with L-selectin-GFP is due to the 
interaction with L-selectin and not due to the presence of the GFP tag. Following 
incubation with the GFP-Trap beads the immunoprecipitated proteins were 
analysed by Western blot, using anti-CaM antibody to visualise CaM bound to L-
selectin. Anti-GFP antibody was also used to assess the quantity of L-selectin 
immunoprecipitated in the different cell lines, so comparison of CaM binding to L-
selectin between the cell lines could be carried out.  
Initial experiments showed that endogenous CaM was co-precipitated in all 
the cell lines (Figure 3.14A, black arrow), with SSAA and ΔM-N showing the greatest 
amount of co-precipitation (Figure 3.14A, lanes 5 and 6 respectively). CaM-RFP 
could also be observed as a faint band in the S364A, SSAA and ΔM-N cell lines, but 
Figure 5.14: Protein expression levels of CaM in the different THP-1 cell lines. (A) Cell lysates 
for the THP-1 cell lines expressing L-selectin-GFP and CaM-RFP were analysed to assess the levels 
of CaM by western blot using an anti-CaM antibody (The blue arrow shows CaM-RFP and the 
black arrow shows endogenous CaM). (B) The protein expression levels of CaM-RFP were 
compared between the cell lines by densitometric analysis, using endogenous CaM as a loading 
control and comparing the mutants to wildtype L-selectin. (C) Densitometric analysis was used to 
compare the difference between CaM-RFP and endogenous CaM in the different cell lines. 




was not visible in wildtype or S367A cell lines (Figure 3.14A blue arrow). However, a 
band corresponding to the molecular weight of endogenous CaM was visible in the 
immunoprecipitation of the THP-1 cells expressing GFP (Figure 3.14A, Lane 1). This 
suggested that there was nonspecific binding occurring between CaM and the GFP-
Trap beads. In an attempt to remove any nonspecific interactions, 1% ovalbumin 
was added to the lysis and wash buffers, which has been previously used in 
immunoprecipitation experiments to limit any nonspecific interactions with L-
selectin (3). When the experiment was repeated in these conditions, CaM was no 
longer observed in the lane corresponding to THP-1 cells expressing GFP (Figure 
3.14C, Lane 1). Endogenous CaM was still present in the pull-down of all the cell 
lines (Figure 3.14C, black arrow), however, under these conditions wildtype L-
selectin bound best to CaM (Figure 3.14C, Lane 2), with all the mutants co-
precipitating much less CaM, suggesting that mutating the tail of L-selectin affected 
its ability to effectively co-precipitate CaM. The extent of this difference was 
assessed using densitometric analysis, using the level of full length L-selectin-GFP 
for each cell line as the loading control (Figure 3.14D) and comparing all the mutant 
cell lines to the results observed with wildtype L-selectin-GFP. The results clearly 
showed that wildtype L-selectin-GFP immunoprecipated the greatest amount of 
CaM, with the mutants having similar levels of CaM (Figure 3.14E). It is worth noting 
that, due to time constraints this experiment was only undertaken once and 
therefore further repeats are required in order to carry out statistical analysis of 
this result. CaM-RFP was no longer visible in the pull-down from the lysate of any 
cell line. This was likely due to the fact that the levels of CaM-RFP were much lower 
than endogenous CaM, so was less likely to be bound to L-selectin, meaning less 





































Figure 5.15: GFP-Trap assay for the analysis of CaM interaction with L-selectin in THP-1 cell 
lysates. GFP-Trap assay was carried out to assess the ability of CaM to bind to L-selectin-GFP in 
either wildtype cells or L-selectin mutants. For each experiment 2x107 THP-1 cells were collected 
by centrifugation and the cells were lysed. The lysate was then incubated with pre-equilibrated 
GFP-Trap beads and any proteins interacting with the beads were precipitated by centrifugation. 
The precipitated proteins were analysed by Western blot using anti-CaM and anti-GFP antibodies. 
Initial pull-down was carried out without ovalbumin and levels of CaM (A) and GFP (B) were 
assessed. 1% ovalbumin was then added to the lysis and wash buffer to block nonspecific 
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5.3.7 FRET/FLIM analysis of CaM and L-selectin in THP-1 cells plated 
on poly-L-lysine 
 As explained in Section 5.2, GFP and RFP can act as a donor and acceptor 
pair for FRET. As the THP-1 cell lines produced here express L-selectin-GFP and 
CaM-RFP, FRET/FLIM analysis was carried out to gain an insight into the interaction 
between these two proteins in intact cells. To study the interaction in resting cells, 
without any activation, cells were taken from suspension and plated onto poly-L-
lysine (PLL)-coated glass coverslips and fixed in 4 % paraformaldehyde (PFA) prior to 
FRET/FLIM analysis. Analysis showed that the FRET efficiency between wildtype L-
selectin-GFP and CaM-RFP was very low (Figure 5.15A and F), showing there was no 
interaction between the two proteins. The same analysis was carried out with cells 
expressing L-selectin-ΔM-N-GFP and CaM-RFP and the results showed the FRET 
efficiency was similar to that observed with wildtype L-selectin-GFP, suggesting as 
with wildtype L-selectin, there was no interaction between ΔM-N-L-selectin-GFP 
and CaM-RFP in resting cells (Figure 5.15B and F).  
 The interaction between L-selectin and CaM was also assessed with the 
serine to alanine mutants in resting cells. The results showed that the FRET 
efficiency in cells expressing S367A-L-selectin-GFP was similar to that in cells 
expressing wildtype L-selectin-GFP (Figure 3.15D and F). This suggests that there 
was little or no interaction between S367A-L-selectin-GFP and CaM-RFP, as with the 
wildtype cells. However, the FRET efficiency for S364A-L-selectin-GFP/CaM-RFP 
(Figure 3.15C) and SSAA-L-selectin-GFP/CaM-RFP (Figure 3.15E) was significantly 
higher than that observed with wildtype L-selectin-GFP, showing an interaction 
between L-selectin-GFP and CaM-RFP in these cell lines, with the greatest amount 
of interaction occurring with S364A (Figure 3.15F). This implies that mutating S364 
to alanine enhances the interaction of CaM with L-selectin in resting cells. As this 
mutation blocks the phosphorylation of this residue it is possible that 
phosphorylation of S364 is involved in abrogating the binding of CaM to L-selectin 
under resting conditions.     
endogenous CaM immunoprecipitated was analysed, using full length L-selectin-GFP to adjust 
the density of CaM, with the levels compared to wildtype L-selectin-GFP, for the experiment 
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Figure 5.16: FRET efficiency between CaM-RFP and L-selectin-GFP in resting THP-1 cell lines. 
THP-1 cells were plated on PLL covered coverslips, fixed with 4% PFA and mounted on slides 
ready for FRET/FLIM analysis. Images showing the  FRET efficiency between CaM-RFP and L-
selectin-GFP in resting cells were taken for wildtype L-selectin (A), S364A (B), S367A (C), SSAA (D) 
and ΔM-N (E), with the left panel showing the GFP signal, the middle panel showing the 
fluorescence lifetime and the right panel showing the RFP signal. (F) The FRET efficiency for the 
cell lines was measured and statistical analysis was carried out using a One-way Annova followed 
by a Tukey’s post-hoc test. Images and measurements were taken by Dr Maddy Parsons, King’s 










5.4.1 Generation of Stably Transduced THP-1 Cell lines 
 THP-1 cells expressing CaM-RFP and different mutants of L-selectin-GFP 
were successfully produced for use in future studies of the interaction between the 
two molecules. Analysis of the lysate of these cells showed that the level of CaM-
RFP was much lower than endogenous CaM. This could lead to misinterpretation of 
results from FRET analysis of the interaction between L-selectin and CaM, as 
binding of endogenous CaM to L-selectin-GFP would block the binding sites for 
CaM-RFP, leading to no FRET being observed even though CaM binding was 
occurring and therefore inaccurate conclusions. In the future it may be 
advantageous to knock out endogenous CaM before introducing CaM-RFP to 
ensure this is not a problem. Additionally, overexpressing CaM-RFP in THP-1 cells 
could confirm if the results were due to a dilution effect of exogenous CaM-RFP 
versus endogenous CaM. By shifting the pool of available CaM towards the 
exogenous CaM-RFP may lead to increased co-precipitation of CaM-RFP with L-
selectin-GFP. 
 It is worth noting that some of the Western blot bands corresponding to 
endogenous CaM are saturated and bleeding into one another (Figure 5.13). This is 
a problem with using x-ray film to detect bands of different intensities, where the 
long exposure required to visualise the lower levels of protein expression causes 
over exposure of bands representing higher protein expression levels. This can be 
overcome by using a digital Western blot scanner, which is capable of detecting all 
protein bands at once without causing saturation of the higher intensity bands. This 
will mean a more accurate densitometric analysis can be undertaken. 
 Moesin-RFP was also successfully expressed in THP-1 cell lines expressing L-
selectin-GFP, both wildtype and the mutants. Images of these cells showed that the 
distribution of moesin-RFP was found at the membrane, with areas of high 
expression observed. It has previously been shown that moesin is located primarily 
at the cell membrane in both neutrophils (439) and differentiated THP-1 cells (440). 
This is to be expected as it is known that ERM proteins interact with the plasma 
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membrane (264). It is possible that the high intensity fluorescence signal represents 
the uropod of the cell. Several proteins, including CD43, CD44 and PSGL-1 are 
concentrated at the uropod and these molecules have been shown to interact with 
ERM proteins (271,274,441,442). It was shown that ezrin did co-localize with these 
molecules in the uropod of T-cells (443). It is therefore feasible that moesin also 
accumulates to the uropod in THP-1 cells through its interaction with these 
transmembrane proteins. These transmembrane proteins could be used to 
decipher the location of moesin within the THP-1 cells. Fluorescently tagged 
antibodies against CD43, CD44 or PSGL-1 could be used to indicate their location 
within the cell and it would be possible observe if this signal co-localises with the 
high intensity RFP signal observed with moesin-RFP. Work in the Ivetic lab is 
currently underway to address such questions. 
 Cloning of ezrin-RFP has so far been unsuccessful. Using a partial digest to 
carry out the cloning can be repeated. If this is still unsuccessful it may be useful to 
obtain a different lentiviral vector containing RFP with different restriction sites 
that are not present in the ezrin sequence. This would enable the use of 
conventional cloning for the production of ezrin-RFP. 
 
5.4.2 Monitoring the discrepancies between FRET and biochemical 
approaches. 
 To study the interaction between CaM and wildtype L-selectin-GFP in THP-1 
cells two methods were used: GFP-Trap assay to detect L-selectin-GFP and any of its 
binding partners, and FRET/FLIM analysis to observe the interaction in intact cells. 
The results of these two experiments produced very different results, with the GFP-
Trap assay showing an interaction between wildtype L-selectin-GFP and CaM and 
the FRET/FLIM analysis showing no interaction. It is possible that this is due to 
endogenous CaM binding to L-selectin and blocking CaM-RFP from binding. It is also 
possible that the interaction between the cell and PLL affects the interaction 
between L-selectin and CaM. PLL coats the surface of the glass coverslip with 
cationic sites which are capable of interacting with anionic sites on the surface of 
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the cell (444). This process often results in the flattening of the cell to a degree 
which is not physiological (444). It is possible that this flattening alters signalling 
within THP-1 cells, leading to CaM dissociation from L-selectin. To test if PLL affects 
the interaction, THP-1 cells could be fixed prior to immobilization on PLL. 
 Another reason for these differences is likely to be due to the different 
methodology used. GFP-Trap pull-down experiments involve creating cell lysates 
and studying the interaction of the proteins in solution. Whereas the FRET analysis 
is carried out on intact cells fixed to PLL-coated cover slips. One major difference 
between these two methods is the presence of an intact plasma membrane with 
the FRET/FLIM analysis. As L-selectin is a transmembrane protein it is conceivable 
that the plasma membrane may play a role in regulating the binding of its partners. 
Deng et al (2011)(216) studied the interaction between CaM and the cytosolic tail 
of L-selectin by embedding the L-selectin tail and transmembrane domain into 
liposomes. They found that when a negatively charged phospholipid, 
phospohotidylserine (PS), was embedded in to liposomes the cytosolic tail of L-
selectin was located closer to the surface of the membrane compared to liposomes 
that did not contain PS and CaM binding was not observed (216). This difference 
was due to an electrostatic interaction between the negatively charged PS and the 
positively charged amino acids of the L-selectin tail, which directly competed for 
CaM binding (216,417). Leukocyte plasma membranes, such as monocytes, contain 
approximately 7.5% PS (445), with the majority being located within the inner 
leaflet of the lipid bilayer (446,447). This makes it likely that the mechanism 
observed by Deng et al (2011) with liposomes may also occur inside the cell. This 
would explain why CaM binding to L-selectin is not seen when FRET/FLIM analysis is 
carried out in resting cells. The binding was observed with the GFP-Trap assay, 
however, as the plasma membrane was disrupted by the lysis, the cytosolic tail of L-
selectin is free in solution and so is capable of interacting with free CaM.  
To test if PS in the plasma membrane of THP-1 cells is responsible for 
blocking the interaction between L-selectin and CaM, the cells could be transduced 
with the protein annexin A5, which binds to PS with a high affinity (448). Annexin 
A5 binding to PS could potentially block the interaction between L-selectin and PS 
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and therefore promote the interaction with CaM. It is also possible to force the 
movement of PS from the inner membrane to the outer using a synthetic PS 
scramblase (449). If CaM binding was observed after treatment with this 
scramblase it would suggest that PS in the cell membrane is responsible for 
blocking the interaction between L-selectin and CaM in resting cells.  
 The role of the membrane in the regulation of CaM binding to L-selectin 
raises the question of how CaM association occurs to protect L-selectin from 
shedding. It has been shown that when CaM was inhibited using the CaM specific 
inhibitors calmidazolium, trifluoperazine and W7, L-selectin was down-regulated 
(215), leading to the hypothesis that CaM binding in resting cells protects L-selectin 
from cleavage. However, the FRET data shown here suggests that CaM is unable to 
bind to L-selectin in resting cells, possibly due to L-selectin interacting with the 
plasma membrane. It is possible that there is an early activation step that leads to 
CaM binding, before dissociation occurs at a later time point. There are several 
potential mechanisms that could lead to CaM association. It has been shown in 
Jurkat T cells that a subpopulation of L-selectin is located in lipid rafts (450). The L-
selectin antibody Dreg56 was used to crosslink L-selectin, simulating ligand binding, 
and this led to an increase in the amount of L-selectin found in the lipid rafts (450). 
It was also found that the L-selectin located in the lipid rafts was tyrosine 
phosphorylated, suggesting this could be a possible signal that leads to the re-
localisation of L-selectin after cell activation. It is possible that this movement to 
the lipid raft will lead to L-selectin no longer interacting with the cell membrane 
and allow CaM to bind to the cytosolic tail (Figure 5.16(i)).  
 It is also possible that other binding partners of L-selectin may enable CaM 
to bind. It has been shown that the FERM domain of moesin is able to bind to L-
selectin embedded in liposomes containing up to 20% of PS (223). It has long been 
established that the FERM domain is able to interact with the plasma membrane 
(264). It was also observed that binding of moesin-FERM domain to L-selectin 
caused it to separate from the membrane surface by interacting with the positive 
amino acids within the cytosolic tail of L-selectin and blocking their interaction with 
the anionic membrane surface and this allowed CaM binding (223). This means that 
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it is possible that early activation of the cell leads to moesin association with L-
selectin, which in turn allows CaM to bind (Figure 5.16(iii)). 
As was mentioned in Sections 1.3.6 and 4.4.2, upon leukocyte activation an 
influx of calcium is induced and it is possible that this affects the interaction 
between CaM and L-selectin, especially given the fact that CaM is a calcium binding 
protein. As has been explained in Chapter 4, in vitro biophysical experiments 
showed both ApoCaM and CaM-Ca were capable of interacting with L-selectin 
cytosolic peptide, though it was possible there were differences in the binding 
mechanisms. It is therefore possible that in the cell only CaM-Ca is able to interact 
with L-selectin and leukocyte activation and the resultant calcium influx is required 
for the initiation of the interaction between CaM-Ca and L-selectin (Figure 5.16(v)). 
The FRET experiments cannot allow one to determine if the CaM-RFP that is binding 
to L-selectin-GFP is loaded with Ca2+ or not. However, using ionophores to increase 
intracellular Ca2+ levels could be one possible way of addressing if the interaction 
between L-selectin-GFP and CaM-RFP in resting cells is altered by controlling 
intracellular [Ca2+] levels. Drugs, such as 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-
tetraacetic acid (BAPTA), that prevent intracellular increases in [Ca2+] can also be 
used. Interestingly, studies have shown that treatment of leukocytes with calcium 
ionophores induces rapid down regulation of L-selectin (451,452). The exact 
mechanism by which calcium ionophores cause loss of L-selectin remains unclear, 
though the addition of PKC inhibitors did not block the effect (452). It is therefore 
possible that CaM plays a role the down regulation of L-selectin in response to 
calcium influx. 
 Another possibility is that activation of the cell leads to the redistribution of 
PS within the plasma membrane. The externalisation of PS has previously been 
shown to be an apoptotic signal for the recognition of cells to be removed by 
phagocytosis (447). It has also been found in non-apoptotic cells. A population of 
activated/memory CD4+ T-cells were found to have high levels of external PS and 
were found to be healthy (453). It was found that this redistribution of PS occurs 
after activation of the P2X7 receptor (453-455). The P2X7 receptor has been shown 
to be  expressed in THP-1 cells (454), so it is possible that activation of this receptor 
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causes the externalisation of PS in these cells, which leads to L-selectin no longer 
interacting with the plasma membrane and allows CaM binding (Figure 5.16(ii)). It 
would be possible to visualise if PS is externalized after THP-1 cells are activated by 
using a fluorescent probe which binds to PS. Lactadherin is a milk glycoprotein 
which binds to PS. it has previously been tagged with GFP and expressed in several 
different cell types (456). It was shown that in wildtype yeast cells the lactadherin-
GFP was localised at the plasma membrane but in cells deficient for PS the protein 
was cytosolic (456). By comparing THP-1 cells expressing lactadherin-GFP before 
and after activation it will be possible to see if the distribution of this protein was 
altered.  
 Interestingly, it has also been shown that P2X7 receptor activation leads to 
shedding of L-selectin in several different leukocyte cell types (453-455,457). 
Inhibitors of PS translocation also inhibited the shedding of L-selectin induced by 
P2X7 receptor activation (453), showing a clear link between PS redistribution and 
L-selectin shedding. Although both processes have been shown to occur it is not 
known if they happen at the same time or are sequential. It is possible that PS 
redistribution occurs first, allowing CaM binding to take place and regulate the 
shedding of L-selectin. Further experiments are required to decipher if there is a 





































Figure 5.17: Potential Mechanisms of the initiation of CaM binding to L-selectin upon leukocyte 
activation. There are several potential mechanisms that regulate CaM (shown in light blue) 
association to L-selectin. It is possible that in resting cells the cytosolic tail of L-selectin interacts 
with PS (shown in orange) in the plasma membrane. Upon activation L-selectin could be re-
localised to lipid rafts (shown in dark blue)(i), PS could be translocated to the outer membrane (ii) 
or ERM could bind to the cytosolic tail of L-selectin(shown in purple), all of which could lead to 
dissociation of the L-selectin cytosolic tail from the plasma membrane and allow CaM  interaction. 






5.4.3 Mutating the Cytosolic tail of  L-selectin affects CaM binding  
 When GFP-Trap beads were used to immunoprecipitate L-selectin and its 
binding partners it was found that the sheddase resistant mutant ΔM-N did not 
bind as effectively to L-selectin when compared to wildtype L-selectin. This 
difference may be due to the fact that ΔM-N cells do not produce the 
transmembrane and cytosolic domain, known as the “stump”. It is possible that 
CaM binds to a greater exent to the stump of L-selectin, as this contains the binding 
site without the large extracellular domain, which may interfere with the binding. 
The FRET data showed that in resting cells CaM did not interact with ΔM-N-L-
selectin, as with the wildtype L-selectin. This shows that if L-selectin does interact 
with the plasma membrane, as described above, blocking the cleavage of L-selectin 
does not affect this interaction. 
 Serine to alanine mutants were used to assess the affect of blocking 
phosphorylation on the interaction between L-selectin and CaM. The GFP-Trap 
immunoprecipitation results showed that all the serine to alanine mutants co-
precipitated less CaM. This is not consistant with in vitro data that showed CaM was 
able to bind to the serine to alanine mutant peptides with similar affinities as 
wildtype (see Section 4.3.3 and Table 7.1 for a summary of the results). This 
highlights how the methodology and context in which the interaction is measured 
affects the result. With the single serine to alanine mutants, S367A and S364A, it is 
possible that by blocking phosphorylation of one residue promotes the 
phosphorylation of the other. This increase in phosphorylation at one site may 
affect CaM binding. It is not known what the phosphorylation state of the tail of L-
selectin is in resting cells. The development of antibodies that can differentiate 
between the different possible phosphorylation states would provide useful 
information.  
blocks CaM binding in resting cells. Upon activation, dephosphorylation occurs and CaM is 
able to bind to L-selectin. (v) Another possibility is that in resting cells CaM is in its Apo form 
and is not able to interact with L-selectin. Upon activation there is an influx of calcium, which 




 The FRET data for S364A and S367A showed that S367A behaves similar to 
wildtype L-selectin, with no interaction observed, but the interaction does occur in 
the S364A mutant cell line. This suggests there maybe a role for S364 
phosphorylation in blocking the interaction between L-selectin and CaM in resting 
cells, and furthermore suggests that S364 may be constitutively phosphorylated in 
resting THP-1 cells (Figure 5.16(iv)). This may be the method of regulation in place 
of L-selectin interacting with the cell membrane as described above, or it could be a 
mixture of the two. Deciphering the phosphorylation state of the tail at different 
stages may show that it is very dynamic, with phosphorylation and 
dephosphorylation occuring at several different stages to control the complex 
mechanism of CaM binding and regulation of L-selectin shedding. It has been shown 
that basal shedding of L-selectin occurs and this turnover of L-selectin is at a slower 
rate than activated shedding (458). It is therefore possible that phosphorylation and 
dephosphorylation is responsible for basal shedding in resting cells. 
The GFP-Trap assay results for the SSAA-L-selectin mutant showed that 
lower levels of CaM were pulled down. It is possible that the double mutation of 
the tail leads to the disruption of the overall secondary structure of the tail, leading 
to CaM not binding as tightly as with wildtype L-selectin. CaM normally binds to 
alpha helical structures and it is possible that the double serine to alanine mutation 
affects the capability of the tail to form a helix and therefore will affect CaM 
binding. The FRET data however, shows that CaM is capable of binding to the SSAA 
mutant in the cell, with a greater interaction observed with this mutant compared 
to wildtype L-selectin-GFP. This again shows that phosphorylation of S364 may be 
responsible for blocking the interaction in wildtype L-selectin-GFP cells. This data 
shows how complex the regulation of the interaction between L-selectin and CaM 
is. It is also possible that the mutants studied here affect the binding of other 
proteins, such as moesin or ezrin, to L-selectin and by affecting this interaction it 
may also affect the interaction with CaM. By studying the interaction between the 
L-selectin mutants and moesin and ezrin this may help provide information about 
the importance of these residues in regulating the interaction, which in turn may 
provide information about the interaction between CaM and L-selectin. It will also 
be useful to study the interaction of all three in vivo. 
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Chapter 6: Monitoring L-selectin/CaM interaction 
during Leukocyte Transendothelial Migration 
6.1 Introduction 
 In Chapters 4 and 5 the interaction between L-selectin and CaM was studied 
both in vitro and in resting cells, with an emphasis on deciphering the role of serine 
phosphorylation in regulating the interaction. The results revealed that CaM was 
able to interact with L-selectin both when the serine residues were mutated to 
alanine and when they were phosphorylated in vitro. Interestingly, analysis of the 
interaction in resting THP-1 cells, by GFPTrap assay and FRET/FLIM analysis, 
suggested that mutating serine residues within the cytosolic tail did affect the 
interaction between L-selectin and CaM. The GFPTrap assay implied that L-selectin 
mutations S364A, S367A and SSAA abrogated the binding of CaM to L-selectin 
(Section 5.3.6). Whereas the FRET/FLIM analysis showed that mutating S364, S367 
or both serine residues to alanine promoted the interaction between L-selectin-GFP 
and CaM-RFP under resting conditions (Section 5.3.7). The differences in these 
results suggested that the context in which the interaction was studied plays a 
pivotal role in the regulation of the interaction.  
Following the results from the previous chapters, it was important to 
investigate the interaction between L-selectin-GFP and CaM-RFP during 
transendothelial migration (TEM). It is well known that direct binding between CaM 
and L-selectin protects L-selectin from shedding (215). However, much of our 
understanding that relates to shedding is on leukocytes activated purely in 
suspension. Static transmigration assays (i.e. without flow) have previously shown 
that L-selectin is shed during recruitment, suggesting that the CaM/L-selectin 
interaction is lost at some point during TEM, however, exactly at what stage the 
dissociation occurs remains unclear. Furthermore, the sub-cellular distribution of 
the CaM/L-selectin interaction could be different within any given leukocyte. In 
other words, although L-selectin is expressed in many different leukocyte subsets, it 
could be regulated very differently within any given cell. By using FRET/FLIM 
analysis to study the interaction between L-selectin and CaM during TEM, it is 
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possible to pinpoint where and when the CaM/L-selectin interaction is lost. This will 
provide an important insight into L-selectin shedding during TEM.  
In this chapter the interaction between CaM-RFP and L-selectin-GFP was 
assessed in THP-1 cells undergoing TEM under flow conditions. Analysis was 
undertaken with both wildtype and mutant L-selectin-GFP cells to assess whether 
mutating L-selectin affected this interaction at any stage of the transmigration 
process. Western blotting of the GFP tag was used as a measure of L-selectin 
shedding during TEM, which was also used to correlate CaM dissociation from the 
L-selectin tail. The formation of pseudopod-like protrusions by THP-1 cells was 
assessed – specifically within the transmigrated part of the cell. Circularity and cell 
area were monitored to establish a possible link between the shedding of L-selectin 
and a change in cell shape during TEM.  
6.2 Experimental Procedure 
 In order to study the interaction between L-selectin and CaM during TEM, 
the parallel plate flow chamber assay was used in combination with FRET/FLIM 
analysis. The parallel plate flow chamber assay is a method developed to study the 
interaction between leukocytes and endothelial cells under shear stress conditions 
(7). This method involves culturing endothelial cells on to fibronectin-coated glass 
coverslips until a monolayer is established. The monolayers are then activated with 
TNF-α prior to their assembly in to the flow chamber (see Section 2.20 for details of 
the experimental set-up). Leukocyte suspensions are perfused over the endothelial 
monolayer using a syringe pump. The flow rate is set at 0.25 ml/min, which 
corresponds to a shear stress of 1.24 dyn/cm2. This represents a shear stress that is 
physiologically relevant to post capillary venules, where shear stresses of between 
1-5 dyn/cm2 have been measured (459). It should be noted that under this setting, 
THP-1 cells cannot undergo full TEM. The reason for this is likely to be their size. As 
HUVEC are plated on fibronectin-coated glass coverslips, transmigrating THP-1 cells 
have very little space to pass underneath this monolayer. Full TEM is therefore 
rarely observed. This does however, allow the process of TEM to be explored in 
detail, which is normally a rapid event when primary monocytes or neutrophils are 
used (which are much smaller in size than THP-1 cells).  By using the THP-1 cells 
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expressing L-selectin-GFP and CaM-RFP produced in the previous chapter, 
FRET/FLIM analysis was used to study the interaction between the two at different 
times during TEM, which provided information about when the interaction was 
occurring and enabled the deciphering of the regulation of shedding of L-selectin 
during TEM.  
 As CaM binding to L-selectin is important for inhibiting L-selectin shedding, 
it was of interest to determine if mutating the cytosolic tail of L-selectin affected 
the rate of shedding of L-selectin and if this could be linked to the dissociation of 
CaM. A Western blotting method was developed in the Ivetic lab to measure L-
selectin shedding in THP-1 cells undergoing TEM over time. This involved culturing 
HUVEC cells in six well plates to form monolayers. The HUVECs were then activated 
and THP-1 cells were placed on top and incubated for a specified amount of time. 
Cell lysates were then produced and prepared for Western blotting. Full-length and 
cleaved (occasionally referred to as the “stump”) L-selectin-GFP was analysed by 
anti-GFP immunoblotting. By comparing cell lines expressing wildtype and mutant 
L-selectin-GFP, it was possible to assess if the cytoplasmic tail of L-selectin was 
contributing to the shedding event during TEM. 
 Previous work in the Ivetic lab demonstrated a role for L-selectin shedding in 
regulating cell shape change during TEM. For this reason the protrusion dynamics, 
cell area and circularity of THP-1 cells expressing the different forms of L-selectin 
were assessed during recruitment. Cells were scored as having zero, one, two or 
multiple protrusions, with circularity and cell area calculated by drawing around the 
cell perimeter, including any protrusions. ImageJ software was used to carry out the 
analysis. 
6.3 Results 
6.3.1 Monitoring the biochemical interaction between CaM and L-
selectin in THP-1 cells following co-culture with activated 
endothelial cells 
 The interaction between CaM and L-selectin-GFP mutants in resting cells 
was previously assessed using the GFPTrap assay (Section 5.3.6). It was decided to 
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use this same assay to assess if the presence of an activated HUVEC monolayer 
affected the interaction between CaM and L-selectin. This also provides an 
alternative experimental procedure to FRET/FLIM analysis for monitoring the 
CaM/L-selectin interaction. If the experimental data is supportive of the FRET/FLIM 
observation, it would clearly strengthen the observations made with this method.  
The experiment was performed with 2 x 106 THP-1 cells co-cultured with a 
monolayer of TNF-activated HUVEC for five minutes. This time point was chosen as 
it corresponded to the early time point of the FRET/FLIM analysis (Section 6.3.2). 
This would allow direct comparison between the FRET/FLIM analysis and the 
GFPTrap assay results. 
 Initial experiments were carried out using the manufacturer’s protocol for 
lysis and wash buffers (see Section 2.23) and the experimental details were as 
described previously (see Section 2.23.2). The results showed that CaM was co-
precipitated with wildtype L-selectin-GFP and all the L-selectin mutations tested 
(Figure 6.1A), with the greatest amount of co-precipitated CaM being observed in 
the lane corresponding to THP-1 cells expressing ΔM-N-L-selectin-GFP (Figure 6.1A 
lane 6). However, a band corresponding to CaM was also co-precipitated with THP-
1 cells expressing GFP protein alone (Figure 6.1A lane 1), as was observed with the 
GFPTrap assay carried out with resting THP-1 cells (Section 5.3.6, Figure 5.14). As 
explained previously (see Section 5.3.6), 1 % ovalbumin was added to the lysis and 
wash buffers to block any non-specific interactions between CaM and the GFPTrap 
beads. As was observed previously, CaM was no longer co-precipitated in THP-1 
cells expressing GFP with the presence of ovalbumin (Figure 6.1C lane 1). However, 
the addition of ovalbumin also affected the interaction between L-selectin and 
CaM, with very little CaM visible on the western blot with any of the L-selectin-GFP 
cell lines tested (Figure 6.1C lanes 2-6). As the bands were so faint, analysis was not 
possible. The experiment could be repeated with an increase in the number of THP-
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Figure 6.1: GFPTrap assay with THP-1 cells co-cultured with activated HUVECs. GFPTrap 
immunoprecipitation assay was carried out as previously described (Section 5.3.6) except 
THP-1 cells were incubated with TNF-activated HUVEC monolayers for five minutes prior to 
cell lysis. Western blot analysis was carried out with anti-CaM (A) and anti-GFP antibody (B).  
The experiment was repeated with 1 % ovalbumin in the lysis and wash buffers and Western 
blots were analysed with anti-CaM (C) and anti-GFP antibodies (D). The arrow shows 
endogenous CaM.  
A 
B IB: GFP 
C 
D IB: GFP 
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6.3.2 Monitoring the interaction between wildtype L-selectin-GFP 
and CaM-RFP during TEM using FRET/FLIM analysis 
Since biochemical analysis of the interaction between L-selectin and CaM in 
THP-1 cells were co-cultured with TNF-activated HUVEC was unsuccessful, the 
parallel plate flow chamber was used to assess the interaction. This assay allows the 
capture of THP-1 cells undergoing the initial stages of recruitment and TEM, where 
pseudopods of adherent THP-1 cells begin to protrude beneath the HUVEC 
monolayer. THP-1 cells were perfused over activated HUVEC monolayers for a fixed 
period of time. Two different time points were chosen for analysis, an early time 
point of six minutes and a late time point of twenty five minutes. These time points 
were selected as it was previously observed that L-selectin shedding peaked at 
approximately twenty minutes following incubation with TNF-activated HUVECs 
(Karolina Rzeniewicz, unpublished data). This meant that at six minutes L-selectin 
would be predominantly uncleaved, whereas maximal shedding would have 
occurred by twenty five minutes. Studying the interaction between L-selectin and 
CaM within a given cell enables one to specifically address the dynamics of the 
interaction during TEM. 
 The FRET efficiency between CaM-RFP and L-selectin-GFP was measured at 
two thin optical sections to better understand the subcellular distribution of the 
interaction. In other words, the interaction between the two chimeric proteins was 
analysed specifically within the non-transmigrated and transmigrated part of the 
cell (Figure 6.2A). By measuring FRET in both locations the effect of TEM on the 
interaction between L-selectin and CaM could be assessed. After dis-assembly of 
the parallel plate flow chamber, the specimen was rapidly fixed in 4% 
paraformaldehyde followed by permeabilisation and staining with phalliodin-
Alexa633 (see Section 2.21.2 in Materials and Methods for experimental 
procedure). Phalloidin binds to actin filaments (F-actin) within both cell types. More 
importantly, it was used as a marker to determine where the optical sections were 
taken: specifically above and below the HUVEC monolayer. All of the FRET 
measurements were taken by Dr Maddy Parsons at the Randall Division of 
Biophysics and Molecular Biology (KCL).   
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 After six minutes of perfusion, the interaction between L-selectin-GFP and 
CaM-RFP was assessed in both the transmigrated (base) and the non-transmigrated 
(top) parts of the cell (Figure 6.2B). The FRET efficiency was found to be similar 
within both these sub-cellular domains (7.01±0.91% in the non-transmigrated part 
and 8.14±0.68% in the transmigrated part of the cell, Figure 6.2D). When the FRET 
efficiency was analysed at twenty five minutes (Figure 6.2C), little change within the 
non-transmigrated part of the cell had occurred between the two time points 
(6.61±0.47% and 7.01±0.91% respectively, Figure 6.2D). This suggested that CaM-
RFP/L-selectin-GFP interaction was sustained over time and it was likely that 
shedding was not taking place in this sub-cellular domain. In contrast, the FRET 
efficiency between CaM-RFP/L-selectin-GFP in the transmigrated part of the cell 
changed dramatically by twenty five minutes compared to six minutes TEM 
(2.84±0.53% compared to 8.14±0.68%, Figure 6.2D). This suggested that CaM-RFP 
was no longer bound to L-selectin-GFP and that shedding had likely taken place, 
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Figure 6.2: Interaction between wildtype L-selectin and CaM during TEM. THP-1 cells co-expressing 
wildtype L-selectin-GFP and CaM-RFP were perfused over TNF-activated HUVEC monolayers for either 
6 min or 25 min, fixed with 4 % PFA and processed for FRET analysis. Images of the transmigrated 
(top) and non-transmigrated (base) parts of the cell (A) were produced after six minutes of flow (B) 
and twenty five minutes of flow (C). The left panel in (B) and (C) shows confocal images of L-selectin-
GFP, the right panels show the lifetime fluorescence of GFP shown by a pseudo-colour scale, the 
bottom left panel shows the phalloidin-Alexa633 staining and the bottom right panel shows CaM-RFP 
(RFP image taken by fluorescence microscopy). (D) The FRET efficiency between L-selectin-GFP and 
CaM-RFP during TEM was measured at each time point and the difference between the results in the 
top and base of the cell was compared. Results are an average of three experiments with 10-15 cells 
measured for each experiment; error bars represent SEM. Statistical significance was assessed using a 



































6.3.3 Monitoring CaM/L-selectin interaction in the ΔM-N Sheddase 
Resistant Mutant THP-1 cell line during TEM 
 The interaction between the sheddase resistant mutant ΔM-N-L-selectin and 
CaM was assessed using the same method as above, with the FRET efficiency at the 
same time points measured and compared to the results observed with cells 
expressing wildtype L-selectin-GFP. The interaction was studied in this mutant to 
assess if blocking shedding affected the interaction with CaM, especially as CaM 
plays a role in regulating shedding. 
At the six minute time point, the FRET efficiency was very low in both the 
transmigrated and non-transmigrated parts of the cell, both being significantly 
lower than that observed with wildtype L-selectin-GFP cells (Figure 6.3A, B and E). 
This suggested that ΔM-N-L-selectin-GFP and CaM-RFP were not interacting with 
one another. In contrast, after twenty five minutes of flow, the FRET efficiency 
increased in both the transmigrating and the non-transmigrating parts of the cell 
compared to that observed at six minutes TEM (Figure 6.3D and F), suggesting that 
at this later time point CaM-RFP was capable of interacting with ΔM-N-L-selectin-
GFP throughout the entire cell. The FRET efficiency at twenty five minutes in the 
transmigrated and non-transmigrated parts of the cell was compared between the 
wildtype and ΔM-N cell lines (Figure 6.3C and D). The results showed that the FRET 
efficiency in the non-transmigrated part of the cell was similar in both cell lines 
(6.61±0.53% for wildtype and 5.52±0.53% for ΔM-N cells, Figure 6.3F). However, 
the FRET efficiency in the transmigrated part of the cell of ΔM-N was significantly 
higher than that observed with wildtype cells (5.15±0.52% versus 2.83±0.47%, 
Figure 6.3F). It is tempting to suggest at this point that the differences in binding 
observed between the cell lines suggest that the cytoplasmic tail is regulated 
differently between the wildtype and ΔM-N cell lines. One possibility is that serine 
























































Figure 6.3: Comparing the Interaction between L-selectin and CaM in wildtype and ΔM-N 
THP-1 cells. THP-1 cells expressing L-selectin-GFP and CaM-RFP were perfused over 
activated HUVEC monolayers for either 6 min or 25 min and fixed with 4 % PFA to be 
processed for FRET analysis. Images showing the FRET efficiency between L-selectin-GFP 
and CaM-RFP in the transmigrated (top) and non-transmigrated part of the cell after six 
minutes of flow for wildtype (A) and ΔM-N (B) and twenty five minutes of flow for wildtype 
(C) and ΔM-N (D). The left panel in (A-D) shows confocal images of L-selectin-GFP, the right 
panels show the lifetime fluorescence of GFP shown by a pseudo-colour scale, the bottom 
left panel shows the phalloidin-Alexa633 staining and the bottom right panel shows CaM-
RFP (RFP image taken by fluorescence microscopy). (E) The FRET efficiency between L-
selectin-GFP and CaM-RFP during TEM was measured after 6 minutes of flow in cells 
expressing wildtype and ΔM-N-L-selectin-GFP and (F) the same analysis was carried out 
after 25 minutes of flow, with a comparison made between the cell lines. Results are an 
average of three experiments with 10-15 cells measured for each experiment; error bars 
represent SEM. Statistical significance was assessed using a two-tailed unpaired Student’s T 









6.3.4 Monitoring CaM/L-selectin interaction in serine-to-alanine 
mutant THP-1 cell lines undergoing TEM 
 It was hypothesised that phosphorylation of serine residues within the 
cytosolic tail of L-selectin were responsible for the dissociation of CaM during TEM, 
which led to L-selectin cleavage. In the previous chapters (Chapter 4 and 5) the 
interaction was studied using biophysical and biochemical techniques, with 
conflicting results observed. To test if phosphorylation had an effect on the 
interaction during TEM under flow, serine residues within the tail of L-selectin were 
mutated to alanines, so phosphorylation would be blocked. The interaction 
between L-selectin and CaM was then assessed as above, by FRET/FLIM analysis, to 
investigate if blocking phosphorylation of either one or both serine residues 
affected the sub-cellular distribution of the interaction seen with wildtype L-
selectin-GFP THP-1 cells during TEM under flow conditions.  
 The FRET efficiency of cells expressing S364A-L-selectin-GFP was measured 
in the non-transmigrated and transmigrated parts of the cell after six minutes of 
flow (Figure 6.4B) and then compared to the results observed with cells expressing 
wildtype L-selectin-GFP (Figure 6.4A). The comparison revealed that the FRET 
efficiencies were very similar in all parts of the cell for both cell lines (Figure 6.4E), 
showing the S364A mutation had no effect on the ability of CaM-RFP to bind to L-
selectin-GFP after six minutes of flow. 
 Comparison between the FRET efficiency measured for cells expressing 
S367A-L-selectin-GFP (Figure 6.4C) and wildtype L-selectin-GFP after six minutes of 
recruitment (Figure 6.4A) revealed the FRET efficiency in the non-transmigrated 
part of the cell was similar in both cell lines. However, the FRET efficiency in the 
transmigrated part of the cell was significantly lower in cells expressing S367A-L-
selectin-GFP (Figure 6.4E). This shows that there is a reduction in the interaction 
between CaM-RFP and L-selectin-GFP in the transmigrated part of the cell with this 











Figure 6.4: Comparing the FRET efficiencies between L-selectin-GFP and CaM-RFP during TEM in 
wildtype and mutant cell lines after six minutes of flow. THP-1 cells expressing L-selectin-GFP and CaM-
RFP were perfused for 6 min over HUVEC monolayers activated with TNF-α and then fixed with 4 % PFA.  
Images showing the FRET efficiency between L-selectin-GFP and CaM-RFP in the transmigrated (top) and 
non-transmigrated (base) part of the cell after six minutes of TEM for wildtype (A), S364A (B), S367A (C) 
and SSAA (D). The left panel shows images of L-selectin-GFP, the right panels show the lifetime 
fluorescence of GFP shown by a pseudo-colour scale, the bottom left panel shows the phalloidin-
Alexa633 staining and the bottom right panel shows CaM-RFP (RFP image taken by fluorescence 
microscopy). (E) Summary of the FRET efficiency between L-selectin-GFP and CaM-RFP during TEM for 







The same analysis was undertaken using cells expressing SSAA-L-selectin-
GFP (Figure 6.4D). Comparison to wildtype L-selectin-GFP showed that the FRET 
efficiency in the transmigrated part of the cell was significantly lower in cells 
expressing SSAA-L-selectin-GFP (Figure 6.4E), similarly to cells expressing S367A-L-
selectin-GFP. Interestingly, the FRET efficiency was also significantly lower in the 
non-transmigrated part of the cell with the SSAA mutation. This result implies the 
SSAA mutation reduces CaM binding in all subcellular locations after six minutes of 
flow. Whether this may have something to do with binding of this mutant tail of L-
selectin to the inner leaflet of the plasma membrane, as discussed in Section 5.4.2, 
is currently not known. 
 The FRET efficiency in the different cell lines was then assessed after twenty 
five minutes of recruitment. As for the results at six minutes, the results with the L-
selectin-GFP mutants were compared those found with wildtype-L-selectin-GFP. 
Analysis of cells expressing S364A-L-selectin-GFP (Figure 6.5B) showed that the 
FRET efficiency in the non-transmigrated part of the cell was significantly higher 
than that of cells expressing wildtype-L-selectin-GFP (6.61±0.53% for wildtype cells 
versus 11.99±1.08% for S364A cells, Figure 6.5E).  In the transmigrated part of the 
cell there was also a significant difference in the FRET efficiency between the cell 
lines, with a much higher FRET efficiency observed with cells expressing S364A-L-
selectin-GFP (2.83±0.47% for wildtype versus 7.56±1.37% for S364A, Figure 6.5E). 
This showed that the interaction between CaM-RFP and L-selectin-GFP was 
maintained in all parts of the cell when S364 was mutated to alanine. This is in 
contrast to wildtype L-selectin-GFP cells, where the interaction was lost in the 
transmigrated part of the cell at the twenty five minute time point. This further 
implies that the S364A mutation will block the shedding of L-selectin in the 
transmigrated part of the cell, and implies that the L-selectin tail is phosphorylated 
differently in the transmigrated part of the tail versus the non-transmigrated part. 
GFP. Results show the average of three experiments with 10-15 cells measured each time, with 
error bars representing SEM. To test statistical significance between the top and base within each 
cell line was assessed using an unpaired, two-tailed Student’s T test (black lines).  Statistical 
significance of the differences between the cell lines in the top or base (blue lines) of the cells was 
assessed using one-way Anova, followed by Tukey’s post-hoc test. *=p<0.05. All FRET analysis was 
carried out by Dr Maddy Parsons, KCL. 
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 At twenty five minutes, comparison between the wildtype (Figure 6.5A) and 
S367A-L-selectin-GFP (Figure 6.5C) cell lines showed that both cell lines had a 
similar level of FRET efficiency in the non-transmigrated part of the cell (6.61±0.53% 
and 4.6±0.57% respectively, Figure 6.5E) and the transmigrated part of the cell 
(2.83±0.47% and 2.21±0.70% respectively, Figure 6.5E). These results reveal that 
the S367A mutation had no effect on the sub-cellular distribution of the CaM-
RFP/L-selectin-GFP interaction after twenty five minutes of flow. 
 The FRET efficiency after twenty five minutes of flow was compared 
between wildtype (Figure 6.5A) and SSAA-L-selectin-GFP (Figure 6.5D) cell lines. The 
results indicated that there was no difference in the FRET efficiency in the non-
transmigrated part of the cell in either cell line (6.61±0.53% for wildtype and 
6.45±0.60% for SSAA-L-selectin-GFP, Figure 6.5E). In the transmigrated part of the 
cell, the FRET efficiency was significantly higher in cells expressing SSAA-L-selectin-
GFP compared to cells expressing wildtype L-selectin-GFP (Figure 6.5E). This is likely 
due to the presence of the S364A mutation, blocking the dissociation of CaM-RFP in 
the transmigrated part of the cell.  
Taken together, this data suggests that blocking phosphorylation of S364 by 
alanine mutation inhibited the loss of interaction between L-selectin-GFP and CaM-
RFP in the transmigrated part of the cell after twenty five minutes of recruitment. It 
is therefore likely that the shedding of L-selectin was also blocked. Mutating S367 
to alanine also affected the interaction between L-selectin-GFP and CaM-RFP, with 
the interaction being disrupted in the transmigrated part of the cell at the six 
minute time point (possibly through binding to phosphatidyl serine (PS)). This 
suggests it is likely that phosphorylation of the tail of L-selectin plays an important 















































Figure 6.5: Comparing the FRET efficiencies between L-selectin-GFP and CaM-RFP during 
TEM in wildtype and mutant cell lines after twenty five minutes of flow. THP-1 cells 
expressing L-selectin-GFP and CaM-RFP were perfused over TNF-α activated HUVEC 
monolayers for 25 min and fixed with 4 % PFA ready for FRET/FLIM analysis.  Images showing 
the FRET efficiency between L-selectin-GFP and CaM-RFP in the transmigrated (top) and non-
transmigrated (base) part of the cell after twenty five minutes of TEM for wildtype (A), S364A 











6.3.5 Co-Culturing of THP-1 cells with activated HUVEC monolayers 
to assess the shedding of L-selectin 
 The analysis of the interaction between CaM-RFP and L-selectin-GFP using 
FRET/FLIM analysis showed that the S364A mutation blocked the dissociation of 
CaM from L-selectin during TEM. It is therefore possible that L-selectin shedding 
would also be blocked by the S364A mutation, as CaM has been shown to bind to L-
selectin and inhibit its shedding from the cell surface (215). To test if this was the 
case, shedding of L-selectin was visualised by Western blot analysis. By using an 
anti-GFP antibody all bands corresponding to the different cleavage products of L-
selectin could be observed as the GFP tag would still be present at the C-terminal. 
As it is not practically possible to perform Western blot analysis on THP-1 cells 
under flow conditions, a static assay was developed to overcome this. HUVEC 
monolayers were grown to confluence in fibronectin-coated six well plates and 
THP-1 cells were co-cultured with activated monolayers for zero, five, ten, twenty, 
thirty or sixty minutes. Lysates were prepared from bound and unbound THP-1 cells 
and used in Western blots to assess the GFP signals derived from full length and 
cleaved (known as the stump) L-selectin (Figure 6.6). More importantly, this 
allowed one to closely monitor L-selectin shedding over time. Previous experiments 
had shown that the anti-GFP antibody did not recognise any components of the 
HUVEC lysate (Karolina Rzeniewicz, unpublished data), so any signal detected by the 
anti-GFP antibody would be derived exclusively from the THP-1 cell lysate. THP-1 
cells expressing wildtype, S364A- or S367A-L-selectin-GFP were co-cultured with 
HUVEC monolayers to assess the effect of these mutations on shedding of L-
selectin. 
panel shows the lifetime fluorescence of GFP shown by a pseudo-colour scale, the bottom left 
panel shows the phalloidin-Alexa633 staining and the bottom right panel shows CaM-RFP 
(RFP image taken by fluorescence microscopy). (E) Summary of the FRET efficiency between 
L-selectin-GFP and CaM-RFP during TEM for wildtype, S364A, S367A and SSAA. Results show 
the average of three experiments with 10-15 cells measured each time. Error bars represent 
SEM. To test statistical significance between the top and base within each cell line was 
assessed using an unpaired two-tailed Student’s T test (black lines).  Statistical significance of 
the differences between the cell lines in the top (red lines) or base (blue lines) of the cells was 
assessed using one-way Anova, followed by Tukey’s post-hoc test. *=p<0.05, **=p<0.001. All 

























Figure 6.6: Schematic of THP-1 cell co-culture with TNF-α activated HUVEC experiment. 
HUVEC cells were grown in fibronectin-coated six well dishes until confluent. The HUVEC 
cells were then activated with TNF-α and 0.75 x106 THP-1 cells were placed in each well of 
the dish. The THP-1 cells were then incubated with the HUVEC monolayer for the time 
indicated in each well, after which point the unbound and bound fractions were collected 
and cell lysates were produced. the cell lysates were then analysed by Western blot, with 
anti-GFP antibody used to visualise L-selectin-GFP. 
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Analysis of the unbound and bound fractions of THP-1 cells expressing 
wildtype L-selectin-GFP at the different time points showed that a majority of the 
cells were bound after five minutes of incubation, with only faint bands 
corresponding to L-selectin-GFP observed in the unbound fraction after this time 
point (Figure 6.7A, Left Panel). As maximal THP-1 cell binding to activated HUVEC 
monolayers was achieved by five minutes of co-culture, all other time points were 
compared to this as a base line value. In other words, shedding of L-selectin was 
calculated from a start time of 5 minutes. Signals derived from both the full length 
and the stump of L-selectin (Figure 6.7A, Right Panel) were assessed at each time 
point by densitometric analysis (see Materials and Methods, Section 2.16.3).  
The results for THP-1 cells expressing wildtype L-selectin-GFP showed that 
the levels of full length L-selectin did not significantly change over time (Figure 
6.7B). The levels of the stump of L-selectin-GFP did increase slightly between five 
and ten minutes. The level then remained similar between ten and twenty minutes 
before decreasing between twenty and sixty minutes (Figure 6.7C). However, these 
changes were not quite significant due to variation between the experiments (one-
way Anova p=0.054). It was possible that the downward trend in stump levels 
observed between twenty and sixty minutes was a result of the stump being 
cleared from the plasma membrane and degraded (e.g. via an endocytic pathway). 
This suggested that a majority of shedding occurred between five and twenty 
minutes, after which time the rate of shedding decreased, possibly returning to 
basal levels. Since these experiments were performed, members of the Ivetic lab 
had realised that the anti-GFP antibody used in these experiments had lost their 












































Figure 6.7: Co-Culture of wildtype L-selectin THP-1 cells with TNF-α activated HUVECs. (A) Western blot analysis of the levels of L-selectin after co-culture 
with HUVECs for increasing lengths of time (0 to 60 minutes). The unbound and bound fractions were collected and cell lysates were produced. Western blots 
were probed with anti-GFP antibody to visualise the different forms of L-selectin. The level of actin at each time point was also assessed for the use as a 
loading control. Western blot is representative of three independent experiments. Levels of full length (B) and the stump (C) of L-selectin were analysed using 
densitometric analysis, with actin used as a loading control and all other time points compared relative to five minutes. Results shown are the mean of three 







With the cell line expressing S364A-L-selectin-GFP it was observed that 
bands corresponding to L-selectin-GFP were visible in the unbound fraction at later 
time points compared to wildtype L-selectin-GFP cells, with faint bands remaining 
visible at sixty minutes (Figure 6.8A, Left Panel). As the number of cells added to 
each well was carefully calculated using a hemocytometer, this suggested that the 
S364A-L-selectin-GFP cells may bind less efficiently to the HUVEC monolayer than 
wildtype L-selectin cells. It is possible that this less efficient binding of cells with this 
mutant may be a result of fewer THP-1 cell protrusions being produced (see Section 
6.4.3 for a discussion of this possibility). The L-selectin-GFP signal was similar in all 
the unbound fractions after ten minutes. For this reason the ten minute time point 
was used for the base line value of L-selectin-GFP to which all other time points 
would be compared. As with the wildtype L-selectin-GFP cells, the levels of full 
length and stump of L-selectin-GFP (Figure 6.8A, Right Panel) were assessed using 
densitometric analysis.  
The levels of full length L-selectin did not change over time with cells 
expressing S364A-L-selectin-GFP (Figure 6.8B), similarly to the observation made 
with cells expressing wildtype L-selectin-GFP. Analysis of the level of L-selectin 
stump formation in cells expressing S364A-L-selectin-GFP showed there was little 
change in the levels of the stump over time (Figure 6.8C). This was a variation from 
the change in stump levels observed with THP-1 cells expressing wildtype L-selectin-
GFP, which showed a slight increase between five and ten minutes and a decrease 
in formation of the stump after twenty minutes. As the level of the stump did not 
change with the S364A-L-selectin-GFP cell line, this suggested that mutation of S364 
(to block selective phosphorylation at this site) reduced the extent of L-selectin 
shedding upon cell activation observed in THP-1 cells expressing wildtype L-
selectin-GFP. 
THP-1 cells expressing S367A-L-selectin-GFP were also analysed under 
similar conditions. Western blot analysis revealed that L-selectin-GFP was detected 
in the unbound fraction after five minutes of co-culture with HUVEC (Figure 6.9A, 
Left panel), suggesting a good proportion of THP-1 cells remained unbound at this 
time point. As with S364A-L-selectin-GFP cells, this may be because fewer 
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protrusions are produced with these cells, meaning they are easier to dissociate 
from the membrane (Section 6.3.6.3.5). After ten minutes the anti-GFP signal in the 
unbound fraction had decreased. This indicated that a majority of the THP-1 cells 
had bound to the HUVEC monolayer by this time point. Based on this, it was 
decided that the ten minute time point would be used as the baseline level of L-
selectin-GFP to which all other time points could be compared. Densitometric 
analysis was used to compare the changes in the protein levels of full length and 
the stump of L-selectin-GFP during co-culture with activated HUVEC monolayer 
(Figure 6.9A, Right Panel). The results showed that the levels of full length L-selectin 
tended to increase as the time the cells were co-cultured with HUVECs progressed, 
with the anti-GFP signal at sixty minutes being significantly higher than that at five 
and ten minutes (Figure 6.9B). The trend in increase in the level of full length L-
selectin observed with THP-1 cells expressing S367A-L-selectin-GFP was potentially 
different from the results observed with wildtype L-selectin-GFP, but, due to the 
large error bars produced by variation in the experiments, it was unclear if this was 
significant. The level of the stump with cells expressing S367A-L-selectin-GFP 
tended to increase up to twenty minutes, followed by a decrease between twenty 
and sixty minutes, although this was not significant, again due to the variation 
between experiments (Figure 6.9C). This trend was very similar to that observed 
with wildtype L-selectin-GFP. Taken together these results imply that the rate of 
shedding of S367A-L-selectin-GFP followed a similar trend to that observed with 
wildtype L-selectin-GFP, but due to the variation between the experiments, and the 
quality of the anti-GFP antibody, it was unclear if this mutation did have an effect 



















































Figure 6.8: Co-Culture of S364A-L-selectin-GFP THP-1 cells with activated HUVECs. (A)  A Western blot representing the levels of full length and the stump of L-
selectin-GFP after co-culture with HUVECs for increasing lengths of time, from 0 to 60 minutes. At each time point the unbound and bound fractions were collected 
and cell lysates were produced. The Western Blot was probed with anti-GFP antibody to assess the levels of L-selectin-GFP and the level of actin was assessed to use 
as a loading control. The levels of full length (B) and the stump (C) of L-selectin were assessed using densitometric analysis with actin used as a loading control to 
normalise variation. The levels of both full length and the stump of L-selectin in the bound fraction at all the time points were compared to the levels at ten minutes, 
where the majority of THP-1 cells bound to the endothelium. Results shown are the mean of three experiments with error bars showing the standard deviation. 
















































Figure 6.9: Co-Culture of S367A-L-selectin-GFP THP-1 cells with activated HUVECs. THP-1 cells expressing S367A-L-selectin-GFP were after co-cultured with 
HUVECs for increasing lengths of time (0 to 60 minutes). The unbound and bound cells were then collected and cell lysates were produced. The levels of L-
selectin-GFP were analysed by Western blot (A). The blot is representative of three independent experiments. Levels of full length (B) and the stump (C) of L-
selectin were analysed by densitometric analysis using actin as a loading control and comparing the levels at all other time points to those at ten minutes. 
Results shown are the mean of three experiments with error bars showing the standard deviation. Statistical significance was analysed using one-way Anova 




6.3.6 Analysing the role of the L-selectin tail in regulating cell 
morphological changes during TEM under flow conditions. 
Once leukocytes exit the circulation and enter the surrounding 
microenvironment, directionality becomes an important determinant in how efficiently 
they undergo chemotaxis towards an inflammatory insult. Chemokines are released by 
stromal cells surrounding a site of inflammation and act as essential soluble guidance 
cues for leukocyte migration towards any given inflammatory insult (460,461). Glycans, 
such as heparan sulphate proteoglycans (HSPGs) that decorate extracellular matrix 
proteins, provide an appropriate scaffold for chemokine immobilisation (153). These 
immobilised chemokines will provide a gradient that can be sensed by the emigrated 
leukocyte (462,463). The receptors for chemokines are located at the cell’s leading 
edge (463-466), which facilitates directional migration. Previous reports have shown 
that antibody or ligand-induced clustering of L-selectin promotes the surface 
expression of chemokine receptors (208,209,467,468). This suggests that L-selectin 
engagement is a pre-requisite for chemokine expression in some leukocytes. Another 
report showed that clustering of L-selectin on naïve T-cells increases cell 
responsiveness to chemokines in vivo, but does not affect the overall expression of the 
chemokine receptor at the cell surface (208). Interestingly, blocking the shedding of L-
selectin in mice through the generation of a “sheddase-resistant” L-selectin knock-in 
mutation dramatically affected chemotaxis (123), although the mechanism underlying 
this observation is not fully understood. Although these reports would suggest that 
shedding forms an important mechanism in sensing chemokine gradients and possibly 
directionality, collectively they are disjointed – as these studies are derived from 
different research labs that ask rather specific questions. In respect of this thesis 
chapter, it was of interest to understand: (a) whether L-selectin shedding contributes 
to cell shape change during TEM, and (b) whether the cytoplasmic tail of L-selectin is a 
key regulatory domain of such responses.  
Wide field fluorescence time-lapse microscopy of THP-1 cells undergoing TEM 
under flow conditions revealed distinct morphological changes as recruitment 
progressed towards eventual TEM. To assess if mutating L-selectin affected cell shape 
change during TEM, three different parameters were measured during recruitment:  
(i) Cell area 
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(ii) Cell circularity 
(iii) Protrusion number  
These characteristics were chosen as they provide information about the dynamic 
nature of the cells during TEM. By measuring cell area, information about how far the 
cell spreads during TEM could be obtained. The circularity provides information about 
how polarised the cell becomes during TEM. The number of protrusions provides 
information about the cell’s “invasiveness” (i.e. the more pseudopods that protrude 
beneath the endothelium, the more invasive the cell is) and priming directionality of 
migration during chemotaxis; one protrusion would show clear directionality whereas 
multiple protrusions would show a lack of directionality. Digital videos obtained during 
each flow assay were analysed to monitor these parameters at an early time point of 
seven minutes, a middle time point of fifteen minutes and a late time point of twenty 
five minutes to determine how they changed over time.   
6.3.6.1 Analysis of Cell Area 
 The area of the cell was measured using ImageJ software to draw around the 
perimeter of the cell, including the protrusions, and calculating the area of the shape 
produced (Figure 6.10). Cells expressing mutated forms of L-selectin were directly 
compared to cells expressing wildtype L-selectin-GFP to decipher whether mutating L-










A (i) A (ii) 
Figure 6.10: Analysis of cell area. Images of cells from the flow chamber assay were 
opened with ImageJ for the measurement of the cell area. A (i) shows the initial image 



































































When the area of cells expressing ΔM-N-L-selectin-GFP were compared to 
those expressing wildtype L-selectin-GFP, the results showed that there was no 
significant difference in cell area between these cell lines after seven minutes of 
recruitment (Figure 6.11A). However, after fifteen minutes, cells expressing ΔM-N-L-
selectin-GFP were significantly larger in area than those expressing wildtype L-selectin-
GFP (with a cell area of 1088±21.1 arbitrary units (AU) for ΔM-N versus a cell area of 
984±47.9 AU for wildtype, Figure 6.11B). This difference became more significant by 
twenty five minutes (Figure 6.11C). This highlights the fact that as recruitment of THP-1 
cells progressed, cells expressing the sheddase-resistant form of L-selectin become 
















Figure 6.11: Cell area of THP-1 cells expressing either wildtype or ΔM-N-L-selectin-GFP during 
TEM under flow conditions. The cell area was calculated using ImageJ for THP-1 cell lines 
expressing either wildtype or ΔM-N-L-selectin-GFP undergoing recruitment at seven minutes 
(A), fifteen minutes (B) and twenty five minutes (C). For each experiment three fields of view 
were analysed and between 10 and 40 cells per field of view were measured. Results shown 
are the mean of three experiments with standard deviation as error bars. An independent two-




































































Cells expressing the S364A mutant form of L-selectin-GFP were compared to 
cells expressing wildtype L-selectin-GFP to decipher if this mutant affected the area of 
the cell during recruitment. After seven minutes recruitment cells expressing S364A-L-
selectin-GFP were significantly larger in area than those expressing wildtype L-selectin-
GFP (an area of 833±48 AU for S364A compared to an area of 681±46.3 AU for 
wildtype, Figure 6.12A)). However, after fifteen (Figure 6.12B) and twenty five minutes 
(Figure 6.12C) of recruitment there was no significant difference between the area of 
cells expressing S364A-L-selectin-GFP and wildtype L-selectin-GFP. This suggested that 
at early stages of recruitment THP-1 cells expressing S364A-L-selctin-GFP were more 
spread than those expressing wildtype L-selectin-GFP. However, at later stages of TEM 

















Figure 6.12: Cell area of THP-1 cells expressing either wildtype or S364A-L-selectin-GFP during 
TEM under flow. ImageJ software was used to calculate the cell area of THP-1 cell lines 
expressing either wildtype or S364A-L-selectin-GFP undergoing TEM at seven minutes (A), 
fifteen minutes (B) and twenty five minutes (C). Three fields of view were analysed for each 
experiment, with between 10 and 40 cells per field of view were measured. Results shown are 
the mean of three independent experiments with error bars representing the standard 










































































Next, the area of THP-1 cells expressing S367A-L-selectin-GFP was compared to 
wildtype L-selectin-GFP cells. After seven minutes of flow, cells expressing wildtype L-
selectin-GFP had a significantly greater area than those expressing S367A-L-selectin-
GFP (an area of 681±46.3 AU and 536±21.4 AU respectively, Figure 6.13A). This 
difference became more significant after fifteen minutes of TEM (Figure 6.13B). 
However, after twenty five minutes of flow both cell lines had a similar area 
(821±20.11 AU for wildtype and 759±46.6 AU for S367A, Figure 6.13C). This would 
suggest that at early stages of recruitment cells expressing S367A-L-selectin-GFP were 
smaller than wildtype L-selectin-GFP and therefore less spread. Interestingly, as TEM 

















Figure 6.13: Cell area of THP-1 cells expressing either wildtype or S367A-L-selectin-GFP during 
TEM under flow conditions. The cell area of THP-1 cell lines expressing either wildtype or S367A-
L-selectin-GFP undergoing TEM at seven minutes (A), fifteen minutes (B) and twenty five minutes 
(C) was calculated using ImageJ. For each experiment three fields of view were analysed and 
between 10 and 40 cells per field of view were measured. Results shown are the mean of three 
experiments with standard deviation as error bars. An independent two-tailed Student’s t test 








































































Cells expressing SSAA-L-selectin-GFP were next compared to cells expressing 
wildtype L-selectin-GFP cells during TEM. After seven minutes of flow, cells expressing 
wildtype L-selectin-GFP had a significantly greater area than cells expressing SSAA-L-
selectin-GFP (681±46.3 AU and 488±54.3 AU respectively, Figure 6.14A). The same 
result was also observed after fifteen minutes (Figure 6.14B). Analysis after twenty five 
minutes of TEM revealed that the cell area of both cell lines was similar (Figure 6.14C). 
This analysis suggests that at early stages of recruitment cells expressing SSAA-L-
selectin-GFP spread less than wildtype L-selectin-GFP cells, but at the later stages of 
recruitment both cell lines spread to a similar degree. The phenotype displayed by the 

















Figure 6.14: Cell area of THP-1 cells expressing either wildtype or SSAA-L-selectin-GFP during 
TEM under flow conditions. During TEM the cell area was calculated at seven minutes (A), 
fifteen minutes (B) and twenty five minutes (C) for THP-1 cell lines expressing either wildtype or 
SSAA-L-selectin-GFP using ImageJ software. For each experiment three fields of view were 
analysed and between 10 and 40 cells per field of view were measured. Results shown are the 
average of three experiments with standard deviation as error bars. An independent two-tailed 






The change in cell area over time was analysed in the different cell lines to 
assess how cell spreading altered during the progression of recruitment. Cells 
expressing wildtype L-selectin-GFP increased in area significantly between seven and 
fifteen minutes, but the area significantly decreased between fifteen and twenty five 
minutes (Figure 6.15A). This suggested that between seven and fifteen minutes the 
cells were spreading and sending out protrusions, but between fifteen and twenty five 
minutes the protrusions were being retracted, leading to a decrease in the spread 
area. From these results, it seems that the altered CaM/L-selectin interaction, and 
therefore shedding, could be a driver for these observed changes in spreading. 
THP-1 cells expressing ΔM-N-L-selectin-GFP had the same pattern of change in 
cell area as wildtype L-selectin-GFP cells between seven and fifteen minutes, with an 
increase in the cell area observed. However, between fifteen and twenty five minutes 
the cell area of ΔM-N-L-selectin-GFP cells did not change (Figure 6.15B), showing that 
the protrusions were not retracted, as they appear to be with cells expressing wildtype 
L-selectin-GFP.  
Analysis of the cell area of THP-1 cells expressing S364A-L-selectin-GFP showed 
that there was no change in cell area as time progressed (Figure 6.15C). This shows a 
clear difference from the results observed with wildtype L-selectin-GFP cells, where 
the cell area fluctuated over time.  
Both S367A-L-selectin-GFP (Figure 6.15D) and SSAA-L-selectin-GFP (Figure 
6.15E) were smaller in area than wildtype L-selectin-GFP cells at seven minutes. The 
cell area significantly increased between seven and fifteen minutes, but not to the 
same extent as wildtype L-selectin-GFP cells. Between fifteen and twenty five minutes, 
the spread area of the S367A-L-selectin-GFP and SSAA-L-selectin-GFP cell lines showed 
a slight increase, with a cell area similar to that seen in wildtype L-selectin-GFP cells at 
this time point. This data suggested that S367A- and SSAA-L-selectin-GFP cells spread 
at a slower rate than wildtype L-selectin cells and did not spread as far during the TEM. 
It also suggests that the overall phenotype of the SSAA L-selectin was most similar to S367A, 











































































































































Figure 6.15: Analysis of the change in cell area during TEM under flow conditions. (A) The 
area of THP-1 cells expressing wildtype L-selectin-GFP was analysed over time during 
recruitment. The change in cell area over time was then analysed for each of the mutant 
cell lines and compared to the results for cells expressing wildtype L-selectin-GFP ((B) 
shows the results for ΔM-N, (C) shows the results for S364A, (D) shows the results for 
S367A and (E) shows the results for SSAA). For each experiment three fields of view were 
analysed and between 10 and 40 cells per field of view were measured. Results shown are 
the mean of three experiments with standard deviation as error bars. Statistical 
significance between the cell area at each time point was assessed for each cell line using a 
One-way Annova followed by Tukey’s post hoc test (shown in black) and an independent 
two-tailed Student’s t test was used to assess statistical significance between wildtype and 




















































6.3.6.2 Analysis of Cell Circularity 
The circularity of the THP-1 cells during recruitment was assessed using the 
same images as above, with ImageJ software used for the calculation of circularity. 
Circularity was assessed to decipher whether there was a link between the changes in 
cell area observed above and a decrease in circularity, suggesting the cells were 
sending out protrusions and becoming more polarised – rather than adopting a “fried 
egg” morphology. Circularity was calculated using the formula:  24 perimeterarea  
and was measured on a scale between zero and one, with one being a perfect circle 
and the number decreasing towards zero as the shape becomes more elongated. As 
with cell area, the circularity was assessed after seven, fifteen and twenty five minutes 
of recruitment in the different cell lines, with each mutant being compared to the 
results for cell expressing wildtype L-selectin-GFP. Moreover, changes in circularity will 
allow monitoring of dynamic changes in circularity over time between cell lines.  
 The results comparing the circularity of cells expressing ΔM-N-L-selectin-GFP to 
those expressing wildtype L-selectin-GFP showed that there was no significant 
difference in the circularity between the different cell lines after seven (Figure 6.16A), 
fifteen (Figure 6.16B) and twenty five minutes (Figure 6.16C) of recruitment. This 























































The circularity of cells expressing S364A-L-selectin-GFP was compared to cells 
expressing wildtype L-selectin-GFP. The results showed that at seven minutes there 
was no significant difference in the circularity of the cell lines (Figure 6.17A). After 
fifteen minutes of recruitment, cells expressing S364A-L-selectin-GFP tended to remain 
more circular than those expressing wildtype L-selectin-GFP, but this was not 
significant (Figure 6.17B). This was also the case after twenty five minutes of flow 
(Figure 6.17C). Altogether, these results imply that there was little difference in the 
circularity between these cell lines, though cell expressing S364A-L-selectin-GFP 










Figure 6.16: Circularity of THP-1 cells expressing either wildtype or ΔM-N-L-selectin-GFP 
during recruitment under flow. The circularity was calculated using ImageJ for THP-1 cell 
lines expressing either wildtype or ΔM-N-L-selectin-GFP undergoing recruitment at seven 
minutes (A), fifteen minutes (B) and twenty five minutes (C). For each experiment three fields 
of view were analysed and between 10 and 40 cells per field of view were measured. Results 
shown are the mean of three experiments with standard deviation as error bars. An 
independent two-tailed Student’s t test was used to assess statistical significance.  
Figure 6.17: Circularity of THP-1 cells expressing either wildtype or S364A-L-selectin-GFP during 
TEM under flow conditions. ImageJ software was used to calculate the circularity of THP-1 cell 
lines expressing either wildtype or S364A-L-selectin-GFP undergoing TEM at seven minutes (A), 
fifteen minutes (B) and twenty five minutes (C). For each independent experiment three fields of 
view were analysed and between 10 and 40 cells per field of view were measured. Results shown 
are the mean of three experiments with error bars representing the standard deviation. An 
independent two-tailed Student’s t test was used to assess statistical significance. 














































When the circularity of cells expressing S367A-L-selectin-GFP was compared to 
cells expressing wildtype L-selectin-GFP the results showed that after seven minutes of 
recruitment S367A-L-selectin-GFP cells were significantly more circular in nature than 
wildtype L-selectin-GFP cells (0.814±0.012 versus 0.734±0.040, Figure 6.18A). S367A-L-
selectin-GFP cells were also significantly more circular than wildtype L-selectin-GFP 
cells after fifteen (Figure 6.18B) and twenty five minutes (Figure 6.18C) of recruitment. 
This shows that cells expressing S367A-L-selectin-GFP generally lacked the ability to 














Figure 6.18: Circularity of THP-1 cells expressing either wildtype or S367A-L-selectin-GFP during 
TEM under flow. The circularity of THP-1 cell lines expressing either wildtype or S367A-L-selectin-
GFP was calculated using ImageJ after seven minutes (A), fifteen minutes (B) and twenty five 
minutes (C) of flow. Three fields of view were analysed for each experiment, with between 10 and 
40 cells per field of view being measured. Results shown are the mean of three experiments with 
standard deviation as error bars. An independent two-tailed Student’s t test was used to assess 















































The same analysis as above was carried with cells expressing SSAA-L-selectin-
GFP. When the circularity of these cells was compared to that of cells expressing 
wildtype L-selectin-GFP, after seven minutes of recruitment there was no significant 
difference in the circularity of either cell line (Figure 6.19A). The results after fifteen 
minutes of recruitment showed the circularity of cells expressing SSAA-L-selectin-GFP 
was significantly greater than that of cells expressing wildtype L-selectin-GFP 
(0.703±0.015 for SSAA compared to 0.596±0.009 for wildtype, Figure 6.19B). This was 
also observed after twenty five minutes of recruitment (0.714±0.023 versus 
0.629±0.047, Figure 6.19C). These results showed that during recruitment, cells 
expressing SSAA-L-selectin-GFP were more circular and less spread than cells 
expressing wildtype L-selectin-GFP. As with the cell area results, the circularity 












Figure 6.19: Circularity of THP-1 cells expressing either wildtype or SSAA-L-selectin-GFP during 
recruitment under flow conditions. The circularity of cells was calculated using ImageJ for THP-1 
cell lines expressing either wildtype or SSAA-L-selectin-GFP undergoing recruitment at seven 
minutes (A), fifteen minutes (B) and twenty five minutes (C). For each experiment three fields of 
view were analysed and between 10 and 40 cells per field of view were measured. Results shown 
are the means of three experiments with standard deviation as error bars. An independent two-






As with cell area (Figure 6.15), the circularity over time was assessed for each 
cell line to analyse how it changed as recruitment progressed. The circularity of cells 
expressing wildtype L-selectin-GFP decreased between seven and fifteen minutes of 
recruitment. After twenty five minutes of recruitment the circularity remained 
significantly less than that observed at seven minutes (Figure 6.20A).  
Cells expressing ΔM-N-L-selectin-GFP showed a similar dynamic profile of 
circularity change during recruitment as wildtype L-selectin-GFP, with the circularity 
decreasing between seven and fifteen minutes and remaining low (approx. 0.6) 
between fifteen and twenty five minutes (Figure 6.20B).  
The results for cells expressing S364A-L-selectin-GFP showed no significant 
difference in the circularity of the cells between the time points analysed (Figure 
6.20C). Analysis of cells expressing S367A-L-selectin-GFP revealed that the circularity 
decreased between seven and fifteen minutes, but to a lesser extent than wildtype-L-
selectin-GFP cells (Figure 6.20D). A similar result was also observed with the SSAA-L-
selectin-GFP cell line (Figure 6.20E). These results show that with wildtype L-selectin-
GFP cells, as recruitment proceeds, the cells become less circular. However, mutating 
L-selectin affected this, with the mutants S367A- and SSAA-L-selectin-GFP, remaining 
more circular than wildtype cells and the S364A-L-selectin-GFP mutant causing no 





























































Figure 6.20: Analysis of the change in cell circularity during THP-1 recruitment under 
flow conditions. (A) The circularity of cells expressing wildtype L-selectin-GFP was 
analysed over time during recruitment. The change in cell circularity over time was then 
analysed for each of the mutant cell lines and compared to the results for cells 
expressing wildtype L-selectin-GFP ((B) shows the results for ΔM-N, (C) shows the results 
for S364A, (D) shows the results for S367A and (E) shows the results for SSAA). For each 
experiment three fields of view were analysed and between 10 and 40 cells per field of 
view were measured. Results shown are the mean of three experiments with standard 
deviation as error bars. Statistical significance between the cell circularity at each time 
point was assessed for each cell line using a One-way Annova followed by Tukey’s post 
hoc test (indicated by black lines).  An independent two-tailed Student’s t test was used 
to assess statistical significance between wildtype and mutant cell lines at each time 


















































































































































































































ΔM-N area ΔM-N circularity
When the results for cell area and circularity were analysed together, there was 
a strong correlation between the two parameters, with an increase in cell area causing 
a decrease in circularity (Figure 6.21). This correlation was apparent across all the cell 
lines studied. This showed that as cell area increased during recruitment the cells 










Figure 6.21: Comparison of the changes in cell area and circularity of THP-1 cells during 
recruitment under flow. The changes cell area and circularity during recruitment was 
compared for THP-1 cells expressing wildtype L-selectin-GFP (A), ΔM-N-L-selectin-GFP (B), 
S364A-L-selectin-GFP (C), S367A-L-selectin-GFP (D) and SSAA-L-selectin-GFP (E). For each 
experiment three fields of view were analysed and between 10 and 40 cells per field of view 









6.3.6.3 Analysis of Protrusion Dynamics 
Analysis of the spread cell area and circularity during recruitment indicated 
that, as TEM progressed, the THP-1 cells spread and became more polarised, 
suggesting the cells were extending protrusions beneath the monolayer. As the spread 
area and circularity in some cell lines would change over time (Figure 6.21), this 
suggested that the protrusions were extending and retracting over time. To assess if 
these changes were in fact due to dynamic changes in protrusions during recruitment, 
the number of protrusions emanating from each cell was analysed over time. Mutating 
the cytosolic tail of L-selectin-GFP or blocking shedding of L-selectin-GFP significantly 
altered the extent of cell spreading during TEM under flow conditions (Section 6.3.6.1). 
For this reason, analysis of protrusion dynamics was carried out on cells expressing 
wildtype L-selectin-GFP, with the results compared to those found with each of the L-
selectin-GFP mutants. The number of protrusions was analysed at time points similar 
to those indicated before. The cells were categorized as having zero, one, two or 
multiple protrusions (Figure 6.22), with the percentage of cells with each number of 









Previously in the lab THP-1 cells transduced with GFP protein were analysed as 
a control, to ensure the presence of GFP did not affect the protrusion dynamics. The 
results for GFP and wildtype L-selectin-GFP cells were compared at seven and fifteen 
minutes. At the earlier time point both cell lines had similar percentages of cells with 
one or multiple protrusions, but a significantly greater percentage of wildtype L-
Figure 6.22: Examples of Protrusion numbers. Images of cells from the flow chamber 
assay showing examples of cells scored as having one protrusion (A (i)), two protrusions (A 
(ii)) and multiple protrusions (A (iii)).  
A (i) A (ii) A (iii) 
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selectin-GFP cells had two protrusions (Figure 6.23A). After fifteen minutes of 
recruitment there was no significant difference in the protrusion dynamics between 
either of the cell lines (Figure 6.23B). These results show that cells expressing wildtype 
L-selectin-GFP tend to have a greater number of protrusions at the earlier time point 
than GFP cells, suggesting they possibly display a more invasive phenotype. As time 
progressed this effect was diminished, as shown by the decrease in cells classified as 
having multiple protrusions (analysis was undertaken by Karolina Rzeniewicz, PhD 













Figure 6.23: Analysis of protrusion dynamics in THP-1 cells during recruitment under flow 
conditions. THP-1 cell protrusion numbers were analysed as cells were recruited to TNF-α-
activated HUVEC monolayers. Analysis was undertaken at seven minutes (A) and fifteen 
minutes (B) with results for cells expressing GFP and those expressing wildtype L-selectin-
GFP compared. Results represent the mean of three independent experiments, with three 
fields of view analysed for each experiment. Error bars represent SEM. Statistical analysis 
was assessed using two-tailed unpaired Student’s T test, *=p<0.05.Experiments and 





































































6.3.6.3.1 Analysis of Protrusion Numbers of THP-1 cells expressing Wildtype L-
selectin-GFP  
The cell lines analysed in this report were transduced with both L-selectin-GFP 
and CaM-RFP. In order to be able to compare the L-selectin-GFP mutant with wildtype 
L-selectin-GFP cell lines, the protrusion dynamics were first assessed in THP-1 cells 
expressing wildtype L-selectin-GFP and CaM-RFP (referred to hereafter as wildtype L-
selectin-GFP). The results were analysed in two ways, firstly cells were scored as having 
zero, one, two or multiple protrusions at seven, fifteen or twenty five minutes (Figure 
6.24A-C). In addition, cells possessing a specific protrusion number were grouped in to 
a single category over time (Figure 6.25A-D). This allowed analysis of the protrusion 
number that was most common at each time point as well as assessing how the 
number of cells with a given number of protrusions changed as recruitment 
progressed. The same method of analysis was then used for the L-selectin-GFP mutant 
cell lines to allow direct comparison between the mutant and wildtype cells. 
  One protrusion was the most prevalent phenotype at seven minutes (Figure 
6.24A). At fifteen minutes the percentage of cells with one protrusion remained 
significantly higher than those with zero, one, two or multiple protrusions (Figure 
























Next, cells were categorised on the basis of protrusion number over time. The 
results showed that the percentage of cells with zero protrusions tended to decrease 
over time, but this was not significant (Figure 6.25A). The percentage of cells extending 
a single protrusion tended to increase over time, but once again not significantly 
(Figure 6.25B). Similarly, there was no significant change in the percentage of cells with 
two protrusions over time (Figure 6.25C). Analysis of the percentage of cells with 
multiple protrusions at each time point showed that the percentage of this phenotype 
tended to decrease as time progressed, but this was not significant (Figure 6.25D). 
Together, these results showed that, as time progressed, cells with zero and multiple 
protrusions tended to decrease while the percentage of cells with a single protrusion 
tended to increase. 
These results correlate with the results observed for cell area and circularity, 
with the number of cells protruding increasing between seven and fifteen minutes, 
corresponding with an increase in area and a decrease in circularity. Between fifteen 
and twenty five minutes, when cell area decreased and circularity increased (Figure 





Figure 6.24: Analysis of THP-1 protrusion numbers during TEM with cells expressing wildtype 
L-selectin-GFP. Time-lapse microscopy was used to produce movies of THP-1 cells expressing 
wildtype L-selectin-GFP undergoing TEM. Analysis of protrusion dynamics was carried by scoring 
cells as having zero, one, two or multiple protrusions at seven (A), fifteen (B) and twenty five (C) 
minutes. Results represent the mean of three experiments, with three fields of view studied for 
each experiment and 20-100 cells analysed for each field of view. Error bars represent standard 
deviation. Statistically significant differences were assessed using One-Way Annova with Tukey’s 

























































































6.3.6.3.2 Analysis of Protrusion Numbers of cells expressing ΔM-N-L-selectin-GFP 
The same analysis of protrusion dynamics was carried out using the sheddase 
resistant THP-1 cell line expressing ΔM-N-L-selectin-GFP. At seven minutes the 
percentage of cells with each protrusion number was similar (Figure 6.26A). After 
fifteen minutes of recruitment a majority of cells produced one protrusion, with two 
protrusions being the next most common phenotype (Figure 6.26B). At twenty five 
minutes there are very few cells with no protrusions. The percentage of cells with one, 
two or multiple protrusions were similar at this time point (Figure 6.26C).  
The change in the protrusion number of ΔM-N-L-selectin-GFP cells was 
assessed over time. The results showed that the percentage of cells with zero 
protrusions significantly decreased as time progressed (from 23.9±9.1% at seven 
minutes to 6±3.9% at twenty five minutes, Figure 6.26D). There was no change in the 
percentage of cells with one protrusion at the different time points (Figure 6.26E). 
Figure 6.25: Analysis of Protrusion Dynamics of THP-1 cells expressing wildtype L-selectin-GFP 
during TEM under flow conditions. The percentage of cells with zero (A), one (B), two (C) or 
multiple (D) protrusions was analysed as TEM progressed. Results are the mean of three 
experiments with error bars showing the standard deviation. For each experiment three fields of 
view were analysed with 20-100 cells characterised per field of view. Statistical analysis was 





Cells expressing ΔM-N-L-selectin-GFP with two protrusions increased significantly 
between seven and fifteen minutes (Figure 6.26F)and the percentage of cells with 
multiple protrusions tended to increase as time progressed, but not significantly 
(Figure 6.26G).   
6.3.6.3.3 Comparison of Protrusion Dynamics of Wildtype and ΔM-N-L-selectin-GFP 
Comparison between cells expressing wildtype and ΔM-N-L-selectin-GFP 
revealed that at seven minutes there were no significant differences in the 
percentages of cells with any of the protrusion numbers (Figure 6.26A). After fifteen 
minutes of recruitment there were significantly more cells with multiple protrusions in 
the ΔM-N-L-selectin-GFP cell line compared to wildtype cells (16.6±2.5% and 3.9±2.0% 
respectively, Figure 6.26B), which persisted at twenty five minutes (Figure 6.26C).  
These results show that as TEM progressed cells expressing ΔM-N-L-selectin-
GFP had a greater number of cells with multiple protrusions compared to cells 
expressing wildtype L-selectin-GFP. This was interesting, as it correlated with ΔM-N-L-
selectin-GFP cells having a significantly larger cell area at fifteen and twenty five 
minutes compared to wildtype L-selectin-GFP cells (Figure 6.11). It is therefore likely 
that the difference in cell area is a result of ΔM-N-L-selectin-GFP cells sending out a 




































































































































































Figure 6.26: Analysis of THP-1 protrusion dynamics during TEM with cells expressing ΔM-N L-
selectin-GFP, with a comparison between the mutant and wildtype results. Time-lapse 
microscopy was used to produce movies of THP-1 cells, expressing either wildtype or ΔM-N L-
selectin-GFP, undergoing TEM. Analysis of protrusion dynamics was carried out at seven, fifteen 
and twenty five minutes, with cells scored for having no, one, two or multiple protrusions for 
both cell lines. Data was summarised by assessing the percentage of cells with each phenotype 
at seven (A), fifteen (B) and twenty five (C) minutes. The change in the percentage of cells with 
each protrusion number over time was also assessed (D-G). Results represent the mean of three 


























6.3.6.3.4 Analysis of Protrusion Dynamics of cells expressing S364A-L-selectin-GFP 
The protrusion dynamics of the cell line expressing the L-selectin mutant 
S364A-L-selectin-GFP was also assessed as above. The results showed that at seven 
minutes the percentage of cells with one protrusion was significantly higher than other 
protrusion numbers (Figure 6.27A). The percentage of cells with multiple protrusions 
was also significantly lower than those with either zero or two protrusions. This 
distribution of protrusion numbers was conserved at fifteen (Figure 6.27B) and twenty 
five minutes (Figure 6.27C). 
When the change in the percentage of cells carrying a specific protrusion 
number was analysed over time, the results showed that as time progressed there was 
no change in the percentage of cells with zero (Figure 6.27D), one (Figure 6.27E), two 
(Figure 6.27F) or multiple protrusions (Figure 6.27G). This directly correlated with the 
results observed for both cell area and circularity with this cell line, where there was 
no change as time progressed (Sections 6.3.61 and 6.3.6.2). This provides further 
evidence that changes in cell area and circularity is a result of the changes in 
protrusion number.  
6.3.6.3.5 Comparison of Protrusion Dynamics of Wildtype and S364A-L-selectin-GFP 
 Given that the number of cells with each protrusion did not change as 
recruitment progressed, it was of interest how this compared to cells expressing 
wildtype L-selectin-GFP. The percentage of cells with zero protrusions was significantly 
higher at fifteen  and twenty five minutes for cells expressing S364A-L- compared to 
cells expressing selectin-GFP wildtype L-selectin-GFP (Figure 6.27D). As TEM 
progressed, cells expressing wildtype L-selectin-GFP tended to have a larger proportion 
of cells with one protrusion compared to cells expressing S364A-L-selectin-GFP, with a 
significant difference observed at twenty five minutes (Figure 6.27E). The percentage 
of cells with two protrusions was similar for both cell lines at every time point (Figure 
6.27F). Comparison of the percentage of cells with multiple protrusions at each time 
each field of view. Error bars represent standard deviation of three experiments. Statistically 
significant differences within the ΔM-N cell line were assessed using One-Way Anova with 
Tukey’s post-hoc test (represented by the black lines). Statistical differences between 
wildtype and ΔM-N cell lines at each point were assessed using an independent, two-tailed 
Student’s T test (red lines), *=p<0.05, **=p<0.01. 
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point revealed that the percentage of cells was similar in both cell lines at seven 
minutes and twenty five minutes. At fifteen minutes the percentage of cells with 
multiple protrusions was significantly higher with cells expressing S364A-L-selectin-GFP 
(Figure 6.27G). These results confirm that mutating the residue S364 to alanine 
blocked the change in protrusion dynamics over time, compared to cells expressing 
























































































































































































6.3.6.3.6 Analysis of Protrusion Number of Cells Expressing S367A-L-selectin-GFP 
The S367A L-selectin-GFP mutant cell line was analysed to assess the effect of 
this mutant on protrusion dynamics. The results showed that at all time points 
analysed a majority of the cells had either zero or one protrusion, with very few having 
multiple protrusions (Figure 6.28A-C).  
The change in protrusion dynamics of S367A-L-selectin-GFP cells was analysed 
over time. The results showed that the number of cells with zero protrusions 
decreased between seven and fifteen minutes significantly (from 38.9±5.3% to 
24.4±3.4%, Figure 6.28D). The percentage of cells with one protrusion increased 
between seven and fifteen minutes, with the percentage of cells at fifteen and twenty 
five minutes being significantly higher than that at seven minutes (Figure 6.28E). As 
time progressed there was no change in the percentage of cells with two (Figure 6.28F) 
or multiple protrusions (Figure 6.28G).  
6.3.6.3.7 Comparison of Protrusion Numbers of Wildtype and S367A-L-selectin-GFP 
 When comparing wildtype and S367A-L-selectin-GFP cell lines, the results 
showed that the percentage of cells with zero protrusions was significantly higher with 
the S367A-L-selectin-GFP cell line compared to wildtype L-selectin-GFP cells at all the 
time points analysed (Figure 6.28D). In contrast, wildtype L-selectin-GFP cells had a 
higher percentage of cells with two protrusions compared to S367A-L-selectin-GFP, 
with a significant difference observed at fifteen and twenty five minutes (Figure 6.28F). 
The percentage of cells with multiple protrusions tended to be higher with wildtype L-
selectin-GFP cells than S367A-L-selectin-GFP cells, but this was only significant at 
twenty five minutes (Figure 6.28G).  
Figure 6.27: Analysis of THP-1 protrusion dynamics during TEM with cells expressing S364A L-
selectin-GFP, with a comparison between the mutant and wildtype results. Movies of THP-1 
cells, expressing either wildtype or S364A L-selectin-GFP, undergoing TEM were produced by 
time-lapse microscopy. Analysis of protrusion dynamics was carried out at seven (A), fifteen (B) 
and twenty five minutes (C), with cells scored for having no, one, two or multiple protrusions for 
both cell lines. The change in the percentage of cells with each protrusion number over time 
was also assessed (D-G). Results represent the mean of three experiments, with three fields of 
view studied for each experiment and 20-100 cells analysed for each field of view and error bars 
representing the standard deviation. Statistically significant differences within the S364A cell 
line was assessed using One-Way Anova with Tukey’s post-hoc test (represented by black lines). 
Statistical differences between wildtype and S364A cell lines at each point were assessed using a 
Student’s T test (red lines),*=p<0.05, **=p<0.01. 
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These results show that mutating residue S367 to alanine reduces the number 
of protrusions the THP-1 cells produce during recruitment and this inhibition of 
protrusion formation becomes more apparent as TEM progressed. The fact that cells 
expressing S367A-L-selectin-GFP produce fewer protrusions was consistent with them 
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6.3.6.3.8 Analysis of Protrusion Dynamics of Cell Expressing SSAA-L-selectin-GFP 
The protrusion dynamics of cells expressing the double serine to alanine 
mutation of L-selectin (SSAA) was also assessed. After seven minutes of recruitment, a 
majority of the cells had zero or one protrusion, with very few cells with two or 
multiple protrusions (Figure 6.29A). The results at fifteen minutes showed that a 
majority of the cells had one protrusion, very few had multiple protrusions and a 
similar percentage had either zero or two protrusions (22.4±1.3% and 24.9±1.2% 
respectively, Figure 6.29B). At twenty five minutes the results were similar to that 
observed at fifteen minutes (Figure 6.29C).  
How the percentage of cells with each protrusion number changed over time 
was also assessed. The results showed that the percentage of cells not protruding 
decreased over time (Figure 6.29D). The percentage of cells with one protrusion 
increased significantly between seven and fifteen minutes (from 51.0±3.6% to 
59.2±0.36%, Figure 6.29E). For both two (Figure 6.29F) and multiple (Figure 6.29G) 
protrusions the percentage of cells increased between seven and fifteen minutes and 
then remained the same between fifteen and twenty five minutes. In general these 
results showed that the percentage of cells with zero protrusions decreased over time 
and the percentage of cells with two or multiple protrusions increased. 
6.3.6.3.9 Comparison of Protrusion Numbers of Wildtype and SSAA-L-selectin-GFP 
Comparison between cells  expressing wildtype and SSAA-L-selectin-GFP 
showed that at seven minutes more SSAA-L-selectin-GFP cells were not protruding 
compared to wildtype L-selectin-GFP cells, but this was just under statistical 
Figure 6.28: Analysis of THP-1 protrusion dynamics during TEM with cells expressing S367A L-
selectin-GFP, with a comparison between the mutant and wildtype results. Time-lapse 
microscopy was used to produce movies of THP-1 cells undergoing TEM, expressing either 
wildtype or S367A L-selectin-GFP. Analysis of protrusion dynamics was carried out by scoring 
cells as having zero, one, two or multiple protrusions for both cell lines. Data was summarised 
by assessing the percentage of cells with each phenotype at seven (A), fifteen (B) and twenty 
five (C) minutes. The change in the percentage of cells with each protrusion number over time 
was also assessed (D-G). Results represent the mean of three experiments, with three fields of 
view studied for each experiment and 20-100 cells analysed for each field of view. Error bars 
represent standard deviation. Statistically significant differences within the S367A cell line were 
assessed using One-Way Anova with Tukey’s post-hoc test (black lines).  Statistical differences 
between wildtype and S367A cell lines at each point were assessed using a Student’s T test (red 
lines), *=p<0.05, **=p<0.01, ***=p<0.005. 
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significance (p=0.0507, Figure 6.29A). The results for all other protrusion numbers at 
seven minutes were similar for both wildtype and SSAA-L-selectin-GFP cell lines. This 
pattern was also observed at fifteen (Figure 6.29B) and twenty five minutes (Figure 
6.29C). These results show that the SSAA-L-selectin-GFP mutant leads to an increase in 
the number of cells not protruding at all the time points studied.  
Once again these results correlate with the analysis of the cell area and 
circularity, with SSAA-L-selectin-GFP cells being smaller in size, more circular and 
having fewer cells protruding than wildtype L-selectin-GFP cells. This provides further 
evidence that the changes in cell area and circularity observed during TEM is a result of 

















































































































































































* * * * 
A 
Figure 6.29: Analysis of THP-1 protrusion dynamics during TEM with cells expressing SSAA L-
selectin-GFP, with a comparison between the mutant and wildtype results. Time-lapse microscopy 
was used to produce movies of THP-1 cells, expressing either wildtype or SSAA L-selectin-GFP, 
whilst undergoing TEM. Analysis of protrusion dynamics was carried out at seven (A), fifteen (B) and 
twenty five (C) minutes, with cells scored for having no, one, two or multiple protrusions for both 
cell lines. The change in the percentage of cells with each protrusion number over time was also 
assessed (D-G). Results represent the mean of three experiments, with three fields of view studied 
for each experiment and 20-100 cells analysed for each field of view. Error bars represent standard 
deviation. Statistically significant differences within the SSAA cell line was assessed using One-Way 
Anova with Tukey’s post-hoc test (black lines). Statistical differences between wildtype and SSAA 





 In the previous chapters the interaction between CaM and L-selectin was 
studied in vitro using biophysical and biochemical techniques, and subsequently in 
resting THP-1 cell lines. Experiments in this chapter focussed on the CaM/L-selectin 
interaction when THP-1 cells were co-cultured with HUVECs, either under static or flow 
conditions. Using FRET/FLIM approaches enabled direct assessment of interaction 
during TEM.   
6.4.1 Loss of interaction between L-selectin and CaM in transmigrated 
pseudopods of THP-1 cells 
 Analysis of the interaction between wildtype L-selectin-GFP and CaM-RFP 
during TEM by FRET/FLIM showed that the interaction was detected in all parts of the 
cell at early time points, but the interaction was exclusively lost in the transmigrated 
part of the cell at later time points (Section 6.3.2). This suggested that L-selectin was 
shed in the transmigrated part of the cell at this time, but not in the non-transmigrated 
part of the cell. This led to the question of why a polarity in cleavage of L-selectin 
occurred. It was possible that L-selectin was retained in the non-transmigrated part of 
the cell to allow it to play a role in secondary tethering (see Section 1.2.1). Secondary 
tethering is thought to be important for amplifying the accumulation of leukocytes to 
the endothelium. It has been shown that blocking L-selectin with a function blocking 
antibody causes a loss of secondary tethering (469-472). Alon et al (1996) (469) found 
that L-selectin-dependent secondary tethering accounted for 70% of the accumulated 
neutrophils on P- and E-selectin. Secondary tethering has also been observed in vivo 
(318), with L-selectin deficient mice lacking secondary tethering (318), again showing 
the role of L-selectin in this process.  
 It has previously been thought that L-selectin was only responsible for the 
initial capture of leukocytes from the blood flow and then was quickly shed once cells 
had firmly adhered to the endothelium (97,127). The results here suggested that L-
selectin remained bound to CaM up to six minutes after capture, so was therefore 
presumably still in its full length form. The images taken at six minutes clearly showed 
that the cell had begun to transmigrate, with clear protrusions observed under the 
HUVEC monolayer. The fact that L-selectin is un-cleaved at this point allows it to play a 




proteins in the extracellular matrix and basement membrane such as heparan sulphate 
proteoglycans (Section 1.3.5.2) (HSPGs)(153). It is possible that L-selectin binding to 
these “sub-endothelial” ligands is required for the directional migration of the 
leukocyte towards the inflammatory insult. A Previous study using an elaborate in vivo 
chemotaxis model demonstrated that L-selectin-deficient leukocytes accumulate on 
the endothelial surface at the same rate as wildtype cells, but undergo less emigration 
(130). The study also showed that L-selectin-deficient leukocytes failed to chemotax 
towards a soluble chemokine (130). The fact that L-selectin remains intact six minutes 
after capture suggests that it could play a role in signalling to promote directed cell 
migration, or at least during TEM.  
 
6.4.2 Phosphorylation of S364 promotes the dissociation of CaM 
specifically within the non-transmigrated part of the cell 
 The FRET efficiency results for the serine-to-alanine mutants showed that when 
S364 was mutated to S364A, CaM failed to dissociate within the transmigrated part of 
the cell, suggesting that it is possible that phosphorylation of this residue was 
responsible for the dissociation of CaM seen in wildtype L-selectin-GFP cells (Figure 
6.30). It has been shown that activation of PKC isozymes by either PMA or 
chemoattractant receptors resulted in an increase in phosphorylation of L-selectin (95) 
and that the phosphorylation occurred at the serine residues, as the responses were 
blocked by the SSAA mutation (95). Further analysis revealed the PKC isozymes θ and ι  
were responsible for the phosphorylation (214). It is therefore likely that L-selectin is 











Cells expressing wildtype L-selectin-GFP and the S367A-L-selectin-GFP mutation 
had a similar profile of interaction with CaM-RFP at twenty five minutes. However, at 
six minutes the interaction between S367A-L-selectin-GFP and CaM-RFP was also lost 
in the transmigrated part of the cell, unlike wildtype L-selectin-GFP cells. This could be 
because blocking the phosphorylation of S367 promotes the phosphorylation of S364, 
leading to a decrease in the interaction between CaM and L-selectin. Using anti-
phospho-serine antibodies to study the phosphorylation state of the cytosolic tail of L-
selectin after activation may help provide information about whether mutating one 
serine to alanine affects the phosphorylation state of the other. The role of other 
binding partners of L-selectin must also be taken into account. The ERM proteins may 
be important in enabling CaM to interact with L-selectin and the S367A mutation could 
affect the ERM interaction and as a result the CaM is no longer able to interact with L-
selectin.  
As explained in the previous chapter (Section 5.3.7), CaM and L-selectin do not 
interact with one another in resting THP-1 cells, possibly due to the tail of L-selectin 
interacting with PS in the plasma membrane. It is possible that phosphorylation of 
S367 is responsible for dissociation of L-selectin from the plasma membrane. It is 
predicted that the interaction between the plasma membrane and L-selectin is due to 
electrostatic interactions between positive amino acids in the cytosolic tail of L-selectin 
and negatively charged PS in the plasma membrane. It is therefore probable that the 
addition of the negatively charged phosphate group to S367 will interrupt this charge-
charge interaction. This may explain why the FRET efficiency between L-selectin-
S367A-GFP and CaM-RFP is much lower in the transmigrated part of the cell at six 
minutes compared to wildtype L-selectin-GFP cells. It is possible that at the early time 
point L-selectin is still interacting with the plasma membrane in the S367A mutated 
cells and as a result CaM-RFP is not able to interact with L-selectin.  This may also 
Figure 6.30: Potential mechanism of L-selectin shedding in monocytes undergoing TEM. After six 
minutes of TEM, CaM (blue circle) was bound to the tail of L-selectin (green line) in both the 
transmigrated and non-transmigrated parts of the cell and therefore L-selectin was protected from 
extracellular cleavage. At twenty five minutes residue S364 was phosphorylated (red P) in the 
transmigrated part of the cell only leading to CaM dissociation in this subcellular region and 
shedding of L-selectin. The fact that L-selectin remains intact in the non-transmigrated part of the 
cell allows it to play a potential role in secondary tethering of leukocytes. 
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explain why the FRET efficiency in resting THP-1 cells was much higher with the S364A 
mutation (Figure 5.15). It is possible that when phosphorylation of S364 is blocked by 
the alanine mutation it promotes phosphorylation of S367. This could mean that L-
selectin is no longer able to interact with PS in the plasma membrane and therefore 
CaM binding is observed in the S364A mutant in resting cells. Again, phospho-specific 
antibodies would prove to be an invaluable resource in deciphering the subcellular 
distribution of S364 and S367 phosphorylation during TEM. 
It is plausible that phosphorylation of the two serine residues regulate L-
selectin differently, with phosphorylation of S367 occurring early after cell activation, 
causing interruption of the interaction between L-selectin and the plasma membrane 
and allowing CaM to bind to L-selectin and protect it from shedding. At a later time 
point, between six and twenty five minutes after recruitment, S364 is phosphorylated, 
causing CaM dissociation from L-selectin and therefore L-selectin cleavage. (Figure 
6.31). By producing cell lines with one serine residue mutated to alanine and the other 
mutated to aspartate to mimic phosphorylation (e.g. S364A/S367D or S364D/S367A 
mutants, where one residue mimics phosphorylation and phosphorylation of the other 
residue is blocked) it may be possible to assess the role of phosphorylation of each 
residue individually without the complication of not knowing the phosphorylation 
status of the other serine residue. This will provide clear evidence of the role of 
phosphorylation of each residue and enable one to decipher the difference between 
the two. One will need to consider the structural constraints a double 
alanine/aspartate mutant may make on the cytoplasmic tail, so caution should be 





Figure 6.31: The possible role of phosphorylation of different serine residues in the cytosolic tail of L-selectin. It is hypothesised that 
phosphorylation of the serine residues play a role in regulating L-selectin function. One possibility is that in resting THP-1 cells both serine 
residues are unphosphorylated and the tail of L-selectin interacts with PS (shown in orange) in the plasma membrane, meaning CaM (shown in 
blue) is not able to interact with L-selectin. Early after cell activation, S367 is phosphorylated by PKC isozymes. This means the interaction 
between L-selectin and PS in the plasma membrane is disrupted and CaM is able to bind to L-selectin and protect it from shedding. At a later 
point of TEM, phosphorylation also occurs at residue S364. This leads to CaM dissociation and L-selectin is cleaved by ADAM 17 at the 
extracellular cleavage site. 
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The FRET efficiency results for SSAA at twenty five minutes are similar to those 
of S364A at the same time point, with CaM interacting with L-selectin in all parts of the 
cell. This was consistent with phosphorylation of S364 being responsible the 
dissociation of CaM in the transmigrated part of the cell. However, at six minutes little 
to no interaction between CaM and SSAA-L-selectin was observed. This may support 
the hypothesis that phosphorylation of S367 is required to disrupt the tail of L-selectin 
interacting with the plasma membrane and allow CaM binding at the early time point. 
It is also possible that this mutation affects the association of the other binding 
partners of L-selectin and this in turn may affect the interaction of CaM.  Studying the 
interaction between this mutant and the other partners, such as moesin, may provide 
information as to why CaM binding was altered with this mutation.  
The sheddase-resistant mutant ΔM-N-L-selectin-GFP had a similar profile of 
interaction as the SSAA-L-selectin-GFP mutant, with no interaction observed at six 
minutes and interaction in all subcellular locations of the cell at twenty five minutes. 
As with SSAA this may be due to this mutation affecting the dynamic 
phosphorylation/dephosphorylation of the tail. As this form of L-selectin cannot be 
shed, it is susceptible to continual phosphorylation/dephosphorylation and this 
dysregulation of phosphorylation may lead to the differences in CaM binding observed 
here. 
The results above suggest that the phosphorylation state of the tail at 
particular stages of TEM may be important in regulating CaM binding and, if this was 
affected, it could alter CaM binding. The limitation of the FRET/FLIM analysis here was 
that it only allows analysis of the interaction at very specific time points, with the cells 
being fixed at a certain time after the start of the flow chamber assay. This only 
provides information of the interaction at that particular time point. It was possible 
that CaM dissociates and re-associates several times during TEM. One possible way of 
monitoring the interaction continuously during TEM is to use real time FRET, where the 
FRET efficiency is measured as the experiment progresses. Real time FRET would also 
give vital clues as to whether the interaction was influenced by protrusions, if the 
protrusions themselves had an influence on the interaction, or both. Currently, this 
technique is rare and is under development in only very few labs around the world and 
is discussed in more detail in Section 7.6. 
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Since writing this thesis, Dr Angela Rey Gallardo from the Ivetic lab has 
confirmed that phospho-mimic serine-to-aspartate mutagenesis of the cytoplasmic 
serines confirmed that the S364D-GFP mutant blocked interaction with CaM-RFP at 
both six and twenty five minutes. In contrast, binding of CaM-RFP to the S367D-GFP 
mutant behaved similarly to wild type L-selectin. Lastly, the SSDD-GFP mutant blocked 
interaction to a similar extent as S364D. This provides further evidence that 
phosphorylation of S364 is important in regulating the interaction between L-selectin 
and CaM. 
 
6.4.3 Shedding is compromised in serine-to-alanine mutants when 
THP-1 cells are co-cultured with HUVEC 
  Co-culturing THP-1 cells with HUVEC monolayers revealed that in cells 
expressing wildtype L-selectin, the maximal level of stump formation of L-selectin was 
seen at around ten minutes, suggesting that the highest level of shedding occurred at 
this time. When S364 is mutated to alanine there was no significant difference in the 
levels of stump at any of the time points, suggesting there was no peak time of 
shedding. The S367A mutant had a similar profile of stump formation at the different 
time points as wildtype L-selectin cells, with peak shedding possibly occurring between 
ten and twenty minutes, but due to the fact that large error bars were produced it was 
not possible the make firm conclusions. In fact, the results from this assay were 
disappointing due to the variable detection of the anti-GFP antibody. Several 
contaminating bands were also visible between full length L-selectin-GFP and the 
stump making analysis of the results difficult. An alternative antibody has recently 
been purchased, which provides a clearer signal. These experiments can now be 
repeated with the new antibody in the hope that clearer results are produced. Due to 
the limitations of this method and the fact that different baselines had to be used, it 
was not possible to undertake direct comparison between the different cell lines. This 
meant that the trend in protein level changes was compared to assess if there was a 
difference. This was not ideal and in the future the assay could be modified, possibly 
by lowering the number of THP-1 cells used in the assay so the same baseline can be 
used for all cell lines. 
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 Although the anti-GFP antibody used in these experiments lacked specificity for 
L-selectin-GFP, one interesting observation from this assay was the fact that GFP signal 
was observed in the unbound fraction after incubation with the HUVEC monolayer 
increased when the serine residues in the L-selectin cytosolic tail were mutated to 
alanine, with the S364A-L-selectin-GFP cells having the strongest signal in the unbound 
fraction (Figure 6.8). This suggested that the serine to alanine mutations led to the 
THP-1 cells not binding as effectively to the HUVEC monolayer compared to wildtype 
cells. It is possible that this binding deficiency could be linked to an inability of the cells 
to send protrusions beneath the HUVEC monolayer. Analysis of the protrusion 
dynamics revealed that cells expressing S367A-L-selectin-GFP sent out fewer 
protrusions, with a greater proportion of cells not protruding, compared to wildtype L-
selectin-GFP cells (Figure 6.28). This could result in the cells being more easily removed 
from the HUVEC monolayer, during wash steps. The results for cells expressing S364A-
L-selectin-GFP showed that the protrusion dynamics did not change as TEM progressed 
(Figure 6.27) and the same was true for cell area (Figure 6.12). This suggests that 
although these cells did send out protrusions, they are smaller in size than wildtype L-
selectin-GFP cells and may not have protruded as far under the monolayer. As a result 
of this S364A-L-selectin-GFP cells may be removed from the HUVEC monolayer more 
readily than wildtype L-selectin-GFP cells and may explain why a greater number of 
cells were found in the unbound fraction. Clearly, more work is required to optimise 
this technique before any firm conclusions can be made. 
  
6.4.4 Mutating the tail of L-selectin affects the size, shape and number 
of protrusions of the cell during TEM 
 The analysis of the cell area, circularity and protrusion number during TEM 
showed that these factors were affected by mutation of L-selectin, with S367A- and 
SSAA-L-selectin-GFP cells being in general, smaller, more circular and producing fewer 
protrusions than wildtype and ΔM-N-L-selectin-GFP cells being larger and producing 
more protrusions. S364A-L-selectin-GFP cells were similar to wildtype at early time 
points, but as TEM progressed this similarity was lost.  
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Protrusions have been observed in several different leukocytes following cell 
capture (473). The function of these protrusions is not entirely clear but it is thought 
that they play a crucial role in TEM. They are thought to be produced as leukocytes 
remain on the apical surface of the endothelium and patrol the local environment until 
a suitable place for diapedesis is found (473). Once on the basolateral surface, it is 
thought that they search for an area in the basement membrane permissive for 
migration towards the extravascular space (473). It is also possible that the protrusions 
detect subendothelial chemokines to direct leukocyte chemotaxis (474). It has been 
shown that the integrin LFA-1 is responsible for the movement of the invasive 
protrusions in lymphocytes and it has been shown to interact with its ligand ICAM-1 on 
the luminal surface of the endothelial and basolateral surface (474). As the adhesion 
between these protrusions and the endothelium must be strong to resist the shear 
flow in the vessel it is expected that this process is integrin-dependent and not 
selectin-dependent. This leads to the question as to why mutations in L-selectin affect 
the size and number of these protrusions. The fact that inhibiting the shedding of L-
selectin leads to an increase in the number of protrusions suggests that extracellular 
cleavage of L-selectin may play an important role in limiting the number of protrusions. 
Results have suggested that cleavage of L-selectin is required for directional migration 
towards a chemokine in the mouse cremaster (123,475). This implies that the multiple 
protrusion phenotype could be responsible for the loss of directional migration (Figure 
6.32). The reason S367A- and SSAA-L-selectin-GFP cell lines do not protrude to the 
same extent as wildtype L-selectin-GFP cells remains unclear. It is possible that other 
binding partners of L-selectin, such as moesin or ezrin, may play a role in regulating 
protrusion dynamics in correlation with L-selectin shedding. It is possible that these 
mutations affect moesin/ezrin interacting with L-selectin and as a result protrusion 
formation is affected. Further research is required to prove if this is the case. Another 
possibility to take into consideration is the importance of dynamic changes in 
phosphorylation of L-selectin as TEM progresses. Phosphorylation of S367 may be 
required for enhancing the production of protrusions. Further research is required fully 























Figure 6.32: Shedding of L-selectin may limit the number of protrusions produced during TEM. 
(A) In leukocytes expressing wildtype L-selectin (shown in green), as cells transmigrate L-selectin is 
cleaved from the surface, leading to few protrusions and cells undergo directional migration. (B) 
When L-selectin shedding is blocked, cells produce multiple protrusions, which leads to a 





Chapter 7: Discussion 
 The purpose of this thesis was to investigate the interaction between L-selectin 
and its binding partners moesin and CaM and in doing so decipher the mechanisms 
regulating the interactions. As this was an interdisciplinary PhD, both biophysical and 
cell biological methods were utilised to gain further insight into the interaction. To this 
end, recombinant proteins were produced as described in Chapter 3, with the proteins 
produced used to study the interaction with L-selectin cytosolic tail peptides using 
biophysical techniques such as ITC, NMR and MST (Chapter 4). In conjunction with this 
THP-1 cells were engineered to express L-selectin-GFP and CaM-RFP/moesin-RFP (as 
described in Chapter 5) and this allowed the analysis of the interaction in intact cells 
and during TEM (Chapter 6). 
 The main findings of the biophysical analysis are: i) CaM interacts with wildtype 
L-selectin cytosolic tail peptide in the presence and absence of calcium, though the 
binding mechanisms may differ, and ii) neither phosphorylation nor alanine mutation 
of serine residues in the cytosolic tail of L-selectin affect the interaction between the 
two molecules. The cell biological results also provide some interesting results, 
namely: i) CaM dissociates from L-selectin specifically in the transmigrated part of the 
cell as TEM progresses, suggesting L-selectin is cleaved only in this part of the cell, ii) 
blocking the phosphorylation of S364 by mutating it to alanine inhibits the dissociation 
of CaM in the transmigrated part of the cell during TEM and iii) mutating serine 
residues within L-selectin affects the protrusion dynamics of the cell as TEM 
progresses. These results are summarised in Table 7.1. 
As previously explained (Section 1.3.7.3) CaM has been implicated in protecting 
L-selectin from shedding, with phosphorylation of serine residues 364 and 367 
predicted to regulate CaM binding to L-selectin. The biophysical data here does not 
support this theory, whereas the cell biological data does suggest phosphorylation of 
S364 is responsible for the dissociation of CaM from L-selectin. This discrepancy 
highlights the importance of studying proteins in the correct context. In the case of 
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Table 7.1: Summary of the interaction between L-selectin and CaM studied using different methodologies. A comparison of the results from the different methods 
used to study the interaction between L-selectin and CaM, including biophysical, biochemical and in vivo methods, highlighting the differences observed with these 
methods. ND= Not Done, showing experiments that were not carried out. 
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7.1 What leads to the interaction between CaM and L-selectin 
upon THP-1 binding to activated endothelial cells?  
The results in Section 5.3.7 of this thesis show that the L-selectin/CaM 
interaction is not observed in resting cells (analysed in poly-L-lysine-bound cells), most 
likely due to the tail of L-selectin interacting with the inner leaflet of the plasma 
membrane. The interaction is then present in all parts of the cell once recruitment to 
the endothelial monolayer has occurred, showing the association must occur at some 
point after adhesion to the activated endothelium. Possible mechanisms allowing CaM 
interaction upon activation are shown in Figure 5.16. A tempting hypothesis is that 
binding of ERMs causes the dissociation of L-selectin tail from the plasma membrane 
and allows CaM binding, which has been shown to occur in vitro (223). To test if this is 
the case in THP-1 cells, the FRET/FLIM between L-selectin-GFP and moesin/ezrin-RFP 
can be assessed in resting cells and after six minutes of flow. It would be expected that 
the interaction between L-selectin-GFP and moesin/ezrin-GFP would be lacking in 
resting cells but present after 6 minutes of recruitment if ERMs are responsible for 
desorbing the tail of L-selectin from the plasma membrane upon cell activation.  
It is also plausible that S367 phosphorylation is required for the dissociation of 
L-selectin from the plasma membrane at early stages of recruitment (Figure 6.31). This 
is highlighted by the fact that S367A-L-selectin-GFP and CaM-RFP did not interact in 
the transmigrated part of the cell after six minutes of flow (Figure 6.4), suggesting S367 
phosphorylation maybe required for the CaM binding in the transmigrated part of the 
cell. This could be supported by the FRET/FLIM results in resting cells (Figure 5.15), 
where the interaction between CaM-RFP and S364A-L-selectin-GFP observed may be a 
result of this alanine mutation promoting the phosphorylation of S367 and therefore 
dissociation of L-selectin from the plasma membrane, allowing CaM to bind.  
One cannot formally exclude that phosphorylation of one of the serine residues 
is dramatically affected by blocking the phosphorylation of the other. For example, 
S364 may be hyper-phosphorylated in the S367A mutant and this could be responsible 
for blocking CaM binding to L-selectin in the transmigrated part of the cell. To test if 
this is the case, experiments could be undertaken using L-selectin embedded into 
liposomes enriched with different types of phospholipids, similar to the experiments 
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carried out by Deng et al (2011) (216), except using the serine to alanine or serine to 
aspartate (as a phosphomimetic mutation) mutants of L-selectin and assessing if the 
interaction between the L-selectin cytosolic tail and the liposome is affected by any of 
these mutations.  
7.2 How is polarisation of L-selectin shedding controlled?   
The mechanism controlling the location of CaM dissociation and therefore L-
selectin shedding in the transmigrated part of the cell remains unclear. It is possible 
that ligation of L-selectin with ECM ligands activates signalling pathways, leading to the 
phosphorylation of L-selectin and therefore CaM dissociation, as described below in 
more detail (Section 7.4). It is also possible that ADAM17, the metalloprotease 
responsible for cleaving L-selectin (details in Section 1.3.4), is localised to specific parts 
of the cell during TEM. It has been shown that ADAM17 expression increases in T-cells 
stimulated with PMA (476), however, the location of the expression during TEM has 
not been investigated. It would be interesting to observe if an increase ADAM17 
surface expression correlates with the location of L-selectin shedding during TEM. 
ADAM17 has been shown to be associated with lipid rafts (101,477), with the 
thought that this compartmentalisation is a possible method of restricting its activity. 
Analysis has revealed that the proportion of the ADAM17 substrate TNF-α in the lipid 
raft increased when cells are treated with metalloprotease inhibitors (477), suggesting 
TNF-α relocated to the lipid raft in preparation for ADAM17 cleavage. It is possible that 
L-selectin clustering promotes its movement to lipid rafts (discussed in more detail in 
Section 7.4) to facilitate its cleavage by ADAM17. Interestingly, the disruption of lipid 
rafts by depleting cholesterol increases ADAM17-dependent cleavage of TNF-α and its 
receptors (477), as well as interleukin-6 receptor (IL-6R) (478), showing that the 
presence of lipid rafts provides an environment for the control of the location of 
shedding. This provides a possible method of regulation for limiting shedding to the 
transmigrated part of the cell, with specific signals activated upon diapedesis leading 
to L-selectin relocation to lipid rafts exclusively in that part of the cell.  
It is possible that activation of p38 mitogen-activated protein kinase (MAPK) 
plays a role in regulating L-selectin shedding. p38 has been shown to be activated by L-
selectin clustering (193) and this leads to the shedding of L-selectin (96,479). Analysis 
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of the mechanism behind this revealed that p38 phosphorylates the tail of ADAM17, 
which increases its surface expression (6). This could mean that ADAM17 activity is 
limited to the transmigrated part of the cell by the activation of p38 only occurring in 
this location. 
7.3 The importance of the polarisation of L-selectin shedding: Is 
there a direct link to regulating protrusions?  
The fact that CaM dissociated from L-selectin in the transmigrated part of the 
cell raised the question why polarisation of shedding occurs. The intact L-selectin on 
the non-transmigrated part of the cell may play a role in secondary tethering, which is 
thought to enhance the recruitment of leukocytes to the endothelium. The importance 
of L-selectin-dependent secondary tethering is discussed in Section 6.4.1. Interestingly, 
L-selectin-dependent secondary tethering has been observed in atherosclerotic 
plaques and has therefore been implicated in recruiting more leukocytes to the 
plaques and therefore enhancing the development of the disease (318). It would 
therefore be interesting to understand the mechanism behind the protection of L-
selectin shedding in the non-transmigrated part of the cell as inducing the shedding of 
L-selectin at this location may be a possible therapeutic target for protecting against 
the development of atherosclerosis.  
 When L-selectin is shed, levels of soluble L-selectin (sL-selectin) are detectable 
in the blood (480), with such increases observed in many disease states, including type 
I diabetes (481), myocardial ischemia during angina (482) and systemic lupus 
erythematous (483). sL-selectin still retains its ligand binding capability (480) and is 
hypothesised to act as a repressor of leukocyte tethering by competing with ligands. 
The results here suggest that L-selectin is shed below the endothelium during TEM and 
this raises the question as to how it can be detected in the blood. One possibility is 
that endothelial cells transport sL-selectin from the abluminal to luminal side by 
retrograde transcytosis (463). Several different cytokines have been shown to be 
transported in this manner by endothelial cells so they can be presented to leukocytes. 
These include interleukin-8 (Il-8) (484), chemokine C-C motif ligand 2 (CCL2) (485,486) 
and chemokine C-X-C motif ligand 10 (CXCL10) (486), with cargo vesicles containing 
caveolin implicated in the process (484,486,487). Interestingly, heparan sulphate (HS) 
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has been shown to be important in the transcytosis of Il-8, with the C-terminal of this 
molecule shown to interact with HS (484). When this interaction is blocked, Il-8 is not 
present on the luminal surface of the endothelium (484). As explained in Section 
1.3.5.2 L-selectin is capable of binding to HS presented on proteoglycans. It is 
therefore possible that sL-selectin interacting with HS facilitates its transportation to 
the luminal surface so it can act to inhibit the recruitment of further leukocytes. 
Limiting the shedding of L-selectin to the transmigrated part of the cell will 
mean that the stump of L-selectin is only generated in this part of the cell. As stated in 
Section 1.3.4 it is possible the stump acts as a signalling molecule to activate different 
signalling pathways from full length L-selectin. The activation of L-selectin stump-
specific signalling pathways in the transmigrated part of the cell implies that they 
might be important for the directional migration. This was assessed in vivo by placing a 
KC-coated agarose cube on the surface of the cremaster a specific distance from a post 
capillary venule and leukocyte migration towards the chemoattractant was assessed in 
wildtype, L-selectin KO, and sheddase-resistant mice (123,130). The results showed the 
lack of stump formation blocked chemotactic migration (123,130). It is possible that 
p38 MAPK is involved in the formation of the stump for chemotaxis. As stated above 
(Section 7.2), p38 has been implicated in L-selectin shedding and when p38 is inhibited 
emigration and chemotaxis is blocked (488). This provides further evidence that 
shedding of L-selectin and therefore stump formation is important for chemotaxis. 
Analysis of cell protrusion number suggested that shedding of L-selectin is 
required for limiting the number of protrusions as TEM progresses (Section 6.4.4). 
Signalling through the formation of the stump may be responsible for reducing the 
number of protrusions and therefore promoting chemotaxis as stated above. It 
remains unclear the reason why cells expressing S367A had fewer protrusions than 
wildtype cells. It is possible that this mutation leads to hyper-phosphorylation of S364, 
leading to CaM dissociation and L-selectin shedding, potentially reducing the number 
of protrusions. It is also possible that serine to alanine mutations affect the binding of 
other partners to L-selectin. A likely candidate is the ERM family of proteins via their 
interaction with cell division control protein 42 (Cdc42). It has been shown that Cdc42 
is a regulator in the formation of invasive filopodia in T-cells at the apical endothelial 
surface (489). Cdc42 is a member of the RhoGTPase family, which have been shown to 
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regulate cytoskeletal dynamics. When T-cells were treated with an inhibitor of Cdc42, 
the cells were able to arrest on HUVECs, but did not crawl or undergo TEM and no 
invasive filopodia were observed (489), showing the importance of Cdc42 activity in 
the formation of protrusions and their role in diapedesis. It has previously been shown 
that ERMs can regulate the activity of RhoGTPases (Section 1.5.2). Dbl is a RhoGEF 
which activates Cdc42. It has been shown that ezrin binds to Dbl and recruits it to lipid 
rafts and this leads to activation of Cdc42 at these sites (281). The expression of a 
dominant negative form of ezrin led to a reduction in Cdc42 activity and inhibited cell 
migration in MDA-MB-231 cell line (281). This shows that ezrin may play a role in 
protrusion formation in these cells via Cdc42 activation. It is therefore possible a 
similar mechanism exists in the THP-1 cell line. It is plausible that ERM interaction with 
L-selectin is required for the formation of protrusions and L-selectin shedding limits 
this process. Unearthing the effect of the serine to alanine mutations on the ERM/L-
selectin interaction during TEM may provide evidence that ERMs are responsible for 
controlling protrusion number of THP-1 cells during TEM.  
 
7.4 Is there a link between L-selectin shedding and clustering? 
 It has been shown that L-selectin exists as a monomer in the plasma membrane 
(490) and  cross-linking of L-selectin with antibody (6) or using multivalent ligands 
(114,180) causes shedding of L-selectin. It is hypothesised that this is due to the 
clustering of L-selectin. As it was observed in this thesis that CaM only dissociates from 
L-selectin in the transmigrated part of the cell and it is therefore likely L-selectin is only 
shed in this location, it was of interest to determine if this correlated with the 
clustering of L-selectin. Previously in the lab the clustering of L-selectin has been 
investigated using THP-1 cells transduced with L-selectin-GFP and L-selectin-RFP, so 
FRET/FLIM analysis could be undertaken to observe where and when L-selectin 
clustered during TEM. Interestingly, the results showed that L-selectin was only 
clustered in the transmigrated part of the cell after fifteen minutes of recruitment 
(Karolina Rzeniewicz, unpublished data), correlating with the location of the predicted 
shedding of L-selectin. It would therefore be plausible to predict that clustering of L-
selectin is a prerequisite for the shedding of L-selectin. The mechanism behind this 
remains unclear, though membrane location may be important. It has been shown that 
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cross-linking of L-selectin in Jurkat cells relocates it to lipid rafts (450,491). It is possible 
that tyrosine phosphorylation of the cytosolic tail of L-selectin may act as a signal for 
the movement of L-selectin to the lipid rafts as a study revealed that L-selectin located 
in lipid rafts is tyrosine phosphorylated (450). To test the importance of tyrosine 
phosphorylation, cells expressing a tyrosine to alanine mutated form of L-selectin 
could be generated and the location of the adhesion molecule could be assessed after 
cell activation to observe if this mutation blocks the translocation of L-selectin to lipid 
rafts. As described in Section 7.2 ADAM17 is located in lipid rafts and therefore L-
selectin re-localisation to the lipid raft may be required for shedding.  
 As described in Section 1.3.5.3 multivalent ligands have been shown to cause 
the shedding of L-selectin through the clustering of L-selectin, with a distance of 17-35 
Å between the ligands required for the induction of shedding. HSPGs have been 
suggested as potential ligands for L-selectin in the ECM (see Section 1.3.5.2 for details). 
The HS side chains of HSPGs range from 50 to 150 saccharides in length and are only 
sulphated at particular sections, normally 2-8 saccharides in length (492). These highly 
sulphated regions, designated S domains, are uniformly distributed along the chain 
and are separated by non-sulphated regions 16-18 saccharides in length (493), which 
equates to approximately 17 Å between each S domain (494). It may be the case that 
the S domains of HSPGs are responsible for clustering L-selectin and causing the 
shedding of L-selectin. This provides an interesting hypothesis for the regulation of L-
selectin shedding in the transmigrated part of the cell, summarised in Figure 7.1. 
Clustering of L-selectin by multivalent ligands in the ECM causes the re-localisation of 
L-selectin to lipid rafts and activates signalling pathways. After a time L-selectin is 




Figure 7.1: Model of clustering of L-selectin inducing shedding. (A) Once the leukocyte has begun transmigration, L-selectin encounters multivalent 
ligands, such as HSPGs, in the ECM which cause L-selectin to cluster (①). It is likely that this activates signalling pathways in the cell, such as PKC and 
p38 activation (②). At this time CaM (shown in blue) is bound to the tail of L-selectin, protecting it from shedding. (B) Activation of p38 and PKC may 
result in the phosphorylation of ADAM17 (by p38) and L-selectin (by PKCs)(①, leading to the activation of ADAM17and the dissociation of CaM from L-




Interestingly, clustering of L-selectin is also thought to be important for 
initialising signalling pathways, as highlighted by Killock et al (2009)(3). As described in 
Section 1.3.6 the Ras pathway is activated by L-selectin cross-linking via Sos/Grb (197), 
with Sos shown to interact with ERMs (282) and CaM interacting with k-Ras (286). It is 
therefore plausible that clustering of L-selectin results in activation of the Ras pathway 
by bring k-Ras and Sos into close proximity (Figure 7.2). It is possible that clustering of 
L-selectin induces its shedding via the activation of this signalling pathway. Ras 
signalling has been shown to activate the enzyme Rac-1 in lymphocytes (495), with k-
Ras specifically shown to be able to activate Rac-1 (Figure 7.2, 1)(496). In turn Rac-1 is 
capable of activating phospholipase C (PLC) β2 and γ2 (Figure 7.2, 2)(497), both of 
which are expressed in leukocytes (498,499). PLCs produces diacylglycerol (DAG) 
(Figure 7.2, 3), which in turn is capable of activating conventional and novel PKCs 
(Figure 7.2, 4)(500), such as PKCθ, which has been shown to interact with and 
phosphorylate L-selectin (Figure 7.2, 5, details in Section 1.3.7.2). It is therefore 
conceivable that Ras activation leads to the activation of PKC, which in turn 
phosphorylates L-selectin causing CaM dissociation and shedding (Figure 7.2, 6). As 
stated in Section 7.2, L-selectin clustering also activates p38, which phosphorylates and 
activates ADAM17. The Ras/Rac pathway is also capable of activating p38 (Figure 7.2, 
7) (501). It is therefore possible that PKCs and p38, activated by Ras signalling, act in 

























Figure 7.2: Activation of the Ras signalling pathway following clustering of L-selectin. It is proposed 
that in its monomeric form L-selectin interacts with CaM and ERM in a trimeric complex. It has been 
shown that CaM is able to interact with k-Ras and ERM interacts with Sos. Clustering of L-selectin 
may result in the activation of the Ras signalling pathway by bring k-Ras and Sos into close proximity 
of each other. This could potentially activate PKCs, via Rac activation of PLC (1-4), which could result 
in the phosphorylation of the cytosolic tail of L-selectin (5). This would result in the dissociation of 
CaM from L-selectin (6), meaning the adhesion molecule would be shed. At the same time Ras/Rac 
signalling may also activate p38 MAPK (7), which has been shown to phosphorylate and activate 
ADAM17 (8), enabling it to cleave L-selectin. PKCs may interact with the stump of L-selectin, inducing 
PKC-dependent signalling events. Figure modified from Killock, D. J., and Ivetic, A. (2010) The 
cytoplasmic domains of TNF-a-converting enzyme (TACE/ADAM17) and L-selectin are regulated 




7.5 The importance of L-selectin cytosolic tail modification in 
regulating leukocyte activity 
 The results in this thesis highlight the importance of modifications to the 
cytosolic tail of L-selectin in regulating leukocyte function. Phosphorylation of serine 
residues plays a role in regulating CaM binding (Section 6.3.4) and controlling the 
invasiveness of the leukocyte by regulating the protrusion dynamics (Section 6.3.6.3). 
It is worth noting that in this thesis the role of serine phosphorylation is investigated 
by mutating the residues to alanine and thereby blocking phosphorylation. This means 
that one can only presume that the resulting phenotypes are due to the inhibition of 
phosphorylation. However, it is not possible to discern if the alanine mutations are 
interfering with L-selectin activity independently of blocking phosphorylation. For this 
reason studies should be carried out using alanine to aspartate mutations to act as 
phosphomimetics, so results with both mutations can be analysed together to provide 
clearer information. In the Ivetic lab experiments with cell lines co-expressing CaM-RFP 
with L-selectin S364D-GFP or S367D-GFP have been undertaken. Results have revealed 
that the S364D mutation blocks CaM interaction with L-selectin in all parts of the cell 
at all time points assessed during the flow chamber assay (Dr Angela Rey, unpublished 
data). This correlates with the fact that when phosphorylation of S364 is blocked by 
alanine mutation, CaM dissociation is inhibited. In contrast, the S367D mutant does 
not affect binding to CaM, and is in fact indistinguishable from the FRET profiles of 
wildtype L-selectin (Dr Angela Rey, unpublished data) at early and late time points. 
Where the S367A mutant showed reduced binding to CaM, the S367D had restored 
this level of interaction to wildtype levels. These results would favour the idea that 
phosphorylation of S367 is actually dissociating the L-selectin tail from the plasma 
membrane. There is however, one drawback to using phosphomimetic mutants as 
they cannot be dephosphorylated. The data in this thesis hints at the fact that dynamic 
phosphorylation/dephosphorylation of the L-selectin cytosolic tail may be important 
for the correct regulation of activity, as highlighted by results with the ΔM-N-L-selectin 
mutant (Section 6.4.2). The ideal situation would be to monitor the phosphorylation 
state of L-selectin in real time as TEM progresses. The generation of phospho-specific 
antibodies to detect the phosphorylated species at S364 or S367 in primary 
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transmigrating monocytes would help complement the molecular mechanism 
uncovered so far. 
 
7.6 Concluding Remarks 
 The results in this thesis reveal the complexity of the regulation of L-selectin 
interacting with its binding partners, with the interactions varying depending upon the 
activation status of the cell. Due to experimental limitations it was not possible to 
pinpoint the exact moment of CaM association/dissociation from L-selectin during TEM 
in real time. One possible way of following the dynamic interaction between L-selectin 
and its binding partners during TEM would be to carry out real-time FRET. Technology 
has been developed in order to a acquire high speed FLIM data and has been used to 
analyse FRET efficiency in pituitary cells plated on coverslips and placed in a chamber 
with media (502). However, with moving objects spurious signals are generated (503), 
so using this method in conjunction with the parallel plate flow chamber would not be 
possible. A previous study was able to assess the activity of RhoA in T-cells during 
crawling and transmigration on HUVEC monolayers using real-time FRET (504). It is 
possible that the same method could be employed to assess the interaction of L-
selectin with its binding partners. It is worth noting however, that flow was not used in 
the above experiment, so therefore it will have to be assessed if this technique can be 
used to measure the real-time FRET with the parallel plate flow chamber assay. 
This thesis focuses on the role of L-selectin and its binding partners during TEM. 
It is likely however, that L-selectin works in conjunction with other adhesion molecules 
to regulate cell activity. An example of this has been highlighted by work in the Ivetic 
lab. It was revealed that the cross-linking of other adhesion molecules, namely CD43 
and PECAM-1 led to the clustering of L-selectin (Karolina Rzeniewicz, unpublished 
data). This would suggest there is a signalling event linking the different adhesion 
molecules, though the mechanism behind this remains unclear. It will be important to 
decipher the signals that link the adhesion molecules, and understand how signals 
converge to regulate the process of recruitment, as this may provide novel targets for 
therapeutics. This would be particularly useful in understanding under acute and 
chronic inflammatory settings. 
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The results provided in this thesis show the effect of blocking the phosphorylation of 
serine residues in the cytosolic tail of L-selectin expressed in a monocytic cell line. The 
next step would be to assess the effect these mutations have on leukocyte activity in 
an animal model. This could be investigated using lentivirus to deliver wildtype L-
selectin-GFP and mutated L-selectin-RFP into the bone marrow of L-selectin knockout 
mice. It would then be possible to assess the response of the different leukocytes to an 
inflammatory insult. The response to acute inflammation could be assessed by 
injecting zymosan into the peritoneal cavity to induce peritonitis. The number of 
neutrophils and monocytes recruited to the peritoneum could then be assessed 48-
72hrs after injection and the number of GFP-positive and RFP-positive cells could be 
compared to decipher if the mutation had an effect on leukocyte recruitment. It would 
also be interesting to assess if mutating L-selectin has an effect on chronic 
inflammation, such as the development of atherosclerosis. A similar method above 
could be used to analyse this, except L-selectin/ApoE double knockout mice could be 
transduced with the lentivirus. The mice would then be fed a high fat diet to induce 
the development of atherosclerotic plaques and the recruitment of the different 
leukocytes to the plaques could then be assessed. This would allow one to observe if 
the mutations that effect leukocyte TEM in the parallel plate flow chamber have an 
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